Query psy1672
Match_columns 600
No_of_seqs 510 out of 3798
Neff 8.5
Searched_HMMs 46136
Date Fri Aug 16 20:16:15 2013
Command hhsearch -i /work/01045/syshi/Psyhhblits/psy1672.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/1672hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG4194|consensus 100.0 6.6E-35 1.4E-39 301.5 4.9 302 51-357 295-613 (873)
2 KOG4237|consensus 100.0 6.9E-32 1.5E-36 268.5 7.7 239 11-254 31-404 (498)
3 KOG4194|consensus 99.9 9.5E-25 2.1E-29 226.6 7.1 296 51-358 319-708 (873)
4 KOG4237|consensus 99.7 1.2E-18 2.6E-23 174.4 -1.7 198 52-254 49-247 (498)
5 KOG0617|consensus 99.5 8.2E-16 1.8E-20 138.0 -2.9 164 38-208 22-186 (264)
6 KOG0444|consensus 99.5 7.4E-15 1.6E-19 154.3 -0.5 186 31-221 107-298 (1255)
7 PLN00113 leucine-rich repeat r 99.5 3.4E-13 7.4E-18 160.8 13.1 133 73-205 162-294 (968)
8 PLN00113 leucine-rich repeat r 99.4 5.1E-13 1.1E-17 159.3 12.6 157 50-208 94-273 (968)
9 KOG0617|consensus 99.4 5.8E-15 1.3E-19 132.6 -5.0 170 32-209 38-213 (264)
10 cd05762 Ig8_MLCK Eighth immuno 99.4 3.6E-12 7.7E-17 108.2 11.5 94 256-358 2-95 (98)
11 KOG0444|consensus 99.4 8.7E-14 1.9E-18 146.4 -0.3 162 41-208 94-258 (1255)
12 KOG0618|consensus 99.3 9.2E-14 2E-18 152.7 -3.6 185 18-207 280-488 (1081)
13 cd05852 Ig5_Contactin-1 Fifth 99.3 9.3E-12 2E-16 99.5 8.6 73 269-353 1-73 (73)
14 cd05855 Ig_TrkB_d5 Fifth domai 99.3 1.5E-11 3.3E-16 99.3 9.4 77 273-353 2-78 (79)
15 cd05745 Ig3_Peroxidasin Third 99.3 1.1E-11 2.5E-16 99.4 8.4 74 268-353 1-74 (74)
16 cd05851 Ig3_Contactin-1 Third 99.3 2.2E-11 4.7E-16 101.2 10.2 86 255-353 2-87 (88)
17 KOG0472|consensus 99.3 9.6E-14 2.1E-18 139.7 -5.4 165 35-208 145-310 (565)
18 cd05894 Ig_C5_MyBP-C C5 immuno 99.3 3.6E-11 7.9E-16 99.4 10.8 84 262-353 3-86 (86)
19 cd05892 Ig_Myotilin_C C-termin 99.3 3.4E-11 7.3E-16 96.7 9.9 75 272-353 1-75 (75)
20 cd05747 Ig5_Titin_like M5, fif 99.3 4.1E-11 8.9E-16 100.5 10.8 89 254-351 3-91 (92)
21 cd04975 Ig4_SCFR_like Fourth i 99.3 3.7E-11 8E-16 102.3 10.6 87 262-354 11-100 (101)
22 cd05869 Ig5_NCAM-1 Fifth immun 99.3 3.9E-11 8.5E-16 101.7 10.7 95 255-353 3-97 (97)
23 cd05737 Ig_Myomesin_like_C C-t 99.3 3.7E-11 8.1E-16 100.8 10.2 84 261-353 8-92 (92)
24 PRK15387 E3 ubiquitin-protein 99.3 2.4E-11 5.2E-16 137.2 11.8 143 21-187 196-338 (788)
25 PRK15370 E3 ubiquitin-protein 99.2 2E-11 4.3E-16 138.5 10.5 159 29-208 180-338 (754)
26 cd05867 Ig4_L1-CAM_like Fourth 99.2 6.2E-11 1.3E-15 95.6 10.2 75 269-353 1-75 (76)
27 cd05863 Ig2_VEGFR-3 Second imm 99.2 3.4E-11 7.3E-16 94.2 8.2 66 272-354 1-66 (67)
28 cd05735 Ig8_DSCAM Eight immuno 99.2 1E-10 2.2E-15 97.2 11.6 83 269-357 1-85 (88)
29 PF14580 LRR_9: Leucine-rich r 99.2 5.6E-12 1.2E-16 117.7 4.1 107 74-184 18-126 (175)
30 cd05723 Ig4_Neogenin Fourth im 99.2 6.6E-11 1.4E-15 94.1 9.6 71 271-353 1-71 (71)
31 PF14580 LRR_9: Leucine-rich r 99.2 5.9E-12 1.3E-16 117.6 4.1 138 35-177 5-146 (175)
32 KOG0472|consensus 99.2 2.7E-13 5.9E-18 136.5 -5.9 169 32-208 119-288 (565)
33 cd05730 Ig3_NCAM-1_like Third 99.2 1.2E-10 2.5E-15 98.3 11.0 84 262-355 11-94 (95)
34 cd05868 Ig4_NrCAM Fourth immun 99.2 8.6E-11 1.9E-15 94.8 9.6 75 269-353 1-75 (76)
35 PRK15387 E3 ubiquitin-protein 99.2 4.6E-11 9.9E-16 135.0 10.9 99 100-208 343-458 (788)
36 cd05893 Ig_Palladin_C C-termin 99.2 9E-11 2E-15 94.3 9.5 75 272-353 1-75 (75)
37 PRK15370 E3 ubiquitin-protein 99.2 4.5E-11 9.8E-16 135.6 10.3 118 30-162 202-319 (754)
38 cd04969 Ig5_Contactin_like Fif 99.2 7.8E-11 1.7E-15 94.2 8.8 73 269-353 1-73 (73)
39 cd04971 Ig_TrKABC_d5 Fifth dom 99.2 1.2E-10 2.6E-15 95.0 10.0 77 273-353 2-80 (81)
40 cd05865 Ig1_NCAM-1 First immun 99.2 1.3E-10 2.8E-15 98.0 10.5 87 260-353 6-95 (96)
41 cd05859 Ig4_PDGFR-alpha Fourth 99.2 9.4E-11 2E-15 99.9 9.6 87 263-354 12-100 (101)
42 cd05744 Ig_Myotilin_C_like Imm 99.2 1.6E-10 3.5E-15 92.9 10.2 75 272-353 1-75 (75)
43 cd05854 Ig6_Contactin-2 Sixth 99.2 1.6E-10 3.5E-15 95.3 10.3 81 270-355 1-83 (85)
44 cd04972 Ig_TrkABC_d4 Fourth do 99.2 1.2E-10 2.7E-15 97.2 9.6 84 261-353 7-90 (90)
45 PF07679 I-set: Immunoglobulin 99.2 1.1E-10 2.3E-15 97.3 9.2 90 255-353 1-90 (90)
46 cd05748 Ig_Titin_like Immunogl 99.2 2.1E-10 4.5E-15 91.9 10.4 73 272-353 2-74 (74)
47 cd05732 Ig5_NCAM-1_like Fifth 99.2 1.9E-10 4.1E-15 97.1 10.4 89 261-353 8-96 (96)
48 cd04978 Ig4_L1-NrCAM_like Four 99.2 1.6E-10 3.5E-15 93.0 9.5 75 269-353 1-75 (76)
49 cd05728 Ig4_Contactin-2-like F 99.2 1.5E-10 3.3E-15 95.5 9.3 81 260-353 5-85 (85)
50 cd05870 Ig5_NCAM-2 Fifth immun 99.2 2.3E-10 4.9E-15 97.2 10.4 89 261-353 8-98 (98)
51 cd04968 Ig3_Contactin_like Thi 99.2 2.7E-10 5.8E-15 94.6 10.6 82 259-353 6-87 (88)
52 cd05857 Ig2_FGFR Second immuno 99.1 3E-10 6.5E-15 93.6 10.2 82 264-353 4-85 (85)
53 cd05746 Ig4_Peroxidasin Fourth 99.1 1.8E-10 3.9E-15 91.0 8.2 68 272-351 1-68 (69)
54 cd05864 Ig2_VEGFR-2 Second imm 99.1 1.8E-10 3.8E-15 91.1 7.9 68 272-353 1-68 (70)
55 cd07693 Ig1_Robo First immunog 99.1 3.9E-10 8.5E-15 95.6 10.7 97 255-353 2-99 (100)
56 cd05876 Ig3_L1-CAM Third immun 99.1 2.8E-10 6.1E-15 90.4 8.9 70 272-353 1-70 (71)
57 cd05891 Ig_M-protein_C C-termi 99.1 3.7E-10 8E-15 94.7 10.0 84 261-353 8-92 (92)
58 cd05763 Ig_1 Subgroup of the i 99.1 4.6E-10 1E-14 90.2 9.5 74 272-353 1-74 (75)
59 cd05726 Ig4_Robo Fhird immunog 99.1 5.8E-10 1.3E-14 93.1 10.3 83 269-357 1-85 (90)
60 cd05725 Ig3_Robo Third immunog 99.1 4.2E-10 9.2E-15 88.8 8.7 69 272-353 1-69 (69)
61 cd05764 Ig_2 Subgroup of the i 99.1 5.6E-10 1.2E-14 89.4 9.4 73 269-353 1-74 (74)
62 cd04976 Ig2_VEGFR Second immun 99.1 5.3E-10 1.2E-14 88.8 9.1 69 272-353 1-69 (71)
63 cd04974 Ig3_FGFR Third immunog 99.1 3.9E-10 8.4E-15 94.1 8.6 81 269-353 1-89 (90)
64 cd05743 Ig_Perlecan_D2_like Im 99.1 5.3E-10 1.1E-14 90.6 9.1 76 269-353 1-76 (78)
65 cd04970 Ig6_Contactin_like Six 99.1 6.2E-10 1.3E-14 91.8 9.6 81 270-355 1-83 (85)
66 cd05738 Ig2_RPTP_IIa_LAR_like 99.1 6.6E-10 1.4E-14 89.1 9.1 72 272-353 1-73 (74)
67 cd05758 Ig5_KIRREL3-like Fifth 99.1 1E-09 2.2E-14 93.1 10.7 89 259-351 6-97 (98)
68 cd05760 Ig2_PTK7 Second immuno 99.1 8.8E-10 1.9E-14 89.1 9.8 72 272-353 1-74 (77)
69 KOG0618|consensus 99.1 4.4E-12 9.6E-17 139.7 -5.5 153 49-206 241-441 (1081)
70 cd05858 Ig3_FGFR-2 Third immun 99.1 9.1E-10 2E-14 91.9 9.4 81 269-353 1-89 (90)
71 cd05740 Ig_CEACAM_D4 Fourth im 99.1 1.3E-09 2.9E-14 91.0 10.3 80 261-353 10-90 (91)
72 cd05866 Ig1_NCAM-2 First immun 99.1 1.2E-09 2.6E-14 91.3 10.1 85 259-353 5-91 (92)
73 cd05773 Ig8_hNephrin_like Eigh 99.0 1.6E-09 3.6E-14 93.7 11.0 84 267-356 21-107 (109)
74 cd05856 Ig2_FGFRL1-like Second 99.0 7.4E-10 1.6E-14 90.3 8.2 80 263-353 3-82 (82)
75 cd05736 Ig2_Follistatin_like S 99.0 1.9E-09 4.2E-14 86.8 9.9 74 272-354 1-74 (76)
76 cd05724 Ig2_Robo Second immuno 99.0 1.8E-09 3.8E-14 89.1 9.7 80 261-351 3-84 (86)
77 cd05722 Ig1_Neogenin First imm 99.0 1.7E-09 3.7E-14 91.2 9.7 83 260-352 5-94 (95)
78 cd05765 Ig_3 Subgroup of the i 99.0 1.4E-09 3E-14 88.6 8.6 79 269-353 1-81 (81)
79 cd05731 Ig3_L1-CAM_like Third 99.0 1.4E-09 3.1E-14 86.1 8.4 70 272-353 1-70 (71)
80 cd04973 Ig1_FGFR First immunog 99.0 1.6E-09 3.4E-14 88.1 8.7 78 262-353 2-79 (79)
81 cd05898 Ig5_KIRREL3 Fifth immu 99.0 2.8E-09 6.1E-14 89.8 10.3 93 255-351 2-97 (98)
82 cd05739 Ig3_RPTP_IIa_LAR_like 99.0 1.8E-09 4E-14 85.2 8.5 68 269-351 1-68 (69)
83 cd05853 Ig6_Contactin-4 Sixth 99.0 2.1E-09 4.5E-14 88.2 9.1 82 270-356 1-84 (85)
84 cd05848 Ig1_Contactin-5 First 99.0 2.6E-09 5.7E-14 89.9 10.0 68 268-346 18-86 (94)
85 cd04977 Ig1_NCAM-1_like First 99.0 3.4E-09 7.5E-14 88.8 9.6 85 259-352 5-91 (92)
86 cd05850 Ig1_Contactin-2 First 99.0 5.3E-09 1.1E-13 88.0 10.7 83 258-351 5-92 (94)
87 cd05849 Ig1_Contactin-1 First 99.0 3.8E-09 8.3E-14 88.6 9.4 71 269-351 19-91 (93)
88 cd05742 Ig1_VEGFR_like First i 98.9 5E-09 1.1E-13 86.2 9.0 81 269-353 1-83 (84)
89 cd05734 Ig7_DSCAM Seventh immu 98.9 4.8E-09 1E-13 85.1 8.7 75 272-352 1-78 (79)
90 KOG1259|consensus 98.9 1.4E-10 2.9E-15 113.2 -1.3 129 75-209 284-413 (490)
91 cd05749 Ig2_Tyro3_like Second 98.9 5.4E-09 1.2E-13 85.2 8.3 71 260-347 4-75 (81)
92 cd07702 Ig2_VEGFR-1 Second imm 98.9 7.4E-09 1.6E-13 82.2 8.7 69 272-352 1-69 (72)
93 cd05750 Ig_Pro_neuregulin Immu 98.9 5.2E-09 1.1E-13 83.8 7.9 73 272-350 1-74 (75)
94 cd05733 Ig6_L1-CAM_like Sixth 98.9 7.1E-09 1.5E-13 83.7 8.4 67 272-347 1-71 (77)
95 KOG1259|consensus 98.9 2.1E-10 4.6E-15 111.8 -1.3 134 96-246 281-414 (490)
96 cd05874 Ig6_NrCAM Sixth immuno 98.9 1.5E-08 3.3E-13 81.8 9.3 67 272-347 1-71 (77)
97 cd05756 Ig1_IL1R_like First im 98.9 8.4E-09 1.8E-13 86.7 8.0 83 262-353 7-94 (94)
98 PF13855 LRR_8: Leucine rich r 98.9 1.5E-09 3.2E-14 83.5 3.0 59 76-134 2-60 (61)
99 cd05861 Ig1_PDGFR-alphabeta Fr 98.8 4.3E-08 9.3E-13 80.6 11.1 80 269-353 1-82 (84)
100 KOG0532|consensus 98.8 3.2E-10 6.9E-15 119.3 -2.2 166 35-208 58-247 (722)
101 cd05875 Ig6_hNeurofascin_like 98.8 2.6E-08 5.6E-13 80.5 9.1 68 272-348 1-72 (77)
102 COG4886 Leucine-rich repeat (L 98.8 4E-09 8.8E-14 112.9 5.5 148 51-206 118-288 (394)
103 cd05895 Ig_Pro_neuregulin-1 Im 98.8 2.8E-08 6.1E-13 80.0 8.7 74 272-350 1-75 (76)
104 cd04967 Ig1_Contactin First Ig 98.8 3.5E-08 7.5E-13 82.4 9.3 69 268-347 18-87 (91)
105 cd05752 Ig1_FcgammaR_like Frst 98.8 1.3E-08 2.8E-13 82.3 6.5 74 257-352 3-77 (78)
106 PF13855 LRR_8: Leucine rich r 98.8 3.5E-09 7.5E-14 81.4 2.9 60 100-159 2-61 (61)
107 cd05729 Ig2_FGFR_like Second i 98.8 5E-08 1.1E-12 79.9 10.1 82 264-353 4-85 (85)
108 cd05754 Ig3_Perlecan_like Thir 98.7 3.5E-08 7.5E-13 81.3 7.8 77 260-351 7-84 (85)
109 cd05882 Ig1_Necl-1 First (N-te 98.7 5.5E-08 1.2E-12 81.8 7.9 88 261-351 4-93 (95)
110 cd00116 LRR_RI Leucine-rich re 98.7 8.8E-09 1.9E-13 106.6 3.2 135 73-207 79-233 (319)
111 PLN03210 Resistant to P. syrin 98.7 1.8E-07 3.9E-12 113.1 14.5 119 31-157 593-714 (1153)
112 KOG0532|consensus 98.7 1.1E-09 2.3E-14 115.5 -4.3 164 51-221 52-241 (722)
113 cd04979 Ig_Semaphorin_C Immuno 98.7 1.2E-07 2.6E-12 78.8 8.9 84 261-354 3-87 (89)
114 cd05873 Ig_Sema4D_like Immunog 98.6 1.6E-07 3.4E-12 77.4 8.9 69 261-342 3-71 (87)
115 KOG3513|consensus 98.6 1.6E-07 3.4E-12 106.8 11.9 94 254-357 331-424 (1051)
116 PLN03150 hypothetical protein; 98.6 1E-07 2.2E-12 107.6 9.7 84 51-137 420-504 (623)
117 cd07701 Ig1_Necl-3 First (N-te 98.6 2.3E-07 5E-12 78.1 9.1 89 261-352 4-94 (95)
118 PLN03150 hypothetical protein; 98.6 9.7E-08 2.1E-12 107.8 8.8 109 101-209 420-529 (623)
119 cd00116 LRR_RI Leucine-rich re 98.6 1.5E-08 3.3E-13 104.8 1.8 155 51-207 83-262 (319)
120 KOG1859|consensus 98.6 1E-09 2.3E-14 118.1 -7.0 129 76-210 165-294 (1096)
121 KOG3513|consensus 98.6 1.3E-07 2.9E-12 107.4 9.2 81 264-356 436-516 (1051)
122 cd05757 Ig2_IL1R_like Second i 98.6 3.7E-07 8.1E-12 76.3 9.4 78 264-354 5-87 (92)
123 PLN03210 Resistant to P. syrin 98.6 4.4E-07 9.5E-12 109.8 13.3 152 38-204 716-902 (1153)
124 cd05862 Ig1_VEGFR First immuno 98.5 3.4E-07 7.4E-12 75.6 8.4 83 269-354 1-85 (86)
125 COG4886 Leucine-rich repeat (L 98.5 5.3E-08 1.1E-12 104.3 4.4 149 53-209 97-246 (394)
126 cd05860 Ig4_SCFR Fourth immuno 98.5 9.5E-07 2.1E-11 74.1 10.6 88 262-353 11-99 (101)
127 KOG3207|consensus 98.5 1.6E-08 3.5E-13 103.7 -0.1 156 51-207 148-313 (505)
128 cd05727 Ig2_Contactin-2-like S 98.5 2.5E-07 5.4E-12 77.4 6.5 74 263-345 12-86 (96)
129 cd05753 Ig2_FcgammaR_like Seco 98.5 3.3E-07 7.1E-12 75.1 6.4 66 263-345 8-74 (83)
130 cd05871 Ig_Semaphorin_classIII 98.5 8.7E-07 1.9E-11 74.0 9.0 84 263-354 5-89 (91)
131 cd05717 Ig1_Necl-1-3_like Firs 98.5 8E-07 1.7E-11 74.8 8.5 89 261-352 4-94 (95)
132 smart00408 IGc2 Immunoglobulin 98.4 1.1E-06 2.3E-11 66.7 7.8 63 268-343 1-63 (63)
133 PF13306 LRR_5: Leucine rich r 98.4 4.7E-07 1E-11 80.5 6.6 127 63-197 2-128 (129)
134 cd07690 Ig1_CD4 First immunogl 98.4 8.1E-07 1.7E-11 74.4 6.8 82 264-345 2-91 (94)
135 KOG0531|consensus 98.4 5.2E-08 1.1E-12 105.0 -0.6 149 51-209 74-222 (414)
136 KOG1644|consensus 98.4 3.6E-07 7.9E-12 85.1 4.7 102 102-205 45-150 (233)
137 KOG3207|consensus 98.4 9.6E-08 2.1E-12 98.2 0.5 156 51-207 174-338 (505)
138 cd05845 Ig2_L1-CAM_like Second 98.3 9.4E-07 2E-11 73.8 6.2 73 262-345 11-85 (95)
139 cd05885 Ig2_Necl-4 Second immu 98.3 2.6E-06 5.7E-11 68.7 8.4 67 272-345 2-69 (80)
140 smart00409 IG Immunoglobulin. 98.3 7.2E-06 1.6E-10 66.1 11.2 82 263-353 3-85 (86)
141 smart00410 IG_like Immunoglobu 98.3 7.2E-06 1.6E-10 66.1 11.2 82 263-353 3-85 (86)
142 KOG4579|consensus 98.3 2.4E-08 5.3E-13 87.1 -3.7 134 77-213 29-164 (177)
143 PF13895 Ig_2: Immunoglobulin 98.3 1.6E-06 3.4E-11 69.8 6.6 71 264-353 9-80 (80)
144 KOG4221|consensus 98.3 2.2E-06 4.9E-11 97.4 9.9 91 256-357 239-329 (1381)
145 KOG0531|consensus 98.3 1.1E-07 2.4E-12 102.5 -0.5 150 51-210 51-201 (414)
146 TIGR00864 PCC polycystin catio 98.3 3.9E-07 8.5E-12 112.0 3.7 78 177-254 1-81 (2740)
147 PHA02785 IL-beta-binding prote 98.3 5.6E-06 1.2E-10 86.1 11.5 85 261-346 227-319 (326)
148 KOG1644|consensus 98.2 1.7E-06 3.7E-11 80.7 5.9 135 41-180 11-149 (233)
149 cd05759 Ig2_KIRREL3-like Secon 98.2 9E-06 2E-10 66.3 9.6 75 272-351 2-80 (82)
150 PF00047 ig: Immunoglobulin do 98.2 6.3E-06 1.4E-10 63.5 7.3 63 269-338 1-64 (64)
151 KOG1859|consensus 98.2 3.5E-08 7.5E-13 106.7 -7.9 131 49-187 164-295 (1096)
152 cd05713 Ig_MOG_like Immunoglob 98.1 1.8E-05 3.9E-10 67.1 9.6 85 269-353 1-99 (100)
153 KOG4658|consensus 98.1 2.4E-06 5.3E-11 99.0 5.5 140 37-182 511-653 (889)
154 PHA02826 IL-1 receptor-like pr 98.1 1.4E-05 3.1E-10 78.3 9.7 71 264-345 139-214 (227)
155 KOG4579|consensus 98.1 3E-07 6.4E-12 80.5 -2.1 115 51-167 29-143 (177)
156 PF13927 Ig_3: Immunoglobulin 98.1 6.9E-06 1.5E-10 65.0 5.9 73 255-340 2-75 (75)
157 cd05879 Ig_P0 Immunoglobulin ( 98.1 2.3E-05 4.9E-10 68.4 9.5 88 260-348 4-109 (116)
158 PF13306 LRR_5: Leucine rich r 98.1 9.1E-06 2E-10 72.2 7.0 117 50-174 13-129 (129)
159 cd05897 Ig2_IL1R2_like Second 98.0 2.5E-05 5.4E-10 65.4 8.6 75 265-349 6-85 (95)
160 cd05872 Ig_Sema4B_like Immunog 98.0 4.1E-05 8.8E-10 62.7 8.5 71 262-347 4-74 (85)
161 cd05714 Ig_CSPGs_LP Immunoglob 97.9 6.6E-05 1.4E-09 64.4 9.8 85 268-354 1-103 (106)
162 KOG1909|consensus 97.9 4.4E-06 9.6E-11 84.0 2.6 157 50-208 93-283 (382)
163 cd05878 Ig_Aggrecan_like Immun 97.9 6.1E-05 1.3E-09 65.2 9.2 88 268-355 1-108 (110)
164 PHA02826 IL-1 receptor-like pr 97.9 2.5E-05 5.5E-10 76.6 7.0 90 262-353 30-132 (227)
165 cd05900 Ig_Aggrecan Immunoglob 97.9 8.3E-05 1.8E-09 64.4 9.1 87 268-354 1-109 (112)
166 cd05881 Ig1_Necl-2 First (N-te 97.9 8.4E-05 1.8E-09 62.3 8.8 79 261-341 4-84 (95)
167 cd05877 Ig_LP_like Immunoglobu 97.9 9.8E-05 2.1E-09 63.3 9.5 85 268-354 1-103 (106)
168 cd05896 Ig1_IL1RAPL-1_like Fir 97.9 8.8E-05 1.9E-09 62.6 8.7 84 263-352 9-103 (104)
169 cd05888 Ig1_Nectin-4_like Frst 97.9 0.00013 2.9E-09 61.9 10.0 82 271-353 2-99 (100)
170 cd04983 IgV_TCR_alpha_like Imm 97.9 0.0001 2.2E-09 63.5 9.4 83 260-343 4-94 (109)
171 cd05774 Ig_CEACAM_D1 First imm 97.8 0.00011 2.4E-09 62.9 8.6 83 264-352 8-104 (105)
172 cd05741 Ig_CEACAM_D1_like Firs 97.8 8.6E-05 1.9E-09 61.7 7.8 78 269-352 1-91 (92)
173 cd05718 Ig1_PVR_like First imm 97.8 0.00022 4.7E-09 60.1 9.7 82 270-353 1-97 (98)
174 cd05751 Ig1_LILRB1_like First 97.7 0.00011 2.4E-09 61.2 7.6 66 263-341 10-75 (91)
175 PHA02785 IL-beta-binding prote 97.7 0.00012 2.5E-09 76.3 9.2 80 263-356 35-119 (326)
176 cd05880 Ig_EVA1 Immunoglobulin 97.7 0.0001 2.2E-09 64.4 7.3 84 260-344 4-104 (115)
177 KOG4658|consensus 97.7 3E-05 6.4E-10 90.1 4.9 140 35-178 531-675 (889)
178 PF12799 LRR_4: Leucine Rich r 97.7 3.9E-05 8.4E-10 54.4 3.1 37 76-113 2-38 (44)
179 PF12799 LRR_4: Leucine Rich r 97.7 3.6E-05 7.9E-10 54.6 2.9 39 99-138 1-39 (44)
180 KOG4221|consensus 97.7 3.1E-05 6.7E-10 88.5 3.8 91 254-356 328-418 (1381)
181 cd00098 IgC Immunoglobulin Con 97.7 0.00016 3.6E-09 60.4 7.4 75 267-344 11-87 (95)
182 cd05883 Ig2_Necl-2 Second immu 97.7 0.00056 1.2E-08 55.4 10.0 77 272-355 2-81 (82)
183 KOG1909|consensus 97.6 9.5E-06 2.1E-10 81.6 -0.5 160 49-208 120-311 (382)
184 cd05899 IgV_TCR_beta Immunoglo 97.6 0.00014 3E-09 62.9 6.7 81 260-343 4-96 (110)
185 cd05901 Ig_Versican Immunoglob 97.6 0.00056 1.2E-08 59.4 10.2 86 269-354 2-114 (117)
186 cd05715 Ig_P0-like Immunoglobu 97.6 0.00041 8.8E-09 60.6 9.6 83 261-344 5-105 (116)
187 cd05775 Ig_SLAM-CD84_like_N N- 97.6 0.00022 4.7E-09 60.2 7.4 82 267-353 2-96 (97)
188 cd05886 Ig1_Nectin-1_like Firs 97.6 0.00033 7.2E-09 59.2 8.5 81 271-353 2-98 (99)
189 cd05902 Ig_Neurocan Immunoglob 97.6 0.00039 8.5E-09 60.0 8.9 87 268-354 1-107 (110)
190 cd04980 IgV_L_kappa Immunoglob 97.6 0.00027 5.8E-09 60.6 7.8 81 258-341 4-93 (106)
191 cd05761 Ig2_Necl-1-4_like Seco 97.5 0.00067 1.5E-08 55.3 9.0 69 272-345 2-71 (82)
192 KOG4222|consensus 97.5 0.00017 3.7E-09 82.1 6.6 92 258-359 135-228 (1281)
193 smart00082 LRRCT Leucine rich 97.5 3.7E-05 7.9E-10 56.5 0.8 48 205-253 1-50 (51)
194 KOG2982|consensus 97.4 7.9E-05 1.7E-09 73.5 2.6 109 51-159 47-158 (418)
195 cd00099 IgV Immunoglobulin var 97.4 0.00039 8.5E-09 59.2 6.5 78 265-343 2-91 (105)
196 cd04984 IgV_L_lambda Immunoglo 97.4 0.00074 1.6E-08 57.0 8.1 74 265-341 2-85 (98)
197 KOG3665|consensus 97.4 9.7E-05 2.1E-09 83.8 3.2 132 50-185 123-264 (699)
198 cd07705 Ig2_Necl-1 Second immu 97.4 0.0015 3.3E-08 53.3 9.3 69 272-345 2-72 (83)
199 PF07686 V-set: Immunoglobulin 97.4 0.00041 8.8E-09 59.6 6.3 93 260-353 7-114 (114)
200 cd05887 Ig1_Nectin-3_like Firs 97.3 0.0011 2.3E-08 55.7 8.1 82 270-353 1-95 (96)
201 PF08205 C2-set_2: CD80-like C 97.3 0.00093 2E-08 55.2 7.7 73 269-345 14-87 (89)
202 cd05884 Ig2_Necl-3 Second immu 97.3 0.0011 2.5E-08 54.1 7.8 69 272-344 2-71 (83)
203 cd05846 Ig1_MRC-OX-2_like Firs 97.3 0.0017 3.7E-08 54.6 9.1 83 269-353 1-96 (97)
204 cd04982 IgV_TCR_gamma Immunogl 97.3 0.00073 1.6E-08 58.9 6.8 81 260-341 4-99 (116)
205 cd05771 IgC_Tapasin_R Tapasin- 97.1 0.0019 4.1E-08 58.4 8.2 90 254-343 38-132 (139)
206 KOG2982|consensus 97.1 0.0004 8.6E-09 68.7 3.7 83 51-133 73-156 (418)
207 cd05711 Ig_FcalphaRI Immunoglo 97.1 0.0022 4.8E-08 53.7 7.6 68 262-339 8-75 (94)
208 cd00096 Ig Immunoglobulin doma 97.1 0.0043 9.3E-08 46.9 8.8 67 272-343 1-67 (74)
209 cd05889 Ig1_DNAM-1_like First 97.0 0.0036 7.9E-08 52.5 8.3 79 271-351 2-93 (96)
210 smart00407 IGc1 Immunoglobulin 97.0 0.0049 1.1E-07 49.2 8.5 68 272-342 2-71 (75)
211 PRK15386 type III secretion pr 97.0 0.0047 1E-07 65.2 10.6 131 51-205 54-187 (426)
212 KOG2123|consensus 97.0 3.4E-05 7.3E-10 75.4 -5.0 100 74-177 18-123 (388)
213 PHA02987 Ig domain OX-2-like p 97.0 0.0034 7.3E-08 58.4 8.1 89 262-355 23-123 (189)
214 PRK15386 type III secretion pr 97.0 0.0041 9E-08 65.6 9.8 132 31-184 56-190 (426)
215 cd07706 IgV_TCR_delta Immunogl 96.9 0.0024 5.2E-08 55.6 6.9 82 259-341 4-94 (116)
216 KOG2739|consensus 96.9 0.0005 1.1E-08 67.1 2.3 60 74-136 42-104 (260)
217 cd07698 IgC_MHC_I_alpha3 Class 96.9 0.008 1.7E-07 50.1 9.4 69 269-343 14-84 (93)
218 cd05755 Ig2_ICAM-1_like Second 96.8 0.0061 1.3E-07 51.5 8.2 73 265-345 12-88 (100)
219 KOG2739|consensus 96.8 0.00048 1E-08 67.2 1.6 105 95-201 39-149 (260)
220 cd05716 Ig_pIgR Immunoglobulin 96.8 0.0043 9.4E-08 52.2 7.2 78 264-342 2-87 (98)
221 cd05712 Ig_Siglec_N Immunoglob 96.8 0.0056 1.2E-07 53.7 8.0 81 260-341 5-102 (119)
222 KOG4222|consensus 96.7 0.007 1.5E-07 69.5 10.0 94 255-354 316-411 (1281)
223 cd05720 Ig_CD8_alpha Immunoglo 96.7 0.0058 1.3E-07 52.2 7.2 73 265-340 2-90 (104)
224 COG5238 RNA1 Ran GTPase-activa 96.7 0.0017 3.6E-08 63.6 3.9 159 51-209 32-228 (388)
225 cd07694 Ig2_CD4 Second immunog 96.6 0.014 3E-07 47.6 7.9 71 265-353 10-83 (88)
226 KOG3665|consensus 96.6 0.0016 3.4E-08 74.1 3.4 131 74-206 121-261 (699)
227 PF01462 LRRNT: Leucine rich r 96.5 0.0018 3.8E-08 41.0 2.0 28 16-47 1-28 (28)
228 cd07700 IgV_CD8_beta Immunoglo 96.5 0.011 2.3E-07 50.8 7.4 75 265-340 2-93 (107)
229 KOG2120|consensus 96.4 0.00021 4.5E-09 70.7 -3.9 150 51-203 187-346 (419)
230 cd05847 IgC_CH2_IgE CH2 domain 96.4 0.018 3.8E-07 48.2 7.9 76 268-346 13-90 (94)
231 KOG2123|consensus 96.4 0.00021 4.5E-09 70.1 -4.4 97 51-153 21-123 (388)
232 cd05772 IgC_SIRP Signal-regula 96.4 0.035 7.5E-07 48.0 9.8 73 265-343 17-93 (111)
233 cd07699 IgC_L Immunoglobulin C 96.3 0.013 2.8E-07 49.7 6.9 75 265-342 13-89 (100)
234 cd05719 Ig2_PVR_like Second im 96.3 0.033 7.2E-07 46.7 9.0 69 270-346 16-86 (95)
235 cd05768 IgC_CH4 CH4 domain (fo 96.2 0.012 2.6E-07 50.1 6.2 77 265-343 12-92 (102)
236 cd04981 IgV_H Immunoglobulin ( 96.2 0.016 3.5E-07 50.6 6.9 79 261-340 4-97 (117)
237 PF07654 C1-set: Immunoglobuli 96.2 0.029 6.2E-07 45.6 8.0 71 268-344 7-79 (83)
238 COG5238 RNA1 Ran GTPase-activa 96.2 0.0036 7.8E-08 61.4 2.9 156 51-206 94-283 (388)
239 PF01102 Glycophorin_A: Glycop 95.9 0.01 2.3E-07 51.6 4.5 34 363-396 61-94 (122)
240 smart00013 LRRNT Leucine rich 95.9 0.0091 2E-07 39.4 3.2 30 16-49 1-30 (33)
241 cd07696 IgC_CH3 CH3 domain (th 95.9 0.039 8.3E-07 46.4 7.7 76 264-343 9-87 (96)
242 smart00406 IGv Immunoglobulin 95.9 0.015 3.3E-07 46.4 5.2 67 271-338 1-81 (81)
243 cd07703 Ig2_Nectin-2_like Seco 95.9 0.054 1.2E-06 45.4 8.5 75 270-352 16-92 (95)
244 PHA03376 BARF1; Provisional 95.8 0.06 1.3E-06 50.0 9.0 87 263-352 20-120 (221)
245 cd05767 IgC_MHC_II_alpha Class 95.8 0.074 1.6E-06 44.4 9.0 69 268-342 14-84 (94)
246 cd05766 IgC_MHC_II_beta Class 95.8 0.093 2E-06 43.9 9.6 71 268-344 13-85 (94)
247 KOG1026|consensus 95.6 0.031 6.7E-07 63.0 7.6 117 171-292 109-230 (774)
248 cd05770 IgC_beta2m Class I maj 95.6 0.11 2.3E-06 43.4 9.1 69 267-342 13-83 (93)
249 cd05769 IgC_TCR_beta T cell re 95.4 0.074 1.6E-06 46.2 8.0 81 265-348 14-98 (115)
250 cd07697 IgC_TCR_gamma T cell r 95.1 0.15 3.3E-06 42.8 8.5 70 267-342 14-85 (96)
251 cd05771 IgC_Tapasin_R Tapasin- 95.1 0.029 6.2E-07 50.6 4.5 37 320-356 2-38 (139)
252 cd07692 Ig_CD3_epsilon Immunog 94.6 0.064 1.4E-06 41.1 4.5 52 267-341 5-56 (65)
253 cd04985 IgC_CH1 CH1 domain (fi 94.5 0.2 4.3E-06 41.9 7.7 71 268-342 15-87 (95)
254 KOG4597|consensus 94.5 0.06 1.3E-06 56.5 5.4 90 260-356 202-294 (560)
255 cd07691 Ig_CD3_gamma_delta Imm 94.3 0.1 2.2E-06 40.3 5.1 61 268-355 5-65 (69)
256 cd07704 Ig2_Nectin-3-4_like Se 94.1 0.23 5E-06 41.6 7.3 74 263-343 10-85 (97)
257 PF00560 LRR_1: Leucine Rich R 94.0 0.017 3.7E-07 34.2 0.3 16 101-116 2-17 (22)
258 PHA02633 hypothetical protein; 94.0 0.14 3.1E-06 38.6 5.1 38 319-356 18-55 (63)
259 PF02439 Adeno_E3_CR2: Adenovi 93.9 0.14 3E-06 34.3 4.3 21 368-388 5-25 (38)
260 cd04986 IgC_CH2 CH2 domain (se 93.2 0.28 6.1E-06 41.3 6.3 71 266-343 16-90 (99)
261 KOG2120|consensus 92.9 0.0027 5.8E-08 63.0 -7.1 131 76-206 186-324 (419)
262 smart00369 LRR_TYP Leucine-ric 92.5 0.096 2.1E-06 32.2 1.9 21 99-119 2-22 (26)
263 smart00370 LRR Leucine-rich re 92.5 0.096 2.1E-06 32.2 1.9 21 99-119 2-22 (26)
264 PF00560 LRR_1: Leucine Rich R 92.2 0.061 1.3E-06 31.8 0.7 16 77-92 2-17 (22)
265 PF13504 LRR_7: Leucine rich r 91.8 0.1 2.2E-06 28.8 1.2 13 101-113 3-15 (17)
266 cd05721 IgV_CTLA-4 Immunoglobu 91.3 0.64 1.4E-05 40.1 6.3 75 263-339 7-94 (115)
267 KOG1480|consensus 91.0 0.13 2.9E-06 57.1 2.4 71 263-345 138-209 (909)
268 PF08374 Protocadherin: Protoc 90.5 0.49 1.1E-05 44.9 5.2 24 366-389 38-61 (221)
269 PF06365 CD34_antigen: CD34/Po 90.4 1.1 2.4E-05 42.6 7.6 48 367-414 101-148 (202)
270 PTZ00382 Variant-specific surf 90.3 0.058 1.3E-06 45.2 -0.9 33 363-395 63-95 (96)
271 smart00369 LRR_TYP Leucine-ric 90.2 0.21 4.6E-06 30.7 1.8 22 75-96 2-23 (26)
272 smart00370 LRR Leucine-rich re 90.2 0.21 4.6E-06 30.7 1.8 22 75-96 2-23 (26)
273 PF14991 MLANA: Protein melan- 90.0 0.063 1.4E-06 45.2 -1.0 22 378-399 34-55 (118)
274 PF01034 Syndecan: Syndecan do 89.6 0.11 2.3E-06 39.3 0.1 26 369-394 12-37 (64)
275 PHA03042 CD47-like protein; Pr 89.5 2.1 4.5E-05 42.3 8.8 70 269-354 31-105 (286)
276 KOG0473|consensus 89.3 0.0093 2E-07 57.3 -7.2 62 144-207 62-123 (326)
277 PF08204 V-set_CD47: CD47 immu 89.2 0.73 1.6E-05 40.7 5.0 82 269-353 27-119 (130)
278 KOG0473|consensus 88.2 0.015 3.2E-07 55.9 -6.6 93 87-182 30-122 (326)
279 PF13504 LRR_7: Leucine rich r 88.0 0.33 7.2E-06 26.7 1.4 15 172-186 2-16 (17)
280 PF02480 Herpes_gE: Alphaherpe 87.7 0.35 7.7E-06 52.1 2.5 20 320-339 270-289 (439)
281 PF07354 Sp38: Zona-pellucida- 87.5 0.86 1.9E-05 44.8 4.8 49 282-342 11-60 (271)
282 PHA03286 envelope glycoprotein 86.9 0.82 1.8E-05 48.1 4.5 20 320-339 308-327 (492)
283 PF04478 Mid2: Mid2 like cell 86.9 0.098 2.1E-06 46.9 -1.8 24 367-390 50-73 (154)
284 PHA02982 hypothetical protein; 86.9 1.2 2.6E-05 42.1 5.1 83 262-347 32-128 (251)
285 KOG3515|consensus 86.6 0.78 1.7E-05 52.0 4.5 77 265-355 18-96 (741)
286 PF15050 SCIMP: SCIMP protein 83.6 2.5 5.5E-05 36.1 5.1 29 370-398 11-39 (133)
287 KOG3515|consensus 83.4 3.5 7.6E-05 46.9 7.7 77 264-341 107-185 (741)
288 KOG3864|consensus 82.3 0.25 5.3E-06 46.9 -1.5 82 125-206 103-187 (221)
289 PF01299 Lamp: Lysosome-associ 81.1 1 2.2E-05 46.4 2.4 30 366-395 270-299 (306)
290 cd07689 Ig2_VCAM-1 Second immu 79.8 5.6 0.00012 33.4 5.8 71 266-342 12-86 (99)
291 PF07213 DAP10: DAP10 membrane 79.3 2.3 4.9E-05 33.8 3.2 26 364-389 32-57 (79)
292 PF02439 Adeno_E3_CR2: Adenovi 78.9 3.6 7.9E-05 27.7 3.6 30 364-394 5-34 (38)
293 PF03302 VSP: Giardia variant- 78.9 1.1 2.4E-05 47.9 1.8 34 361-394 362-395 (397)
294 PF05790 C2-set: Immunoglobuli 78.6 12 0.00025 30.2 7.2 34 320-353 44-78 (80)
295 PF02009 Rifin_STEVOR: Rifin/s 77.0 1.8 4E-05 44.0 2.6 13 379-391 268-280 (299)
296 PF13908 Shisa: Wnt and FGF in 76.7 3.4 7.5E-05 38.9 4.3 7 368-374 81-87 (179)
297 PHA03282 envelope glycoprotein 76.0 27 0.00059 37.3 10.8 20 320-339 334-353 (540)
298 PF05454 DAG1: Dystroglycan (D 75.5 0.9 2E-05 45.9 0.0 24 375-398 154-177 (290)
299 PF05568 ASFV_J13L: African sw 74.8 5.7 0.00012 35.2 4.7 32 363-394 26-57 (189)
300 PHA03281 envelope glycoprotein 74.6 18 0.0004 39.2 9.3 21 319-339 475-495 (642)
301 PTZ00370 STEVOR; Provisional 74.4 3.6 7.7E-05 41.1 3.8 26 370-396 258-283 (296)
302 TIGR01478 STEVOR variant surfa 74.1 4.4 9.5E-05 40.4 4.3 26 370-396 262-287 (295)
303 smart00365 LRR_SD22 Leucine-ri 74.0 2.6 5.6E-05 26.1 1.8 14 100-113 3-16 (26)
304 PF14575 EphA2_TM: Ephrin type 72.0 2.3 5E-05 33.8 1.5 11 369-379 4-14 (75)
305 PF02124 Marek_A: Marek's dise 72.0 9.8 0.00021 36.6 6.0 23 272-294 92-116 (211)
306 smart00364 LRR_BAC Leucine-ric 71.7 2.6 5.6E-05 26.0 1.3 17 100-116 3-19 (26)
307 PF01034 Syndecan: Syndecan do 71.5 1.3 2.9E-05 33.6 0.1 31 365-396 12-42 (64)
308 PF02038 ATP1G1_PLM_MAT8: ATP1 70.4 5 0.00011 28.9 2.7 25 366-390 14-38 (50)
309 KOG3864|consensus 70.3 0.72 1.6E-05 43.8 -1.9 32 147-178 151-183 (221)
310 PHA03099 epidermal growth fact 69.7 7.2 0.00016 33.9 4.1 20 332-351 65-85 (139)
311 PHA03052 Hypothetical protein; 65.4 12 0.00026 28.9 4.0 35 262-296 5-42 (69)
312 PF15069 FAM163: FAM163 family 64.2 49 0.0011 29.6 8.3 18 367-384 7-24 (143)
313 PF01463 LRRCT: Leucine rich r 64.1 3 6.4E-05 25.4 0.5 24 230-254 2-25 (25)
314 PF11669 WBP-1: WW domain-bind 63.6 14 0.00031 31.2 4.8 9 441-449 83-91 (102)
315 TIGR00864 PCC polycystin catio 63.2 5.2 0.00011 51.7 2.8 36 105-140 1-36 (2740)
316 PF07204 Orthoreo_P10: Orthore 62.9 3.9 8.4E-05 33.5 1.1 15 331-345 16-31 (98)
317 PF05273 Pox_RNA_Pol_22: Poxvi 62.0 5.3 0.00011 36.0 1.9 36 532-567 71-106 (185)
318 PTZ00046 rifin; Provisional 61.9 6.6 0.00014 40.7 2.9 12 385-396 332-343 (358)
319 PHA02865 MHC-like TNF binding 61.8 23 0.00049 36.7 6.7 68 271-342 216-304 (338)
320 TIGR01477 RIFIN variant surfac 61.4 6.8 0.00015 40.5 2.9 11 385-395 327-337 (353)
321 PF11465 Receptor_2B4: Natural 61.4 25 0.00055 29.9 5.7 35 319-353 71-106 (108)
322 KOG4308|consensus 60.9 0.21 4.5E-06 54.6 -8.6 38 51-88 89-128 (478)
323 PF13908 Shisa: Wnt and FGF in 60.3 14 0.0003 34.8 4.6 22 366-387 75-96 (179)
324 KOG1947|consensus 60.2 3.5 7.5E-05 44.8 0.6 13 96-108 211-223 (482)
325 PF10873 DUF2668: Protein of u 60.2 20 0.00042 32.0 5.0 32 364-395 59-90 (155)
326 PF11770 GAPT: GRB2-binding ad 59.9 3.8 8.2E-05 36.6 0.7 28 369-396 10-37 (158)
327 cd05890 Ig2_Nectin-1_like Seco 59.8 28 0.00061 29.0 5.6 71 272-351 23-96 (98)
328 PF05961 Chordopox_A13L: Chord 58.3 22 0.00048 27.3 4.4 25 370-394 3-27 (68)
329 PF13516 LRR_6: Leucine Rich r 58.0 4.1 8.8E-05 24.3 0.4 11 100-110 3-13 (24)
330 KOG3763|consensus 57.5 5.1 0.00011 43.7 1.3 64 97-161 216-284 (585)
331 PF15471 TMEM171: Transmembran 57.2 63 0.0014 32.0 8.4 15 489-503 252-266 (319)
332 PHA03283 envelope glycoprotein 56.8 33 0.00071 37.3 7.0 20 320-339 316-335 (542)
333 PF05808 Podoplanin: Podoplani 56.7 3.6 7.8E-05 37.4 0.0 29 363-391 126-154 (162)
334 PHA03273 envelope glycoprotein 55.6 32 0.0007 36.8 6.7 20 273-292 355-376 (486)
335 PHA03049 IMV membrane protein; 53.8 29 0.00063 26.5 4.4 25 370-394 3-27 (68)
336 KOG0196|consensus 52.6 1.2E+02 0.0026 35.1 10.8 29 366-394 548-576 (996)
337 PHA03265 envelope glycoprotein 52.2 6 0.00013 40.4 0.7 12 385-396 366-377 (402)
338 smart00368 LRR_RI Leucine rich 52.2 12 0.00026 23.4 1.8 12 100-111 3-14 (28)
339 PHA03271 envelope glycoprotein 51.3 31 0.00067 36.4 5.6 21 274-294 365-386 (490)
340 KOG1219|consensus 51.1 1.6E+02 0.0035 38.4 12.0 14 448-461 4087-4100(4289)
341 PF12877 DUF3827: Domain of un 51.0 17 0.00036 40.5 3.9 33 364-397 268-300 (684)
342 KOG3763|consensus 50.5 6.1 0.00013 43.1 0.5 64 73-137 216-284 (585)
343 PF14979 TMEM52: Transmembrane 50.3 1.2E+02 0.0025 27.4 8.2 9 489-497 110-118 (154)
344 PF12273 RCR: Chitin synthesis 50.3 9.1 0.0002 34.0 1.5 7 389-395 23-29 (130)
345 PF12301 CD99L2: CD99 antigen 49.2 31 0.00067 32.1 4.8 32 365-398 114-145 (169)
346 KOG1094|consensus 48.9 3E+02 0.0065 31.0 12.7 6 18-23 22-27 (807)
347 PF04689 S1FA: DNA binding pro 48.9 31 0.00068 26.1 3.8 32 363-394 10-41 (69)
348 PF14575 EphA2_TM: Ephrin type 48.0 21 0.00046 28.3 3.1 16 371-386 2-17 (75)
349 PF06697 DUF1191: Protein of u 48.0 8.6 0.00019 38.5 1.1 8 333-340 175-182 (278)
350 PF10577 UPF0560: Uncharacteri 45.7 23 0.0005 40.6 4.0 28 367-394 274-301 (807)
351 PF04971 Lysis_S: Lysis protei 45.4 28 0.0006 26.9 3.2 22 365-386 32-53 (68)
352 PF06328 Lep_receptor_Ig: Ig-l 45.2 1.1E+02 0.0023 25.2 7.0 67 260-337 9-80 (89)
353 KOG1947|consensus 44.9 9.2 0.0002 41.5 0.8 110 97-206 186-306 (482)
354 PF12768 Rax2: Cortical protei 44.9 31 0.00068 35.0 4.6 28 367-394 230-257 (281)
355 PF06832 BiPBP_C: Penicillin-B 43.9 1.3E+02 0.0029 24.3 7.5 56 271-347 31-86 (89)
356 KOG4341|consensus 41.7 8.9 0.00019 40.6 0.1 112 97-208 292-414 (483)
357 PF03229 Alpha_GJ: Alphavirus 41.5 27 0.00058 29.9 2.8 29 366-394 83-111 (126)
358 PF15176 LRR19-TM: Leucine-ric 41.2 46 0.001 27.8 4.1 27 367-393 19-45 (102)
359 PF15069 FAM163: FAM163 family 40.7 16 0.00034 32.6 1.5 25 368-392 5-29 (143)
360 PHA02914 Immunoglobulin-like d 40.7 65 0.0014 33.9 6.0 89 263-351 273-378 (500)
361 PHA03269 envelope glycoprotein 40.5 41 0.00089 36.2 4.7 113 275-393 449-566 (566)
362 PF12669 P12: Virus attachment 40.0 33 0.00071 25.8 2.9 6 389-394 20-25 (58)
363 PF01102 Glycophorin_A: Glycop 39.7 28 0.0006 30.5 2.8 11 386-396 81-91 (122)
364 PF05545 FixQ: Cbb3-type cytoc 36.1 42 0.00092 24.0 2.9 7 385-391 25-31 (49)
365 COG1470 Predicted membrane pro 35.5 1.5E+02 0.0031 32.2 7.7 39 318-356 445-483 (513)
366 PF07213 DAP10: DAP10 membrane 33.4 1E+02 0.0023 24.6 4.8 44 366-409 30-73 (79)
367 PF14851 FAM176: FAM176 family 32.6 48 0.001 30.3 3.2 18 366-383 25-42 (153)
368 PHA03189 UL14 tegument protein 30.6 3.6E+02 0.0079 27.5 9.2 25 262-286 60-86 (348)
369 PF14914 LRRC37AB_C: LRRC37A/B 30.4 94 0.002 28.0 4.6 22 366-387 120-141 (154)
370 COG4736 CcoQ Cbb3-type cytochr 30.1 59 0.0013 24.6 2.8 22 375-396 15-36 (60)
371 PF15065 NCU-G1: Lysosomal tra 29.8 35 0.00076 35.7 2.2 31 366-396 318-348 (350)
372 TIGR03024 arch_pef_cterm PEF-C 29.6 73 0.0016 19.7 2.6 6 389-394 20-25 (26)
373 COG5526 Lysozyme family protei 29.4 57 0.0012 29.5 3.1 26 549-575 74-101 (191)
374 PF04906 Tweety: Tweety; Inte 29.2 76 0.0016 34.1 4.7 23 367-389 20-42 (406)
375 PF05955 Herpes_gp2: Equine he 28.7 4.9E+02 0.011 24.3 10.2 66 273-341 111-178 (226)
376 PF05393 Hum_adeno_E3A: Human 27.8 1.8E+02 0.0038 23.8 5.2 19 378-396 44-62 (94)
377 PF00558 Vpu: Vpu protein; In 27.6 76 0.0017 25.6 3.2 13 368-380 6-18 (81)
378 PF15096 G6B: G6B family 27.0 1.5E+02 0.0032 27.8 5.4 26 327-355 82-107 (224)
379 KOG4341|consensus 26.6 38 0.00083 36.0 1.8 134 73-206 292-437 (483)
380 PF14851 FAM176: FAM176 family 25.8 1.7E+02 0.0038 26.7 5.6 20 369-388 24-43 (153)
381 PF05454 DAG1: Dystroglycan (D 25.2 24 0.00051 35.9 0.0 34 367-400 149-182 (290)
382 KOG4433|consensus 23.9 1.2E+02 0.0026 32.9 4.7 26 366-391 43-68 (526)
383 PF11007 CotJA: Spore coat ass 23.8 40 0.00087 22.6 0.9 17 565-581 9-25 (36)
384 PF07010 Endomucin: Endomucin; 23.4 1.7E+02 0.0036 28.4 5.2 15 382-396 205-219 (259)
385 PHA03376 BARF1; Provisional 23.2 2.6E+02 0.0056 26.6 6.3 70 270-345 140-210 (221)
386 PRK14750 kdpF potassium-transp 22.9 1.7E+02 0.0037 18.5 3.3 8 370-377 4-11 (29)
387 PRK09801 transcriptional activ 22.1 61 0.0013 33.1 2.4 32 562-593 271-308 (310)
388 PF03381 CDC50: LEM3 (ligand-e 21.4 4.2E+02 0.0091 26.8 8.1 13 330-342 207-219 (278)
No 1
>KOG4194|consensus
Probab=100.00 E-value=6.6e-35 Score=301.52 Aligned_cols=302 Identities=26% Similarity=0.447 Sum_probs=205.9
Q ss_pred ceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEc
Q psy1672 51 TQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNL 130 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 130 (600)
|+.|+|+.|.|..|..+.+. ..++|++|+|++|+|+.+++++|..|..|++|+|++|.|..+..+.|..+.+|++|+|
T Consensus 295 L~~L~lS~NaI~rih~d~Ws--ftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdL 372 (873)
T KOG4194|consen 295 LEQLDLSYNAIQRIHIDSWS--FTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDL 372 (873)
T ss_pred hhhhccchhhhheeecchhh--hcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcC
Confidence 45555555555554444443 3455555555555555555555555555555555555555555555555666666666
Q ss_pred cCCCCCccCc---ccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCcccccccccccEEEccCCcC
Q psy1672 131 ARNPISKIEK---GAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLLKLMMIELHDNPW 207 (600)
Q Consensus 131 s~N~i~~l~~---~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~l~~N~~ 207 (600)
++|.+..... .+|.+|++|+.|.|.+|+|+.|+..+|.++++|++|+|.+|.|.++.+..|+.+ .|+.|.+..-.|
T Consensus 373 r~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf 451 (873)
T KOG4194|consen 373 RSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF 451 (873)
T ss_pred cCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence 6665543322 346666667777777777777777777777777777777777777777777776 677777777778
Q ss_pred ccccccccchhhhcccCCCC--CCCCCCCCccccccccccccccccCc----ccccccccccccccccccceeeeEeec-
Q psy1672 208 VCDCNMRSIKMWLADKKNVP--VQPACTGPERLSGKVFSDLHADDFAC----KPEIRMDSRYVEAVSSENATVVCRVDS- 280 (600)
Q Consensus 208 ~C~C~l~~l~~w~~~~~~~~--~~~~C~~p~~l~g~~l~~l~~~~~~C----~p~i~~~~~~~~v~~G~~v~L~C~v~g- 280 (600)
.|||.+.|+.+|+.+ .... ....|+.|..+.++.+..++..+|.| +|.+...+..+.+..|.+++++|.+.+
T Consensus 452 lCDCql~Wl~qWl~~-~~lq~sv~a~CayPe~Lad~~i~svd~~~lvC~DspkpqI~~qPe~~~al~g~nirftC~a~ss 530 (873)
T KOG4194|consen 452 LCDCQLKWLAQWLYR-RKLQSSVIAKCAYPEPLADQSIVSVDTANLVCDDSPKPQIVTQPETVSALIGENIRFTCNAYSS 530 (873)
T ss_pred EEeccHHHHHHHHHh-cccccceeeeccCCcccccceeEeechhhceecCCCCcceecCchHhhhhhccceEEEEEeccC
Confidence 899999999999984 3333 45689999999999999999999999 577788888888999999999999986
Q ss_pred -CCCCeeEEEEcCeeccCCcccCccceE-EEeeCC----ceeeeeeEEEecCCCCCCeEEEEEEecCCCce-eEEEEEEE
Q psy1672 281 -IPPAAISWYWNGRLLLNNTAFSSYQRI-FVIEQG----EYERKSSLVLTNAQESDSGRFYCVAENRAGIA-DANFTLQV 353 (600)
Q Consensus 281 -~P~p~i~W~~~g~~l~~~~~~~~~~~~-~~~~~g----~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~-~~~v~L~V 353 (600)
..+-.+.|-+++..+...... .+-.+ ....+| ..+..+.|.+.||+..|.|.|+|++.|.+|+. +..+.+.|
T Consensus 531 sasplsi~WR~dnevq~rv~ve-d~a~~~~q~r~~~~~e~~~~~~~L~L~nVt~td~grYQCVvtN~FGStysqk~KltV 609 (873)
T KOG4194|consen 531 SASPLSIEWRKDNEVQPRVDVE-DFATFLSQNRNGTFGEREEYTAILHLDNVTFTDEGRYQCVVTNHFGSTYSQKAKLTV 609 (873)
T ss_pred CCCCceeEeeeccccCcccchh-cchhhhhhhccCccchhhhhhheeeeeeeecccCceEEEEEecccCcchhheeEEEe
Confidence 445589999976643322110 00000 001111 12356789999999999999999999999987 44566766
Q ss_pred EEcc
Q psy1672 354 TYRG 357 (600)
Q Consensus 354 ~~~~ 357 (600)
...|
T Consensus 610 ~~~P 613 (873)
T KOG4194|consen 610 NQAP 613 (873)
T ss_pred eccC
Confidence 5443
No 2
>KOG4237|consensus
Probab=99.97 E-value=6.9e-32 Score=268.48 Aligned_cols=239 Identities=31% Similarity=0.560 Sum_probs=211.3
Q ss_pred hhcCCCCCCCCeecccCCceEEEccCCCCCccCCCCCCCCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCccc
Q psy1672 11 VVSVSSCPSTCICKWKGGKQWMECRDKFLITIPEAPESELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQI 90 (600)
Q Consensus 11 ~~~~~~Cp~~C~C~~~~~~~~v~C~~~~L~~ip~~~~~~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i 90 (600)
.++...||.+|.|...+ ..+|+|+.++|++||..+|.+ +..|+|..|+|+.||+.+|. .+++|+.|+|++|+|+.|
T Consensus 31 ~~~~~~CP~pC~Cs~~~-g~~VdCr~~GL~eVP~~LP~~-tveirLdqN~I~~iP~~aF~--~l~~LRrLdLS~N~Is~I 106 (498)
T KOG4237|consen 31 AHSASACPAPCTCSDVE-GGIVDCRGKGLTEVPANLPPE-TVEIRLDQNQISSIPPGAFK--TLHRLRRLDLSKNNISFI 106 (498)
T ss_pred hhccccCCCCcccCCCC-CceEEccCCCcccCcccCCCc-ceEEEeccCCcccCChhhcc--chhhhceecccccchhhc
Confidence 34467999999999876 678999999999999999998 99999999999999999998 899999999999999999
Q ss_pred CccccCCCCCccEEEccC-CCCCCCCcccc--------------------------------------------------
Q psy1672 91 DSGALDGLTNLIEIDLSD-NLLTSIPSLTF-------------------------------------------------- 119 (600)
Q Consensus 91 ~~~~f~~l~~L~~L~Ls~-N~l~~l~~~~f-------------------------------------------------- 119 (600)
.+++|.+++.|..|-+-+ |+|+.++.+.|
T Consensus 107 ~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~ 186 (498)
T KOG4237|consen 107 APDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQG 186 (498)
T ss_pred ChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccc
Confidence 999999998887766554 77666555333
Q ss_pred --------------------------------------------------------------------------------
Q psy1672 120 -------------------------------------------------------------------------------- 119 (600)
Q Consensus 120 -------------------------------------------------------------------------------- 119 (600)
T Consensus 187 l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP 266 (498)
T KOG4237|consen 187 LAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICP 266 (498)
T ss_pred hhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcCh
Confidence
Q ss_pred ----CCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCcccccccc
Q psy1672 120 ----QSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLL 195 (600)
Q Consensus 120 ----~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~ 195 (600)
..+++|+.|+|++|+|+.+.+.+|.++..+++|.|..|+|..+....|.++..|+.|+|.+|+|+.+.+..|..+.
T Consensus 267 ~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~ 346 (498)
T KOG4237|consen 267 AKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLF 346 (498)
T ss_pred HHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccc
Confidence 3567788888888888888888888888888888888888888888888999999999999999999999999999
Q ss_pred cccEEEccCCcCccccccccchhhhcccCCCCCCCCCCCCccccccccccccccccCcc
Q psy1672 196 KLMMIELHDNPWVCDCNMRSIKMWLADKKNVPVQPACTGPERLSGKVFSDLHADDFACK 254 (600)
Q Consensus 196 ~L~~L~l~~N~~~C~C~l~~l~~w~~~~~~~~~~~~C~~p~~l~g~~l~~l~~~~~~C~ 254 (600)
.|..|++-.|||.|+|++.|+..|+..+. ......|..|..+++..++++...+|.|.
T Consensus 347 ~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~-~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~ 404 (498)
T KOG4237|consen 347 SLSTLNLLSNPFNCNCRLAWLGEWLRKKS-VVGNPRCQSPGFVRQIPISDVAFGDFRCG 404 (498)
T ss_pred eeeeeehccCcccCccchHHHHHHHhhCC-CCCCCCCCCCchhccccchhccccccccC
Confidence 99999999999999999999999999544 55788999999999999999999999996
No 3
>KOG4194|consensus
Probab=99.90 E-value=9.5e-25 Score=226.60 Aligned_cols=296 Identities=25% Similarity=0.411 Sum_probs=214.6
Q ss_pred ceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCC---CccccCCCCCCCE
Q psy1672 51 TQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSI---PSLTFQSVRFLRD 127 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l---~~~~f~~l~~L~~ 127 (600)
|++|+|++|+|+.+++..|. .|..|+.|+|++|.+..|...+|.++.+|+.|||++|.|... ....|.+|++|+.
T Consensus 319 L~~LdLs~N~i~~l~~~sf~--~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFR--VLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ceeEeccccccccCChhHHH--HHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 99999999999999999998 899999999999999999999999999999999999988732 3346888999999
Q ss_pred EEccCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcC------CCcCCCCCc---------ccc-
Q psy1672 128 LNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLN------GNRLSHFPV---------RSV- 191 (600)
Q Consensus 128 L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls------~N~l~~l~~---------~~~- 191 (600)
|.|.+|++..++..+|.++.+|++|+|.+|.|..|.+++|..+ .|+.|.+. +|+|.-+.. ...
T Consensus 397 L~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~qWl~~~~lq~sv~a 475 (873)
T KOG4194|consen 397 LRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLAQWLYRRKLQSSVIA 475 (873)
T ss_pred eeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHHHHHHHhcccccceee
Confidence 9999999999999999999999999999999999999999988 88887764 344432210 000
Q ss_pred -----cccccccEEEccCCcCccccccc------------------------------cc-hhhhcccCCCC-----CCC
Q psy1672 192 -----EPLLKLMMIELHDNPWVCDCNMR------------------------------SI-KMWLADKKNVP-----VQP 230 (600)
Q Consensus 192 -----~~l~~L~~L~l~~N~~~C~C~l~------------------------------~l-~~w~~~~~~~~-----~~~ 230 (600)
+.+.....+.++.-.++|+-..+ ++ ..|-.++...+ ...
T Consensus 476 ~CayPe~Lad~~i~svd~~~lvC~DspkpqI~~qPe~~~al~g~nirftC~a~sssasplsi~WR~dnevq~rv~ved~a 555 (873)
T KOG4194|consen 476 KCAYPEPLADQSIVSVDTANLVCDDSPKPQIVTQPETVSALIGENIRFTCNAYSSSASPLSIEWRKDNEVQPRVDVEDFA 555 (873)
T ss_pred eccCCcccccceeEeechhhceecCCCCcceecCchHhhhhhccceEEEEEeccCCCCCceeEeeeccccCcccchhcch
Confidence 01112223334444455542221 11 34544332221 000
Q ss_pred CCCC-------------CccccccccccccccccCc--------------------ccccccccccccccccccceeeeE
Q psy1672 231 ACTG-------------PERLSGKVFSDLHADDFAC--------------------KPEIRMDSRYVEAVSSENATVVCR 277 (600)
Q Consensus 231 ~C~~-------------p~~l~g~~l~~l~~~~~~C--------------------~p~i~~~~~~~~v~~G~~v~L~C~ 277 (600)
+-.. ...+.-.++.-.+...+.| .|.+...+..++...|+.+.|.|.
T Consensus 556 ~~~~q~r~~~~~e~~~~~~~L~L~nVt~td~grYQCVvtN~FGStysqk~KltV~~~PsFtktP~dltl~tg~mArl~Ca 635 (873)
T KOG4194|consen 556 TFLSQNRNGTFGEREEYTAILHLDNVTFTDEGRYQCVVTNHFGSTYSQKAKLTVNQAPSFTKTPEDLTLRTGQMARLECA 635 (873)
T ss_pred hhhhhhccCccchhhhhhheeeeeeeecccCceEEEEEecccCcchhheeEEEeeccCccccCcccceeecccceeeeee
Confidence 0000 0011111222223334445 366666788888999999999999
Q ss_pred eecCCCCeeEEEEcCee-ccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEEEEEEc
Q psy1672 278 VDSIPPAAISWYWNGRL-LLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTLQVTYR 356 (600)
Q Consensus 278 v~g~P~p~i~W~~~g~~-l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L~V~~~ 356 (600)
+.|.|.|+|.|.++|.. ..... ..|+++..+++ .+.|.|++.+|.|.|+|+|.|.+|..+++++|.|.+.
T Consensus 636 AtG~P~PeIawqkdggtdFPAA~----eRRl~Vmpedd-----~f~Itnvk~eD~GiYtC~A~n~AG~isanAtL~V~e~ 706 (873)
T KOG4194|consen 636 ATGHPRPEIAWQKDGGTDFPAAR----ERRLHVMPEDD-----VFFITNVKIEDQGIYTCTAQNVAGQISANATLTVLET 706 (873)
T ss_pred ccCCCCcceeehhcCCCCCchhh----hheeeecCCCC-----EEEEecccccccceeEEeeeccccceeeceEEEEecC
Confidence 99999999999997643 22221 23455544332 5789999999999999999999999999999999877
Q ss_pred cC
Q psy1672 357 GV 358 (600)
Q Consensus 357 ~~ 358 (600)
|.
T Consensus 707 p~ 708 (873)
T KOG4194|consen 707 PS 708 (873)
T ss_pred Cc
Confidence 53
No 4
>KOG4237|consensus
Probab=99.69 E-value=1.2e-18 Score=174.40 Aligned_cols=198 Identities=26% Similarity=0.396 Sum_probs=176.3
Q ss_pred eEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEcc
Q psy1672 52 QVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLA 131 (600)
Q Consensus 52 ~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls 131 (600)
-..+-++-.|++||.+. -..-..|+|..|+|+.|++++|..+++|+.||||+|+|+.|.+.+|+++.+|..|.+-
T Consensus 49 ~~VdCr~~GL~eVP~~L-----P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvly 123 (498)
T KOG4237|consen 49 GIVDCRGKGLTEVPANL-----PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLY 123 (498)
T ss_pred ceEEccCCCcccCcccC-----CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhh
Confidence 45677888899999775 3477899999999999999999999999999999999999999999999998887766
Q ss_pred C-CCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCcccccccccccEEEccCCcCccc
Q psy1672 132 R-NPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLLKLMMIELHDNPWVCD 210 (600)
Q Consensus 132 ~-N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~l~~N~~~C~ 210 (600)
+ |+|+.++.++|.++..|+.|.+.-|++.++..++|..+++|..|.+.+|.+..+....|..+..++.+.+..|++.|+
T Consensus 124 g~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icd 203 (498)
T KOG4237|consen 124 GNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICD 203 (498)
T ss_pred cCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccc
Confidence 5 999999999999999999999999999999999999999999999999999999998999999999999999999999
Q ss_pred cccccchhhhcccCCCCCCCCCCCCccccccccccccccccCcc
Q psy1672 211 CNMRSIKMWLADKKNVPVQPACTGPERLSGKVFSDLHADDFACK 254 (600)
Q Consensus 211 C~l~~l~~w~~~~~~~~~~~~C~~p~~l~g~~l~~l~~~~~~C~ 254 (600)
|.+.|+...+....-...-..|..|.++..+.+..++...|.|.
T Consensus 204 CnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~ 247 (498)
T KOG4237|consen 204 CNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCS 247 (498)
T ss_pred cccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhh
Confidence 99999877665332222446788999888888888888777775
No 5
>KOG0617|consensus
Probab=99.50 E-value=8.2e-16 Score=137.98 Aligned_cols=164 Identities=23% Similarity=0.340 Sum_probs=143.1
Q ss_pred CCCccCCCCCCCCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCcc
Q psy1672 38 FLITIPEAPESELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSL 117 (600)
Q Consensus 38 ~L~~ip~~~~~~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~ 117 (600)
...++|..+..++++.|-|++|+++.+|+.+- .+.+|+.|++.+|+|+.++.. ++.+++|++|++..|++..+|.
T Consensus 22 sf~~~~gLf~~s~ITrLtLSHNKl~~vppnia---~l~nlevln~~nnqie~lp~~-issl~klr~lnvgmnrl~~lpr- 96 (264)
T KOG0617|consen 22 SFEELPGLFNMSNITRLTLSHNKLTVVPPNIA---ELKNLEVLNLSNNQIEELPTS-ISSLPKLRILNVGMNRLNILPR- 96 (264)
T ss_pred cHhhcccccchhhhhhhhcccCceeecCCcHH---HhhhhhhhhcccchhhhcChh-hhhchhhhheecchhhhhcCcc-
Confidence 34567777777889999999999999999876 699999999999999999665 8999999999999999998887
Q ss_pred ccCCCCCCCEEEccCCCCCc-cCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCccccccccc
Q psy1672 118 TFQSVRFLRDLNLARNPISK-IEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLLK 196 (600)
Q Consensus 118 ~f~~l~~L~~L~Ls~N~i~~-l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~ 196 (600)
.|+.++.|+.|+|.+|.+.. ..++.|..+..|+-|+|+.|.+.-+++ .++++.+|+.|.+.+|.+-+++. .+..+..
T Consensus 97 gfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~-dvg~lt~lqil~lrdndll~lpk-eig~lt~ 174 (264)
T KOG0617|consen 97 GFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPP-DVGKLTNLQILSLRDNDLLSLPK-EIGDLTR 174 (264)
T ss_pred ccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCCh-hhhhhcceeEEeeccCchhhCcH-HHHHHHH
Confidence 69999999999999998764 335667788999999999999998855 57889999999999999999984 5688889
Q ss_pred ccEEEccCCcCc
Q psy1672 197 LMMIELHDNPWV 208 (600)
Q Consensus 197 L~~L~l~~N~~~ 208 (600)
|+.|.+.+|.+.
T Consensus 175 lrelhiqgnrl~ 186 (264)
T KOG0617|consen 175 LRELHIQGNRLT 186 (264)
T ss_pred HHHHhcccceee
Confidence 999999999754
No 6
>KOG0444|consensus
Probab=99.46 E-value=7.4e-15 Score=154.33 Aligned_cols=186 Identities=21% Similarity=0.318 Sum_probs=93.2
Q ss_pred EEEccCCCCCccCCCCCC-CCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCC
Q psy1672 31 WMECRDKFLITIPEAPES-ELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDN 109 (600)
Q Consensus 31 ~v~C~~~~L~~ip~~~~~-~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N 109 (600)
+++.++++|+++|..+.. .++-+|+|++|+|..||...|. ++..|-.|+|++|++..++|. +..|..|+.|+|++|
T Consensus 107 ~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfi--nLtDLLfLDLS~NrLe~LPPQ-~RRL~~LqtL~Ls~N 183 (1255)
T KOG0444|consen 107 ILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFI--NLTDLLFLDLSNNRLEMLPPQ-IRRLSMLQTLKLSNN 183 (1255)
T ss_pred eeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHH--hhHhHhhhccccchhhhcCHH-HHHHhhhhhhhcCCC
Confidence 344444444444443321 2244455555555555554444 444455555555555444443 344444444444444
Q ss_pred CCCCCCccccCCCCCCCEEEccCCCCC-ccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCc
Q psy1672 110 LLTSIPSLTFQSVRFLRDLNLARNPIS-KIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPV 188 (600)
Q Consensus 110 ~l~~l~~~~f~~l~~L~~L~Ls~N~i~-~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~ 188 (600)
.+....-..+..+.+|++|.+++.+-+ .-.+..+..+.+|..++|+.|.+..+ |+.+.++.+|+.|+|++|+|+.+..
T Consensus 184 PL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~v-Pecly~l~~LrrLNLS~N~iteL~~ 262 (1255)
T KOG0444|consen 184 PLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIV-PECLYKLRNLRRLNLSGNKITELNM 262 (1255)
T ss_pred hhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcc-hHHHhhhhhhheeccCcCceeeeec
Confidence 333211111222333333333332211 11133445566677777777777766 5566677777777777777777653
Q ss_pred ccccccccccEEEccCCcCc----cccccccchhhhc
Q psy1672 189 RSVEPLLKLMMIELHDNPWV----CDCNMRSIKMWLA 221 (600)
Q Consensus 189 ~~~~~l~~L~~L~l~~N~~~----C~C~l~~l~~w~~ 221 (600)
......+|++|+++.|+++ |-|.+..+...+.
T Consensus 263 -~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~ 298 (1255)
T KOG0444|consen 263 -TEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYA 298 (1255)
T ss_pred -cHHHHhhhhhhccccchhccchHHHhhhHHHHHHHh
Confidence 2233456667777777664 4566655544433
No 7
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=99.45 E-value=3.4e-13 Score=160.75 Aligned_cols=133 Identities=24% Similarity=0.199 Sum_probs=66.3
Q ss_pred CCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCccee
Q psy1672 73 GLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKL 152 (600)
Q Consensus 73 ~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L 152 (600)
.+.+|+.|+|++|.+....+..|.++++|++|+|++|.+....+..|..+.+|++|+|++|.+....+..|..+++|+.|
T Consensus 162 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 241 (968)
T PLN00113 162 SFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHL 241 (968)
T ss_pred cCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEE
Confidence 45555555555555544444445555555555555555554333345555555555555555544444444555555555
Q ss_pred eCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCcccccccccccEEEccCC
Q psy1672 153 DMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLLKLMMIELHDN 205 (600)
Q Consensus 153 ~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~l~~N 205 (600)
+|++|.+....+..+.++.+|+.|+|++|.+....+..+..+.+|+.|++.+|
T Consensus 242 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n 294 (968)
T PLN00113 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294 (968)
T ss_pred ECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCC
Confidence 55555554444444444555555555555444332233333444444444444
No 8
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=99.43 E-value=5.1e-13 Score=159.28 Aligned_cols=157 Identities=21% Similarity=0.209 Sum_probs=103.5
Q ss_pred CceEEEeeCCCCC-CCChhhhcccCCCCccEEEeecccCc----------------------ccCccccCCCCCccEEEc
Q psy1672 50 LTQVLDMSGNNLQ-ILPKEAFRRAGLLNLQKLFLARCHIG----------------------QIDSGALDGLTNLIEIDL 106 (600)
Q Consensus 50 ~l~~L~Ls~n~L~-~l~~~~f~~~~l~~L~~L~L~~n~l~----------------------~i~~~~f~~l~~L~~L~L 106 (600)
.++.|+|++|++. .+|...|. .+.+|++|+|++|.+. ...+..|..+++|++|+|
T Consensus 94 ~L~~L~Ls~n~~~~~ip~~~~~--~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 171 (968)
T PLN00113 94 YIQTINLSNNQLSGPIPDDIFT--TSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDL 171 (968)
T ss_pred CCCEEECCCCccCCcCChHHhc--cCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEEC
Confidence 4888888888886 67777664 4666666666666554 333444556666666666
Q ss_pred cCCCCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCC
Q psy1672 107 SDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHF 186 (600)
Q Consensus 107 s~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l 186 (600)
++|.+....+..|..+++|++|+|++|.+....+..|..+++|+.|+|++|.+....+..+.++++|+.|+|++|.+...
T Consensus 172 ~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 251 (968)
T PLN00113 172 GGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGP 251 (968)
T ss_pred ccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccc
Confidence 66666544444566666666666666666655555566666777777777776665566677777777777777777655
Q ss_pred CcccccccccccEEEccCCcCc
Q psy1672 187 PVRSVEPLLKLMMIELHDNPWV 208 (600)
Q Consensus 187 ~~~~~~~l~~L~~L~l~~N~~~ 208 (600)
.+..+..+++|+.|++.+|.+.
T Consensus 252 ~p~~l~~l~~L~~L~L~~n~l~ 273 (968)
T PLN00113 252 IPSSLGNLKNLQYLFLYQNKLS 273 (968)
T ss_pred cChhHhCCCCCCEEECcCCeee
Confidence 5566777777888888777643
No 9
>KOG0617|consensus
Probab=99.40 E-value=5.8e-15 Score=132.56 Aligned_cols=170 Identities=23% Similarity=0.384 Sum_probs=141.0
Q ss_pred EEccCCCCCccCCCCCC-CCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCC
Q psy1672 32 MECRDKFLITIPEAPES-ELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNL 110 (600)
Q Consensus 32 v~C~~~~L~~ip~~~~~-~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~ 110 (600)
+..++++++.+|+.+-. .++++|+|.+|+|+++|.++. .+++|+.|++.-|++..++ ..|+.++.|+.|||+.|+
T Consensus 38 LtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~is---sl~klr~lnvgmnrl~~lp-rgfgs~p~levldltynn 113 (264)
T KOG0617|consen 38 LTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSIS---SLPKLRILNVGMNRLNILP-RGFGSFPALEVLDLTYNN 113 (264)
T ss_pred hhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhh---hchhhhheecchhhhhcCc-cccCCCchhhhhhccccc
Confidence 44567889999886543 459999999999999999887 5999999999999998775 459999999999999999
Q ss_pred CC--CCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCc
Q psy1672 111 LT--SIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPV 188 (600)
Q Consensus 111 l~--~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~ 188 (600)
+. .+|. .|..+..|+.|+|++|.+.-++++ ..++++|+.|.+..|.+-.+ |..++.+..|+.|++.+|+++.+++
T Consensus 114 l~e~~lpg-nff~m~tlralyl~dndfe~lp~d-vg~lt~lqil~lrdndll~l-pkeig~lt~lrelhiqgnrl~vlpp 190 (264)
T KOG0617|consen 114 LNENSLPG-NFFYMTTLRALYLGDNDFEILPPD-VGKLTNLQILSLRDNDLLSL-PKEIGDLTRLRELHIQGNRLTVLPP 190 (264)
T ss_pred cccccCCc-chhHHHHHHHHHhcCCCcccCChh-hhhhcceeEEeeccCchhhC-cHHHHHHHHHHHHhcccceeeecCh
Confidence 87 4555 566788999999999999888665 68999999999999999998 5668889999999999999999986
Q ss_pred cccccc---ccccEEEccCCcCcc
Q psy1672 189 RSVEPL---LKLMMIELHDNPWVC 209 (600)
Q Consensus 189 ~~~~~l---~~L~~L~l~~N~~~C 209 (600)
+ +..+ .+-.++.++.|||.-
T Consensus 191 e-l~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 191 E-LANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred h-hhhhhhhhhHHHHhhhhCCCCC
Confidence 4 2222 223456678888863
No 10
>cd05762 Ig8_MLCK Eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). Ig8_MLCK: the eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). MLCK is a key regulator of different forms of cell motility involving actin and myosin II. Agonist stimulation of smooth muscle cells increases cytosolic Ca2+, which binds calmodulin. This Ca2+-calmodulin complex in turn binds to and activates MLCK. Activated MLCK leads to the phosphorylation of the 20 kDa myosin regulatory light chain (RLC) of myosin II and the stimulation of actin-activated myosin MgATPase activity. MLCK is widely present in vertebrate tissues; it phosphorylates the 20 kDa RLC of both smooth and nonmuscle myosin II. Phosphorylation leads to the activation of the myosin motor domain and altered structural properties of myosin II. In smooth muscle MLCK it is involved in initiating contraction. In nonmuscle cells, MLCK may participate in cell division and cell motility; it has
Probab=99.39 E-value=3.6e-12 Score=108.21 Aligned_cols=94 Identities=19% Similarity=0.296 Sum_probs=77.4
Q ss_pred ccccccccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEE
Q psy1672 256 EIRMDSRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFY 335 (600)
Q Consensus 256 ~i~~~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~ 335 (600)
.+...+..+.+..|+.+.|.|.+.|.|++.+.|+++++.+.... ++.+...+ ..+.|.|.++...|+|.|+
T Consensus 2 ~~~~~p~~~~v~~G~~v~l~C~~~G~p~p~v~W~kdg~~l~~~~------~~~~~~~~---~~s~L~I~~~~~~D~G~Yt 72 (98)
T cd05762 2 QIIQFPEDMKVRAGESVELFCKVTGTQPITCTWMKFRKQIQEGE------GIKIENTE---NSSKLTITEGQQEHCGCYT 72 (98)
T ss_pred ceEECCcCEEEECCCEEEEEEEEcccCCCceEEEECCEEecCCC------cEEEEecC---CeeEEEECCCChhhCEEEE
Confidence 44555677888999999999999999999999999999886433 23333222 2358999999999999999
Q ss_pred EEEecCCCceeEEEEEEEEEccC
Q psy1672 336 CVAENRAGIADANFTLQVTYRGV 358 (600)
Q Consensus 336 C~a~N~~G~~~~~v~L~V~~~~~ 358 (600)
|.|+|..|.+.+++.|.|..++.
T Consensus 73 c~a~N~~G~~~~~~~l~V~~~P~ 95 (98)
T cd05762 73 LEVENKLGSRQAQVNLTVVDKPD 95 (98)
T ss_pred EEEEcCCCceeEEEEEEEecCCC
Confidence 99999999999999999987654
No 11
>KOG0444|consensus
Probab=99.36 E-value=8.7e-14 Score=146.40 Aligned_cols=162 Identities=27% Similarity=0.379 Sum_probs=109.7
Q ss_pred ccCCCCCC-CCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCcccc
Q psy1672 41 TIPEAPES-ELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTF 119 (600)
Q Consensus 41 ~ip~~~~~-~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f 119 (600)
.||..+.. ..+.+|||++|+|.++|...- ...++-.|+|++|+|..|+...|.+|..|-+||||+|++..+|+ ..
T Consensus 94 GiP~diF~l~dLt~lDLShNqL~EvP~~LE---~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPP-Q~ 169 (1255)
T KOG0444|consen 94 GIPTDIFRLKDLTILDLSHNQLREVPTNLE---YAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPP-QI 169 (1255)
T ss_pred CCCchhcccccceeeecchhhhhhcchhhh---hhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCH-HH
Confidence 34544332 336667777777777666543 35666677777777777766666677777777777777777766 34
Q ss_pred CCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCc--CcccChhhhcCCCCCCEEEcCCCcCCCCCcccccccccc
Q psy1672 120 QSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESR--LEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLLKL 197 (600)
Q Consensus 120 ~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~--l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L 197 (600)
..+..|++|.|++|++...--..+-.+++|+.|.+++.+ +..+ |..+..+.+|..+||+.|.|+.+| +.+-++.+|
T Consensus 170 RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~-Ptsld~l~NL~dvDlS~N~Lp~vP-ecly~l~~L 247 (1255)
T KOG0444|consen 170 RRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNI-PTSLDDLHNLRDVDLSENNLPIVP-ECLYKLRNL 247 (1255)
T ss_pred HHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcC-CCchhhhhhhhhccccccCCCcch-HHHhhhhhh
Confidence 556667777777776654332333344556666666653 3344 456777889999999999999998 577888999
Q ss_pred cEEEccCCcCc
Q psy1672 198 MMIELHDNPWV 208 (600)
Q Consensus 198 ~~L~l~~N~~~ 208 (600)
+.|+|++|.+.
T Consensus 248 rrLNLS~N~it 258 (1255)
T KOG0444|consen 248 RRLNLSGNKIT 258 (1255)
T ss_pred heeccCcCcee
Confidence 99999999865
No 12
>KOG0618|consensus
Probab=99.31 E-value=9.2e-14 Score=152.67 Aligned_cols=185 Identities=23% Similarity=0.257 Sum_probs=146.3
Q ss_pred CCCCeecccCCceEEEccCCCCCccCCCCC-CCCceEEEeeCCCCCCCChhhhcc-----------------------cC
Q psy1672 18 PSTCICKWKGGKQWMECRDKFLITIPEAPE-SELTQVLDMSGNNLQILPKEAFRR-----------------------AG 73 (600)
Q Consensus 18 p~~C~C~~~~~~~~v~C~~~~L~~ip~~~~-~~~l~~L~Ls~n~L~~l~~~~f~~-----------------------~~ 73 (600)
|..|.|.|.- ..+.|....+..+|.... .+.+++|+|..|+|..+|+..|.. ..
T Consensus 280 p~ri~~~~~L--~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~ 357 (1081)
T KOG0618|consen 280 PLRISRITSL--VSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENN 357 (1081)
T ss_pred HHHHhhhhhH--HHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchh
Confidence 3455555432 446778888999988665 455999999999999888765542 12
Q ss_pred CCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceee
Q psy1672 74 LLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLD 153 (600)
Q Consensus 74 l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~ 153 (600)
+..|+.|++.+|.++.---..|.++++|+.|+|++|+|.++|...+.+++.|++|+|++|+++.++ .....+..|++|.
T Consensus 358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp-~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLP-DTVANLGRLHTLR 436 (1081)
T ss_pred hHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhh-HHHHhhhhhHHHh
Confidence 335666777777776543445788899999999999999999999999999999999999999986 6678889999999
Q ss_pred CCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCcccccccccccEEEccCCcC
Q psy1672 154 MSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLLKLMMIELHDNPW 207 (600)
Q Consensus 154 Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~l~~N~~ 207 (600)
..+|+|..++ .+..++.|+.+|++.|.|+.+.......-++|++|++.+|.+
T Consensus 437 ahsN~l~~fP--e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 437 AHSNQLLSFP--ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hcCCceeech--hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999999985 577899999999999999976543333337899999999985
No 13
>cd05852 Ig5_Contactin-1 Fifth Ig domain of contactin-1. Ig5_Contactin-1: fifth Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=99.30 E-value=9.3e-12 Score=99.47 Aligned_cols=73 Identities=33% Similarity=0.567 Sum_probs=61.4
Q ss_pred cccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEE
Q psy1672 269 SENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADAN 348 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~ 348 (600)
|+.+.|.|.+.|.|.|+|.|++++..+... .++.+..++ .|.|.+++.+|.|.|+|.|+|..|.++.+
T Consensus 1 G~~~~l~C~~~g~P~p~v~W~k~~~~l~~~------~r~~~~~~g------~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~ 68 (73)
T cd05852 1 GGRVIIECKPKAAPKPKFSWSKGTELLVNN------SRISIWDDG------SLEILNITKLDEGSYTCFAENNRGKANST 68 (73)
T ss_pred CCeEEEEEecceeCCCEEEEEeCCEecccC------CCEEEcCCC------EEEECcCChhHCEEEEEEEECCCCceeEE
Confidence 678999999999999999999988766432 244444444 79999999999999999999999999988
Q ss_pred EEEEE
Q psy1672 349 FTLQV 353 (600)
Q Consensus 349 v~L~V 353 (600)
+.|.|
T Consensus 69 ~~l~~ 73 (73)
T cd05852 69 GVLSV 73 (73)
T ss_pred EEEEC
Confidence 88764
No 14
>cd05855 Ig_TrkB_d5 Fifth domain (immunoglobulin-like) of Trk receptor TrkB. TrkB_d5: the fifth domain of Trk receptor TrkB, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors, which mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. The Trks are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkB shares significant sequence homology and domain organization with TrkA, and TrkC. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. In some cell systems NT-3 can activate TrkA and TrkB receptors. TrKB transcripts are found throughout multiple structures of the central and peripheral nervous systems.
Probab=99.30 E-value=1.5e-11 Score=99.34 Aligned_cols=77 Identities=21% Similarity=0.350 Sum_probs=60.1
Q ss_pred eeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEEE
Q psy1672 273 TVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTLQ 352 (600)
Q Consensus 273 ~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L~ 352 (600)
.+.|.+.|.|.|+|+|+++|+.+.... .....+...+.....+.|.|.+++..|.|.|+|+|+|..|.+++++.++
T Consensus 2 ~i~~~v~G~P~Pti~W~kng~~l~~~~----~~~~~~~~~~~~~~~~~L~i~~~~~~D~G~YtC~A~N~~G~~~~~~~~~ 77 (79)
T cd05855 2 CIPFTVKGNPKPTLQWFHEGAILNESE----YICTKIHVINNTEYHGCLQLDNPTHLNNGIYTLVAKNEYGEDEKNVSAH 77 (79)
T ss_pred eEEEEEeEeCCCceEEEECCEECCCCc----ceeeeeEeecccceEEEEEECCCCcccCEEEEEEEEcCCcccceEEEee
Confidence 367999999999999999999886543 1112222222223457899999999999999999999999999998886
Q ss_pred E
Q psy1672 353 V 353 (600)
Q Consensus 353 V 353 (600)
+
T Consensus 78 f 78 (79)
T cd05855 78 F 78 (79)
T ss_pred c
Confidence 5
No 15
>cd05745 Ig3_Peroxidasin Third immunoglobulin (Ig)-like domain of peroxidasin. Ig3_Peroxidasin: the third immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells which have undergone programmed cell death, and protection of the organism against non-self.
Probab=99.29 E-value=1.1e-11 Score=99.35 Aligned_cols=74 Identities=23% Similarity=0.441 Sum_probs=61.1
Q ss_pred ccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeE
Q psy1672 268 SSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADA 347 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~ 347 (600)
+|+.+.|.|.+.|.|.|.|.|++++..+.... +..+..+ +.|.|.+++..|.|.|+|.|.|.+|..+.
T Consensus 1 eG~~v~l~C~~~g~P~p~i~W~k~g~~~~~~~------~~~~~~~------~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~ 68 (74)
T cd05745 1 EGQTVDFLCEAQGYPQPVIAWTKGGSQLSVDR------RHLVLSS------GTLRISRVALHDQGQYECQAVNIVGSQRT 68 (74)
T ss_pred CCCeEEEEeECCEecCCEEEEEECCEECCCCC------CeEEccC------CeEEEeeCCHHhCEEEEEEEEeCCCceeE
Confidence 58899999999999999999999988765322 2222222 37999999999999999999999999998
Q ss_pred EEEEEE
Q psy1672 348 NFTLQV 353 (600)
Q Consensus 348 ~v~L~V 353 (600)
.+.|.|
T Consensus 69 ~~~L~V 74 (74)
T cd05745 69 VAQLTV 74 (74)
T ss_pred EEEEeC
Confidence 887764
No 16
>cd05851 Ig3_Contactin-1 Third Ig domain of contactin-1. Ig3_Contactin-1: Third Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=99.29 E-value=2.2e-11 Score=101.25 Aligned_cols=86 Identities=24% Similarity=0.313 Sum_probs=69.6
Q ss_pred cccccccccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEE
Q psy1672 255 PEIRMDSRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRF 334 (600)
Q Consensus 255 p~i~~~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y 334 (600)
|.+........+..|+.+.|.|.+.|.|.|.+.|++++..+.... ++. ..+ +.|.|.+++.+|.|.|
T Consensus 2 p~i~~~~~~~~~~~G~~v~l~C~~~G~P~P~v~W~k~~~~~~~~~------~~~--~~~-----~~L~I~~v~~~D~G~Y 68 (88)
T cd05851 2 ADINVKFKDTYALKGQNVTLECFALGNPVPVIRWRKILEPMPATA------EIS--MSG-----AVLKIFNIQPEDEGTY 68 (88)
T ss_pred CceEEccccEEEeCCCcEEEEEEecccCCCEEEEEECCcCCCCCC------EEe--cCC-----CEEEECcCChhhCEEE
Confidence 455566677788899999999999999999999999887554321 221 111 3799999999999999
Q ss_pred EEEEecCCCceeEEEEEEE
Q psy1672 335 YCVAENRAGIADANFTLQV 353 (600)
Q Consensus 335 ~C~a~N~~G~~~~~v~L~V 353 (600)
+|.|.|..|.....+.|.|
T Consensus 69 ~C~A~N~~G~~~~~~~l~V 87 (88)
T cd05851 69 ECEAENIKGKDKHQARVYV 87 (88)
T ss_pred EEEEEcCCCceEEEEEEEE
Confidence 9999999999998888876
No 17
>KOG0472|consensus
Probab=99.28 E-value=9.6e-14 Score=139.70 Aligned_cols=165 Identities=25% Similarity=0.451 Sum_probs=122.9
Q ss_pred cCCCCCccCCCCCC-CCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCC
Q psy1672 35 RDKFLITIPEAPES-ELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTS 113 (600)
Q Consensus 35 ~~~~L~~ip~~~~~-~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~ 113 (600)
.++++.++|..+.. ..+..|++.+|++..+++... .++.|++|+...|-++.++++ ++++.+|..|+|.+|.|..
T Consensus 145 ~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i---~m~~L~~ld~~~N~L~tlP~~-lg~l~~L~~LyL~~Nki~~ 220 (565)
T KOG0472|consen 145 TNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHI---AMKRLKHLDCNSNLLETLPPE-LGGLESLELLYLRRNKIRF 220 (565)
T ss_pred cccccccCchHHHHHHHHHHhhccccchhhCCHHHH---HHHHHHhcccchhhhhcCChh-hcchhhhHHHHhhhccccc
Confidence 34555555554322 125556677777777666655 367777777777777777654 6777777778888888887
Q ss_pred CCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCcccccc
Q psy1672 114 IPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEP 193 (600)
Q Consensus 114 l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~ 193 (600)
+|. |.++..|.+|+++.|.|..++.....++.+|..|||..|+++.. |+.++.+.+|.+||+++|.|+.++. .+++
T Consensus 221 lPe--f~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~-Pde~clLrsL~rLDlSNN~is~Lp~-sLgn 296 (565)
T KOG0472|consen 221 LPE--FPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEV-PDEICLLRSLERLDLSNNDISSLPY-SLGN 296 (565)
T ss_pred CCC--CCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccC-chHHHHhhhhhhhcccCCccccCCc-cccc
Confidence 773 77777788888888888878777777888899999999999988 4556678889999999999999885 4677
Q ss_pred cccccEEEccCCcCc
Q psy1672 194 LLKLMMIELHDNPWV 208 (600)
Q Consensus 194 l~~L~~L~l~~N~~~ 208 (600)
+ .|+.|.+.+||+.
T Consensus 297 l-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 297 L-HLKFLALEGNPLR 310 (565)
T ss_pred c-eeeehhhcCCchH
Confidence 7 8888999999854
No 18
>cd05894 Ig_C5_MyBP-C C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). Ig_C5_MyBP_C : the C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). MyBP_C consists of repeated domains, Ig and fibronectin type 3, and various linkers. Three isoforms of MYBP_C exist and are included in this group: cardiac(c), and fast and slow skeletal muscle (s) MyBP_C. cMYBP_C has insertions between and inside domains and an additional cardiac-specific Ig domain at the N-terminus. For cMYBP_C an interaction has been demonstrated between this C5 domain and the Ig C8 domain.
Probab=99.27 E-value=3.6e-11 Score=99.40 Aligned_cols=84 Identities=18% Similarity=0.309 Sum_probs=68.0
Q ss_pred ccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecC
Q psy1672 262 RYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 262 ~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~ 341 (600)
..+.+..|+.+.|.|.+.|.|.|.+.|+++++.+.... .++.+...+ ..+.|.|.++..+|+|.|+|.|.|.
T Consensus 3 ~~~~v~~G~~v~l~c~~~G~P~P~v~W~k~~~~i~~~~-----~r~~~~~~~---~~~~L~I~~~~~~D~G~Y~c~a~N~ 74 (86)
T cd05894 3 NTIVVVAGNKLRLDVPISGEPAPTVTWSRGDKAFTETE-----GRVRVESYK---DLSSFVIEGAEREDEGVYTITVTNP 74 (86)
T ss_pred CEEEEEcCCEEEEEeeEeecCCCeEEEEECCEECccCC-----CeEEEEEcC---CeEEEEECCCccCcCEEEEEEEEeC
Confidence 35677899999999999999999999999998876431 233333222 2458999999999999999999999
Q ss_pred CCceeEEEEEEE
Q psy1672 342 AGIADANFTLQV 353 (600)
Q Consensus 342 ~G~~~~~v~L~V 353 (600)
.|.+++++.|.|
T Consensus 75 ~G~~~~~~~l~V 86 (86)
T cd05894 75 VGEDHASLFVKV 86 (86)
T ss_pred CCcEEEEEEEEC
Confidence 999998887764
No 19
>cd05892 Ig_Myotilin_C C-terminal immunoglobulin (Ig)-like domain of myotilin. Ig_Myotilin_C: C-terminal immunoglobulin (Ig)-like domain of myotilin. Mytolin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to the latter family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Myotilin is most abundant in skeletal and cardiac muscle, and is involved in maintaining sarcomere integrity. It binds to alpha-actinin, filamin and actin. Mutations in myotilin lead to muscle disorders.
Probab=99.27 E-value=3.4e-11 Score=96.70 Aligned_cols=75 Identities=29% Similarity=0.573 Sum_probs=59.9
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
+.|.|.+.|.|.|.|.|+++++.+.... .++.+..++. ....|.|.+++.+|.|.|+|.|.|..|.+...+.|
T Consensus 1 v~l~C~v~G~P~P~i~W~k~~~~i~~~~-----~r~~~~~~~~--g~~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~a~L 73 (75)
T cd05892 1 VKLECQISAIPPPKIFWKRNNEMVQYNT-----DRISLYQDNS--GRVTLLIKNVNKKDAGWYTVSAVNEAGVATCHARL 73 (75)
T ss_pred CEEEEEEEecCCCeEEEEECCEECcCCC-----CeEEEEEcCC--CcEEEEECCCChhhCEEEEEEEEcCcCeEEEEEEE
Confidence 5799999999999999999998876322 2444443321 12379999999999999999999999999988887
Q ss_pred EE
Q psy1672 352 QV 353 (600)
Q Consensus 352 ~V 353 (600)
.|
T Consensus 74 ~V 75 (75)
T cd05892 74 DV 75 (75)
T ss_pred eC
Confidence 64
No 20
>cd05747 Ig5_Titin_like M5, fifth immunoglobulin (Ig)-like domain of human titin C terminus and similar proteins. Ig5_Titin_like: domain similar to the M5, fifth immunoglobulin (Ig)-like domain from the human titin C terminus. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic; depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone, and appears to function similar to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching.
Probab=99.26 E-value=4.1e-11 Score=100.49 Aligned_cols=89 Identities=28% Similarity=0.514 Sum_probs=71.9
Q ss_pred ccccccccccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeE
Q psy1672 254 KPEIRMDSRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGR 333 (600)
Q Consensus 254 ~p~i~~~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~ 333 (600)
.|.+...+..+.+..|+.+.|.|.+.|.|.|.+.|+++++.+.... ++.+...+ ..+.|.|.+++.+|+|.
T Consensus 3 ~~~~~~~p~~~~~~~G~~~~L~C~~~g~P~p~v~W~k~g~~l~~~~------~~~~~~~~---~~~~L~i~~~~~~D~G~ 73 (92)
T cd05747 3 PATILTKPRSLTVSEGESARFSCDVDGEPAPTVTWMREGQIIVSSQ------RHQITSTE---YKSTFEISKVQMSDEGN 73 (92)
T ss_pred CCcccccCccEEEeCCCcEEEEEEEeecCCCEEEEEECCEECCCCC------cEEEEEcC---CeeEEEECCCCcccCEe
Confidence 3556666778889999999999999999999999999988765322 33333222 24689999999999999
Q ss_pred EEEEEecCCCceeEEEEE
Q psy1672 334 FYCVAENRAGIADANFTL 351 (600)
Q Consensus 334 Y~C~a~N~~G~~~~~v~L 351 (600)
|+|.|+|..|.++..+.|
T Consensus 74 Y~C~a~N~~G~~~~~~~l 91 (92)
T cd05747 74 YTVVVENSEGKQEAQFTL 91 (92)
T ss_pred EEEEEEcCCCCEeEEEEe
Confidence 999999999998887765
No 21
>cd04975 Ig4_SCFR_like Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR) and similar proteins. Ig4_SCFR_like; fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). In addition to SCFR this group also includes the fourth Ig domain of platelet-derived growth factor receptors (PDGFR), alpha and beta, the fourth Ig domain of macrophage colony stimulating factor (M-CSF), and the Ig domain of the receptor tyrosine kinase KIT. SCFR and the PDGFR alpha and beta have similar organization: an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR, this fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth SCFR_Ig-like domain abolishes
Probab=99.26 E-value=3.7e-11 Score=102.33 Aligned_cols=87 Identities=29% Similarity=0.447 Sum_probs=69.5
Q ss_pred ccccccccccceeeeEeec-CCCCeeEEEEcCeeccCCcccCccceEEEeeC--CceeeeeeEEEecCCCCCCeEEEEEE
Q psy1672 262 RYVEAVSSENATVVCRVDS-IPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQ--GEYERKSSLVLTNAQESDSGRFYCVA 338 (600)
Q Consensus 262 ~~~~v~~G~~v~L~C~v~g-~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~--g~~~~~s~L~I~~v~~~d~G~Y~C~a 338 (600)
..+++.+|+.+.|.|.+.| .|+|.+.|+++|..+.... +..+... ......+.|.|..+..+|.|.|+|.|
T Consensus 11 ~~~~v~~G~~v~L~c~v~g~~P~p~v~W~Kdg~~i~~~~------~~~~~~~~~~~~~~~~~L~i~~v~~~D~G~Ytc~A 84 (101)
T cd04975 11 TTIFVNLGENLNLVVEVEAYPPPPHINWTYDNRTLTNKL------TEIVTSENESEYRYVSELKLVRLKESEAGTYTFLA 84 (101)
T ss_pred ceEEEECCCCEEEEEEEEecCCCCccEEEeCCeeCCCCc------ceeEEEeccCcceEEEEEEEeecCHhhCeeEEEEE
Confidence 4677889999999999999 8999999999999886432 1111111 11223568999999999999999999
Q ss_pred ecCCCceeEEEEEEEE
Q psy1672 339 ENRAGIADANFTLQVT 354 (600)
Q Consensus 339 ~N~~G~~~~~v~L~V~ 354 (600)
+|..|.++..+.|.|.
T Consensus 85 ~N~~G~~~~t~~L~V~ 100 (101)
T cd04975 85 SNSDASKSLTFELYVN 100 (101)
T ss_pred ECCCccEEEEEEEEEE
Confidence 9999999998888873
No 22
>cd05869 Ig5_NCAM-1 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig5_NCAM-1: The fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM) and heterophilic (NCAM-non-NCAM) interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (tr
Probab=99.26 E-value=3.9e-11 Score=101.67 Aligned_cols=95 Identities=26% Similarity=0.382 Sum_probs=69.6
Q ss_pred cccccccccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEE
Q psy1672 255 PEIRMDSRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRF 334 (600)
Q Consensus 255 p~i~~~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y 334 (600)
|.|...+....+..|+.++|.|.+.|.|.|.++|+++++.+...... ...++.+.+.. ..+.|.|.+++.+|.|.|
T Consensus 3 p~i~~~~~~~~~~~g~~v~l~C~~~G~P~P~v~W~~~~~~~~~~~~~-~~~~~~v~~~~---~~~~L~I~~v~~~D~G~Y 78 (97)
T cd05869 3 PKITYVENQTAMELEEQITLTCEASGDPIPSITWRTSTRNISSEEKT-LDGHIVVRSHA---RVSSLTLKYIQYTDAGEY 78 (97)
T ss_pred ceEEEccCceEEEcCCCEEEEEEeeEeCCCEEEEEECCccccCCccc-cCccEEEEcCc---cEEEEEEecCccCcCEEE
Confidence 44444444445556899999999999999999999988766432211 11233332222 236899999999999999
Q ss_pred EEEEecCCCceeEEEEEEE
Q psy1672 335 YCVAENRAGIADANFTLQV 353 (600)
Q Consensus 335 ~C~a~N~~G~~~~~v~L~V 353 (600)
+|.|.|.+|.+++++.|.|
T Consensus 79 ~C~A~N~~G~~~~~~~l~v 97 (97)
T cd05869 79 LCTASNTIGQDSQSMYLEV 97 (97)
T ss_pred EEEEecCCCCeeEEEEEEC
Confidence 9999999999998888764
No 23
>cd05737 Ig_Myomesin_like_C C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Ig_Myomesin_like_C: domain similar to the C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Myomesin and M-protein are both structural proteins localized to the M-band, a transverse structure in the center of the sarcomere, and are candidates for M-band bridges. Both proteins are modular, consisting mainly of repetitive Ig-like and fibronectin type III (FnIII) domains. Myomesin is expressed in all types of vertebrate striated muscle; M-protein has a muscle-type specific expression pattern. Myomesin is present in both slow and fast fibers; M-protein is present only in fast fibers. It has been suggested that myomesin acts as a molecular spring with alternative splicing as a means of modifying its elasticity.
Probab=99.26 E-value=3.7e-11 Score=100.75 Aligned_cols=84 Identities=24% Similarity=0.380 Sum_probs=68.0
Q ss_pred cccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeC-CceeeeeeEEEecCCCCCCeEEEEEEe
Q psy1672 261 SRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQ-GEYERKSSLVLTNAQESDSGRFYCVAE 339 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~-g~~~~~s~L~I~~v~~~d~G~Y~C~a~ 339 (600)
+..+++.+|+.+.|.|.+.|.|.|++.|+++++.+.... +..+... + ..+.|.|.+++.+|+|.|+|.|+
T Consensus 8 p~~v~v~~G~~v~L~C~v~G~P~p~v~W~k~g~~l~~~~------~~~~~~~~~---~~~~L~I~~v~~~D~G~Y~C~a~ 78 (92)
T cd05737 8 PDVVTIMEGKTLNLTCTVFGDPDPEVSWLKNDQALALSD------HYNVKVEQG---KYASLTIKGVSSEDSGKYGIVVK 78 (92)
T ss_pred CceEEEeCCCcEEEEEEEEecCCCeEEEEECCEECccCC------CEEEEEcCC---CEEEEEEccCChhhCEEEEEEEE
Confidence 456788899999999999999999999999998875432 2223222 2 12479999999999999999999
Q ss_pred cCCCceeEEEEEEE
Q psy1672 340 NRAGIADANFTLQV 353 (600)
Q Consensus 340 N~~G~~~~~v~L~V 353 (600)
|..|.++..+.+.|
T Consensus 79 N~~G~~~~~~~v~v 92 (92)
T cd05737 79 NKYGGETVDVTVSV 92 (92)
T ss_pred ECCCcceEEEEEeC
Confidence 99999988887764
No 24
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.26 E-value=2.4e-11 Score=137.23 Aligned_cols=143 Identities=22% Similarity=0.326 Sum_probs=98.8
Q ss_pred CeecccCCceEEEccCCCCCccCCCCCCCCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCC
Q psy1672 21 CICKWKGGKQWMECRDKFLITIPEAPESELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTN 100 (600)
Q Consensus 21 C~C~~~~~~~~v~C~~~~L~~ip~~~~~~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~ 100 (600)
|.|-.. +...++|...+|+.+|..++.. ++.|++.+|+|+.+|. .+++|+.|+|++|+|+.++. ..++
T Consensus 196 ~~Cl~~-~~~~LdLs~~~LtsLP~~l~~~-L~~L~L~~N~Lt~LP~------lp~~Lk~LdLs~N~LtsLP~----lp~s 263 (788)
T PRK15387 196 RACLNN-GNAVLNVGESGLTTLPDCLPAH-ITTLVIPDNNLTSLPA------LPPELRTLEVSGNQLTSLPV----LPPG 263 (788)
T ss_pred HHHhcC-CCcEEEcCCCCCCcCCcchhcC-CCEEEccCCcCCCCCC------CCCCCcEEEecCCccCcccC----cccc
Confidence 445432 2567999999999999987765 9999999999999885 36799999999999998853 2457
Q ss_pred ccEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCC
Q psy1672 101 LIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNG 180 (600)
Q Consensus 101 L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~ 180 (600)
|+.|+|++|.|+.++. . ..+|+.|+|++|+++.++. .+++|+.|+|++|+|+.++. . ..+|+.|++++
T Consensus 264 L~~L~Ls~N~L~~Lp~-l---p~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~Lp~-l---p~~L~~L~Ls~ 331 (788)
T PRK15387 264 LLELSIFSNPLTHLPA-L---PSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPA-L---PSELCKLWAYN 331 (788)
T ss_pred cceeeccCCchhhhhh-c---hhhcCEEECcCCccccccc----cccccceeECCCCccccCCC-C---ccccccccccc
Confidence 7888888888777665 2 2456677777777766543 23567777777777666532 1 12344444444
Q ss_pred CcCCCCC
Q psy1672 181 NRLSHFP 187 (600)
Q Consensus 181 N~l~~l~ 187 (600)
|.|..++
T Consensus 332 N~L~~LP 338 (788)
T PRK15387 332 NQLTSLP 338 (788)
T ss_pred Ccccccc
Confidence 5444443
No 25
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.24 E-value=2e-11 Score=138.46 Aligned_cols=159 Identities=21% Similarity=0.282 Sum_probs=114.4
Q ss_pred ceEEEccCCCCCccCCCCCCCCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccC
Q psy1672 29 KQWMECRDKFLITIPEAPESELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSD 108 (600)
Q Consensus 29 ~~~v~C~~~~L~~ip~~~~~~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~ 108 (600)
...+.+.+.+++.+|..++.. ++.|+|++|+|+.+|...+ .+|+.|+|++|+|+.++.. + ..+|+.|+|++
T Consensus 180 ~~~L~L~~~~LtsLP~~Ip~~-L~~L~Ls~N~LtsLP~~l~-----~nL~~L~Ls~N~LtsLP~~-l--~~~L~~L~Ls~ 250 (754)
T PRK15370 180 KTELRLKILGLTTIPACIPEQ-ITTLILDNNELKSLPENLQ-----GNIKTLYANSNQLTSIPAT-L--PDTIQEMELSI 250 (754)
T ss_pred ceEEEeCCCCcCcCCcccccC-CcEEEecCCCCCcCChhhc-----cCCCEEECCCCccccCChh-h--hccccEEECcC
Confidence 567888888999999877766 9999999999999997654 4899999999999888653 2 24788889999
Q ss_pred CCCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCc
Q psy1672 109 NLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPV 188 (600)
Q Consensus 109 N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~ 188 (600)
|.|+.+|.... .+|+.|+|++|.++.++...+ .+|+.|+|++|+|+.++.. + ..+|+.|+|++|.+..++.
T Consensus 251 N~L~~LP~~l~---s~L~~L~Ls~N~L~~LP~~l~---~sL~~L~Ls~N~Lt~LP~~-l--p~sL~~L~Ls~N~Lt~LP~ 321 (754)
T PRK15370 251 NRITELPERLP---SALQSLDLFHNKISCLPENLP---EELRYLSVYDNSIRTLPAH-L--PSGITHLNVQSNSLTALPE 321 (754)
T ss_pred CccCcCChhHh---CCCCEEECcCCccCccccccC---CCCcEEECCCCccccCccc-c--hhhHHHHHhcCCccccCCc
Confidence 98888876432 468888888888887754322 4788888888888877432 2 1345666666666666553
Q ss_pred ccccccccccEEEccCCcCc
Q psy1672 189 RSVEPLLKLMMIELHDNPWV 208 (600)
Q Consensus 189 ~~~~~l~~L~~L~l~~N~~~ 208 (600)
... ++|+.|++.+|.+.
T Consensus 322 ~l~---~sL~~L~Ls~N~Lt 338 (754)
T PRK15370 322 TLP---PGLKTLEAGENALT 338 (754)
T ss_pred ccc---ccceeccccCCccc
Confidence 221 34555555555544
No 26
>cd05867 Ig4_L1-CAM_like Fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig4_L1-CAM_like: fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=99.24 E-value=6.2e-11 Score=95.59 Aligned_cols=75 Identities=33% Similarity=0.546 Sum_probs=61.2
Q ss_pred cccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEE
Q psy1672 269 SENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADAN 348 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~ 348 (600)
|+.+.|.|.+.|.|.|+++|+++|..+..... ..+.. ..+ +.|.|.+++.+|+|.|+|.|.|..|.....
T Consensus 1 G~~v~l~C~~~G~P~p~i~W~k~g~~i~~~~~---~~~~~-~~~------~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~ 70 (76)
T cd05867 1 GETARLDCQVEGIPTPNITWSINGAPIEGTDP---DPRRH-VSS------GALILTDVQPSDTAVYQCEARNRHGNLLAN 70 (76)
T ss_pred CCeEEEEEEeeEeCCCeEEEEECCEECCCCCC---CceEE-eeC------CEEEECCCChhhCEEEEEEEECCCCeEEEE
Confidence 67899999999999999999999987754321 11222 222 379999999999999999999999999998
Q ss_pred EEEEE
Q psy1672 349 FTLQV 353 (600)
Q Consensus 349 v~L~V 353 (600)
+.|+|
T Consensus 71 ~~l~V 75 (76)
T cd05867 71 AHVHV 75 (76)
T ss_pred EEEEE
Confidence 88877
No 27
>cd05863 Ig2_VEGFR-3 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). Ig2_VEGFR-3: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-3 (Flt-4) binds two members of the VEGF family (VEGF-C and -D) and is involved in tumor angiogenesis and growth.
Probab=99.24 E-value=3.4e-11 Score=94.20 Aligned_cols=66 Identities=23% Similarity=0.480 Sum_probs=56.2
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
++|.|.+.|.|.|.++|+++|+.+.... ..+.|.|.++..+|+|.|+|+|+|..|..++++.+
T Consensus 1 ~~l~c~v~g~P~P~v~W~kdg~~l~~~~-----------------~~~~L~i~~v~~~D~G~YtC~a~N~~g~~~~~~~~ 63 (67)
T cd05863 1 VKLPVKVAAYPPPEFQWYKDGKLISGKH-----------------SQHSLQIKDVTEASAGTYTLVLWNSAAGLEKRISL 63 (67)
T ss_pred CEEEEEEEEeCCCEEEEEECCEECcccC-----------------CcCEEEECCCCHHHCEEEEEEEEECCccEEEEEEE
Confidence 4789999999999999999998875211 12479999999999999999999999988888877
Q ss_pred EEE
Q psy1672 352 QVT 354 (600)
Q Consensus 352 ~V~ 354 (600)
.+.
T Consensus 64 ~l~ 66 (67)
T cd05863 64 ELI 66 (67)
T ss_pred EEE
Confidence 763
No 28
>cd05735 Ig8_DSCAM Eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig8_DSCAM: the eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=99.23 E-value=1e-10 Score=97.17 Aligned_cols=83 Identities=25% Similarity=0.348 Sum_probs=65.7
Q ss_pred cccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEe--eCCceeeeeeEEEecCCCCCCeEEEEEEecCCCcee
Q psy1672 269 SENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVI--EQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIAD 346 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~--~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~ 346 (600)
|+.++|.|.+.|.|++.+.|.++++.+.... .+..+. ..+ ....+.|.|.++..+|+|.|+|.|.|..|..+
T Consensus 1 g~~~~l~C~~~g~p~~~i~W~k~~~~i~~~~-----~r~~~~~~~~~-~~~~s~L~I~~~~~~D~G~YtC~A~N~~G~~~ 74 (88)
T cd05735 1 GQKKEMSCTAHGEKPIIVRWEKEDRIINPEM-----SRYLVSTKEVG-DEVISTLQILPTVREDSGFFSCHAINSYGEDR 74 (88)
T ss_pred CCeEEEEEEEECCCCCEEEEeeCCEECCCCC-----CcEEEEEecCC-CcEEEEEEECCCCcccCEEEEEEEEcCCCcce
Confidence 6789999999999999999999998764321 122222 122 13346899999999999999999999999999
Q ss_pred EEEEEEEEEcc
Q psy1672 347 ANFTLQVTYRG 357 (600)
Q Consensus 347 ~~v~L~V~~~~ 357 (600)
..+.|.|...+
T Consensus 75 ~~~~L~V~~~P 85 (88)
T cd05735 75 GIIQLTVQEPP 85 (88)
T ss_pred EEEEEEEeCCC
Confidence 99999997543
No 29
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=99.23 E-value=5.6e-12 Score=117.73 Aligned_cols=107 Identities=28% Similarity=0.458 Sum_probs=22.6
Q ss_pred CCCccEEEeecccCcccCccccC-CCCCccEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCccee
Q psy1672 74 LLNLQKLFLARCHIGQIDSGALD-GLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKL 152 (600)
Q Consensus 74 l~~L~~L~L~~n~l~~i~~~~f~-~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L 152 (600)
..+++.|+|++|.|..|.. +. .+.+|+.|+|++|.|+.+.. +..+++|++|++++|.|+.+.......+++|+.|
T Consensus 18 ~~~~~~L~L~~n~I~~Ie~--L~~~l~~L~~L~Ls~N~I~~l~~--l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 18 PVKLRELNLRGNQISTIEN--LGATLDKLEVLDLSNNQITKLEG--LPGLPRLKTLDLSNNRISSISEGLDKNLPNLQEL 93 (175)
T ss_dssp ------------------S----TT-TT--EEE-TTS--S--TT------TT--EEE--SS---S-CHHHHHH-TT--EE
T ss_pred ccccccccccccccccccc--hhhhhcCCCEEECCCCCCccccC--ccChhhhhhcccCCCCCCccccchHHhCCcCCEE
Confidence 3345555555555555432 22 34455555555555555442 4444555555555555554432211234444445
Q ss_pred eCCCCcCcccCh-hhhcCCCCCCEEEcCCCcCC
Q psy1672 153 DMSESRLEHISP-EAFTGAKSLESIKLNGNRLS 184 (600)
Q Consensus 153 ~Ls~n~l~~i~~-~~~~~l~~L~~L~Ls~N~l~ 184 (600)
+|++|+|..+.. ..+..+++|+.|+|.+|.+.
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 554444443321 22233344444444444433
No 30
>cd05723 Ig4_Neogenin Fourth immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig4_Neogenin: fourth immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=99.23 E-value=6.6e-11 Score=94.09 Aligned_cols=71 Identities=24% Similarity=0.507 Sum_probs=57.8
Q ss_pred cceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEE
Q psy1672 271 NATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFT 350 (600)
Q Consensus 271 ~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~ 350 (600)
++.|.|.+.|.|.|.+.|++++..+.... +..+..++ .|.|.+++.+|.|.|+|.|.|..|..++++.
T Consensus 1 ~v~l~C~~~G~P~p~v~W~k~g~~~~~~~------~~~~~~~~------~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~ 68 (71)
T cd05723 1 DVIFECEVTGKPTPTVKWVKNGDMVIPSD------YFKIVKEH------NLQVLGLVKSDEGFYQCIAENDVGNVQASAQ 68 (71)
T ss_pred CEEEEEEEEEeCCCEEEEEECCeECCCCC------CEEEEecC------CEEEEcCCcccCEEEEEEEEcCCCEEEEEEE
Confidence 36899999999999999999988765322 33333333 5788899999999999999999999998888
Q ss_pred EEE
Q psy1672 351 LQV 353 (600)
Q Consensus 351 L~V 353 (600)
|.|
T Consensus 69 L~V 71 (71)
T cd05723 69 LII 71 (71)
T ss_pred EEC
Confidence 764
No 31
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=99.23 E-value=5.9e-12 Score=117.60 Aligned_cols=138 Identities=22% Similarity=0.286 Sum_probs=54.1
Q ss_pred cCCCCCccCCCCCCCCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCC
Q psy1672 35 RDKFLITIPEAPESELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSI 114 (600)
Q Consensus 35 ~~~~L~~ip~~~~~~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l 114 (600)
+...+.+++.......+++|+|++|.|+.|..-.. .+.+|+.|+|++|.|+.+.. |..+++|+.|++++|.|+++
T Consensus 5 t~~~i~~~~~~~n~~~~~~L~L~~n~I~~Ie~L~~---~l~~L~~L~Ls~N~I~~l~~--l~~L~~L~~L~L~~N~I~~i 79 (175)
T PF14580_consen 5 TANMIEQIAQYNNPVKLRELNLRGNQISTIENLGA---TLDKLEVLDLSNNQITKLEG--LPGLPRLKTLDLSNNRISSI 79 (175)
T ss_dssp -------------------------------S--T---T-TT--EEE-TTS--S--TT------TT--EEE--SS---S-
T ss_pred cccccccccccccccccccccccccccccccchhh---hhcCCCEEECCCCCCccccC--ccChhhhhhcccCCCCCCcc
Confidence 34445566665555458999999999998864322 47899999999999999964 88999999999999999999
Q ss_pred CccccCCCCCCCEEEccCCCCCccCc-ccccCCCCcceeeCCCCcCcccCh---hhhcCCCCCCEEE
Q psy1672 115 PSLTFQSVRFLRDLNLARNPISKIEK-GAFQFVPGLVKLDMSESRLEHISP---EAFTGAKSLESIK 177 (600)
Q Consensus 115 ~~~~f~~l~~L~~L~Ls~N~i~~l~~-~~~~~l~~L~~L~Ls~n~l~~i~~---~~~~~l~~L~~L~ 177 (600)
.......+++|+.|+|++|+|..+.. ..+..+++|+.|+|.+|.+..... ..+..+++|+.||
T Consensus 80 ~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 80 SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 76433468999999999999987654 457789999999999999876532 2345677777766
No 32
>KOG0472|consensus
Probab=99.21 E-value=2.7e-13 Score=136.50 Aligned_cols=169 Identities=24% Similarity=0.363 Sum_probs=135.8
Q ss_pred EEccCCCCCccCCCCCC-CCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCC
Q psy1672 32 MECRDKFLITIPEAPES-ELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNL 110 (600)
Q Consensus 32 v~C~~~~L~~ip~~~~~-~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~ 110 (600)
.+|....+.++|..+.. ..+..|+..+|++..+|.+.+ .+.+|..|++.+|++..+++..+. ++.|++||...|.
T Consensus 119 l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~slp~~~~---~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~ 194 (565)
T KOG0472|consen 119 LDCSSNELKELPDSIGRLLDLEDLDATNNQISSLPEDMV---NLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNL 194 (565)
T ss_pred hhccccceeecCchHHHHhhhhhhhccccccccCchHHH---HHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhh
Confidence 44556666666655432 236777778888888888777 477888888888888888777555 8899999999999
Q ss_pred CCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCccc
Q psy1672 111 LTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPVRS 190 (600)
Q Consensus 111 l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~ 190 (600)
++.+|+ .++.+.+|..|+|..|+|..++ .|.++..|.+|+++.|+|.-++.+...++.+|..|||.+|++++.|.+
T Consensus 195 L~tlP~-~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pde- 270 (565)
T KOG0472|consen 195 LETLPP-ELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPDE- 270 (565)
T ss_pred hhcCCh-hhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCchH-
Confidence 999988 4778888999999999998886 588888899999999999988888888899999999999999999854
Q ss_pred ccccccccEEEccCCcCc
Q psy1672 191 VEPLLKLMMIELHDNPWV 208 (600)
Q Consensus 191 ~~~l~~L~~L~l~~N~~~ 208 (600)
+..+.+|..||+++|.+.
T Consensus 271 ~clLrsL~rLDlSNN~is 288 (565)
T KOG0472|consen 271 ICLLRSLERLDLSNNDIS 288 (565)
T ss_pred HHHhhhhhhhcccCCccc
Confidence 456677888999998754
No 33
>cd05730 Ig3_NCAM-1_like Third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig3_NCAM-1_like: domain similar to the third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1,and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the
Probab=99.21 E-value=1.2e-10 Score=98.31 Aligned_cols=84 Identities=24% Similarity=0.478 Sum_probs=68.2
Q ss_pred ccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecC
Q psy1672 262 RYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 262 ~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~ 341 (600)
....+..|+.+.|.|.+.|.|.|.+.|+++|..+.... .+.....++ +.|.|.+++.+|.|.|+|.|+|.
T Consensus 11 ~~~~~~~G~~v~L~C~~~g~P~p~v~W~k~g~~~~~~~-----~~~~~~~~~-----~~L~I~~v~~~D~G~Y~C~a~N~ 80 (95)
T cd05730 11 VNATANLGQSVTLACDADGFPEPTMTWTKDGEPIESGE-----EKYSFNEDG-----SEMTILDVDKLDEAEYTCIAENK 80 (95)
T ss_pred cceEEeCCCCEEEEEeccEeCCCEEEEEECCEECcCCC-----CEEEEeCCC-----CEEEECCCChhhCEEEEEEEEcC
Confidence 34567899999999999999999999999998775431 122222222 46999999999999999999999
Q ss_pred CCceeEEEEEEEEE
Q psy1672 342 AGIADANFTLQVTY 355 (600)
Q Consensus 342 ~G~~~~~v~L~V~~ 355 (600)
.|..+..+.|.|..
T Consensus 81 ~G~~~~~~~L~V~~ 94 (95)
T cd05730 81 AGEQEAEIHLKVFA 94 (95)
T ss_pred CCeEEEEEEEEEEe
Confidence 99999999998853
No 34
>cd05868 Ig4_NrCAM Fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). Ig4_ NrCAM: fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six IG-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=99.21 E-value=8.6e-11 Score=94.77 Aligned_cols=75 Identities=28% Similarity=0.482 Sum_probs=60.3
Q ss_pred cccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEE
Q psy1672 269 SENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADAN 348 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~ 348 (600)
|+.++|.|.+.|.|.|+|.|+++|+.+..... ...... ++ +.|.|.+++..|.|.|+|.|+|..|...++
T Consensus 1 g~~~~l~C~a~G~P~P~i~W~k~g~~i~~~~~----~~~~~~-~~-----~~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~ 70 (76)
T cd05868 1 GEDGTLICRANGNPKPSISWLTNGVPIEIAPT----DPSRKV-DG-----DTIIFSKVQERSSAVYQCNASNEYGYLLAN 70 (76)
T ss_pred CCCEEEEEEeeEeCCCeEEEEECCEEccccCC----CceEEe-cC-----CEEEECCCCHhhCEEEEEEEEcCCCEEEEE
Confidence 67899999999999999999999988753221 111111 22 268899999999999999999999999999
Q ss_pred EEEEE
Q psy1672 349 FTLQV 353 (600)
Q Consensus 349 v~L~V 353 (600)
+.|.|
T Consensus 71 ~~l~v 75 (76)
T cd05868 71 AFVNV 75 (76)
T ss_pred EEEEe
Confidence 98876
No 35
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.21 E-value=4.6e-11 Score=134.97 Aligned_cols=99 Identities=27% Similarity=0.354 Sum_probs=54.8
Q ss_pred CccEEEccCCCCCCCCccccCC-----------------CCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCccc
Q psy1672 100 NLIEIDLSDNLLTSIPSLTFQS-----------------VRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHI 162 (600)
Q Consensus 100 ~L~~L~Ls~N~l~~l~~~~f~~-----------------l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i 162 (600)
+|++|+|++|+|+.+|.. +.. ..+|+.|+|++|.|+.++.. ..+|+.|++++|.|+.+
T Consensus 343 ~Lq~LdLS~N~Ls~LP~l-p~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~LP~l----~s~L~~LdLS~N~LssI 417 (788)
T PRK15387 343 GLQELSVSDNQLASLPTL-PSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVL----PSELKELMVSGNRLTSL 417 (788)
T ss_pred ccceEecCCCccCCCCCC-CcccceehhhccccccCcccccccceEEecCCcccCCCCc----ccCCCEEEccCCcCCCC
Confidence 566666666666665531 110 12345555555555544321 23455566666666555
Q ss_pred ChhhhcCCCCCCEEEcCCCcCCCCCcccccccccccEEEccCCcCc
Q psy1672 163 SPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLLKLMMIELHDNPWV 208 (600)
Q Consensus 163 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~l~~N~~~ 208 (600)
+. . ..+|+.|+|++|+|+.+|. .+..+..|..|++++|+|.
T Consensus 418 P~-l---~~~L~~L~Ls~NqLt~LP~-sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 418 PM-L---PSGLLSLSVYRNQLTRLPE-SLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred Cc-c---hhhhhhhhhccCcccccCh-HHhhccCCCeEECCCCCCC
Confidence 32 1 2345666666666666653 3556677777777777765
No 36
>cd05893 Ig_Palladin_C C-terminal immunoglobulin (Ig)-like domain of palladin. Ig_Palladin_C: C-terminal immunoglobulin (Ig)-like domain of palladin. Palladin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to this family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Palladin binds to alpha-actinin ezrin, vasodilator-stimulated phosphoprotein VASP, SPIN90 (DIP, mDia interacting protein), and Src. Palladin also binds F-actin directly, via its Ig3 domain. Palladin is expressed as several alternatively spliced isoforms, having various combinations of Ig-like domains, in a cell-type-specific manner. It has been suggested that palladin's different Ig-like domains may be specialized for distinct functions.
Probab=99.21 E-value=9e-11 Score=94.27 Aligned_cols=75 Identities=28% Similarity=0.464 Sum_probs=59.5
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
+.|.|.+.|.|.|.|.|++++..+.... .++.+..++. ....|.|.+++.+|.|.|+|.|.|..|..+.++.|
T Consensus 1 v~l~C~v~G~P~P~v~W~k~~~~l~~~~-----~~~~~~~~~~--~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~a~L 73 (75)
T cd05893 1 VRLECRVSGVPHPQIFWKKENESLTHNT-----DRVSMHQDNC--GYICLLIQGATKEDAGWYTVSAKNEAGIVSCTARL 73 (75)
T ss_pred CEEEEEEeEecCCEEEEEECCEECCCCC-----CeEEEEEcCC--CEEEEEECCCCHHHCEEEEEEEEcCCCEEEEEEEE
Confidence 5799999999999999999998775322 2444433321 12369999999999999999999999999988877
Q ss_pred EE
Q psy1672 352 QV 353 (600)
Q Consensus 352 ~V 353 (600)
.|
T Consensus 74 ~V 75 (75)
T cd05893 74 DV 75 (75)
T ss_pred eC
Confidence 64
No 37
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.20 E-value=4.5e-11 Score=135.61 Aligned_cols=118 Identities=20% Similarity=0.267 Sum_probs=77.8
Q ss_pred eEEEccCCCCCccCCCCCCCCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCC
Q psy1672 30 QWMECRDKFLITIPEAPESELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDN 109 (600)
Q Consensus 30 ~~v~C~~~~L~~ip~~~~~~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N 109 (600)
..++..+++++.+|..+... |++|+|++|+|+.+|...+ .+|+.|+|++|.+..++.. + ..+|+.|+|++|
T Consensus 202 ~~L~Ls~N~LtsLP~~l~~n-L~~L~Ls~N~LtsLP~~l~-----~~L~~L~Ls~N~L~~LP~~-l--~s~L~~L~Ls~N 272 (754)
T PRK15370 202 TTLILDNNELKSLPENLQGN-IKTLYANSNQLTSIPATLP-----DTIQEMELSINRITELPER-L--PSALQSLDLFHN 272 (754)
T ss_pred cEEEecCCCCCcCChhhccC-CCEEECCCCccccCChhhh-----ccccEEECcCCccCcCChh-H--hCCCCEEECcCC
Confidence 45677777888888766654 8888888888888876543 3677888888887777543 2 246777788877
Q ss_pred CCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCccc
Q psy1672 110 LLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHI 162 (600)
Q Consensus 110 ~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i 162 (600)
+|+.+|...+ .+|+.|+|++|.++.++.... .+|+.|++++|.+..+
T Consensus 273 ~L~~LP~~l~---~sL~~L~Ls~N~Lt~LP~~lp---~sL~~L~Ls~N~Lt~L 319 (754)
T PRK15370 273 KISCLPENLP---EELRYLSVYDNSIRTLPAHLP---SGITHLNVQSNSLTAL 319 (754)
T ss_pred ccCccccccC---CCCcEEECCCCccccCcccch---hhHHHHHhcCCccccC
Confidence 7777765322 367777777777776643211 2445555555555544
No 38
>cd04969 Ig5_Contactin_like Fifth Ig domain of contactin. Ig5_Contactin_like: Fifth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.20 E-value=7.8e-11 Score=94.17 Aligned_cols=73 Identities=34% Similarity=0.581 Sum_probs=60.8
Q ss_pred cccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEE
Q psy1672 269 SENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADAN 348 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~ 348 (600)
|+.+.|.|.+.|.|.|.+.|+++++.+... .++.+..++ .|.|.+++..|.|.|+|.|.|..|..+.+
T Consensus 1 G~~v~L~C~~~g~P~p~v~W~k~~~~~~~~------~~~~~~~~~------~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~ 68 (73)
T cd04969 1 GGDVIIECKPKAAPKPTISWSKGTELLTNS------SRICIWPDG------SLEILNVTKSDEGKYTCFAENFFGKANST 68 (73)
T ss_pred CCeEEEEEeeeEcCCCEEEEEECCEEcccC------CCEEECCCC------eEEEccCChhHCEEEEEEEECCCCceEEE
Confidence 678999999999999999999998876532 234443333 79999999999999999999999999988
Q ss_pred EEEEE
Q psy1672 349 FTLQV 353 (600)
Q Consensus 349 v~L~V 353 (600)
+.|.|
T Consensus 69 ~~l~V 73 (73)
T cd04969 69 GSLSV 73 (73)
T ss_pred EEEEC
Confidence 88764
No 39
>cd04971 Ig_TrKABC_d5 Fifth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d5: the fifth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrkB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor foun
Probab=99.20 E-value=1.2e-10 Score=95.00 Aligned_cols=77 Identities=22% Similarity=0.388 Sum_probs=59.7
Q ss_pred eeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeC--CceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEE
Q psy1672 273 TVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQ--GEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFT 350 (600)
Q Consensus 273 ~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~--g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~ 350 (600)
.+.|.+.|.|.|+|+|+++|+.+.... ......... ......+.|.|.+++..|+|.|+|+|+|..|.+++++.
T Consensus 2 ~i~~~v~G~P~P~v~W~k~g~~i~~~~----~~~~~~~~~~~~~~~~~~~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~ 77 (81)
T cd04971 2 CIPFTVRGNPKPTLTWYHNGAVLNESD----YIRTEIHYEVTTPTEYHGCLQFDNPTHVNNGNYTLVASNEYGQDSKSIS 77 (81)
T ss_pred eEEEEeEeeCCCcEEEEECCEECcCCC----ceeEEEEeecccccccEEEEEECCCCcccCeEEEEEEEeCCCCeeeEEE
Confidence 468999999999999999999886543 111222211 12234568999999999999999999999999999888
Q ss_pred EEE
Q psy1672 351 LQV 353 (600)
Q Consensus 351 L~V 353 (600)
+++
T Consensus 78 ~~~ 80 (81)
T cd04971 78 AHF 80 (81)
T ss_pred eee
Confidence 875
No 40
>cd05865 Ig1_NCAM-1 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. Ig1_NCAM-1: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (trans
Probab=99.20 E-value=1.3e-10 Score=98.04 Aligned_cols=87 Identities=30% Similarity=0.487 Sum_probs=66.6
Q ss_pred ccccccccccccceeeeEeecCCC-CeeEEEE-cCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEE
Q psy1672 260 DSRYVEAVSSENATVVCRVDSIPP-AAISWYW-NGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCV 337 (600)
Q Consensus 260 ~~~~~~v~~G~~v~L~C~v~g~P~-p~i~W~~-~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~ 337 (600)
.+....+..|+.++|.|.+.|.|. |.+.|++ ++..+.... .++.+..++. ..+.|.|.+++.+|+|.|+|.
T Consensus 6 ~p~~~~v~~G~~v~l~C~v~G~P~~p~i~W~~~~g~~l~~~~-----~r~~v~~~~~--~~~~L~I~~v~~~D~G~YtC~ 78 (96)
T cd05865 6 VPSQGEISVGESKFFLCQVAGEAKDKDISWFSPNGEKLTPNQ-----QRISVVRNDD--YSSTLTIYNANIDDAGIYKCV 78 (96)
T ss_pred eCCccEECCCCeEEEEEEEeCCCCCCEEEEECCCCcCccccC-----CeEEEEeCCC--CceEEEEeccChhhCEEEEEE
Confidence 345567888999999999999995 7999998 676554321 1333333321 246899999999999999999
Q ss_pred EecCC-CceeEEEEEEE
Q psy1672 338 AENRA-GIADANFTLQV 353 (600)
Q Consensus 338 a~N~~-G~~~~~v~L~V 353 (600)
|.|.+ |..++++.|.|
T Consensus 79 A~N~~~g~~~~s~~l~v 95 (96)
T cd05865 79 VSNEDEGESEATVNVKI 95 (96)
T ss_pred EEcCCCCcEEEEEEEEE
Confidence 99997 88888888765
No 41
>cd05859 Ig4_PDGFR-alpha Fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. IG4_PDGFR-alpha: The fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFR alpha binds to all three PDGFs, whereas the PDGFR beta (not included in this group) binds only to PDGF-B. PDGF alpha is organized as an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFR alpha and PDGFR beta are essential for normal development.
Probab=99.19 E-value=9.4e-11 Score=99.93 Aligned_cols=87 Identities=31% Similarity=0.434 Sum_probs=68.4
Q ss_pred cccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeC--CceeeeeeEEEecCCCCCCeEEEEEEec
Q psy1672 263 YVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQ--GEYERKSSLVLTNAQESDSGRFYCVAEN 340 (600)
Q Consensus 263 ~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~--g~~~~~s~L~I~~v~~~d~G~Y~C~a~N 340 (600)
..++..|..+.|.|.+.|.|+|.+.|+++|+.+..... ....... ......+.|.|.+++.+|+|.|+|.|.|
T Consensus 12 ~~~~~~~~~~~l~~~v~g~P~P~v~W~kdg~~l~~~~~-----~~~~~~~~~~~~~~~s~L~I~~v~~~D~G~Ytc~A~N 86 (101)
T cd05859 12 LEFANLHEVKEFVVEVEAYPPPQIRWLKDNRTLIENLT-----EITTSEHNVQETRYVSKLKLIRAKEEDSGLYTALAQN 86 (101)
T ss_pred eEEEecCCcEEEEEEEEEeCCCceEEEECCEECcCCcc-----eEEeccccccceeeccEEEEeeCCHHHCEEEEEEEEc
Confidence 45677899999999999999999999999998875431 1111010 1123346899999999999999999999
Q ss_pred CCCceeEEEEEEEE
Q psy1672 341 RAGIADANFTLQVT 354 (600)
Q Consensus 341 ~~G~~~~~v~L~V~ 354 (600)
..|.++.++.|.|.
T Consensus 87 ~~g~~~~t~~l~V~ 100 (101)
T cd05859 87 EDAVKSYTFALQIQ 100 (101)
T ss_pred CCceEEEEEEEEEE
Confidence 99999988888773
No 42
>cd05744 Ig_Myotilin_C_like Immunoglobulin (Ig)-like domain of myotilin, palladin, and myopalladin. Ig_Myotilin_like_C: immunoglobulin (Ig)-like domain in myotilin, palladin, and myopalladin. Myotilin, palladin, and myopalladin function as scaffolds that regulate actin organization. Myotilin and myopalladin are most abundant in skeletal and cardiac muscle; palladin is ubiquitously expressed in the organs of developing vertebrates and plays a key role in cellular morphogenesis. The three family members each interact with specific molecular partners: all three bind to alpha-actinin; in addition, palladin also binds to vasodilator-stimulated phosphoprotein (VASP) and ezrin, myotilin binds to filamin and actin, and myopalladin also binds to nebulin and cardiac ankyrin repeat protein (CARP).
Probab=99.19 E-value=1.6e-10 Score=92.91 Aligned_cols=75 Identities=35% Similarity=0.580 Sum_probs=59.5
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
++|.|.+.|.|.|.|.|+++++.+.... .++.+..++. ....|.|.+++.+|.|.|+|.|.|.+|.+...+.|
T Consensus 1 v~L~C~v~G~P~P~v~W~k~~~~i~~~~-----~r~~~~~~~~--~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l 73 (75)
T cd05744 1 VRLECRVSAIPPPQIFWKKNNEMLTYNT-----DRISLYQDNC--GRICLLIQNANKEDAGWYTVSAVNEAGVVSCNARL 73 (75)
T ss_pred CEEEEEEeecCCCeEEEEECCEECCCCC-----CcEEEEEcCC--CeEEEEECCCCcccCEEEEEEEEcCCCcEEEEEEE
Confidence 5799999999999999999998875322 2344443321 12369999999999999999999999999988877
Q ss_pred EE
Q psy1672 352 QV 353 (600)
Q Consensus 352 ~V 353 (600)
.|
T Consensus 74 ~v 75 (75)
T cd05744 74 DV 75 (75)
T ss_pred eC
Confidence 64
No 43
>cd05854 Ig6_Contactin-2 Sixth Ig domain of contactin-2. Ig6_Contactin-2: Sixth Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=99.18 E-value=1.6e-10 Score=95.27 Aligned_cols=81 Identities=27% Similarity=0.342 Sum_probs=61.1
Q ss_pred ccceeeeEeecCCCC--eeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeE
Q psy1672 270 ENATVVCRVDSIPPA--AISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADA 347 (600)
Q Consensus 270 ~~v~L~C~v~g~P~p--~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~ 347 (600)
++++|.|.+.|.|.| .+.|+++++.+..... ..+....... ...+.|+|.+++..|.|.|+|.|.|.+|..++
T Consensus 1 ~~~~L~C~a~g~P~p~~~v~W~~~g~~i~~~~~---~~~~~~~~~~--~~~~~L~I~~v~~~D~G~YtC~A~n~~g~~~~ 75 (85)
T cd05854 1 ENLTLQCHASHDPTMDLTFTWSLDDFPIDLDKP---NGHYRRMEVK--ETIGDLVIVNAQLSHAGTYTCTAQTVVDSASA 75 (85)
T ss_pred CcEEEEEEEecCCCCCeEEEEEECCeEccccCC---CCcEEEEEec--ceEeEEEEccCChhhCeEEEEEEecCCCCEEE
Confidence 468999999999987 5799999987754321 1111111100 12358999999999999999999999999999
Q ss_pred EEEEEEEE
Q psy1672 348 NFTLQVTY 355 (600)
Q Consensus 348 ~v~L~V~~ 355 (600)
++.|.|..
T Consensus 76 ~~~L~V~~ 83 (85)
T cd05854 76 SATLVVRG 83 (85)
T ss_pred EEEEEEEC
Confidence 99998854
No 44
>cd04972 Ig_TrkABC_d4 Fourth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d4: the fourth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor fo
Probab=99.18 E-value=1.2e-10 Score=97.16 Aligned_cols=84 Identities=19% Similarity=0.309 Sum_probs=66.1
Q ss_pred cccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEec
Q psy1672 261 SRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAEN 340 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N 340 (600)
+....+..|+.+.|.|.+.|.|.|.+.|++++..+.... ...... ....+.|.|.++..+|.|.|+|.|.|
T Consensus 7 p~~~~v~~G~~v~l~C~~~G~P~p~v~W~~~g~~~~~~~------~~~~~~---~~~~~~L~I~~v~~~D~g~Y~C~A~N 77 (90)
T cd04972 7 PNATVVYEGGTATIRCTAEGSPLPKVEWIIAGLIVIQTR------TDTLET---TVDIYNLQLSNITSETQTTVTCTAEN 77 (90)
T ss_pred CcCEEEcCCCcEEEEEEEEEcCCCeEEEEECCEEccCCc------cEEEEe---cCCEEEEEEecCCcccCEEEEEEEEC
Confidence 455668899999999999999999999999998764322 111111 11235799999999999999999999
Q ss_pred CCCceeEEEEEEE
Q psy1672 341 RAGIADANFTLQV 353 (600)
Q Consensus 341 ~~G~~~~~v~L~V 353 (600)
..|.+.+.+.|.|
T Consensus 78 ~~G~~~~~~~L~v 90 (90)
T cd04972 78 PVGQANVSVQVTV 90 (90)
T ss_pred CCCceeEEEEEeC
Confidence 9999998887754
No 45
>PF07679 I-set: Immunoglobulin I-set domain; InterPro: IPR013098 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents I-set domains, which are found in several cell adhesion molecules, including vascular (VCAM), intercellular (ICAM), neural (NCAM) and mucosal addressin (MADCAM) cell adhesion molecules, as well as junction adhesion molecules (JAM). I-set domains are also present in several other diverse protein families, including several tyrosine-protein kinase receptors, the hemolymph protein hemolin, the muscle proteins titin, telokin, and twitchin, the neuronal adhesion molecule axonin-1 [], and the signalling molecule semaphorin 4D that is involved in axonal guidance, immune function and angiogenesis [].; PDB: 3MTR_A 2EDK_A 3DMK_B 1KOA_A 3NCM_A 2NCM_A 2V9Q_A 2CR3_A 3QQN_A 3QR2_A ....
Probab=99.18 E-value=1.1e-10 Score=97.25 Aligned_cols=90 Identities=34% Similarity=0.611 Sum_probs=74.0
Q ss_pred cccccccccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEE
Q psy1672 255 PEIRMDSRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRF 334 (600)
Q Consensus 255 p~i~~~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y 334 (600)
|.+...+..+.+..|+.++|.|.+.+.|.+++.|+++++.+.... +..+...+ ..+.|.|.+++..|.|.|
T Consensus 1 P~~~~~~~~~~v~~G~~~~l~c~~~~~p~~~v~W~~~~~~l~~~~------~~~~~~~~---~~~~L~I~~v~~~D~G~Y 71 (90)
T PF07679_consen 1 PVFTKKPKDVTVKEGESVTLECEVSGNPPPTVTWYKNGRPLTSSQ------RYQIESDG---GSSSLTIKNVTREDAGTY 71 (90)
T ss_dssp EEEEEESSEEEEETTSEEEEEEEEEESSSSEEEEEETTEEEESSS------SEEEEEET---TEEEEEESSESGGGSEEE
T ss_pred CEEEEecCCEEEeCCCEEEEEEEEEeCCCCcccccccccceeeee------eeeeeccc---ceeEEccCCCChhhCEEE
Confidence 345555678889999999999999999999999999998887633 33333332 346899999999999999
Q ss_pred EEEEecCCCceeEEEEEEE
Q psy1672 335 YCVAENRAGIADANFTLQV 353 (600)
Q Consensus 335 ~C~a~N~~G~~~~~v~L~V 353 (600)
+|.|+|..|..++.+.|.|
T Consensus 72 ~C~~~n~~g~~~~~~~l~V 90 (90)
T PF07679_consen 72 TCVASNSSGEATASVNLTV 90 (90)
T ss_dssp EEEEEETTEEEEEEEEEEE
T ss_pred EEEEEECCCEEEEEEEEEC
Confidence 9999999999999888865
No 46
>cd05748 Ig_Titin_like Immunoglobulin (Ig)-like domain of titin and similar proteins. Ig_Titin_like: immunoglobulin (Ig)-like domain found in titin-like proteins. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic, depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone. It appears to function similarly to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching. Within the sarcomere, titin is also attached to or is associated with myosin binding protein C (MyBP-C). MyBP-C appears to contribute to the generation of passive tension by titin, and similar to titin has repeated Ig-like and FN-
Probab=99.18 E-value=2.1e-10 Score=91.93 Aligned_cols=73 Identities=26% Similarity=0.454 Sum_probs=59.3
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
+.|.|.+.|.|.|.+.|+++|+.+.... ++.+...+ ..+.|.|.+++..|+|.|+|.|.|..|.++..+.|
T Consensus 2 ~~l~c~~~G~P~p~v~W~k~g~~l~~~~------~~~~~~~~---~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l 72 (74)
T cd05748 2 VRLEVPISGRPTPTVTWSKDGKPLKLSG------RVQIETTA---SSTSLVIKNAERSDSGKYTLTLKNPAGEKSATINV 72 (74)
T ss_pred EEEEeeEeeeCCCeEEEEECCEEcCCCC------eEEEEECC---CeEEEEECCCCcCcCEEEEEEEECCCccEEEEEEE
Confidence 6799999999999999999998874322 33333222 24589999999999999999999999999988887
Q ss_pred EE
Q psy1672 352 QV 353 (600)
Q Consensus 352 ~V 353 (600)
.|
T Consensus 73 ~V 74 (74)
T cd05748 73 KV 74 (74)
T ss_pred EC
Confidence 64
No 47
>cd05732 Ig5_NCAM-1_like Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM) and similar proteins. Ig5_NCAM-1 like: domain similar to the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM mole
Probab=99.17 E-value=1.9e-10 Score=97.15 Aligned_cols=89 Identities=31% Similarity=0.427 Sum_probs=67.4
Q ss_pred cccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEec
Q psy1672 261 SRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAEN 340 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N 340 (600)
.....+.+|+.+.|.|.+.|.|.|.+.|++++..+...... ...++.+.... ..+.|.|.+++.+|.|.|+|.|.|
T Consensus 8 ~~~~~~~~g~~v~l~C~~~g~p~p~v~W~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~L~I~~v~~~D~G~Y~C~a~N 83 (96)
T cd05732 8 LENQTAVELEQITLTCEAEGDPIPEITWRRATRNFSEGDKS-LDGRIVVRGHA---RVSSLTLKDVQLTDAGRYDCEASN 83 (96)
T ss_pred cCceeEecCCcEEEEEEEeEcCCCcEEEEECCcccCCCCcc-ccceEEEeCCc---cEEEEEECcCCcCcCEEeEEEEEe
Confidence 34567788999999999999999999999988655432211 11233332221 246899999999999999999999
Q ss_pred CCCceeEEEEEEE
Q psy1672 341 RAGIADANFTLQV 353 (600)
Q Consensus 341 ~~G~~~~~v~L~V 353 (600)
..|.++.++.|.|
T Consensus 84 ~~G~~~~s~~l~v 96 (96)
T cd05732 84 RIGGDQQSMYLEV 96 (96)
T ss_pred CCCCcEEEEEEeC
Confidence 9999988887764
No 48
>cd04978 Ig4_L1-NrCAM_like Fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). Ig4_L1-NrCAM_like: fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). These proteins belong to the L1 subfamily of cell adhesion molecules (CAMs) and are comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. These molecules are primarily expressed in the nervous system. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=99.17 E-value=1.6e-10 Score=92.97 Aligned_cols=75 Identities=27% Similarity=0.426 Sum_probs=61.0
Q ss_pred cccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEE
Q psy1672 269 SENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADAN 348 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~ 348 (600)
|+.+.|.|.+.|.|.|+|.|++++..+...... ...... .+.|.|.+++..|.|.|+|.|.|..|...+.
T Consensus 1 G~~~~l~C~~~g~P~p~i~W~~~g~~~~~~~~~----~~~~~~------~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~ 70 (76)
T cd04978 1 GETGRLDCEAEGIPQPTITWRLNGVPIEELPPD----PRRRVD------GGTLILSNVQPNDTAVYQCNASNVHGYLLAN 70 (76)
T ss_pred CCeEEEEEEceeeCCCEEEEEECCEECCCCCCc----ceEEcc------CCEEEECCCChhhCEEEEEEEEccCCeEEEe
Confidence 678999999999999999999999877643311 111111 2479999999999999999999999999999
Q ss_pred EEEEE
Q psy1672 349 FTLQV 353 (600)
Q Consensus 349 v~L~V 353 (600)
+.|.|
T Consensus 71 ~~l~V 75 (76)
T cd04978 71 AFVHV 75 (76)
T ss_pred EEEEE
Confidence 88876
No 49
>cd05728 Ig4_Contactin-2-like Fourth Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig4_Contactin-2-like: fourth Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=99.17 E-value=1.5e-10 Score=95.51 Aligned_cols=81 Identities=35% Similarity=0.441 Sum_probs=66.8
Q ss_pred ccccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEe
Q psy1672 260 DSRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAE 339 (600)
Q Consensus 260 ~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~ 339 (600)
.+....+..|+.+.|.|.+.|.|.|.+.|++++..+.... ++.. .+ +.|.|.+++.+|.|.|+|.|.
T Consensus 5 ~p~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~g~~~~~~~------~~~~-~~------~~L~i~~~~~~D~G~Y~C~a~ 71 (85)
T cd05728 5 VISDTEADIGSSLRWECKASGNPRPAYRWLKNGQPLASEN------RIEV-EA------GDLRITKLSLSDSGMYQCVAE 71 (85)
T ss_pred cCCccEEcCCCcEEEEEEeeEeCCCEEEEEECCEECCCCC------eEEE-eC------CEEEEeeCCHHHCEEEEEEEE
Confidence 4566788899999999999999999999999998765322 3322 22 379999999999999999999
Q ss_pred cCCCceeEEEEEEE
Q psy1672 340 NRAGIADANFTLQV 353 (600)
Q Consensus 340 N~~G~~~~~v~L~V 353 (600)
|..|...+++.|.|
T Consensus 72 N~~G~~~~~~~l~V 85 (85)
T cd05728 72 NKHGTIYASAELAV 85 (85)
T ss_pred CCCCeEEEEEEEEC
Confidence 99999988877754
No 50
>cd05870 Ig5_NCAM-2 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). Ig5_NCAM-2: the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=99.16 E-value=2.3e-10 Score=97.20 Aligned_cols=89 Identities=29% Similarity=0.421 Sum_probs=66.0
Q ss_pred cccccccccccceeeeEeecCCCCeeEEEEc--CeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEE
Q psy1672 261 SRYVEAVSSENATVVCRVDSIPPAAISWYWN--GRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVA 338 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~--g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a 338 (600)
.....+.+|+.++|.|.+.|.|.|.|.|+++ +..+.... .....++.+.... ..+.|.|.+++.+|+|.|+|.|
T Consensus 8 ~~~~~~~~G~~v~l~C~~~G~P~p~i~W~k~~~g~~~~~~~-~~~~~r~~v~~~~---~~~~L~I~~v~~~D~G~Y~C~A 83 (98)
T cd05870 8 LKNETTVENGAATLSCKAEGEPIPEITWKRASDGHTFSEGD-KSPDGRIEVKGQH---GESSLHIKDVKLSDSGRYDCEA 83 (98)
T ss_pred eccEEEcCCCcEEEEEecccCCCCeEEEEECCCCceeccCC-cCcCceEEEeecC---CeeEEEEeeCCcCCCEEEEEEE
Confidence 4567888999999999999999999999993 43332211 0112344333221 2357999999999999999999
Q ss_pred ecCCCceeEEEEEEE
Q psy1672 339 ENRAGIADANFTLQV 353 (600)
Q Consensus 339 ~N~~G~~~~~v~L~V 353 (600)
.|..|...+++.|.|
T Consensus 84 ~N~~G~~~~~~~l~~ 98 (98)
T cd05870 84 ASRIGGHQKSMYLDI 98 (98)
T ss_pred eccCCcceeEEEEeC
Confidence 999999988877754
No 51
>cd04968 Ig3_Contactin_like Third Ig domain of contactin. Ig3_Contactin_like: Third Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.16 E-value=2.7e-10 Score=94.63 Aligned_cols=82 Identities=23% Similarity=0.285 Sum_probs=65.9
Q ss_pred cccccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEE
Q psy1672 259 MDSRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVA 338 (600)
Q Consensus 259 ~~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a 338 (600)
..+....+..|+.+.|.|.+.|.|.|++.|++++..+.... ... . ..+.|.|.+++.+|+|.|+|.|
T Consensus 6 ~~p~~~~~~~g~~v~l~C~~~g~P~p~v~W~k~~~~~~~~~------~~~-~------~~~~L~i~~v~~~D~G~Y~C~a 72 (88)
T cd04968 6 VFPKDTYALKGQNVTLECFALGNPVPQIKWRKVDGSMPSSA------EIS-M------SGAVLKIPNIQFEDEGTYECEA 72 (88)
T ss_pred ECCCceEEeCCCcEEEEEEeeEeCCCEEEEEECCCcCCCcc------EEE-E------eCCEEEECCCCcccCEEEEEEE
Confidence 34566778899999999999999999999999776443221 111 1 1247999999999999999999
Q ss_pred ecCCCceeEEEEEEE
Q psy1672 339 ENRAGIADANFTLQV 353 (600)
Q Consensus 339 ~N~~G~~~~~v~L~V 353 (600)
.|..|..+....|.|
T Consensus 73 ~N~~G~~~~~~~l~V 87 (88)
T cd04968 73 ENIKGKDTHQGRIYV 87 (88)
T ss_pred EECCCcEEEEEEEEE
Confidence 999999988888776
No 52
>cd05857 Ig2_FGFR Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. Ig2_FGFR: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three IG-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin sulfate proteoglycans.
Probab=99.14 E-value=3e-10 Score=93.57 Aligned_cols=82 Identities=22% Similarity=0.416 Sum_probs=64.3
Q ss_pred ccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCC
Q psy1672 264 VEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAG 343 (600)
Q Consensus 264 ~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G 343 (600)
..+..|+.+.|.|.+.|.|.|.+.|+++|..+...... ....... ....|.|.+++.+|.|.|+|.|.|..|
T Consensus 4 ~~v~~G~~~~L~C~~~g~P~p~i~W~k~g~~l~~~~~~---~~~~~~~-----~~~~l~i~~~~~~D~G~Y~C~a~N~~G 75 (85)
T cd05857 4 HAVPAANTVKFRCPAAGNPTPTMRWLKNGKEFKQEHRI---GGYKVRN-----QHWSLIMESVVPSDKGNYTCVVENEYG 75 (85)
T ss_pred EEcCCCCEEEEEEEcCCCCCCEEEEEECCEECCCCCce---eeeEEeC-----CceEEEEccCCcccCEEEEEEEEeCCC
Confidence 35678999999999999999999999999887643311 1111111 124689999999999999999999999
Q ss_pred ceeEEEEEEE
Q psy1672 344 IADANFTLQV 353 (600)
Q Consensus 344 ~~~~~v~L~V 353 (600)
..+..+.|.|
T Consensus 76 ~~~~~~~l~v 85 (85)
T cd05857 76 SINHTYHLDV 85 (85)
T ss_pred EEEEEEEEEC
Confidence 9998888764
No 53
>cd05746 Ig4_Peroxidasin Fourth immunoglobulin (Ig)-like domain of peroxidasin. Ig4_Peroxidasin: the fourth immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted, and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells, which have undergone programmed cell death, and protection of the organism against non-self.
Probab=99.14 E-value=1.8e-10 Score=90.99 Aligned_cols=68 Identities=24% Similarity=0.519 Sum_probs=55.6
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
+.|.|.+.|.|.|.+.|++++..+.... ++.+..+ +.|.|.+++.+|.|.|+|.|.|..|.++.++.|
T Consensus 1 v~L~C~~~g~P~p~i~W~k~g~~~~~~~------~~~~~~~------~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~L 68 (69)
T cd05746 1 VQIPCSAQGDPEPTITWNKDGVQVTESG------KFHISPE------GYLAIRDVGVADQGRYECVARNTIGYASVSMVL 68 (69)
T ss_pred CEeEecceEeCCCEEEEEECCEECCCCC------CEEECCC------CEEEECcCChhhCEEEEEEEECCCCcEEEEEEe
Confidence 5789999999999999999988765322 3333222 379999999999999999999999999887765
No 54
>cd05864 Ig2_VEGFR-2 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). Ig2_VEGF-2: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-2 (KDR/Flk-1) is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF-A also interacts with VEGFR-1, which it binds more strongly than VEGFR-2. VEGFR-2 and -1 may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=99.13 E-value=1.8e-10 Score=91.13 Aligned_cols=68 Identities=24% Similarity=0.458 Sum_probs=55.4
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
+.+.|.+.|.|.|.+.|+++|+.+.... +. .. ...|.|.++..+|+|.|+|.|.|..|..+...++
T Consensus 1 ~~~~c~v~G~P~P~v~W~k~g~~l~~~~------~~--~~------~~~L~I~~v~~~D~G~YtC~a~N~~G~~~~~~t~ 66 (70)
T cd05864 1 VKIPVKYYGYPPPEVKWYKNGQLIVLNH------TF--KR------GVHLTIYEVTEKDAGNYTVVLTNPITKEEQRHTF 66 (70)
T ss_pred CEEEeEEEEeCCCEEEEEECCEECCCCC------EE--cc------CCEEEECcCCHHHCEEEEEEEEECCCceeeEEEE
Confidence 4689999999999999999999886432 11 11 1369999999999999999999999988777666
Q ss_pred EE
Q psy1672 352 QV 353 (600)
Q Consensus 352 ~V 353 (600)
.+
T Consensus 67 ~l 68 (70)
T cd05864 67 QL 68 (70)
T ss_pred EE
Confidence 65
No 55
>cd07693 Ig1_Robo First immunoglobulin (Ig)-like domain in Robo (roundabout) receptors and similar proteins. Ig1_Robo: domain similar to the first immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit res
Probab=99.13 E-value=3.9e-10 Score=95.60 Aligned_cols=97 Identities=26% Similarity=0.394 Sum_probs=67.3
Q ss_pred cccccccccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEE
Q psy1672 255 PEIRMDSRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRF 334 (600)
Q Consensus 255 p~i~~~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y 334 (600)
|.+...+..+.+..|+.+.|.|.+.|.|.|.+.|+++|..+........ .+.....++... ...+.+..++..|.|.|
T Consensus 2 P~i~~~p~~~~v~~G~~~~l~C~~~g~P~p~i~W~k~g~~l~~~~~~~~-~~~~~~~~~~~~-~~~i~~~~~~~~D~G~Y 79 (100)
T cd07693 2 PRIVEHPSDLIVSKGDPATLNCKAEGRPTPTIQWLKNGQPLETDKDDPR-SHRIVLPSGSLF-FLRVVHGRKGRSDEGVY 79 (100)
T ss_pred CeEEecCceeEEcCCCeEEEEeeCCcCCCCEEEEEECCEECccccCCCC-cceEEecCCcEE-EEEeeccCCCcCcCEEE
Confidence 4555667778889999999999999999999999999988765321111 112222333111 11222334478999999
Q ss_pred EEEEecCCCc-eeEEEEEEE
Q psy1672 335 YCVAENRAGI-ADANFTLQV 353 (600)
Q Consensus 335 ~C~a~N~~G~-~~~~v~L~V 353 (600)
+|.|+|..|. .++.+.|.|
T Consensus 80 ~C~a~N~~G~~~s~~~~l~v 99 (100)
T cd07693 80 VCVAHNSLGEAVSRNASLEV 99 (100)
T ss_pred EEEEEccccceecceEEEEe
Confidence 9999999999 567777765
No 56
>cd05876 Ig3_L1-CAM Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM: third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=99.13 E-value=2.8e-10 Score=90.41 Aligned_cols=70 Identities=29% Similarity=0.505 Sum_probs=55.8
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
+.|.|.+.|.|.|.+.|++++..+.... ..... ..+.|.|.+++.+|+|.|+|.|.|..|..+..+.|
T Consensus 1 ~~L~C~~~G~P~P~v~W~k~~~~~~~~~-------~~~~~-----~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l 68 (71)
T cd05876 1 LVLECIAEGLPTPEVHWDRIDGPLSPNR-------TKKLN-----NNKTLQLDNVLESDDGEYVCTAENSEGSARHHYTV 68 (71)
T ss_pred CEEEEEeeEecCCeEEEEECCcCCCCCc-------eeEEc-----CCCEEEEcccCHHhCEEEEEEEEcCCCeEEEEEEE
Confidence 4689999999999999999886553211 11111 12489999999999999999999999999988888
Q ss_pred EE
Q psy1672 352 QV 353 (600)
Q Consensus 352 ~V 353 (600)
.|
T Consensus 69 ~V 70 (71)
T cd05876 69 TV 70 (71)
T ss_pred EE
Confidence 76
No 57
>cd05891 Ig_M-protein_C C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). Ig_M-protein_C: the C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). M-protein is a structural protein localized to the M-band, a transverse structure in the center of the sarcomere, and is a candidate for M-band bridges. M-protein is modular consisting mainly of repetitive IG-like and fibronectin type III (FnIII) domains, and has a muscle-type specific expression pattern. M-protein is present in fast fibers.
Probab=99.13 E-value=3.7e-10 Score=94.66 Aligned_cols=84 Identities=23% Similarity=0.378 Sum_probs=67.1
Q ss_pred cccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEe-eCCceeeeeeEEEecCCCCCCeEEEEEEe
Q psy1672 261 SRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVI-EQGEYERKSSLVLTNAQESDSGRFYCVAE 339 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~-~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~ 339 (600)
+..+.+.+|+.+.|.|.+.|.|.|.+.|+++++.+.... ++.+. ..+ ..+.|.|.+++.+|+|.|+|.|.
T Consensus 8 p~~v~v~eG~~v~L~C~v~g~P~p~i~W~k~~~~~~~~~------~~~~~~~~~---~~~~L~I~~~~~~D~G~Y~C~a~ 78 (92)
T cd05891 8 PDVVTIMEGKTLNLTCTVFGNPDPEVIWFKNDQDIELSE------HYSVKLEQG---KYASLTIKGVTSEDSGKYSINVK 78 (92)
T ss_pred CCcEEEcCCCEEEEEEEEEEeCCCeEEEEECCEECCCCC------CEEEEEcCC---CEEEEEECCCChhhCEEEEEEEE
Confidence 557788999999999999999999999999988765322 22221 122 12479999999999999999999
Q ss_pred cCCCceeEEEEEEE
Q psy1672 340 NRAGIADANFTLQV 353 (600)
Q Consensus 340 N~~G~~~~~v~L~V 353 (600)
|..|.++..+.|.|
T Consensus 79 N~~G~~~~~~~v~~ 92 (92)
T cd05891 79 NKYGGETVDVTVSV 92 (92)
T ss_pred eCCCceeeEEEEEC
Confidence 99999998887764
No 58
>cd05763 Ig_1 Subgroup of the immunoglobulin (Ig) superfamily. Ig_1: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.11 E-value=4.6e-10 Score=90.17 Aligned_cols=74 Identities=27% Similarity=0.495 Sum_probs=56.4
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
++|.|.+.|.|.|++.|++++....... ...++.+...+ +.|.|.+++.+|+|.|+|.|.|..|..+..+.|
T Consensus 1 a~l~C~~~G~P~P~v~W~k~~~~~~~~~---~~~~~~~~~~~-----~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~~~l 72 (75)
T cd05763 1 ARLECAATGHPTPQIAWQKDGGTDFPAA---RERRMHVMPED-----DVFFIVDVKIEDTGVYSCTAQNTAGSISANATL 72 (75)
T ss_pred CEeEeecccccCCEEEEEeCCCccCCcc---cccceEEecCC-----CEEEEeeCCcccCEEEEEEEEcCCCEEEeeEEE
Confidence 4789999999999999999875322111 11233332222 378999999999999999999999999988888
Q ss_pred EE
Q psy1672 352 QV 353 (600)
Q Consensus 352 ~V 353 (600)
.|
T Consensus 73 ~V 74 (75)
T cd05763 73 TV 74 (75)
T ss_pred EE
Confidence 76
No 59
>cd05726 Ig4_Robo Fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig4_Robo: domain similar to the fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=99.10 E-value=5.8e-10 Score=93.06 Aligned_cols=83 Identities=30% Similarity=0.330 Sum_probs=62.6
Q ss_pred cccceeeeEeecCCCCeeEEEEcCeeccC--CcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCcee
Q psy1672 269 SENATVVCRVDSIPPAAISWYWNGRLLLN--NTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIAD 346 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~g~~l~~--~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~ 346 (600)
|+.++|.|.+.|.|.|.+.|++++..+.. ........++.+..+ +.|.|.+++.+|+|.|+|.|.|..|...
T Consensus 1 G~~v~L~C~~~g~P~p~v~W~k~g~~~~~~~~~~~~~~~r~~v~~~------~~L~I~~v~~~D~G~Y~C~a~N~~G~~~ 74 (90)
T cd05726 1 GRTVTFQCEATGNPQPAIFWQKEGSQNLLFSYQPPQSSSRFSVSQT------GDLTITNVQRSDVGYYICQTLNVAGSIL 74 (90)
T ss_pred CCEEEEEEECCccCCCEEEEEeCCCcceeecccCCCCCCeEEECCC------CeEEEeeCChhhCEEEEEEEEcCCCceE
Confidence 67899999999999999999997753211 000011223333323 3799999999999999999999999999
Q ss_pred EEEEEEEEEcc
Q psy1672 347 ANFTLQVTYRG 357 (600)
Q Consensus 347 ~~v~L~V~~~~ 357 (600)
..+.|.|....
T Consensus 75 ~~~~l~V~~~~ 85 (90)
T cd05726 75 TKAYLEVTDVI 85 (90)
T ss_pred EEEEEEEeecc
Confidence 99999996543
No 60
>cd05725 Ig3_Robo Third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig3_Robo: domain similar to the third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=99.10 E-value=4.2e-10 Score=88.80 Aligned_cols=69 Identities=28% Similarity=0.462 Sum_probs=55.5
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
++|.|.+.|.|+|.+.|++++..+.. .+..+..+ ..|.|.+++.+|+|.|+|.|.|..|..+..+.|
T Consensus 1 v~l~C~~~g~P~p~v~W~k~~~~~~~-------~~~~~~~~------~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l 67 (69)
T cd05725 1 VEFQCEVGGDPVPTVLWRKEDGELPK-------GRAEILDD------KSLKIRNVTAGDEGSYTCEAENMVGKIEASASL 67 (69)
T ss_pred CEEEEECccCCCCEEEEEECCccCCC-------CcEEEeeC------CEEEECcCChhHCEEEEEEEEcCCCcEEEEEEE
Confidence 57899999999999999998764432 12333332 379999999999999999999999999888877
Q ss_pred EE
Q psy1672 352 QV 353 (600)
Q Consensus 352 ~V 353 (600)
.|
T Consensus 68 ~V 69 (69)
T cd05725 68 TV 69 (69)
T ss_pred EC
Confidence 54
No 61
>cd05764 Ig_2 Subgroup of the immunoglobulin (Ig) superfamily. Ig_2: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.10 E-value=5.6e-10 Score=89.38 Aligned_cols=73 Identities=33% Similarity=0.615 Sum_probs=58.2
Q ss_pred cccceeeeEeecCCCCeeEEEE-cCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeE
Q psy1672 269 SENATVVCRVDSIPPAAISWYW-NGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADA 347 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~-~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~ 347 (600)
|+.+.|.|.+.|.|.|.+.|++ +++.+.... +.....+ +.|.|.+++..|.|.|+|+|.|..|.++.
T Consensus 1 G~~~~l~C~~~g~P~p~v~W~~~~~~~~~~~~------~~~~~~~------~~L~i~~~~~~D~G~Y~C~a~N~~G~~~~ 68 (74)
T cd05764 1 GQRATLRCKARGDPEPAIHWISPDGKLISNSS------RTLVYDN------GTLDILITTVKDTGSFTCIASNAAGEATA 68 (74)
T ss_pred CCeEEEEEEccCcCCCEEEEEeCCCEEecCCC------eEEEecC------CEEEEEECChhhCEEEEEEEECCCCeEEE
Confidence 6789999999999999999997 565554321 2223333 37899999999999999999999999988
Q ss_pred EEEEEE
Q psy1672 348 NFTLQV 353 (600)
Q Consensus 348 ~v~L~V 353 (600)
.+.|+|
T Consensus 69 ~~~l~v 74 (74)
T cd05764 69 TVELHI 74 (74)
T ss_pred EEEEEC
Confidence 887764
No 62
>cd04976 Ig2_VEGFR Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). Ig2_VEGFR: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A. VEGFR-1 may play an inhibitory part in these processes by binding VEGF and interfering with its interaction with VEGFR-2. VEGFR-1 has a signa
Probab=99.09 E-value=5.3e-10 Score=88.81 Aligned_cols=69 Identities=26% Similarity=0.541 Sum_probs=57.0
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
+.|.|.+.|.|.|.+.|+++|+.+.... +. ... ...|.|.+++.+|+|.|+|.|.|..|..++++.+
T Consensus 1 ~~l~c~v~g~P~p~v~W~k~g~~l~~~~------~~-~~~------~~~L~I~~v~~~D~G~YtC~a~N~~g~~~~~~~~ 67 (71)
T cd04976 1 VRLPVKVKAYPPPEIQWYKNGKLISEKN------RT-KKS------GHSLTIKDVTEEDAGNYTVVLTNKQAKLEKRLTF 67 (71)
T ss_pred CEEEeEEEEeCCCEEEEEECCEECCCCC------EE-EcC------CCEEEECcCCHHHCEEEEEEEEcCCccEEEEEEE
Confidence 4689999999999999999998876432 11 111 2479999999999999999999999998888877
Q ss_pred EE
Q psy1672 352 QV 353 (600)
Q Consensus 352 ~V 353 (600)
.+
T Consensus 68 ~~ 69 (71)
T cd04976 68 TL 69 (71)
T ss_pred EE
Confidence 76
No 63
>cd04974 Ig3_FGFR Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig3_FGFR: third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs.
Probab=99.09 E-value=3.9e-10 Score=94.14 Aligned_cols=81 Identities=21% Similarity=0.288 Sum_probs=57.5
Q ss_pred cccceeeeEeecCCCCeeEEEEcC----eeccCCcccCccceEEEeeC----CceeeeeeEEEecCCCCCCeEEEEEEec
Q psy1672 269 SENATVVCRVDSIPPAAISWYWNG----RLLLNNTAFSSYQRIFVIEQ----GEYERKSSLVLTNAQESDSGRFYCVAEN 340 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~g----~~l~~~~~~~~~~~~~~~~~----g~~~~~s~L~I~~v~~~d~G~Y~C~a~N 340 (600)
|+.++|.|.+.|.|.|+|+|++++ ..+.... ......... ........|.|.+++.+|.|.|+|.|.|
T Consensus 1 G~~v~l~C~v~g~P~P~i~W~k~~~~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N 76 (90)
T cd04974 1 GSDVEFHCKVYSDAQPHIQWLKHVEVNGSKYGPDG----LPYVTVLKVAGINTTDNESEVLYLRNVSFDDAGEYTCLAGN 76 (90)
T ss_pred CCcEEEEEEEeCCCCCeEEEEEecccCCceeCCCC----CceEEEEEecCCcccccccceEEEeccccccCcEEEEEeec
Confidence 678999999999999999999953 2221110 011111111 0001124789999999999999999999
Q ss_pred CCCceeEEEEEEE
Q psy1672 341 RAGIADANFTLQV 353 (600)
Q Consensus 341 ~~G~~~~~v~L~V 353 (600)
..|...+++.|.|
T Consensus 77 ~~G~~~~sa~L~V 89 (90)
T cd04974 77 SIGPSHHSAWLTV 89 (90)
T ss_pred ccCcccCCEEEEe
Confidence 9999999888876
No 64
>cd05743 Ig_Perlecan_D2_like Immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Ig_Perlecan_D2_like: the immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Perlecan consists of five domains. Domain I has three putative heparan sulfate attachment sites; domain II has four LDL receptor-like repeats, and one Ig-like repeat; domain III resembles the short arm of laminin chains; domain IV has multiple Ig-like repeats (21 repeats in human perlecan); and domain V resembles the globular G domain of the laminin A chain and internal repeats of EGF. Perlecan may participate in a variety of biological functions including cell binding, LDL-metabolism, basement membrane assembly and selective permeability, calcium binding, and growth- and neurite-promoting activities.
Probab=99.09 E-value=5.3e-10 Score=90.61 Aligned_cols=76 Identities=22% Similarity=0.409 Sum_probs=59.8
Q ss_pred cccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEE
Q psy1672 269 SENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADAN 348 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~ 348 (600)
|+.+.|.|.+.|.|.|.+.|++++..+.... ++.+...+ ..+.|.|.++..+|.|.|+|.|.|..|.....
T Consensus 1 G~~v~l~C~~~g~P~p~v~W~~~~~~~~~~~------~~~~~~~~---~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~ 71 (78)
T cd05743 1 GETVEFTCVATGVPTPIINWRLNWGHVPDSA------RVSITSEG---GYGTLTIRDVKESDQGAYTCEAINTRGMVFGI 71 (78)
T ss_pred CCEEEEEEEEEEecCCEEEEEECCeECCCCC------CEEEEECC---CEEEEEECCCChHHCEEEEEEEEecCCEEEec
Confidence 6789999999999999999999887664322 33333222 23579999999999999999999999998777
Q ss_pred EEEEE
Q psy1672 349 FTLQV 353 (600)
Q Consensus 349 v~L~V 353 (600)
..+.+
T Consensus 72 ~~~~~ 76 (78)
T cd05743 72 PDGIL 76 (78)
T ss_pred ccEEE
Confidence 66654
No 65
>cd04970 Ig6_Contactin_like Sixth Ig domain of contactin. Ig6_Contactin_like: Sixth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.09 E-value=6.2e-10 Score=91.80 Aligned_cols=81 Identities=23% Similarity=0.383 Sum_probs=60.0
Q ss_pred ccceeeeEeecCCCC--eeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeE
Q psy1672 270 ENATVVCRVDSIPPA--AISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADA 347 (600)
Q Consensus 270 ~~v~L~C~v~g~P~p--~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~ 347 (600)
+.+.|.|.+.|.|.| .+.|+++|+.+........+.+.... ...+.|.|.+++..|+|.|+|.|.|..|..++
T Consensus 1 e~~~L~C~~~g~P~p~i~~~W~~~g~~i~~~~~~~~~~~~~~~-----~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~~ 75 (85)
T cd04970 1 ESITLQCHASHDPTLDLTFTWSFNGVPIDFDKDGGHYRRVGGK-----DSNGDLMIRNAQLKHAGKYTCTAQTVVDSLSA 75 (85)
T ss_pred CcEEEEEEEecCCCCCeEEEEEECCeEeeccCCCccEEEEecc-----cccceEEEccCCHHhCeeeEEEEecCCCcEEE
Confidence 367899999999988 56899999877543211001111111 12358999999999999999999999999999
Q ss_pred EEEEEEEE
Q psy1672 348 NFTLQVTY 355 (600)
Q Consensus 348 ~v~L~V~~ 355 (600)
++.|.|..
T Consensus 76 ~~~l~V~~ 83 (85)
T cd04970 76 SADLIVRG 83 (85)
T ss_pred EEEEEEEC
Confidence 99988854
No 66
>cd05738 Ig2_RPTP_IIa_LAR_like Second immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig2_RPTP_IIa_LAR_like: domain similar to the second immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple Ig-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains.
Probab=99.08 E-value=6.6e-10 Score=89.05 Aligned_cols=72 Identities=33% Similarity=0.556 Sum_probs=55.8
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCce-eEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIA-DANFT 350 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~-~~~v~ 350 (600)
++|.|.+.|.|.|.|.|++++..+.... ..++....++ .|.|.+++.+|.|.|+|.|.|..|.. +..+.
T Consensus 1 a~l~C~~~G~P~p~v~W~k~~~~~~~~~----~~~~~~~~~g------~L~i~~~~~~D~G~Y~C~a~N~~G~~~s~~a~ 70 (74)
T cd05738 1 ATMLCAASGNPDPEITWFKDFLPVDTTS----NGRIKQLRSG------ALQIENSEESDQGKYECVATNSAGTRYSAPAN 70 (74)
T ss_pred CEEEEEEeEecCCEEEEEECCEECccCC----CCCEEEcCCc------EEEECCCChhhCEEEEEEEECCCCceEcccEE
Confidence 4799999999999999999988765322 2233333333 68999999999999999999999985 55566
Q ss_pred EEE
Q psy1672 351 LQV 353 (600)
Q Consensus 351 L~V 353 (600)
|.|
T Consensus 71 l~v 73 (74)
T cd05738 71 LYV 73 (74)
T ss_pred EEE
Confidence 654
No 67
>cd05758 Ig5_KIRREL3-like Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2) and similar proteins. Ig5_KIRREL3-like: domain similar to the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=99.08 E-value=1e-09 Score=93.14 Aligned_cols=89 Identities=28% Similarity=0.379 Sum_probs=66.7
Q ss_pred cccccccccccccceeeeEeecCCCC-eeEEEEcCeeccCCcccCccceEEEeeCC-ceeeeeeEEEecCCCCC-CeEEE
Q psy1672 259 MDSRYVEAVSSENATVVCRVDSIPPA-AISWYWNGRLLLNNTAFSSYQRIFVIEQG-EYERKSSLVLTNAQESD-SGRFY 335 (600)
Q Consensus 259 ~~~~~~~v~~G~~v~L~C~v~g~P~p-~i~W~~~g~~l~~~~~~~~~~~~~~~~~g-~~~~~s~L~I~~v~~~d-~G~Y~ 335 (600)
..+....+..|+.+.|.|.+.|.|.| .|.|+++++.+.... ..++.+.... .....+.|.|.++..+| .|.|+
T Consensus 6 ~~~~~~~~~~G~~v~L~C~~~g~P~P~~v~W~~~~~~i~~~~----~~r~~i~~~~~~~~~~s~L~I~~v~~~d~~G~Y~ 81 (98)
T cd05758 6 TSEATQYAILGDKGRVECFIFSTPPPDRIVWTWKENELESGS----SGRYTVETDPSPGGVLSTLTISNTQESDFQTSYN 81 (98)
T ss_pred cCCCcEEEeCCCcEEEEEEEcccCCCCEeEEEECCEEccCCC----CCCEEEEEecCCCceEEEEEECCccccccceeEE
Confidence 34455667899999999999999999 699999998775432 1233333221 11234689999999855 89999
Q ss_pred EEEecCCCceeEEEEE
Q psy1672 336 CVAENRAGIADANFTL 351 (600)
Q Consensus 336 C~a~N~~G~~~~~v~L 351 (600)
|.|.|..|.++..+.|
T Consensus 82 C~A~N~~G~~~~~~~L 97 (98)
T cd05758 82 CTAWNSFGSGTAIISL 97 (98)
T ss_pred EEEEcCCCcccEEEEe
Confidence 9999999999887765
No 68
>cd05760 Ig2_PTK7 Second immunoglobulin (Ig)-like domain of protein tyrosine kinase (PTK) 7, also known as CCK4. Ig2_PTK7: domain similar to the second immunoglobulin (Ig)-like domain in protein tyrosine kinase (PTK) 7, also known as CCK4. PTK7 is a subfamily of the receptor protein tyrosine kinase family, and is referred to as an RPTK-like molecule. RPTKs transduce extracellular signals across the cell membrane, and play important roles in regulating cell proliferation, migration, and differentiation. PTK7 is organized as an extracellular portion having seven Ig-like domains, a single transmembrane region, and a cytoplasmic tyrosine kinase-like domain. PTK7 is considered a pseudokinase as it has several unusual residues in some of the highly conserved tyrosine kinase (TK) motifs; it is predicted to lack TK activity. PTK7 may function as a cell-adhesion molecule. PTK7 mRNA is expressed at high levels in placenta, melanocytes, liver, lung, pancreas, and kidney. PTK7 is overexpressed in s
Probab=99.08 E-value=8.8e-10 Score=89.07 Aligned_cols=72 Identities=32% Similarity=0.599 Sum_probs=55.3
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCcee--EEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIAD--ANF 349 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~--~~v 349 (600)
++|.|.+.|.|.|.+.|+++|..+.... .+..+... .+.|.|.+++.+|.|.|+|.|.|.+|... +.+
T Consensus 1 v~L~C~~~g~P~p~v~W~k~g~~l~~~~-----~~~~~~~~-----~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~s~~~~ 70 (77)
T cd05760 1 VTLRCHIDGHPRPTYQWFRDGTPLSDGQ-----GNYSVSSK-----ERTLTLRSAGPDDSGLYYCCAHNAFGSVCSSQNF 70 (77)
T ss_pred CEEEEEeeecCCCcEEEEECCEECCCCC-----ccEEEeCC-----CCEEEEeeCCcccCEEEEEEEEeCCCeEeeCceE
Confidence 5799999999999999999998775432 12222221 24799999999999999999999999874 455
Q ss_pred EEEE
Q psy1672 350 TLQV 353 (600)
Q Consensus 350 ~L~V 353 (600)
+|.|
T Consensus 71 ~l~v 74 (77)
T cd05760 71 TLSI 74 (77)
T ss_pred EEEE
Confidence 5555
No 69
>KOG0618|consensus
Probab=99.06 E-value=4.4e-12 Score=139.65 Aligned_cols=153 Identities=29% Similarity=0.352 Sum_probs=84.5
Q ss_pred CCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCc-----------------------ccCccccCCCCCccEEE
Q psy1672 49 ELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIG-----------------------QIDSGALDGLTNLIEID 105 (600)
Q Consensus 49 ~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~-----------------------~i~~~~f~~l~~L~~L~ 105 (600)
.+++++++++|+++.+|.-+. .+.+|+.|.+.+|+|. .+++ ...+++.|+.|+
T Consensus 241 ~nl~~~dis~n~l~~lp~wi~---~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~-~le~~~sL~tLd 316 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSNLPEWIG---ACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPP-FLEGLKSLRTLD 316 (1081)
T ss_pred ccceeeecchhhhhcchHHHH---hcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCC-cccccceeeeee
Confidence 346666666666666663332 3556666665555554 3333 244577888888
Q ss_pred ccCCCCCCCCccccC-------------------------CCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCc
Q psy1672 106 LSDNLLTSIPSLTFQ-------------------------SVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLE 160 (600)
Q Consensus 106 Ls~N~l~~l~~~~f~-------------------------~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~ 160 (600)
|..|+|..+|...|. .++.|+.|.|.+|.++.-+-..+.+.++|+.|+|++|+|.
T Consensus 317 L~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~ 396 (1081)
T KOG0618|consen 317 LQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN 396 (1081)
T ss_pred ehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc
Confidence 888888777664331 1123444455555555444444555556666666666666
Q ss_pred ccChhhhcCCCCCCEEEcCCCcCCCCCcccccccccccEEEccCCc
Q psy1672 161 HISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLLKLMMIELHDNP 206 (600)
Q Consensus 161 ~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~l~~N~ 206 (600)
.++...+.+++.|+.|+|++|+|+.++ ..+..+..|++|...+|.
T Consensus 397 ~fpas~~~kle~LeeL~LSGNkL~~Lp-~tva~~~~L~tL~ahsN~ 441 (1081)
T KOG0618|consen 397 SFPASKLRKLEELEELNLSGNKLTTLP-DTVANLGRLHTLRAHSNQ 441 (1081)
T ss_pred cCCHHHHhchHHhHHHhcccchhhhhh-HHHHhhhhhHHHhhcCCc
Confidence 665555666666666666666666555 333333333333333333
No 70
>cd05858 Ig3_FGFR-2 Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor 2 (FGFR2). Ig3_FGFR-2-like; domain similar to the third immunoglobulin (Ig)-like domain of human fibroblast growth factor receptor 2 (FGFR2). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs. FGFR2 is required for male sex determination.
Probab=99.06 E-value=9.1e-10 Score=91.89 Aligned_cols=81 Identities=25% Similarity=0.381 Sum_probs=58.4
Q ss_pred cccceeeeEeecCCCCeeEEEEc----CeeccCCcccCccceEEEeeCCce----eeeeeEEEecCCCCCCeEEEEEEec
Q psy1672 269 SENATVVCRVDSIPPAAISWYWN----GRLLLNNTAFSSYQRIFVIEQGEY----ERKSSLVLTNAQESDSGRFYCVAEN 340 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~----g~~l~~~~~~~~~~~~~~~~~g~~----~~~s~L~I~~v~~~d~G~Y~C~a~N 340 (600)
|+.+.|.|.+.|.|.|.|+|++. +..+.... .....+...+.. ...+.|.|.+++.+|.|.|+|+|.|
T Consensus 1 G~~v~L~C~~~g~P~P~i~W~k~~~~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N 76 (90)
T cd05858 1 GSTVEFVCKVYSDAQPHIQWLKHVEKNGSKYGPDG----LPYVTVLKTAGVNTTDKEMEVLYLRNVTFEDAGEYTCLAGN 76 (90)
T ss_pred CCeEEEEEEEecCCCCEEEEEEecccCCcEeCCCC----CeeEEEeccCCceecCCceeEEEEccCCHHHCEEEEEEEEe
Confidence 67899999999999999999984 33222111 111111111100 1135899999999999999999999
Q ss_pred CCCceeEEEEEEE
Q psy1672 341 RAGIADANFTLQV 353 (600)
Q Consensus 341 ~~G~~~~~v~L~V 353 (600)
..|....++.|.|
T Consensus 77 ~~G~~~~~a~L~V 89 (90)
T cd05858 77 SIGISHHSAWLTV 89 (90)
T ss_pred CCCcccceEEEEE
Confidence 9999998888876
No 71
>cd05740 Ig_CEACAM_D4 Fourth immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). Ig_CEACAM_D4: immunoglobulin (Ig)-like domain 4 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the
Probab=99.05 E-value=1.3e-09 Score=91.04 Aligned_cols=80 Identities=24% Similarity=0.432 Sum_probs=63.3
Q ss_pred cccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEec
Q psy1672 261 SRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAEN 340 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N 340 (600)
+.+..+.+|+.++|.|.+.|. .|.|.|++++..+... ++.+..++ +.|.|.+++.+|.|.|+|.|.|
T Consensus 10 ~~~~~v~~g~~v~l~C~a~g~-~p~i~W~kng~~l~~~-------~~~~~~~~-----~~L~I~~v~~~D~G~Y~C~a~N 76 (91)
T cd05740 10 VGNQPPEDNQPVTLTCEAEGQ-ATYIWWVNNGSLLVPP-------RLQLSNDN-----RTLTFNNVTRSDTGHYQCEASN 76 (91)
T ss_pred cCccccccCCcEEEEEEeCCC-CCEEEEEECCEECCCC-------CEEEeCCC-----CEEEECcCChhhCEEEEEEEEc
Confidence 456788999999999999999 9999999998876432 23332222 3799999999999999999999
Q ss_pred CCCce-eEEEEEEE
Q psy1672 341 RAGIA-DANFTLQV 353 (600)
Q Consensus 341 ~~G~~-~~~v~L~V 353 (600)
..|.. +..+.|.|
T Consensus 77 ~~G~~~S~~~~L~V 90 (91)
T cd05740 77 EVSNMTSDPYILNV 90 (91)
T ss_pred CCCCEEeeeEEEEe
Confidence 99985 44566655
No 72
>cd05866 Ig1_NCAM-2 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2. Ig1_NCAM-2: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2 (OCAM/mamFas II, RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=99.05 E-value=1.2e-09 Score=91.29 Aligned_cols=85 Identities=28% Similarity=0.524 Sum_probs=64.4
Q ss_pred cccccccccccccceeeeEeecCCCCeeEEEE-cCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEE
Q psy1672 259 MDSRYVEAVSSENATVVCRVDSIPPAAISWYW-NGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCV 337 (600)
Q Consensus 259 ~~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~-~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~ 337 (600)
..+....+..|+.+.|.|.+.|.|. .+.|++ ++..+... .++.+..++ ..+.|.|.++..+|+|.|+|.
T Consensus 5 ~~~~~~~v~~G~~v~l~C~~~G~P~-~v~W~k~~g~~~~~~------~r~~~~~~g---~~~~L~I~~v~~~D~G~Y~C~ 74 (92)
T cd05866 5 ISLSKVELSVGESKFFTCTAIGEPE-SIDWYNPQGEKIVSS------QRVVVQKEG---VRSRLTIYNANIEDAGIYRCQ 74 (92)
T ss_pred EEecceEEcCCCeEEEEEEEEEeCC-eEEEEeCCCeEecCC------CCEEEEeCC---CeeEEEEecCChHHCEEEEEE
Confidence 3455677889999999999999998 899998 46555332 234443333 134799999999999999999
Q ss_pred EecCCCce-eEEEEEEE
Q psy1672 338 AENRAGIA-DANFTLQV 353 (600)
Q Consensus 338 a~N~~G~~-~~~v~L~V 353 (600)
|.|..|.. .+++.|.+
T Consensus 75 A~N~~G~~~~~~i~l~~ 91 (92)
T cd05866 75 ATDAKGQTQEATVVLEI 91 (92)
T ss_pred EEcCCCcEEEEEEEEEE
Confidence 99999986 55566654
No 73
>cd05773 Ig8_hNephrin_like Eighth immunoglobulin-like domain of nephrin. Ig8_hNephrin_like: domain similar to the eighth immunoglobulin-like domain in human nephrin. Nephrin is an integral component of the slit diaphragm, and is a central component of the glomerular ultrafilter. Nephrin plays a structural role, and has a role in signaling. Nephrin is a transmembrane protein having a short intracellular portion, and an extracellular portion comprised of eight Ig-like domains, and one fibronectin type III-like domain. The extracellular portions of nephrin, from neighboring foot processes of separate podocyte cells, may interact with each other, and in association with other components of the slit diaphragm, form a porous molecular sieve within the slit pore. The intracellular portion of nephrin is associated with linker proteins, which connect nephrin to the actin cytoskeleton. The intracellular portion is tyrosine phosphorylated, and mediates signaling from the slit diaphragm into the p
Probab=99.05 E-value=1.6e-09 Score=93.75 Aligned_cols=84 Identities=27% Similarity=0.371 Sum_probs=64.6
Q ss_pred cccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEE--EeeCCceeeeeeEEEecCC-CCCCeEEEEEEecCCC
Q psy1672 267 VSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIF--VIEQGEYERKSSLVLTNAQ-ESDSGRFYCVAENRAG 343 (600)
Q Consensus 267 ~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~--~~~~g~~~~~s~L~I~~v~-~~d~G~Y~C~a~N~~G 343 (600)
..|..++|.|.+.|.|.+.+.|++++..+.... .+.. ....+ ....+.|.|.++. .+|.|.|+|.|.|..|
T Consensus 21 ~~g~~v~L~C~a~G~P~p~i~W~k~g~~l~~~~-----~r~~~~~~~~~-~~~~s~L~I~~v~~~~D~G~Y~C~A~N~~G 94 (109)
T cd05773 21 DGSSDANLVCQAQGVPRVQFRWAKNGVPLDLGN-----PRYEETTEHTG-TVHTSILTIINVSAALDYALFTCTAHNSLG 94 (109)
T ss_pred CCCCEEEEEEECcccCCCEEEEEECCEECCCCC-----CeEEEEeeccC-ccceeEEEECcCCccCCCEEEEEEEEeCCc
Confidence 357889999999999999999999998775322 1221 11221 1224689999997 6999999999999999
Q ss_pred ceeEEEEEEEEEc
Q psy1672 344 IADANFTLQVTYR 356 (600)
Q Consensus 344 ~~~~~v~L~V~~~ 356 (600)
.+...+.|.+...
T Consensus 95 ~~~~~i~L~~~~~ 107 (109)
T cd05773 95 EDSLDIQLVSTSR 107 (109)
T ss_pred cCcEEEEEEecCC
Confidence 9999999988644
No 74
>cd05856 Ig2_FGFRL1-like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). Ig2_FGFRL1-like: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). FGFRL1 is comprised of a signal peptide, three extracellular Ig-like modules, a transmembrane segment, and a short intracellular domain. FGFRL1 is expressed preferentially in skeletal tissues. Similar to FGF receptors, the expressed protein interacts specifically with heparin and with FGF2. FGFRL1 does not have a protein tyrosine kinase domain at its C terminus; neither does its cytoplasmic domain appear to interact with a signaling partner. It has been suggested that FGFRL1 may not have any direct signaling function, but instead acts as a decoy receptor trapping FGFs and preventing them from binding other receptors.
Probab=99.04 E-value=7.4e-10 Score=90.33 Aligned_cols=80 Identities=24% Similarity=0.417 Sum_probs=62.7
Q ss_pred cccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCC
Q psy1672 263 YVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRA 342 (600)
Q Consensus 263 ~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~ 342 (600)
.+.+..|+.+.|.|.+.|.|.|.+.|++++..+..... ... ....+.|.|.+++.+|+|.|+|.|.|..
T Consensus 3 ~~~~~~G~~v~L~C~~~g~p~p~i~W~k~~~~~~~~~~------~~~-----~~~~~~L~i~~v~~~D~G~Y~C~a~N~~ 71 (82)
T cd05856 3 VIARPVGSSVRLKCVASGNPRPDITWLKDNKPLTPTEI------GES-----RKKKWTLSLKNLKPEDSGKYTCHVSNRA 71 (82)
T ss_pred ceeccCCCeEEEEEEeeEeCCCcEEEEECCcCCcCCcc------cee-----cCceEEEEEccCChhhCEEEEEEEEcCC
Confidence 34567899999999999999999999998876643221 000 0123579999999999999999999999
Q ss_pred CceeEEEEEEE
Q psy1672 343 GIADANFTLQV 353 (600)
Q Consensus 343 G~~~~~v~L~V 353 (600)
|..++.+.|.|
T Consensus 72 G~~~~~~~v~v 82 (82)
T cd05856 72 GEINATYKVDV 82 (82)
T ss_pred ccEEEEEEEeC
Confidence 99888877753
No 75
>cd05736 Ig2_Follistatin_like Second immunoglobulin (Ig)-like domain of a follistatin-like molecule encoded by the Mahya gene and similar proteins. Ig2_Follistatin_like: domain similar to the second immunoglobulin (Ig)-like domain found in a follistatin-like molecule encoded by the CNS-related Mahya gene. Mahya genes have been retained in certain Bilaterian branches during evolution. They are conserved in Hymenoptera and Deuterostomes, but are absent from other metazoan species such as fruit fly and nematode. Mahya proteins are secretory, with a follistatin-like domain (Kazal-type serine/threonine protease inhibitor domain and EF-hand calcium-binding domain), two Ig-like domains, and a novel C-terminal domain. Mahya may be involved in learning and memory and in processing of sensory information in Hymenoptera and vertebrates. Follistatin is a secreted, multidomain protein that binds activins with high affinity and antagonizes their signaling.
Probab=99.03 E-value=1.9e-09 Score=86.75 Aligned_cols=74 Identities=28% Similarity=0.572 Sum_probs=59.5
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
+.|.|.+.|.|.|.+.|+++++.+.... ..++....++ ..|.|.+++.+|.|.|+|.|.|..|.++..+.|
T Consensus 1 ~~L~C~v~g~P~p~v~W~k~~~~l~~~~----~~~~~~~~~~-----~~l~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l 71 (76)
T cd05736 1 ASLRCHAEGIPLPRLTWLKNGMDITPKL----SKQLTLIANG-----SELHISNVRYEDTGAYTCIAKNEAGVDEDISSL 71 (76)
T ss_pred CEeEeEeeecCCCEEEEEECCEECCCCC----CccEEEeCCC-----CEEEECcCCcccCEEEEEEEEcCCCCcceEEEE
Confidence 4689999999999999999998775432 1233333332 368999999999999999999999999999998
Q ss_pred EEE
Q psy1672 352 QVT 354 (600)
Q Consensus 352 ~V~ 354 (600)
.|.
T Consensus 72 ~V~ 74 (76)
T cd05736 72 FVE 74 (76)
T ss_pred EEE
Confidence 874
No 76
>cd05724 Ig2_Robo Second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig2_Robo: domain similar to the second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antago
Probab=99.02 E-value=1.8e-09 Score=89.11 Aligned_cols=80 Identities=26% Similarity=0.496 Sum_probs=62.3
Q ss_pred cccccccccccceeeeEe-ecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEe
Q psy1672 261 SRYVEAVSSENATVVCRV-DSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAE 339 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v-~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~ 339 (600)
+....+..|+.+.|.|.+ .|.|.|.+.|++++..+.... .+..+..+ +.|.|.+++.+|+|.|+|.|.
T Consensus 3 p~~~~~~~G~~v~l~C~~~~g~p~p~i~W~k~g~~~~~~~-----~~~~~~~~------~~L~I~~~~~~D~G~Y~C~a~ 71 (86)
T cd05724 3 PSDTQVAVGEMAVLECSPPRGHPEPTVSWRKDGQPLNLDN-----ERVRIVDD------GNLLIAEARKSDEGTYKCVAT 71 (86)
T ss_pred CccEEEeCCCCEEEEEECCCCCCCCEEEEEECCEECCCCC-----CCEEEccC------CEEEEeECCcccCEEEEEEEE
Confidence 456677899999999998 699999999999988765421 22333332 379999999999999999999
Q ss_pred cCCCcee-EEEEE
Q psy1672 340 NRAGIAD-ANFTL 351 (600)
Q Consensus 340 N~~G~~~-~~v~L 351 (600)
|..|... ..+.|
T Consensus 72 N~~G~~~s~~~~l 84 (86)
T cd05724 72 NMVGERESAAARL 84 (86)
T ss_pred eccCceeeeeEEE
Confidence 9999864 34444
No 77
>cd05722 Ig1_Neogenin First immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig1_Neogenin: first immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=99.02 E-value=1.7e-09 Score=91.18 Aligned_cols=83 Identities=28% Similarity=0.464 Sum_probs=61.4
Q ss_pred ccccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecC-----CCCCCeEE
Q psy1672 260 DSRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNA-----QESDSGRF 334 (600)
Q Consensus 260 ~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v-----~~~d~G~Y 334 (600)
.+....+..|+.+.|.|.+.|.|.|.+.|+++|..+.... ..+..+..++ .+.|.++ ...|.|.|
T Consensus 5 ~P~~~~~~~g~~v~l~C~v~g~P~p~i~W~k~g~~l~~~~----~~~~~~~~~~------~l~i~~v~~~~~~~~D~G~Y 74 (95)
T cd05722 5 EPSDIVAVRGGPVVLNCSAEGEPPPKIEWKKDGVLLNLVS----DERRQQLPNG------SLLITSVVHSKHNKPDEGFY 74 (95)
T ss_pred CCCCeEEcCCCCEEEeeecccCCCCEEEEEECCeECcccc----CcceEEccCC------eEEEeeeeccCCCCCcCEEE
Confidence 3455667789999999999999999999999998876433 1223333333 4555555 68899999
Q ss_pred EEEEecC-CCce-eEEEEEE
Q psy1672 335 YCVAENR-AGIA-DANFTLQ 352 (600)
Q Consensus 335 ~C~a~N~-~G~~-~~~v~L~ 352 (600)
+|.|.|. .|.. ++.+.|.
T Consensus 75 ~C~a~N~~~G~~~s~~~~l~ 94 (95)
T cd05722 75 QCVAQNDSLGSIVSRTARLT 94 (95)
T ss_pred EEEEECCccCcEEEeeeEEe
Confidence 9999999 9986 5555554
No 78
>cd05765 Ig_3 Subgroup of the immunoglobulin (Ig) superfamily. Ig_3: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.01 E-value=1.4e-09 Score=88.62 Aligned_cols=79 Identities=33% Similarity=0.483 Sum_probs=56.3
Q ss_pred cccceeeeEeecCCCCeeEEEEcCeeccCCcccCc--cceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCcee
Q psy1672 269 SENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSS--YQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIAD 346 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~--~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~ 346 (600)
|+.++|.|.+.|.|.|.+.|++++..-......+. ..++... ..+.|.|.+++.+|+|.|+|.|.|..|...
T Consensus 1 G~~v~l~C~~~g~P~p~v~W~k~~~~~~~~~~~~~~~~~~~~~~------~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~ 74 (81)
T cd05765 1 GETASFHCDVTGRPPPEITWEKQVHGKENLIMRPNHVRGNVVVT------NIGQLVIYNAQPQDAGLYTCTARNSGGLLR 74 (81)
T ss_pred CCcEEEEeeccccCCCcEEEEecCCCCcceeecCCcccCCEEEc------cccEEEEccCCcccCEEEEEEEecCCceEE
Confidence 67899999999999999999996321000000000 0111111 124799999999999999999999999999
Q ss_pred EEEEEEE
Q psy1672 347 ANFTLQV 353 (600)
Q Consensus 347 ~~v~L~V 353 (600)
..+.|.|
T Consensus 75 ~~~~l~v 81 (81)
T cd05765 75 ANFPLSV 81 (81)
T ss_pred EEEEEeC
Confidence 8888764
No 79
>cd05731 Ig3_L1-CAM_like Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM_like: domain similar to the third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM and human neurofascin.
Probab=99.01 E-value=1.4e-09 Score=86.09 Aligned_cols=70 Identities=26% Similarity=0.444 Sum_probs=55.4
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
+.|.|.+.|.|.|.+.|++++..+.... ..... ..+.|.|.+++.+|.|.|+|.|.|..|..+..+.|
T Consensus 1 v~l~C~~~g~P~p~v~W~k~~~~~~~~~-------~~~~~-----~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l 68 (71)
T cd05731 1 LLLECIAEGLPTPEISWIKIGGELPADR-------TKFEN-----FNKTLKIDNVSEEDDGEYRCTASNSLGSARHTISV 68 (71)
T ss_pred CEEEEEeeEecCCeEEEEECCeECCCCc-------eeEec-----CCCEEEECCCCHHHCEEEEEEEEeCCceEEEEEEE
Confidence 4689999999999999999876553211 11111 12479999999999999999999999999888887
Q ss_pred EE
Q psy1672 352 QV 353 (600)
Q Consensus 352 ~V 353 (600)
.|
T Consensus 69 ~V 70 (71)
T cd05731 69 TV 70 (71)
T ss_pred EE
Confidence 76
No 80
>cd04973 Ig1_FGFR First immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig1_FGFR: The first immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for all FGFs.
Probab=99.01 E-value=1.6e-09 Score=88.09 Aligned_cols=78 Identities=23% Similarity=0.394 Sum_probs=61.8
Q ss_pred ccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecC
Q psy1672 262 RYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 262 ~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~ 341 (600)
....+..|+.+.|.|.+.+. .+.+.|+++|..+.... ++.+. . ..|.|.+++.+|+|.|+|.|.|.
T Consensus 2 ~~~~~~~G~~v~l~C~~~~~-~~~v~W~k~g~~l~~~~------~~~~~-~------~~L~I~~~~~~DsG~Y~C~a~n~ 67 (79)
T cd04973 2 ESYSAHPGDLLQLRCRLRDD-VQSINWTKDGVQLGENN------RTRIT-G------EEVQIKDAVPRDSGLYACVTSSP 67 (79)
T ss_pred CcEEecCCCCEEEEEEecCC-CceEEEeeCCcCCCCCc------eEEEe-C------CEEEECCCChhhCEEEEEEEeCC
Confidence 45667899999999999986 56899999998775432 33221 2 26999999999999999999999
Q ss_pred CCceeEEEEEEE
Q psy1672 342 AGIADANFTLQV 353 (600)
Q Consensus 342 ~G~~~~~v~L~V 353 (600)
.|.....+.+.|
T Consensus 68 ~g~~~~~~~v~V 79 (79)
T cd04973 68 SGSDTTYFSVNV 79 (79)
T ss_pred CCcccEEEEEeC
Confidence 999877776653
No 81
>cd05898 Ig5_KIRREL3 Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). Ig5_KIRREL3: the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1). These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development. Neph1 and 2 may mediate axonal guidance and synapse formation in certain areas of the CNS. In the kidney, they participate in the formation of the slit diaphragm.
Probab=99.00 E-value=2.8e-09 Score=89.78 Aligned_cols=93 Identities=30% Similarity=0.443 Sum_probs=70.7
Q ss_pred cccccccccccccccccceeeeEeecCCCC-eeEEEEcCeeccCCcccCccceEEEeeC-CceeeeeeEEEecCCCCC-C
Q psy1672 255 PEIRMDSRYVEAVSSENATVVCRVDSIPPA-AISWYWNGRLLLNNTAFSSYQRIFVIEQ-GEYERKSSLVLTNAQESD-S 331 (600)
Q Consensus 255 p~i~~~~~~~~v~~G~~v~L~C~v~g~P~p-~i~W~~~g~~l~~~~~~~~~~~~~~~~~-g~~~~~s~L~I~~v~~~d-~ 331 (600)
|++....+...+..|+.+.|.|.+.+.|+| .|.|.|.+..+...+ ..++.+.+. ......+.|+|.++...| .
T Consensus 2 pP~i~~~~s~~~~~G~~~~L~C~~~s~P~P~~i~W~w~~~~i~~~~----~~r~~I~~~~~~~g~~S~L~I~~~~~~d~~ 77 (98)
T cd05898 2 PPIISSEQVQYAVRGERGKVKCFIGSTPPPDRIAWAWKENVLESGT----SERYTVERTSTGSGVLSTLTINNIMEADFQ 77 (98)
T ss_pred CCEEecCceEEEeCCCcEEEEEEEccCCCCcEEEEEEccccccCCC----CCCEEEEEEccCCCcEEEEEECCCccccCC
Confidence 344455677788899999999999988887 689999887665443 235555432 112356799999998777 6
Q ss_pred eEEEEEEecCCCceeEEEEE
Q psy1672 332 GRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 332 G~Y~C~a~N~~G~~~~~v~L 351 (600)
|.|.|.|.|..|.++..+.|
T Consensus 78 g~Y~C~a~N~~G~d~~~i~L 97 (98)
T cd05898 78 THYNCTAWNSFGSGTAIIQL 97 (98)
T ss_pred cEEEEEEEeCCccceEEEEe
Confidence 89999999999999988776
No 82
>cd05739 Ig3_RPTP_IIa_LAR_like Third immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig3_RPTP_IIa_LAR_like: domain similar to the third immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple IG-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains. Included in this group is Drosophila LAR (DLAR).
Probab=99.00 E-value=1.8e-09 Score=85.15 Aligned_cols=68 Identities=25% Similarity=0.458 Sum_probs=53.0
Q ss_pred cccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEE
Q psy1672 269 SENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADAN 348 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~ 348 (600)
|+.++|.|.+.|.|.|.|.|+++++.+.... ++.. + .+.|.|.+++ |+|.|+|.|.|..|..+.+
T Consensus 1 G~~v~L~C~a~G~P~P~v~W~k~g~~l~~~~------~~~~---~----~~~L~i~~~~--d~G~Y~C~A~N~~G~~~~~ 65 (69)
T cd05739 1 GGSVNLTCVAVGAPMPYVKWMKGGEELTKED------EMPV---G----RNVLELTNIY--ESANYTCVAISSLGMIEAT 65 (69)
T ss_pred CCeEEEEEEeeecCCCEEEEEECCEECCCcc------ceec---C----ccEEEEeccc--cCeeEEEEEEeCCCEEEEE
Confidence 6789999999999999999999988764322 1111 1 2368888874 7899999999999998877
Q ss_pred EEE
Q psy1672 349 FTL 351 (600)
Q Consensus 349 v~L 351 (600)
+.|
T Consensus 66 a~l 68 (69)
T cd05739 66 AQV 68 (69)
T ss_pred EEE
Confidence 655
No 83
>cd05853 Ig6_Contactin-4 Sixth Ig domain of contactin-4. Ig6_Contactin-4: sixth Ig domain of the neural cell adhesion molecule contactin-4. Contactins are neural cell adhesion molecules, and are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. Highest expresson of contactin-4 is in testes, thyroid, small intestine, uterus and brain. Contactin-4 plays a role in the response of neuroblastoma cells to differentiating agents, such as retinoids. The contactin 4 gene is associated with cerebellar degeneration in spinocerebellar ataxia type 16.
Probab=99.00 E-value=2.1e-09 Score=88.17 Aligned_cols=82 Identities=18% Similarity=0.343 Sum_probs=60.8
Q ss_pred ccceeeeEeec--CCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeE
Q psy1672 270 ENATVVCRVDS--IPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADA 347 (600)
Q Consensus 270 ~~v~L~C~v~g--~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~ 347 (600)
+++.|.|.+.+ .+.+.|.|+++|+.+.... ...++.... + ....+.|.|.+++..|+|.|+|.|+|.++..++
T Consensus 1 ~~~~l~C~v~~d~~l~~~~~W~~dg~~i~~~~---~~~~~~~~~-~-~~~~~~L~I~nv~~~dsG~YtC~a~n~~~~~~a 75 (85)
T cd05853 1 ESIVLPCQVSHDHSLDIVFTWSFNGHLIDFQK---DGDHFERVG-G-QDSAGDLMIRSIQLKHAGKYVCMVQTSVDKLSA 75 (85)
T ss_pred CcEEEEEEeccCCCCCcEEEEEECCEECcccC---CCccEEEec-c-CCCCCcEEEecCCHHHCEEEEEEEEcccCceEE
Confidence 36789999976 4578899999999886321 111222211 1 012358999999999999999999999999999
Q ss_pred EEEEEEEEc
Q psy1672 348 NFTLQVTYR 356 (600)
Q Consensus 348 ~v~L~V~~~ 356 (600)
+..|.|...
T Consensus 76 ~a~L~V~~p 84 (85)
T cd05853 76 AADLIVRGP 84 (85)
T ss_pred EEEEEEecC
Confidence 999988643
No 84
>cd05848 Ig1_Contactin-5 First Ig domain of contactin-5. Ig1_Contactin-5: First Ig domain of the neural cell adhesion molecule contactin-5. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains, anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. In rats, a lack of contactin-5 (NB-2) results in an impairment of the neuronal activity in the auditory system. Contactin-5 is expressed specifically in the postnatal nervous system, peaking at about 3 weeks postnatal. Contactin-5 is highly expressed in the adult human brain in the occipital lobe and in the amygdala; lower levels of expression have been detected in the corpus callosum, caudate nucleus, and spinal cord.
Probab=99.00 E-value=2.6e-09 Score=89.85 Aligned_cols=68 Identities=24% Similarity=0.450 Sum_probs=53.4
Q ss_pred ccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCC-CCCCeEEEEEEecCCCcee
Q psy1672 268 SSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQ-ESDSGRFYCVAENRAGIAD 346 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~-~~d~G~Y~C~a~N~~G~~~ 346 (600)
+|+.+.|.|.+.|.|.|+|+|+++|..+.... ..+.. ..+ +.|.|.++. ..|.|.|+|.|.|.+|...
T Consensus 18 ~g~~v~l~C~~~G~P~P~i~W~k~g~~l~~~~----~~~~~-~~~------g~L~i~~~~~~~D~G~Y~C~A~N~~G~~~ 86 (94)
T cd05848 18 DEKKVILNCEARGNPVPTYRWLRNGTEIDTES----DYRYS-LID------GNLIISNPSEVKDSGRYQCLATNSIGSIL 86 (94)
T ss_pred CCCEEEEEEEeeecCCCEEEEEECCeECccCC----CceEE-eeC------CeEEEccCCccCcCEEEEEEEEcCCCeEE
Confidence 57899999999999999999999998875332 11222 222 368888875 6999999999999999874
No 85
>cd04977 Ig1_NCAM-1_like First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1 and similar proteins. Ig1_NCAM-1 like: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the s
Probab=98.97 E-value=3.4e-09 Score=88.76 Aligned_cols=85 Identities=31% Similarity=0.533 Sum_probs=62.1
Q ss_pred cccccccccccccceeeeEeecCCCCeeEEEE-cCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEE
Q psy1672 259 MDSRYVEAVSSENATVVCRVDSIPPAAISWYW-NGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCV 337 (600)
Q Consensus 259 ~~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~-~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~ 337 (600)
..+....+..|+.+.|.|.+.|.|+ .+.|++ +++.+... .+..+..++ ...+.|+|.+++.+|+|.|+|.
T Consensus 5 v~p~~~~v~~G~~~~l~C~~~G~p~-~i~W~~~~~~~~~~~------~~~~~~~~~--~~~~~L~I~~v~~~D~G~Y~C~ 75 (92)
T cd04977 5 IVPSQGEISVGESKFFLCQVIGEPK-DISWFSPNGEKLVTQ------QQISVVQND--DVRSTLTIYNANIEDAGIYKCV 75 (92)
T ss_pred EecCcEEECCCCeEEEEEEeEeeCC-eEEEECCCCCEeccC------CCEEEEeCC--CCEEEEEEecCCcccCEEEEEE
Confidence 3455677889999999999999974 999998 56554431 122222222 1345899999999999999999
Q ss_pred EecCCCc-eeEEEEEE
Q psy1672 338 AENRAGI-ADANFTLQ 352 (600)
Q Consensus 338 a~N~~G~-~~~~v~L~ 352 (600)
|.|..|. .++++.|.
T Consensus 76 A~N~~g~~~~~sv~l~ 91 (92)
T cd04977 76 ATDAKGTESEATVNLK 91 (92)
T ss_pred EEcCCCCcceeEEEEE
Confidence 9999754 56666664
No 86
>cd05850 Ig1_Contactin-2 First Ig domain of contactin-2. Ig1_Contactin-2: First Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=98.97 E-value=5.3e-09 Score=88.02 Aligned_cols=83 Identities=28% Similarity=0.441 Sum_probs=58.6
Q ss_pred ccccccccccc---cccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCC-CCCCeE
Q psy1672 258 RMDSRYVEAVS---SENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQ-ESDSGR 333 (600)
Q Consensus 258 ~~~~~~~~v~~---G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~-~~d~G~ 333 (600)
...+..+.+.+ |+.++|.|.+.|.|.|.|+|+++|..+.... ..+..+ .+ +.|.|.++. ..|.|.
T Consensus 5 ~~~P~~~~~~~~~~g~~v~l~C~a~g~P~p~i~W~~~g~~l~~~~----~~~~~~-~~------g~L~I~~~~~~~D~G~ 73 (94)
T cd05850 5 EEQPSSLLFPEGSPEEKVTLGCRARASPPATYRWKMNGTEIKFAP----ESRYTL-VA------GNLVINNPQKARDAGS 73 (94)
T ss_pred EECCCCEEecCCCCCCeEEEEeEceeCCCCEEEEEECCEECccCC----CceEEE-EC------CeEEEccCCccCcCEE
Confidence 33344444433 4689999999999999999999998875322 112222 22 368888865 599999
Q ss_pred EEEEEecCCCceeE-EEEE
Q psy1672 334 FYCVAENRAGIADA-NFTL 351 (600)
Q Consensus 334 Y~C~a~N~~G~~~~-~v~L 351 (600)
|+|.|.|..|.... .+.|
T Consensus 74 Y~C~A~N~~G~~~s~~a~l 92 (94)
T cd05850 74 YQCLAINRCGTVVSREANL 92 (94)
T ss_pred EEEEEEcCcCcEEEEEEEE
Confidence 99999999998743 4444
No 87
>cd05849 Ig1_Contactin-1 First Ig domain of contactin-1. Ig1_Contactin-1: First Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may, through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=98.96 E-value=3.8e-09 Score=88.62 Aligned_cols=71 Identities=25% Similarity=0.403 Sum_probs=53.8
Q ss_pred cccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCC-CCCCeEEEEEEecCCCceeE
Q psy1672 269 SENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQ-ESDSGRFYCVAENRAGIADA 347 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~-~~d~G~Y~C~a~N~~G~~~~ 347 (600)
|..+.|.|.+.|.|.|+|.|++++..+.... .+.. ..+ +.|.|.++. ..|.|.|+|.|+|.+|....
T Consensus 19 ~~~v~l~C~a~G~P~P~i~W~k~~~~i~~~~-----~~~~-~~~------g~L~I~~~~~~~D~G~Y~C~A~N~~G~~~s 86 (93)
T cd05849 19 EGKVSVNCRARANPFPIYKWRKNNLDIDLTN-----DRYS-MVG------GNLVINNPDKYKDAGRYVCIVSNIYGKVRS 86 (93)
T ss_pred CCeEEEeCcCccCCCCEEEEEECCEEccCCC-----CeEE-EEC------CEEEECcCCcCCCCEEEEEEEEeCcceEEE
Confidence 4579999999999999999999988764321 1222 222 378998885 68999999999999998743
Q ss_pred -EEEE
Q psy1672 348 -NFTL 351 (600)
Q Consensus 348 -~v~L 351 (600)
.+.|
T Consensus 87 ~~a~l 91 (93)
T cd05849 87 REATL 91 (93)
T ss_pred ccEEE
Confidence 3443
No 88
>cd05742 Ig1_VEGFR_like First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor (R) and similar proteins. Ig1_VEGFR_like: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R) related proteins. The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF-A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF
Probab=98.93 E-value=5e-09 Score=86.16 Aligned_cols=81 Identities=20% Similarity=0.315 Sum_probs=59.2
Q ss_pred cccceeeeEeecC--CCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCcee
Q psy1672 269 SENATVVCRVDSI--PPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIAD 346 (600)
Q Consensus 269 G~~v~L~C~v~g~--P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~ 346 (600)
|+.+.|.|.+.+. |.+.+.|.++++.+...... ..+. ... ......+.|.|.+++.+|+|.|+|.|.|..|..+
T Consensus 1 Ge~~~L~C~~~g~~~~~~~i~W~~~~~~~~~~~~~--~~~~-~~~-~~~~~~s~L~I~~v~~~DsG~Y~C~a~n~~~~~~ 76 (84)
T cd05742 1 GETLVLNCTVLTELNEGVDFQWTYPGKKRGRGKSM--VTRQ-SLS-EATELSSTLTIPNATLKDSGTYTCAASSGTMDQK 76 (84)
T ss_pred CCeEEEEEEEEeCCCccEEEEEecCCcccCCceEe--eccc-ccc-cceEEEEEEEECCCChhhCEEEEEEEccCCCceE
Confidence 6789999999998 88999999877654322110 0011 111 1112456899999999999999999999999988
Q ss_pred EEEEEEE
Q psy1672 347 ANFTLQV 353 (600)
Q Consensus 347 ~~v~L~V 353 (600)
++..+.|
T Consensus 77 ~s~~v~v 83 (84)
T cd05742 77 ESTKVNI 83 (84)
T ss_pred EEEEEEE
Confidence 8877765
No 89
>cd05734 Ig7_DSCAM Seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig7_DSCAM: the seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=98.93 E-value=4.8e-09 Score=85.15 Aligned_cols=75 Identities=24% Similarity=0.445 Sum_probs=52.4
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCc--ccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCce-eEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNT--AFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIA-DAN 348 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~--~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~-~~~ 348 (600)
++|.|.+.|.|.|.+.|++++....... ......++.+..+ +.|.|.+++.+|+|.|+|.|.|..|.+ ++.
T Consensus 1 v~l~C~~~G~P~P~v~W~~~~~~~~~~~~~~~~~~~r~~~~~~------~~L~I~~v~~~D~G~Y~C~a~N~~G~~~s~~ 74 (79)
T cd05734 1 VTLNCSAEGYPPPTIVWKHSKGRGHPQHTHTCCLAGRIQLLSN------GSLLIKHVLEEDSGYYLCKVSNDVGADASKS 74 (79)
T ss_pred CEeEeeCeEeCCCEEEEEECCCccccccccccccCCCEEEecC------CeEEECcCCcccCEEEEEEEEeCCCCCCceE
Confidence 5799999999999999999543211100 0011233333333 479999999999999999999999987 555
Q ss_pred EEEE
Q psy1672 349 FTLQ 352 (600)
Q Consensus 349 v~L~ 352 (600)
+.|.
T Consensus 75 ~~l~ 78 (79)
T cd05734 75 MVLT 78 (79)
T ss_pred EEEe
Confidence 5554
No 90
>KOG1259|consensus
Probab=98.91 E-value=1.4e-10 Score=113.17 Aligned_cols=129 Identities=21% Similarity=0.280 Sum_probs=97.7
Q ss_pred CCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeC
Q psy1672 75 LNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDM 154 (600)
Q Consensus 75 ~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~L 154 (600)
..|+.|+|++|.|+.|+.. ..-+++++.|++|.|.|..+.. ++.+++|+.|+|++|.++.+.. .-..+-+++.|.|
T Consensus 284 q~LtelDLS~N~I~~iDES-vKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls~~~G-wh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLITQIDES-VKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLAECVG-WHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchhhhhhh-hhhccceeEEeccccceeeehh--hhhcccceEeecccchhHhhhh-hHhhhcCEeeeeh
Confidence 4678888888888888543 5677888888888888887765 6678888888888888777632 2335677888888
Q ss_pred CCCcCcccChhhhcCCCCCCEEEcCCCcCCCCC-cccccccccccEEEccCCcCcc
Q psy1672 155 SESRLEHISPEAFTGAKSLESIKLNGNRLSHFP-VRSVEPLLKLMMIELHDNPWVC 209 (600)
Q Consensus 155 s~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~-~~~~~~l~~L~~L~l~~N~~~C 209 (600)
+.|.|..+ ..+.++-+|..||+++|+|..+. ...+.+++-|+.+.+.+||+.-
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 88888776 45667788888888888888765 3566778888888888888654
No 91
>cd05749 Ig2_Tyro3_like Second immunoglobulin (Ig)-like domain of Axl/Tyro3 receptor tyrosine kinases (RTKs). Ig2_Tyro3_like: the second immunoglobulin (Ig)-like domain in the Axl/Tyro3 family of receptor tyrosine kinases (RTKs). This family includes Axl (also known as Ark, Ufo, and Tyro7), Tyro3 (also known as Sky, Rse, Brt, Dtk, and Tif), and Mer (also known as Nyk, c-Eyk, and Tyro12). Axl/Tyro3 family receptors have an extracellular portion with two Ig-like domains followed by two fibronectin-types III (FNIII) domains, a membrane-spanning single helix, and a cytoplasmic tyrosine kinase domain. Axl, Tyro3 and Mer are widely expressed in adult tissues, though they show higher expression in the brain, in the lymphatic and vascular systems, and in the testis. Axl, Tyro3, and Mer bind the vitamin K dependent protein Gas6 with high affinity, and in doing so activate their tyrosine kinase activity. Axl/Gas6 signaling may play a part in cell adhesion processes, prevention of apoptosis, and c
Probab=98.91 E-value=5.4e-09 Score=85.18 Aligned_cols=71 Identities=18% Similarity=0.399 Sum_probs=55.8
Q ss_pred ccccccccccccceeeeEeecCCCC-eeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEE
Q psy1672 260 DSRYVEAVSSENATVVCRVDSIPPA-AISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVA 338 (600)
Q Consensus 260 ~~~~~~v~~G~~v~L~C~v~g~P~p-~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a 338 (600)
.+..+.+..|+.+.|.|.+.|.|.| +|.|+++|+.+.... . ...+.|.|..+ .|.|.|.|+|
T Consensus 4 ~P~~~~v~~G~~v~l~C~a~G~P~P~~I~W~k~g~~l~~~~------------~---~~~s~L~i~~~--~d~g~Y~C~A 66 (81)
T cd05749 4 EPEDLSVTANTPFNLTCQAVGPPEPVEILWWQGGSPLGDPP------------A---PSPSVLNVPGL--NETSKFSCEA 66 (81)
T ss_pred CCCceEEcCCCCEEEEEEeeeecCCeEEEEEECCEECCCCC------------C---CCCCEEEEccc--cCCeEEEEEE
Confidence 4566788999999999999999999 799999998775310 0 01246778776 4789999999
Q ss_pred ecCCCceeE
Q psy1672 339 ENRAGIADA 347 (600)
Q Consensus 339 ~N~~G~~~~ 347 (600)
+|..|....
T Consensus 67 ~N~~G~~~s 75 (81)
T cd05749 67 HNAKGVTTS 75 (81)
T ss_pred EeccCcEEe
Confidence 999997653
No 92
>cd07702 Ig2_VEGFR-1 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). Ig2_VEGFR-1: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-1 binds VEGF-A strongly; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-1 may play an inhibitory rolet in the function of VEGFR-2 by binding VEGF-A and interfering with its interaction with VEGFR-2. VEGFR-1 has a signaling role in mediating monocyte chemotaxis and may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=98.90 E-value=7.4e-09 Score=82.16 Aligned_cols=69 Identities=20% Similarity=0.313 Sum_probs=53.0
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
+.|.|.+.|.|.|++.|+++++.+.... .+.. .++ ..|.|.+++.+|+|.|+|.|+|..........+
T Consensus 1 ~~l~c~v~g~P~P~v~W~kdg~~l~~~~-----~~~~--~~~-----~~L~I~~v~~~D~G~YtC~a~~~~~~~~~~~~i 68 (72)
T cd07702 1 YRLTPKVKAFPAPEVIWLKDGLPAAEKC-----SRYH--VDG-----YSLVIKDVTEEDAGIYTILLGIKQYNLFKNLTI 68 (72)
T ss_pred CeEEeeEEEcCCCeEEEEECCEECCCCC-----cEEE--eCC-----CEEEECcCCHHHCEEEEEEEEccccceEeeEEE
Confidence 4689999999999999999998876432 1221 122 269999999999999999999997766555544
Q ss_pred E
Q psy1672 352 Q 352 (600)
Q Consensus 352 ~ 352 (600)
.
T Consensus 69 ~ 69 (72)
T cd07702 69 T 69 (72)
T ss_pred E
Confidence 3
No 93
>cd05750 Ig_Pro_neuregulin Immunoglobulin (Ig)-like domain in neuregulins (NRGs). Ig_Pro_neuregulin: immunoglobulin (Ig)-like domain in neuregulins (NRGs). NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. There are four members of the neuregulin gene family (NRG1, -2, -3, and -4). The NRG-1 protein, binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. The other NRGs proteins bind one or the other or both of these ErbBs. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates processes such as target cell differentiation, and Schwann cell surv
Probab=98.90 E-value=5.2e-09 Score=83.82 Aligned_cols=73 Identities=25% Similarity=0.468 Sum_probs=54.6
Q ss_pred ceeeeEeec-CCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEE
Q psy1672 272 ATVVCRVDS-IPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFT 350 (600)
Q Consensus 272 v~L~C~v~g-~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~ 350 (600)
+.|.|.+.| .|.|.+.|++++..+...... ....+... ...+.|.|.+++.+|.|.|+|.|.|..|.+...+.
T Consensus 1 ~~l~C~~~g~~P~p~~~W~k~g~~l~~~~~~---~~~~~~~~---~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 74 (75)
T cd05750 1 LVLKCEATSEYPSLRFKWFKDGKELNRKNKP---RNIKIRNK---KKNSELQINKAKLADSGEYTCVVENILGNDTVTAN 74 (75)
T ss_pred CEEEEEccCCCCCceEEEEcCCeeccccCCc---ceEEEEec---CceEEEEEccCCcccCeEEEEEEEEcCCceeEEEe
Confidence 368999999 999999999999877643311 11112111 12458999999999999999999999999876653
No 94
>cd05733 Ig6_L1-CAM_like Sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig6_L1-CAM_like: domain similar to the sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains NrCAM [Ng(neuronglia)CAM-related cell adhesion molecule], which is primarily expressed in the nervous system, and human neurofascin.
Probab=98.89 E-value=7.1e-09 Score=83.73 Aligned_cols=67 Identities=25% Similarity=0.473 Sum_probs=49.9
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCC----CCCeEEEEEEecCCCceeE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQE----SDSGRFYCVAENRAGIADA 347 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~----~d~G~Y~C~a~N~~G~~~~ 347 (600)
++|.|.+.|.|.|+++|++++..+.... ..++.+... .+.|.|.++.. .|.|.|+|.|+|..|.+..
T Consensus 1 i~l~C~~~G~P~P~v~W~k~g~~l~~~~----~~~~~~~~~-----~g~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s 71 (77)
T cd05733 1 IVIKCEAKGNPPPTFSWTRNGTHFDPEK----DPRVTMKPD-----SGTLVIDNMNGGRAEDYEGEYQCYASNELGTAIS 71 (77)
T ss_pred CEEEeeCcccCCCeEEEEECCeECCCCC----CCCEEEeCC-----CCEEEEeccCCCCCcCCCEEEEEEEEcCCCcEEc
Confidence 4789999999999999999998775332 123332221 24788888753 6899999999999998643
No 95
>KOG1259|consensus
Probab=98.88 E-value=2.1e-10 Score=111.83 Aligned_cols=134 Identities=26% Similarity=0.354 Sum_probs=95.6
Q ss_pred CCCCCccEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCE
Q psy1672 96 DGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLES 175 (600)
Q Consensus 96 ~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~ 175 (600)
.....|++||||+|.|+.+.. +..-++.++.|++++|.|..+.. +..+++|+.|+|++|.+..+ ...-.++-+++.
T Consensus 281 dTWq~LtelDLS~N~I~~iDE-SvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls~~-~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLITQIDE-SVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLAEC-VGWHLKLGNIKT 356 (490)
T ss_pred chHhhhhhccccccchhhhhh-hhhhccceeEEeccccceeeehh--hhhcccceEeecccchhHhh-hhhHhhhcCEee
Confidence 345678889999999888876 56677889999999998887733 77888999999999988877 233346778888
Q ss_pred EEcCCCcCCCCCcccccccccccEEEccCCcCccccccccchhhhcccCCCCCCCCCCCCccccccccccc
Q psy1672 176 IKLNGNRLSHFPVRSVEPLLKLMMIELHDNPWVCDCNMRSIKMWLADKKNVPVQPACTGPERLSGKVFSDL 246 (600)
Q Consensus 176 L~Ls~N~l~~l~~~~~~~l~~L~~L~l~~N~~~C~C~l~~l~~w~~~~~~~~~~~~C~~p~~l~g~~l~~l 246 (600)
|.|++|.|.+++ .+.++-+|..|++.+|.+.- +. ..+......|.....+.+..+..+
T Consensus 357 L~La~N~iE~LS--GL~KLYSLvnLDl~~N~Ie~----------ld-eV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 357 LKLAQNKIETLS--GLRKLYSLVNLDLSSNQIEE----------LD-EVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred eehhhhhHhhhh--hhHhhhhheeccccccchhh----------HH-HhcccccccHHHHHhhcCCCcccc
Confidence 999999888875 56677788888888887431 11 111112345665556666665443
No 96
>cd05874 Ig6_NrCAM Sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). Ig6_NrCAM: sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=98.86 E-value=1.5e-08 Score=81.80 Aligned_cols=67 Identities=22% Similarity=0.439 Sum_probs=48.2
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCC----CCCeEEEEEEecCCCceeE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQE----SDSGRFYCVAENRAGIADA 347 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~----~d~G~Y~C~a~N~~G~~~~ 347 (600)
+.|.|.+.|.|.|+|+|++++..+.... ..+..+... .+.|.|..+.. .|.|.|+|.|.|..|....
T Consensus 1 ~~l~C~a~G~P~P~i~W~k~g~~l~~~~----~~~~~~~~~-----~g~l~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s 71 (77)
T cd05874 1 IVIQCEAKGKPPPSFSWTRNGTHFDIDK----DPKVTMKPN-----TGTLVINIMNGEKAEAYEGVYQCTARNERGAAVS 71 (77)
T ss_pred CEEEeeCcccCCCeEEEEECCeECCCcC----CCCEEEeCC-----CceEEEeccccCCCCCCCEEEEEEEEcCCCeEEe
Confidence 4689999999999999999988764322 112222221 23677777664 3789999999999998754
No 97
>cd05756 Ig1_IL1R_like First immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig1_IL1R_like: domain similar to the first immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=98.86 E-value=8.4e-09 Score=86.68 Aligned_cols=83 Identities=23% Similarity=0.325 Sum_probs=62.0
Q ss_pred ccccccccccceeeeEeec-----CCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEE
Q psy1672 262 RYVEAVSSENATVVCRVDS-----IPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYC 336 (600)
Q Consensus 262 ~~~~v~~G~~v~L~C~v~g-----~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C 336 (600)
....+.+|+.+.|.|.+.+ .|.+.|.|++++..+.... ....++. .. .+.|.|.+++.+|+|.|+|
T Consensus 7 ~~~~v~~G~~~~L~C~~~g~~~~~~p~~~v~Wyk~~~~~~~~~--~~~~r~~--~~-----~~~L~I~~~~~~DsG~Y~C 77 (94)
T cd05756 7 KKSYVLEGEPVVIKCPLFYSYIAQSPGLNLTWYKSDGKTPIPT--EERSRMH--QQ-----KDLLWFLPAALEDSGLYTC 77 (94)
T ss_pred eEEEEecCCCeEEECCCCCcccccCCCceEEEEEcCCCCcccc--cccceee--ec-----CCeEEEccCCcccCeEEEE
Confidence 3456678999999999998 6889999999886533211 0011221 11 1379999999999999999
Q ss_pred EEecCCCceeEEEEEEE
Q psy1672 337 VAENRAGIADANFTLQV 353 (600)
Q Consensus 337 ~a~N~~G~~~~~v~L~V 353 (600)
++.|..|..+..+.|.|
T Consensus 78 ~~~N~~g~~~~~~~L~v 94 (94)
T cd05756 78 VVRNSTYCMKVSISLTV 94 (94)
T ss_pred EEcCCCccEEEEEEEEC
Confidence 99999999888777654
No 98
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.85 E-value=1.5e-09 Score=83.50 Aligned_cols=59 Identities=39% Similarity=0.531 Sum_probs=28.6
Q ss_pred CccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEccCCC
Q psy1672 76 NLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNP 134 (600)
Q Consensus 76 ~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~ 134 (600)
+|++|+|++|+|+.+++.+|.++++|++|+|++|.|+.+++..|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444444444444444444444444444444444444444444444444443
No 99
>cd05861 Ig1_PDGFR-alphabeta Frst immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). Ig1_PDGFR-alphabeta: The first immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFRalpha binds to all three PDGFs, whereas the PDGFRbeta binds only to PDGF-B. PDGFRs alpha and beta have similar organization: an extracellular component with five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFRalpha and PDGFRbeta are essential for normal development.
Probab=98.83 E-value=4.3e-08 Score=80.58 Aligned_cols=80 Identities=24% Similarity=0.309 Sum_probs=57.2
Q ss_pred cccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCC--cee
Q psy1672 269 SENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAG--IAD 346 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G--~~~ 346 (600)
|+.++|.|.+.+.|.+.+.|+++++...... .. ......+ .....+.|.|.+++.+|+|.|+|.|.|..+ ...
T Consensus 1 Ge~~~l~C~~~~~~~~~~~W~~~~~~~~~~~--~~--~~~~~~~-~~~~~s~L~I~~~~~~DsG~Y~C~a~n~~~~~~~~ 75 (84)
T cd05861 1 GETITVNCIVQGNEVVDFSWTYPGKDIGKGI--PE--VEEVKVP-ATTLRSTLTFPHATVEDSGTYECAAHESTQDQKAF 75 (84)
T ss_pred CCcEEEEEEEECCCccEEEEEECCccCCCCc--eE--EEEEecC-CcEEEEEEEECCCCcCCCEEEEEEEEECccCccee
Confidence 6789999999999999999998775422111 00 0011111 123457899999999999999999999887 566
Q ss_pred EEEEEEE
Q psy1672 347 ANFTLQV 353 (600)
Q Consensus 347 ~~v~L~V 353 (600)
+++.++|
T Consensus 76 ~sv~i~V 82 (84)
T cd05861 76 KKVNITV 82 (84)
T ss_pred EEEEEEE
Confidence 6777766
No 100
>KOG0532|consensus
Probab=98.82 E-value=3.2e-10 Score=119.28 Aligned_cols=166 Identities=25% Similarity=0.400 Sum_probs=95.2
Q ss_pred cCCCCCccCCCCC---CCCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCC
Q psy1672 35 RDKFLITIPEAPE---SELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLL 111 (600)
Q Consensus 35 ~~~~L~~ip~~~~---~~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l 111 (600)
+++.|..+|..-. .......||+.|++.++|..+-. +..|..|.|..|.+..|+ .++..+..|.+|||+.|++
T Consensus 58 s~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~elp~~~~~---f~~Le~liLy~n~~r~ip-~~i~~L~~lt~l~ls~Nql 133 (722)
T KOG0532|consen 58 SGRRLKEFPRGAASYDLTDTVFADLSRNRFSELPEEACA---FVSLESLILYHNCIRTIP-EAICNLEALTFLDLSSNQL 133 (722)
T ss_pred ccchhhcCCCccccccccchhhhhccccccccCchHHHH---HHHHHHHHHHhccceecc-hhhhhhhHHHHhhhccchh
Confidence 4455555553221 12245566777777666655432 344555555555555442 2344455555555555555
Q ss_pred CCCCccc---------------------cCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCC
Q psy1672 112 TSIPSLT---------------------FQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGA 170 (600)
Q Consensus 112 ~~l~~~~---------------------f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l 170 (600)
..+|... ++.+..|..|+.+.|.+..+++ .+.++.+|+.|++..|++..++++ +. .
T Consensus 134 S~lp~~lC~lpLkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~slps-ql~~l~slr~l~vrRn~l~~lp~E-l~-~ 210 (722)
T KOG0532|consen 134 SHLPDGLCDLPLKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQSLPS-QLGYLTSLRDLNVRRNHLEDLPEE-LC-S 210 (722)
T ss_pred hcCChhhhcCcceeEEEecCccccCCcccccchhHHHhhhhhhhhhhchH-HhhhHHHHHHHHHhhhhhhhCCHH-Hh-C
Confidence 5544421 2234444444444444444422 234455555555556666555443 33 3
Q ss_pred CCCCEEEcCCCcCCCCCcccccccccccEEEccCCcCc
Q psy1672 171 KSLESIKLNGNRLSHFPVRSVEPLLKLMMIELHDNPWV 208 (600)
Q Consensus 171 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~l~~N~~~ 208 (600)
-.|..||++.|++..||. .|.+|..|++|.|++||+.
T Consensus 211 LpLi~lDfScNkis~iPv-~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 211 LPLIRLDFSCNKISYLPV-DFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred CceeeeecccCceeecch-hhhhhhhheeeeeccCCCC
Confidence 357889999999999985 6888999999999999975
No 101
>cd05875 Ig6_hNeurofascin_like Sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). Ig6_hNeurofascin_like: the sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). NF belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and a cytoplasmic domain. NF has many alternatively spliced isoforms having different temporal expression patterns during development. NF participates in axon subcellular targeting and synapse formation, however little is known of the functions of the different isoforms.
Probab=98.81 E-value=2.6e-08 Score=80.45 Aligned_cols=68 Identities=22% Similarity=0.426 Sum_probs=48.8
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCC----CCCeEEEEEEecCCCceeE
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQE----SDSGRFYCVAENRAGIADA 347 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~----~d~G~Y~C~a~N~~G~~~~ 347 (600)
+.|.|.+.|.|.|.|+|++++..+.... ..++.+... .+.|.|..+.. .|.|.|+|.|+|..|.+..
T Consensus 1 ~~l~C~~~G~P~P~v~W~k~g~~~~~~~----~~~~~~~~~-----~~~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s 71 (77)
T cd05875 1 IIIECEAKGNPVPTFQWTRNGKFFNVAK----DPRVSMRRR-----SGTLVIDFSGGGRPEDYEGEYQCFARNNLGTALS 71 (77)
T ss_pred CEEEEeccccCCCEEEEEECCEEccCcC----CCcEEEeCC-----CceEEEeccCCCCCCCCCEEEEEEEEeccceEEE
Confidence 4689999999999999999998663221 223333222 24788887642 4699999999999998754
Q ss_pred E
Q psy1672 348 N 348 (600)
Q Consensus 348 ~ 348 (600)
.
T Consensus 72 ~ 72 (77)
T cd05875 72 N 72 (77)
T ss_pred E
Confidence 3
No 102
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=98.81 E-value=4e-09 Score=112.89 Aligned_cols=148 Identities=30% Similarity=0.448 Sum_probs=74.7
Q ss_pred ceEEEeeCCCCCCCChhhhcccCCC-CccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEE
Q psy1672 51 TQVLDMSGNNLQILPKEAFRRAGLL-NLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLN 129 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~~~~l~-~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~ 129 (600)
++.|++.+|.++.|+.... .+. +|+.|++++|.+..++ ..+..+++|+.|++++|+++.++.. ...++.|+.|+
T Consensus 118 l~~L~l~~n~i~~i~~~~~---~~~~nL~~L~l~~N~i~~l~-~~~~~l~~L~~L~l~~N~l~~l~~~-~~~~~~L~~L~ 192 (394)
T COG4886 118 LTSLDLDNNNITDIPPLIG---LLKSNLKELDLSDNKIESLP-SPLRNLPNLKNLDLSFNDLSDLPKL-LSNLSNLNNLD 192 (394)
T ss_pred eeEEecCCcccccCccccc---cchhhcccccccccchhhhh-hhhhccccccccccCCchhhhhhhh-hhhhhhhhhee
Confidence 4555555555555554443 122 4555555555555542 1244555555555555555555442 11344455555
Q ss_pred ccCCCCCccCcc----------------------cccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCC
Q psy1672 130 LARNPISKIEKG----------------------AFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFP 187 (600)
Q Consensus 130 Ls~N~i~~l~~~----------------------~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~ 187 (600)
+++|.++.++.. .+..+.++..+.+.+|++..+ +..+..+.+|+.|++++|.+..++
T Consensus 193 ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~~i~ 271 (394)
T COG4886 193 LSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQISSIS 271 (394)
T ss_pred ccCCccccCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeec-cchhccccccceeccccccccccc
Confidence 555555544332 233344444444455544443 234455556666666666666665
Q ss_pred cccccccccccEEEccCCc
Q psy1672 188 VRSVEPLLKLMMIELHDNP 206 (600)
Q Consensus 188 ~~~~~~l~~L~~L~l~~N~ 206 (600)
. +..+.+++.|++.+|.
T Consensus 272 ~--~~~~~~l~~L~~s~n~ 288 (394)
T COG4886 272 S--LGSLTNLRELDLSGNS 288 (394)
T ss_pred c--ccccCccCEEeccCcc
Confidence 3 5555666666666654
No 103
>cd05895 Ig_Pro_neuregulin-1 Immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. Ig_Pro_neuregulin-1: immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. There are many NRG-1 isoforms which arise from the alternative splicing of mRNA. NRG-1 belongs to the neuregulin gene family, which is comprised of four genes. This group represents NRG-1. NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, and heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. The NRG-1 protein binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates process
Probab=98.79 E-value=2.8e-08 Score=79.96 Aligned_cols=74 Identities=19% Similarity=0.432 Sum_probs=53.4
Q ss_pred ceeeeEeec-CCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEEEE
Q psy1672 272 ATVVCRVDS-IPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADANFT 350 (600)
Q Consensus 272 v~L~C~v~g-~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~ 350 (600)
+.|.|.+.+ .|.+.+.|+++++.+..... ...+..+... ...+.|.|.+++..|+|.|+|.|.|..|..+.++.
T Consensus 1 ~~L~C~a~~~~p~~~~~W~~~g~~i~~~~~--~~~~~~~~~~---~~~~~L~I~~~~~~DsG~Y~C~a~N~~g~~~~~~~ 75 (76)
T cd05895 1 LVLRCETVSEYPSLRFKWFKNGKEIGAKNK--PDNKIKIRKK---KKSSELQISKASLADNGEYKCMVSSKLGNDSVTAN 75 (76)
T ss_pred CEEEEecccCCCCCceEEEECCcccccCCC--CCceEEEEeC---CcEEEEEECcCCcccCEEEEEEEEeCCCceeEEEe
Confidence 468999874 67789999999887753321 1112222211 12358999999999999999999999998877653
No 104
>cd04967 Ig1_Contactin First Ig domain of contactin. Ig1_Contactin: First Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 weeks postnata
Probab=98.78 E-value=3.5e-08 Score=82.45 Aligned_cols=69 Identities=26% Similarity=0.534 Sum_probs=52.2
Q ss_pred ccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCC-CCCCeEEEEEEecCCCcee
Q psy1672 268 SSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQ-ESDSGRFYCVAENRAGIAD 346 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~-~~d~G~Y~C~a~N~~G~~~ 346 (600)
.|..+.|.|.+.|.|.|+++|+++++.+.... ..+... .+ +.|.|.++. ..|.|.|+|+|+|..|...
T Consensus 18 ~~~~~~l~C~~~g~p~p~i~W~k~~~~l~~~~----~~~~~~-~~------~~L~i~~~~~~~d~G~Y~C~a~N~~G~~~ 86 (91)
T cd04967 18 DEGKVSLNCRARGSPPPTYRWLMNGTEIDDEP----DSRYSL-VG------GNLVISNPSKAKDAGRYQCLASNIVGTVL 86 (91)
T ss_pred CCCEEEEEEeeeEcCCCEEEEEECCEECCCCC----CCCEEE-EC------CEEEEecCCccCCCEEEEEEEEcCCCEEE
Confidence 34679999999999999999999998774322 112221 22 368888887 4899999999999999764
Q ss_pred E
Q psy1672 347 A 347 (600)
Q Consensus 347 ~ 347 (600)
.
T Consensus 87 S 87 (91)
T cd04967 87 S 87 (91)
T ss_pred e
Confidence 3
No 105
>cd05752 Ig1_FcgammaR_like Frst immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig1_FcgammaR_like: domain similar to the first immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=98.78 E-value=1.3e-08 Score=82.31 Aligned_cols=74 Identities=24% Similarity=0.509 Sum_probs=56.2
Q ss_pred cccccccccccccccceeeeEeecCCC-CeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEE
Q psy1672 257 IRMDSRYVEAVSSENATVVCRVDSIPP-AAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFY 335 (600)
Q Consensus 257 i~~~~~~~~v~~G~~v~L~C~v~g~P~-p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~ 335 (600)
+...+....+.+|+.++|.|.+.+.|. +.+.|+++|+.+... ...|.|.++ .+|+|.|+
T Consensus 3 v~~~P~~~~v~~G~~V~L~C~~~~~p~~~~~~W~kng~~l~~~-------------------~~~l~i~~~-~~dsG~Y~ 62 (78)
T cd05752 3 VSLDPPWTTIFQGEKVTLTCNGFNSPEQNSTQWYHNGKLLETT-------------------TNSYRIRAA-NNDSGEYR 62 (78)
T ss_pred EEeCCCCeEeeCCCCEEEEEeCCCCCCCccEEEEECCEEeecc-------------------CCeEEEeec-ccCCEEeE
Confidence 445567778889999999999998876 479999999766211 126889999 99999999
Q ss_pred EEEecCCCceeEEEEEE
Q psy1672 336 CVAENRAGIADANFTLQ 352 (600)
Q Consensus 336 C~a~N~~G~~~~~v~L~ 352 (600)
|.|.|. ..+..+.|.
T Consensus 63 C~a~~~--~~S~~v~l~ 77 (78)
T cd05752 63 CQTQGS--SLSDPVHLE 77 (78)
T ss_pred EECCCC--cCCCCEEEe
Confidence 999986 333334443
No 106
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.78 E-value=3.5e-09 Score=81.41 Aligned_cols=60 Identities=40% Similarity=0.597 Sum_probs=39.3
Q ss_pred CccEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcC
Q psy1672 100 NLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRL 159 (600)
Q Consensus 100 ~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l 159 (600)
+|++|+|++|+|+.+++..|..+++|++|++++|.++.+.+.+|.++++|+.|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 566666666666666666666666666666666666666666666666666666666653
No 107
>cd05729 Ig2_FGFR_like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor and similar proteins. Ig2_FGFR_like: domain similar to the second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three Ig-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin
Probab=98.78 E-value=5e-08 Score=79.87 Aligned_cols=82 Identities=22% Similarity=0.450 Sum_probs=62.9
Q ss_pred ccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCC
Q psy1672 264 VEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAG 343 (600)
Q Consensus 264 ~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G 343 (600)
+.+..|+.++|.|.+.+.|.+.+.|++++..+..... ...... ......|.|.++..+|.|.|+|.|.|..|
T Consensus 4 ~~~~~G~~~~l~C~~~~~p~~~v~W~k~~~~~~~~~~------~~~~~~--~~~~~~l~i~~~~~~d~g~Y~C~~~n~~g 75 (85)
T cd05729 4 HAVPAGSTVRLKCPASGNPRPTITWLKDGKPFKKEHR------IGGYKV--RKKKWTLILESVVPSDSGKYTCIVENKYG 75 (85)
T ss_pred eEecCCCcEEEEEEcCCCCCCeEEEEECCEECcccCc------eeEEEc--cCcEEEEEEeECCcccCEEEEEEEEECCc
Confidence 4566899999999999999999999998877653321 111111 11234789999999999999999999999
Q ss_pred ceeEEEEEEE
Q psy1672 344 IADANFTLQV 353 (600)
Q Consensus 344 ~~~~~v~L~V 353 (600)
..+.++.|.|
T Consensus 76 ~~~~~~~l~v 85 (85)
T cd05729 76 SINHTYKVDV 85 (85)
T ss_pred eEEEEEEEeC
Confidence 9888877754
No 108
>cd05754 Ig3_Perlecan_like Third immunoglobulin (Ig)-like domain found in Perlecan and similar proteins. Ig3_Perlecan_like: domain similar to the third immunoglobulin (Ig)-like domain found in Perlecan. Perlecan is a large multi-domain heparin sulfate proteoglycan, important in tissue development and organogenesis. Perlecan can be represented as 5 major portions; its fourth major portion (domain IV) is a tandem repeat of immunoglobulin-like domains (Ig2-Ig15), which can vary in size due to alternative splicing. Perlecan binds many cellular and extracellular ligands. Its domain IV region has many binding sites. Some of these have been mapped at the level of individual Ig-like domains, including a site restricted to the Ig5 domain for heparin/sulfatide, a site restricted to the Ig3 domain for nidogen-1 and nidogen-2, a site restricted to Ig4-5 for fibronectin, and sites restricted to Ig2 and to Ig13-15 for fibulin-2.
Probab=98.74 E-value=3.5e-08 Score=81.27 Aligned_cols=77 Identities=26% Similarity=0.413 Sum_probs=60.9
Q ss_pred ccccccccccccceeeeEeec-CCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEE
Q psy1672 260 DSRYVEAVSSENATVVCRVDS-IPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVA 338 (600)
Q Consensus 260 ~~~~~~v~~G~~v~L~C~v~g-~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a 338 (600)
.+..+.+..|+.++|.|.+.+ .|.+.+.|++++..+... . ... .+.|.|.+++.+|+|.|+|.|
T Consensus 7 ~p~~~~v~~G~~v~L~C~~~~~~~~~~i~W~~~~~~~~~~--------~-~~~------~~~L~I~~v~~~DsG~Y~C~a 71 (85)
T cd05754 7 EPRSQEVRPGADVSFICRAKSKSPAYTLVWTRVGGGLPSR--------A-MDF------NGILTIRNVQLSDAGTYVCTG 71 (85)
T ss_pred CCCceEEcCCCCEEEEEEcCCCCCCcEEEEEECCCcCCCc--------c-ccc------CCEEEECCCCHHHCEEEEEEE
Confidence 356677889999999999974 688899999977543211 0 111 247999999999999999999
Q ss_pred ecCCCceeEEEEE
Q psy1672 339 ENRAGIADANFTL 351 (600)
Q Consensus 339 ~N~~G~~~~~v~L 351 (600)
.|..|..++.+.|
T Consensus 72 ~n~~g~~~~~~~l 84 (85)
T cd05754 72 SNMLDTDEATATL 84 (85)
T ss_pred eccCCeEeEEEEE
Confidence 9999999887765
No 109
>cd05882 Ig1_Necl-1 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig1_Necl-1: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-1, Necl-1 (also known as celll adhesion molecule 3 (CADM3), SynCAM2, IGSF4). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the format
Probab=98.70 E-value=5.5e-08 Score=81.83 Aligned_cols=88 Identities=17% Similarity=0.252 Sum_probs=59.3
Q ss_pred cccccccccccceeeeEeecCCCCeeEEEEcCeeccC-C-cccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEE
Q psy1672 261 SRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLN-N-TAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVA 338 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~-~-~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a 338 (600)
..++.+..|+.+.|.|.+.+.|.+.|.|+++++.+.. . .......++.+.... .....|.|.+++.+|.|.|+|.+
T Consensus 4 ~~~~tv~~G~tv~L~C~v~g~~~~~v~W~k~~~~~~~~~~~~~~~~~r~~~~~~~--~~~~~L~I~nV~~~D~G~YtC~~ 81 (95)
T cd05882 4 TQDETVAVGGTVTLKCGVKEHDNSSLQWSNTAQQTLYFGEKRALRDNRIQLVKST--PTELIISISNVQLSDEGEYTCSI 81 (95)
T ss_pred cccEEEecCCcEEEEEEEeCCCCCeEEEeccCccEEEeCCeEEEeCCeEEEEeCC--CceEEEEECCCCcccCEEEEEEE
Confidence 4567888999999999999999999999997653211 1 100012233332222 12458999999999999999999
Q ss_pred ecCCCceeEEEEE
Q psy1672 339 ENRAGIADANFTL 351 (600)
Q Consensus 339 ~N~~G~~~~~v~L 351 (600)
... -..++...|
T Consensus 82 ~t~-~~~~~~~~~ 93 (95)
T cd05882 82 FTM-PVRTAKATV 93 (95)
T ss_pred Eee-ccccEEEEE
Confidence 982 233444443
No 110
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=98.68 E-value=8.8e-09 Score=106.62 Aligned_cols=135 Identities=24% Similarity=0.311 Sum_probs=62.0
Q ss_pred CCCCccEEEeecccCcccCccccCCCCC---ccEEEccCCCCCCCC----ccccCCC-CCCCEEEccCCCCCccC----c
Q psy1672 73 GLLNLQKLFLARCHIGQIDSGALDGLTN---LIEIDLSDNLLTSIP----SLTFQSV-RFLRDLNLARNPISKIE----K 140 (600)
Q Consensus 73 ~l~~L~~L~L~~n~l~~i~~~~f~~l~~---L~~L~Ls~N~l~~l~----~~~f~~l-~~L~~L~Ls~N~i~~l~----~ 140 (600)
.+.+|+.|+|++|.+....+..|..+.+ |++|++++|.++... ...+..+ ++|+.|+|++|.++... .
T Consensus 79 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 79 KGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred hcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence 3556666666665554333333333333 666666665554210 0122233 45566666666555211 1
Q ss_pred ccccCCCCcceeeCCCCcCcccC----hhhhcCCCCCCEEEcCCCcCCCCCc----ccccccccccEEEccCCcC
Q psy1672 141 GAFQFVPGLVKLDMSESRLEHIS----PEAFTGAKSLESIKLNGNRLSHFPV----RSVEPLLKLMMIELHDNPW 207 (600)
Q Consensus 141 ~~~~~l~~L~~L~Ls~n~l~~i~----~~~~~~l~~L~~L~Ls~N~l~~l~~----~~~~~l~~L~~L~l~~N~~ 207 (600)
..+..+.+|+.|++++|.+.... ...+..+++|+.|+|++|.+..... ..+..+++|+.|++.+|++
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l 233 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL 233 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcC
Confidence 22334455566666655555311 1122334455666666555543221 1223344555566655543
No 111
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=98.67 E-value=1.8e-07 Score=113.06 Aligned_cols=119 Identities=26% Similarity=0.339 Sum_probs=77.8
Q ss_pred EEEccCCCCCccCCCCCCCCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecc-cCcccCccccCCCCCccEEEccCC
Q psy1672 31 WMECRDKFLITIPEAPESELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARC-HIGQIDSGALDGLTNLIEIDLSDN 109 (600)
Q Consensus 31 ~v~C~~~~L~~ip~~~~~~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n-~l~~i~~~~f~~l~~L~~L~Ls~N 109 (600)
.+...+..+..+|..+...+|+.|+|.+|+|..++.... .+.+|+.|+|+++ .+..++. +..+++|+.|+|++|
T Consensus 593 ~L~~~~~~l~~lP~~f~~~~L~~L~L~~s~l~~L~~~~~---~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c 667 (1153)
T PLN03210 593 LLRWDKYPLRCMPSNFRPENLVKLQMQGSKLEKLWDGVH---SLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDC 667 (1153)
T ss_pred EEEecCCCCCCCCCcCCccCCcEEECcCccccccccccc---cCCCCCEEECCCCCCcCcCCc--cccCCcccEEEecCC
Confidence 344455667777776666678888888888887776553 5778888888766 3555543 667777888888775
Q ss_pred -CCCCCCccccCCCCCCCEEEccCC-CCCccCcccccCCCCcceeeCCCC
Q psy1672 110 -LLTSIPSLTFQSVRFLRDLNLARN-PISKIEKGAFQFVPGLVKLDMSES 157 (600)
Q Consensus 110 -~l~~l~~~~f~~l~~L~~L~Ls~N-~i~~l~~~~~~~l~~L~~L~Ls~n 157 (600)
.+..+|. .+..+.+|+.|+|++| .+..++... ++++|+.|+|++|
T Consensus 668 ~~L~~lp~-si~~L~~L~~L~L~~c~~L~~Lp~~i--~l~sL~~L~Lsgc 714 (1153)
T PLN03210 668 SSLVELPS-SIQYLNKLEDLDMSRCENLEILPTGI--NLKSLYRLNLSGC 714 (1153)
T ss_pred CCccccch-hhhccCCCCEEeCCCCCCcCccCCcC--CCCCCCEEeCCCC
Confidence 3555554 5667777777777765 344443321 4555555555554
No 112
>KOG0532|consensus
Probab=98.66 E-value=1.1e-09 Score=115.45 Aligned_cols=164 Identities=20% Similarity=0.242 Sum_probs=123.6
Q ss_pred ceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEc
Q psy1672 51 TQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNL 130 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 130 (600)
.-+|.|++-++...|...+. ..+..-...+|+.|++..++.. +..+..|+.|.|..|.|..++. .+.++..|.+|+|
T Consensus 52 sg~l~Ls~rrlk~fpr~a~~-~~ltdt~~aDlsrNR~~elp~~-~~~f~~Le~liLy~n~~r~ip~-~i~~L~~lt~l~l 128 (722)
T KOG0532|consen 52 SGRLLLSGRRLKEFPRGAAS-YDLTDTVFADLSRNRFSELPEE-ACAFVSLESLILYHNCIRTIPE-AICNLEALTFLDL 128 (722)
T ss_pred hcccccccchhhcCCCcccc-ccccchhhhhccccccccCchH-HHHHHHHHHHHHHhccceecch-hhhhhhHHHHhhh
Confidence 45688999999999888876 5788888899999999999654 6788899999999999999987 6788889999999
Q ss_pred cCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCcccccccc---------------
Q psy1672 131 ARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLL--------------- 195 (600)
Q Consensus 131 s~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~--------------- 195 (600)
+.|+++.++... ..| -|+.|.+++|+++.++. .++.+..|..|+.+.|.+.+++.. +..+.
T Consensus 129 s~NqlS~lp~~l-C~l-pLkvli~sNNkl~~lp~-~ig~~~tl~~ld~s~nei~slpsq-l~~l~slr~l~vrRn~l~~l 204 (722)
T KOG0532|consen 129 SSNQLSHLPDGL-CDL-PLKVLIVSNNKLTSLPE-EIGLLPTLAHLDVSKNEIQSLPSQ-LGYLTSLRDLNVRRNHLEDL 204 (722)
T ss_pred ccchhhcCChhh-hcC-cceeEEEecCccccCCc-ccccchhHHHhhhhhhhhhhchHH-hhhHHHHHHHHHhhhhhhhC
Confidence 999999886654 344 38888888888888854 455677777777777777766532 11222
Q ss_pred -------cccEEEccCCcCc----cccccccchhhhc
Q psy1672 196 -------KLMMIELHDNPWV----CDCNMRSIKMWLA 221 (600)
Q Consensus 196 -------~L~~L~l~~N~~~----C~C~l~~l~~w~~ 221 (600)
.|..||++.|.+. |.|+++.++....
T Consensus 205 p~El~~LpLi~lDfScNkis~iPv~fr~m~~Lq~l~L 241 (722)
T KOG0532|consen 205 PEELCSLPLIRLDFSCNKISYLPVDFRKMRHLQVLQL 241 (722)
T ss_pred CHHHhCCceeeeecccCceeecchhhhhhhhheeeee
Confidence 3556777777653 6677766654433
No 113
>cd04979 Ig_Semaphorin_C Immunoglobulin (Ig)-like domain of semaphorin. Ig_Semaphorin_C; Immunoglobulin (Ig)-like domain in semaphorins. Semaphorins are transmembrane protein that have important roles in a variety of tissues. Functionally, semaphorins were initially characterized for their importance in the development of the nervous system and in axonal guidance. Later they have been found to be important for the formation and functioning of the cardiovascular, endocrine, gastrointestinal, hepatic, immune, musculoskeletal, renal, reproductive, and respiratory systems. Semaphorins function through binding to their receptors and transmembrane semaphorins also serves as receptors themselves. Although molecular mechanism of semaphorins is poorly understood, the Ig-like domains may involve in ligand binding or dimerization.
Probab=98.66 E-value=1.2e-07 Score=78.84 Aligned_cols=84 Identities=20% Similarity=0.411 Sum_probs=60.3
Q ss_pred cccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEec
Q psy1672 261 SRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAEN 340 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N 340 (600)
+..+.+..|+.+.|.|.+.+ |.+.+.|++++..+..... ...+.... ...|.|.+++.+|+|.|+|.|.|
T Consensus 3 ~~~~~v~~g~~v~L~C~~~~-p~~~i~W~k~~~~~~~~~~--~~~~~~~~-------~~~L~I~~~~~~D~G~Y~C~a~~ 72 (89)
T cd04979 3 EKVVTVVEGNSVFLECSPKS-NLASVVWLFQGGPLQRKEE--PEERLLVT-------EDGLLIRSVSPADAGVYTCQSVE 72 (89)
T ss_pred ceEEEEECCCcEEEEEeCCC-CCceEEEEECCcccccccC--cCceEEEc-------CCCEEEccCCHHHCEEEEEEEec
Confidence 34567788999999999987 8889999998875543211 01122221 12589999999999999999997
Q ss_pred CCC-ceeEEEEEEEE
Q psy1672 341 RAG-IADANFTLQVT 354 (600)
Q Consensus 341 ~~G-~~~~~v~L~V~ 354 (600)
..+ ....++.|+|.
T Consensus 73 ~~~~~~~~~~~l~V~ 87 (89)
T cd04979 73 HGFKQTLATYSLNVL 87 (89)
T ss_pred CccceeEeEEEEEEe
Confidence 654 45666777763
No 114
>cd05873 Ig_Sema4D_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4D. Ig_Sema4D_like; Immunoglobulin (Ig)-like domain of Sema4D. Sema4D is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4D has extracellular Sema and Ig domains, a transmembrane domain, and a short cytoplasmic domain. Sema4D plays a part in the development of GABAergic synapses. Sema4D in addition is an immune semaphorin. It is abundant on resting T cells; its expression is weak on resting B cells and antigen presenting cells (APCs), but is upregulated by various stimuli. The receptor used by Sema4D in the immune system is CD72. Sem4D enhances the activation of B cells and DCs through binding CD72, perhaps by reducing CD72s inhibitory signals. The receptor used by Sema4D in the non-lymphatic tissues is plexin-B1. Sem4D is anchored to the cell surface but its extracellular domain can be released from the cell surface by a metalloproteas
Probab=98.64 E-value=1.6e-07 Score=77.38 Aligned_cols=69 Identities=25% Similarity=0.527 Sum_probs=54.8
Q ss_pred cccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEec
Q psy1672 261 SRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAEN 340 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N 340 (600)
+....+..|+++.|.|.+.+ +.++|.|.++|+.+.... .+..+ .++ .|.|.+++.+|+|.|+|.|.+
T Consensus 3 P~~~~v~~G~~v~L~C~~~~-~~~~i~W~~ng~~i~~~~-----~r~~~-~~~------~L~I~nv~~~DsG~Y~C~a~e 69 (87)
T cd05873 3 PRQRTFKLGNNAELKCSPKS-NLARVVWKFDGKVLTPES-----AKYLL-YRD------GLLIFNASEADAGRYQCLSVE 69 (87)
T ss_pred cceEEEECCCCEEEEEECCC-CCCeEEEEECCEECCCCC-----ceEEE-ECC------cEEEeCCCHHHCEEEEEEEEe
Confidence 45667889999999999865 678999999999876432 23332 223 699999999999999999998
Q ss_pred CC
Q psy1672 341 RA 342 (600)
Q Consensus 341 ~~ 342 (600)
..
T Consensus 70 ~~ 71 (87)
T cd05873 70 KS 71 (87)
T ss_pred cc
Confidence 75
No 115
>KOG3513|consensus
Probab=98.64 E-value=1.6e-07 Score=106.79 Aligned_cols=94 Identities=31% Similarity=0.478 Sum_probs=78.3
Q ss_pred ccccccccccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeE
Q psy1672 254 KPEIRMDSRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGR 333 (600)
Q Consensus 254 ~p~i~~~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~ 333 (600)
.|.........++..|+++++.|++.|.|.|.|.|.+||.++..... .++..+ .+ +.|.|.+++..|+|.
T Consensus 331 ~P~w~~~~~d~~~~~gs~v~~eC~a~g~P~p~v~WlkNg~pl~~~~r---~~~~~i-~~------g~L~is~v~~~dsg~ 400 (1051)
T KOG3513|consen 331 PPYWLQKPQDTEADTGSNVTLECKASGKPNPTVKWLKNGEPLEPAER---DPRYKI-DD------GTLIISNVQESDSGV 400 (1051)
T ss_pred CchhhcccceeEecCCCCeEEEEEecCCCCCceEEeeCCeecCccCC---CcceEE-eC------CEEEEEecccccCeE
Confidence 46666667778889999999999999999999999999999875442 122322 23 379999999999999
Q ss_pred EEEEEecCCCceeEEEEEEEEEcc
Q psy1672 334 FYCVAENRAGIADANFTLQVTYRG 357 (600)
Q Consensus 334 Y~C~a~N~~G~~~~~v~L~V~~~~ 357 (600)
|+|.|+|..|...+++.|.|....
T Consensus 401 YQC~A~Nk~G~i~anA~L~V~a~~ 424 (1051)
T KOG3513|consen 401 YQCIAENKYGTIYANAELKVLASA 424 (1051)
T ss_pred EEeeeecccceEeeeeEEEEEccC
Confidence 999999999999999999997653
No 116
>PLN03150 hypothetical protein; Provisional
Probab=98.62 E-value=1e-07 Score=107.58 Aligned_cols=84 Identities=26% Similarity=0.284 Sum_probs=46.8
Q ss_pred ceEEEeeCCCCCC-CChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEE
Q psy1672 51 TQVLDMSGNNLQI-LPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLN 129 (600)
Q Consensus 51 l~~L~Ls~n~L~~-l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~ 129 (600)
++.|+|++|.+.. +|.. +. .+.+|+.|+|++|.+....+..|..+++|+.|+|++|+|+...+..+..+++|+.|+
T Consensus 420 v~~L~L~~n~L~g~ip~~-i~--~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~ 496 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPND-IS--KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN 496 (623)
T ss_pred EEEEECCCCCccccCCHH-Hh--CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEE
Confidence 6667777777763 3333 32 466666666666666544444455566666666666655543333455555555555
Q ss_pred ccCCCCCc
Q psy1672 130 LARNPISK 137 (600)
Q Consensus 130 Ls~N~i~~ 137 (600)
|++|.++.
T Consensus 497 Ls~N~l~g 504 (623)
T PLN03150 497 LNGNSLSG 504 (623)
T ss_pred CcCCcccc
Confidence 55555443
No 117
>cd07701 Ig1_Necl-3 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig1_Necl-3: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-3, Necl-3 (also known as cell adhesion molecule 2 (CADM2), SynCAM2, IGSF4D). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-3 accumulates in central and peripheral nervous system tissue, and has been shown to selectively interact with oligodendrocytes.
Probab=98.60 E-value=2.3e-07 Score=78.12 Aligned_cols=89 Identities=19% Similarity=0.299 Sum_probs=59.8
Q ss_pred cccccccccccceeeeEeecCCCCeeEEEEcCeecc--CCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEE
Q psy1672 261 SRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLL--NNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVA 338 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~--~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a 338 (600)
..++.+.+|+.++|.|.+.+.|.+.+.|++.++.+. .........|+.+.... .....|.|.+++.+|+|.|+|.+
T Consensus 4 ~~~v~v~eG~~v~L~C~~~~~p~~~v~W~~~~~~~l~~~~~~~~~~~r~~~~~~~--~~~~sL~I~~v~~~DsG~Y~C~~ 81 (95)
T cd07701 4 TQNVTVVEGGTANLTCRVDQNDNTSLQWSNPAQQTLYFDDKKALRDNRIELVRAS--WHELSISISDVSLSDEGQYTCSL 81 (95)
T ss_pred cceEEEecCCcEEEEEEEecCCceEEEEeCCCCeEEEEcCcccccCCCEEEEECC--CCcEEEEECcCCcccCEEEEEEe
Confidence 456788999999999999999999999987433211 11101122344332221 13458999999999999999999
Q ss_pred ecCCCceeEEEEEE
Q psy1672 339 ENRAGIADANFTLQ 352 (600)
Q Consensus 339 ~N~~G~~~~~v~L~ 352 (600)
.+..+. .....|.
T Consensus 82 ~t~~~~-~~~~~l~ 94 (95)
T cd07701 82 FTMPVK-TSKAYLT 94 (95)
T ss_pred EeecCc-cEEEEEE
Confidence 985433 4444444
No 118
>PLN03150 hypothetical protein; Provisional
Probab=98.60 E-value=9.7e-08 Score=107.79 Aligned_cols=109 Identities=25% Similarity=0.313 Sum_probs=77.7
Q ss_pred ccEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCC
Q psy1672 101 LIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNG 180 (600)
Q Consensus 101 L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~ 180 (600)
++.|+|++|.++...+..+..+++|+.|+|++|.+....+..+..+++|+.|+|++|++....+..++++++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 67788888887755555677788888888888888766666677788888888888888776677777888888888888
Q ss_pred CcCCCCCcccccc-cccccEEEccCCcCcc
Q psy1672 181 NRLSHFPVRSVEP-LLKLMMIELHDNPWVC 209 (600)
Q Consensus 181 N~l~~l~~~~~~~-l~~L~~L~l~~N~~~C 209 (600)
|.+....+..+.. +.++..+++.+|+..|
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCcccc
Confidence 8777443333433 2345566777776555
No 119
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=98.59 E-value=1.5e-08 Score=104.83 Aligned_cols=155 Identities=27% Similarity=0.312 Sum_probs=76.6
Q ss_pred ceEEEeeCCCCCCCChhhhcccCC---CCccEEEeecccCccc----CccccCCC-CCccEEEccCCCCCCCC----ccc
Q psy1672 51 TQVLDMSGNNLQILPKEAFRRAGL---LNLQKLFLARCHIGQI----DSGALDGL-TNLIEIDLSDNLLTSIP----SLT 118 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~~~~l---~~L~~L~L~~n~l~~i----~~~~f~~l-~~L~~L~Ls~N~l~~l~----~~~ 118 (600)
++.|++++|.+.......+. .+ ++|+.|++++|++... ....+..+ ++|+.|+|++|.++.-. ...
T Consensus 83 L~~L~l~~~~~~~~~~~~~~--~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLE--SLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred eeEEEccCCCCChhHHHHHH--HHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 66666666666533322222 12 2366666666665421 11223444 56666666666665211 112
Q ss_pred cCCCCCCCEEEccCCCCCccC----cccccCCCCcceeeCCCCcCcccCh----hhhcCCCCCCEEEcCCCcCCCCCccc
Q psy1672 119 FQSVRFLRDLNLARNPISKIE----KGAFQFVPGLVKLDMSESRLEHISP----EAFTGAKSLESIKLNGNRLSHFPVRS 190 (600)
Q Consensus 119 f~~l~~L~~L~Ls~N~i~~l~----~~~~~~l~~L~~L~Ls~n~l~~i~~----~~~~~l~~L~~L~Ls~N~l~~l~~~~ 190 (600)
+..+.+|+.|+|++|.++... ...+..+++|+.|+|++|.+..... ..+..+++|+.|++++|.+.......
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~ 240 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAA 240 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHH
Confidence 344455666666666655211 1123334566666666666653322 22344566666666666665422111
Q ss_pred cc-----ccccccEEEccCCcC
Q psy1672 191 VE-----PLLKLMMIELHDNPW 207 (600)
Q Consensus 191 ~~-----~l~~L~~L~l~~N~~ 207 (600)
+. ....|+.|++.+|.+
T Consensus 241 l~~~~~~~~~~L~~L~l~~n~i 262 (319)
T cd00116 241 LASALLSPNISLLTLSLSCNDI 262 (319)
T ss_pred HHHHHhccCCCceEEEccCCCC
Confidence 11 124566666666554
No 120
>KOG1859|consensus
Probab=98.59 E-value=1e-09 Score=118.13 Aligned_cols=129 Identities=22% Similarity=0.308 Sum_probs=104.0
Q ss_pred CccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCC
Q psy1672 76 NLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMS 155 (600)
Q Consensus 76 ~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls 155 (600)
.|...+++.|.+..++ .++.-++.|+.|||++|+++.+. .+..++.|+.|||++|.+..++.-....+. |+.|.|+
T Consensus 165 ~L~~a~fsyN~L~~mD-~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMD-ESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHHhHH-HHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 4555566667776664 45777889999999999999876 577889999999999999988765555555 9999999
Q ss_pred CCcCcccChhhhcCCCCCCEEEcCCCcCCCCCc-ccccccccccEEEccCCcCccc
Q psy1672 156 ESRLEHISPEAFTGAKSLESIKLNGNRLSHFPV-RSVEPLLKLMMIELHDNPWVCD 210 (600)
Q Consensus 156 ~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~-~~~~~l~~L~~L~l~~N~~~C~ 210 (600)
+|.++.+ ..+.++.+|+.||+++|-|..... ..+..+..|+.|+|++||+-|.
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 9999887 467789999999999998876542 3456678899999999999885
No 121
>KOG3513|consensus
Probab=98.58 E-value=1.3e-07 Score=107.40 Aligned_cols=81 Identities=36% Similarity=0.578 Sum_probs=71.1
Q ss_pred ccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCC
Q psy1672 264 VEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAG 343 (600)
Q Consensus 264 ~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G 343 (600)
..+..|..+.+.|.+.+.|.|.++|.+.++.+.+ ..|+.+.++| +|.|.+++.+|.|.|+|+|+|..|
T Consensus 436 ~~a~~g~~v~i~C~~~asP~p~~~W~k~~~~~~~------~~r~~i~edG------tL~I~n~t~~DaG~YtC~A~N~~G 503 (1051)
T KOG3513|consen 436 VMAVVGGTVTIDCKPFASPKPKVSWLKGGEKLLQ------SGRIRILEDG------TLEISNVTRSDAGKYTCVAENKLG 503 (1051)
T ss_pred EEEEeCCeEEEeeccCCCCcceEEEEcCCccccc------CceEEECCCC------cEEecccCcccCcEEEEEEEcccC
Confidence 4677899999999999999999999997774433 4577788887 899999999999999999999999
Q ss_pred ceeEEEEEEEEEc
Q psy1672 344 IADANFTLQVTYR 356 (600)
Q Consensus 344 ~~~~~v~L~V~~~ 356 (600)
.++....|.|...
T Consensus 504 ~a~~~~~L~Vkd~ 516 (1051)
T KOG3513|consen 504 KAESTGNLIVKDA 516 (1051)
T ss_pred ccceEEEEEEecC
Confidence 9999999988654
No 122
>cd05757 Ig2_IL1R_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig2_IL1R_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three IG-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta. This group also contains ILIR-like 1 (IL1
Probab=98.57 E-value=3.7e-07 Score=76.26 Aligned_cols=78 Identities=21% Similarity=0.364 Sum_probs=59.9
Q ss_pred ccccccccceeeeEeec-----CCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEE
Q psy1672 264 VEAVSSENATVVCRVDS-----IPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVA 338 (600)
Q Consensus 264 ~~v~~G~~v~L~C~v~g-----~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a 338 (600)
..+..|..+.|.|...+ .|.|.+.|+++++.+.... +. +..+ +.|.|.+++.+|+|.|+|.|
T Consensus 5 ~~~~~g~~~~l~Cp~~~~~~~~~~~p~i~Wyk~~~~i~~~~------~~-~~~~------~~L~I~~v~~~DsG~YtC~~ 71 (92)
T cd05757 5 QILFSTKGGKIVCPDLDDFKNENTLPPVQWYKDCKLLEGDR------KR-FVKG------SKLLIQNVTEEDAGNYTCKL 71 (92)
T ss_pred EEEeeccCCEEECCChHHccCCCCCCcEEEeECCEECCCCc------cE-EecC------CEEEEeeCChhhCEEEEEEE
Confidence 45678999999997753 2578999999998876432 11 1122 47999999999999999999
Q ss_pred ecCCCceeEEEEEEEE
Q psy1672 339 ENRAGIADANFTLQVT 354 (600)
Q Consensus 339 ~N~~G~~~~~v~L~V~ 354 (600)
.|..|.....++..+.
T Consensus 72 ~n~~~~~~~~~t~t~~ 87 (92)
T cd05757 72 TFTHNGKQYNVTRTIS 87 (92)
T ss_pred EecCCCEEEEEEEEEE
Confidence 9999988777666553
No 123
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=98.56 E-value=4.4e-07 Score=109.78 Aligned_cols=152 Identities=19% Similarity=0.365 Sum_probs=73.7
Q ss_pred CCCccCCCCCCCCceEEEeeCCCCCCCChhhhcccCCCCccEEE-------------------------------eeccc
Q psy1672 38 FLITIPEAPESELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLF-------------------------------LARCH 86 (600)
Q Consensus 38 ~L~~ip~~~~~~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~-------------------------------L~~n~ 86 (600)
.+..+|... . +++.|+|++|.+..+|... .+.+|+.|. |++|.
T Consensus 716 ~L~~~p~~~-~-nL~~L~L~~n~i~~lP~~~----~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~ 789 (1153)
T PLN03210 716 RLKSFPDIS-T-NISWLDLDETAIEEFPSNL----RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIP 789 (1153)
T ss_pred Ccccccccc-C-CcCeeecCCCccccccccc----cccccccccccccchhhccccccccchhhhhccccchheeCCCCC
Confidence 355555432 2 3899999999988887643 244444444 44442
Q ss_pred C-cccCccccCCCCCccEEEccCC-CCCCCCccccCCCCCCCEEEccCCC-CCccCcccccCCCCcceeeCCCCcCcccC
Q psy1672 87 I-GQIDSGALDGLTNLIEIDLSDN-LLTSIPSLTFQSVRFLRDLNLARNP-ISKIEKGAFQFVPGLVKLDMSESRLEHIS 163 (600)
Q Consensus 87 l-~~i~~~~f~~l~~L~~L~Ls~N-~l~~l~~~~f~~l~~L~~L~Ls~N~-i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~ 163 (600)
. ..+ +..|.++++|+.|+|++| .++.+|... .+++|+.|+|++|. +..+ +. ...+|+.|+|++|.|+.+
T Consensus 790 ~l~~l-P~si~~L~~L~~L~Ls~C~~L~~LP~~~--~L~sL~~L~Ls~c~~L~~~-p~---~~~nL~~L~Ls~n~i~~i- 861 (1153)
T PLN03210 790 SLVEL-PSSIQNLHKLEHLEIENCINLETLPTGI--NLESLESLDLSGCSRLRTF-PD---ISTNISDLNLSRTGIEEV- 861 (1153)
T ss_pred Ccccc-ChhhhCCCCCCEEECCCCCCcCeeCCCC--CccccCEEECCCCCccccc-cc---cccccCEeECCCCCCccC-
Confidence 2 222 233445555555555443 344444321 34455555555443 2111 11 123455555555555554
Q ss_pred hhhhcCCCCCCEEEcCC-CcCCCCCcccccccccccEEEccC
Q psy1672 164 PEAFTGAKSLESIKLNG-NRLSHFPVRSVEPLLKLMMIELHD 204 (600)
Q Consensus 164 ~~~~~~l~~L~~L~Ls~-N~l~~l~~~~~~~l~~L~~L~l~~ 204 (600)
|..+..+++|+.|+|++ +.+..++. .+..++.|+.+++.+
T Consensus 862 P~si~~l~~L~~L~L~~C~~L~~l~~-~~~~L~~L~~L~l~~ 902 (1153)
T PLN03210 862 PWWIEKFSNLSFLDMNGCNNLQRVSL-NISKLKHLETVDFSD 902 (1153)
T ss_pred hHHHhcCCCCCEEECCCCCCcCccCc-ccccccCCCeeecCC
Confidence 23444555555555554 34444432 233444455555443
No 124
>cd05862 Ig1_VEGFR First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). IG1_VEGFR: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF_A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angioge
Probab=98.55 E-value=3.4e-07 Score=75.57 Aligned_cols=83 Identities=24% Similarity=0.326 Sum_probs=57.0
Q ss_pred cccceeeeEeecCCC--CeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCcee
Q psy1672 269 SENATVVCRVDSIPP--AAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIAD 346 (600)
Q Consensus 269 G~~v~L~C~v~g~P~--p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~ 346 (600)
|+.+.|.|.+.+.+. ..+.|.++++......... ..+... .......+.|.|.+++.+|+|.|+|.|+|..|...
T Consensus 1 Ge~~~L~C~~~~~~~~~~~~~W~~p~~~~~~~~~~~-~~~~~~--~~~~~~~s~L~I~~~~~~DsG~Y~C~a~n~~~~~~ 77 (86)
T cd05862 1 GEKLVLNCTARTELNVGIDFQWDYPGKKEQRAKSVS-ENRRSL--QEHTELSSTLTIENVTLSDLGRYTCTASSGQMIAK 77 (86)
T ss_pred CCcEEEEEEEEeCCCCcEEEEEEcCCcccccceecc-cccccc--cccceeeeEEEEecCCcccCEEEEEEEeecceEec
Confidence 678999999987654 4779988775432111000 001111 11123457899999999999999999999999888
Q ss_pred EEEEEEEE
Q psy1672 347 ANFTLQVT 354 (600)
Q Consensus 347 ~~v~L~V~ 354 (600)
....|.|.
T Consensus 78 ~~t~~~V~ 85 (86)
T cd05862 78 NSTIVIVH 85 (86)
T ss_pred ccEEEEEe
Confidence 88877773
No 125
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=98.54 E-value=5.3e-08 Score=104.28 Aligned_cols=149 Identities=31% Similarity=0.401 Sum_probs=115.2
Q ss_pred EEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCC-CccEEEccCCCCCCCCccccCCCCCCCEEEcc
Q psy1672 53 VLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLT-NLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLA 131 (600)
Q Consensus 53 ~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~-~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls 131 (600)
.|+++.|.+..-..... .+..++.|.+.+|.+..|++. ...+. +|+.|++++|.+..++. .+..+++|+.|+++
T Consensus 97 ~l~~~~~~~~~~~~~~~---~~~~l~~L~l~~n~i~~i~~~-~~~~~~nL~~L~l~~N~i~~l~~-~~~~l~~L~~L~l~ 171 (394)
T COG4886 97 SLDLNLNRLRSNISELL---ELTNLTSLDLDNNNITDIPPL-IGLLKSNLKELDLSDNKIESLPS-PLRNLPNLKNLDLS 171 (394)
T ss_pred eeeccccccccCchhhh---cccceeEEecCCcccccCccc-cccchhhcccccccccchhhhhh-hhhccccccccccC
Confidence 47777777744443443 568899999999999999764 34453 89999999999999863 46789999999999
Q ss_pred CCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCcccccccccccEEEccCCcCcc
Q psy1672 132 RNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLLKLMMIELHDNPWVC 209 (600)
Q Consensus 132 ~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~l~~N~~~C 209 (600)
+|++..++.. ...+++|+.|++++|++..++.. ...+..|+.|.+++|.+..+. ..+..+.++..+.+.+|++.+
T Consensus 172 ~N~l~~l~~~-~~~~~~L~~L~ls~N~i~~l~~~-~~~~~~L~~l~~~~N~~~~~~-~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 172 FNDLSDLPKL-LSNLSNLNNLDLSGNKISDLPPE-IELLSALEELDLSNNSIIELL-SSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred Cchhhhhhhh-hhhhhhhhheeccCCccccCchh-hhhhhhhhhhhhcCCcceecc-hhhhhcccccccccCCceeee
Confidence 9999998653 23788999999999999999653 345666999999999644443 345666777777788887665
No 126
>cd05860 Ig4_SCFR Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). Ig4_SCFR: The fourth Immunoglobulin (Ig)-like domain in stem cell factor receptor (SCFR). SCFR is organized as an extracellular component having five IG-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR. This fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth domain abolishes the ligand-induced dimerization of SCFR and completely inhibits signal transduction.
Probab=98.53 E-value=9.5e-07 Score=74.13 Aligned_cols=88 Identities=18% Similarity=0.308 Sum_probs=70.7
Q ss_pred ccccccccccceeeeEeecCCCCe-eEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEec
Q psy1672 262 RYVEAVSSENATVVCRVDSIPPAA-ISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAEN 340 (600)
Q Consensus 262 ~~~~v~~G~~v~L~C~v~g~P~p~-i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N 340 (600)
..++|.+|+.+.|.|.+++.|+|+ +.|.+++..+..... ........++....+.|.+..+..+|.|.|+|.|.|
T Consensus 11 ~~~~v~~gE~~~L~V~ieAYP~p~~~~W~~~~~~l~~~~~----~~~~~~~~~~~rY~S~L~L~Rlk~~E~G~YTf~a~N 86 (101)
T cd05860 11 TTIFVNAGENLDLIVEYEAYPKPEHQQWIYMNRTLTNTSD----HYVKSRNESNNRYVSELHLTRLKGTEGGTYTFLVSN 86 (101)
T ss_pred ceEEEECCCCEEEEEEEEeCCCCeeeEEEcCCcccCcccc----ceeEEeccCceEEEEEEEEeecChhhCcEEEEEEEC
Confidence 456789999999999999999997 999998887665442 112222223345778999999999999999999999
Q ss_pred CCCceeEEEEEEE
Q psy1672 341 RAGIADANFTLQV 353 (600)
Q Consensus 341 ~~G~~~~~v~L~V 353 (600)
..+.++..+.|.|
T Consensus 87 ~~~~~s~tF~l~v 99 (101)
T cd05860 87 SDASASVTFNVYV 99 (101)
T ss_pred CCCeEEEEEEEEE
Confidence 9999888888876
No 127
>KOG3207|consensus
Probab=98.53 E-value=1.6e-08 Score=103.73 Aligned_cols=156 Identities=19% Similarity=0.169 Sum_probs=101.6
Q ss_pred ceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCc-cccCCCCCccEEEccCCCCCC--CCccccCCCCCCCE
Q psy1672 51 TQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDS-GALDGLTNLIEIDLSDNLLTS--IPSLTFQSVRFLRD 127 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~-~~f~~l~~L~~L~Ls~N~l~~--l~~~~f~~l~~L~~ 127 (600)
++.|||+.|-+..+..-.--...|++|+.|+|+.|++..... ..-..+..|+.|.|+.+.|+. +.+ .....++|+.
T Consensus 148 v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~-~~~~fPsl~~ 226 (505)
T KOG3207|consen 148 VRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQW-ILLTFPSLEV 226 (505)
T ss_pred ceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHH-HHHhCCcHHH
Confidence 677777777776544332222367777777777776643321 111245667777777777762 211 2344677888
Q ss_pred EEccCCCCCccCcccccCCCCcceeeCCCCcCcccCh-hhhcCCCCCCEEEcCCCcCCCCCccc------ccccccccEE
Q psy1672 128 LNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISP-EAFTGAKSLESIKLNGNRLSHFPVRS------VEPLLKLMMI 200 (600)
Q Consensus 128 L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~-~~~~~l~~L~~L~Ls~N~l~~l~~~~------~~~l~~L~~L 200 (600)
|+|..|....+.......+..|++|+|++|++-.... ...+.++.|+.|+++.+.++++..-. ...+++|+.|
T Consensus 227 L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L 306 (505)
T KOG3207|consen 227 LYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYL 306 (505)
T ss_pred hhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceee
Confidence 8888885444434445567788899999988877642 24567888999999999888765322 2456788999
Q ss_pred EccCCcC
Q psy1672 201 ELHDNPW 207 (600)
Q Consensus 201 ~l~~N~~ 207 (600)
++..|++
T Consensus 307 ~i~~N~I 313 (505)
T KOG3207|consen 307 NISENNI 313 (505)
T ss_pred ecccCcc
Confidence 9998885
No 128
>cd05727 Ig2_Contactin-2-like Second Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig2_Contactin-2-like: second Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=98.50 E-value=2.5e-07 Score=77.43 Aligned_cols=74 Identities=18% Similarity=0.309 Sum_probs=55.7
Q ss_pred cccccccccceeeeEee-cCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecC
Q psy1672 263 YVEAVSSENATVVCRVD-SIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 263 ~~~v~~G~~v~L~C~v~-g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~ 341 (600)
...+.+|+.+.|.|... |.|.+.+.|++++..+.-. ...+..+... .+.|.|.+++.+|+|.|+|.|+|.
T Consensus 12 ~~~v~eG~~~~L~C~pP~g~P~p~~~W~k~~~~~~~~----~d~r~~~~~~-----~G~L~fs~v~~~D~g~Y~C~A~n~ 82 (96)
T cd05727 12 EVKVKEGWGVVLFCDPPPHYPDLSYRWLLNEFPNFIP----EDGRRFVSQT-----NGNLYIAKVEASDRGNYSCFVSSP 82 (96)
T ss_pred ceeeeeCCcEEEeeCCCCCCCCCEEEEEECCcccccc----cCCCeEEeCC-----CCcEEEeecCHhhCceeEEEEEec
Confidence 45678899999999776 8899999999987543211 1223333331 248999999999999999999999
Q ss_pred CCce
Q psy1672 342 AGIA 345 (600)
Q Consensus 342 ~G~~ 345 (600)
++..
T Consensus 83 ~~~~ 86 (96)
T cd05727 83 SSTK 86 (96)
T ss_pred ccCC
Confidence 8654
No 129
>cd05753 Ig2_FcgammaR_like Second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig2_FcgammaR_like: domain similar to the second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=98.47 E-value=3.3e-07 Score=75.13 Aligned_cols=66 Identities=20% Similarity=0.234 Sum_probs=52.1
Q ss_pred cccccccccceeeeEee-cCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecC
Q psy1672 263 YVEAVSSENATVVCRVD-SIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 263 ~~~v~~G~~v~L~C~v~-g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~ 341 (600)
...+.+|+.++|.|.+. +.+.+.+.|+++++.+.... ..+.|.|.+++.+|+|.|+|.|.|.
T Consensus 8 ~~~V~~G~~vtL~C~~~~~~~~~~~~w~k~g~~~~~~~-----------------~~~~l~I~~~~~~dsG~Y~C~~~~~ 70 (83)
T cd05753 8 SRVVFEGEPLVLRCHGWKNKPVYKVTYYRDGKAKKYSH-----------------SNSNLSIPQATLSDSGSYHCSGIIG 70 (83)
T ss_pred cceecCCCCEEEEeeCCCCCcceEEEEEECCeEccccC-----------------CCceEEECccCHHHCEEEEEEEEeC
Confidence 34678999999999986 46677899999886553111 1237999999999999999999999
Q ss_pred CCce
Q psy1672 342 AGIA 345 (600)
Q Consensus 342 ~G~~ 345 (600)
.|..
T Consensus 71 ~~~~ 74 (83)
T cd05753 71 SYDY 74 (83)
T ss_pred Ccee
Confidence 8753
No 130
>cd05871 Ig_Semaphorin_classIII Immunoglobulin (Ig)-like domain of class III semaphorin. Ig_Semaphorin_class III; Immunoglobulin (Ig)-like domain of class III semaphorins. Semaphorins are classified into various classes on the basis of structural features additional to the Sema domain. Class III semaphorins are a vertebrate class having a Sema domain, an Ig domain, a short basic domain, and are secreted. They have been shown to be axonal guidance cues and have a part in the regulation of the cardiovascular, immune and respiratory systems. Sema3A, the prototype member of this class III subfamily, induces growth cone collapse and is an inhibitor of axonal sprouting. In perinatal rat cortex as a chemoattractant, it functions to direct, for pyramidal neurons, the orientated extension of apical dendrites. It may play a role, prior to the development of apical dendrites, in signaling the radial migration of newborn cortical neurons towards the upper layers. Sema3A selectively inhibits vascula
Probab=98.47 E-value=8.7e-07 Score=73.95 Aligned_cols=84 Identities=23% Similarity=0.372 Sum_probs=57.0
Q ss_pred cccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEe-cC
Q psy1672 263 YVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAE-NR 341 (600)
Q Consensus 263 ~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~-N~ 341 (600)
.+.+.+|+.+.|.|.. +.|.|.+.|++...............+... ..+.|.|.+++.+|+|.|+|.|. |.
T Consensus 5 ~~~~~eG~~v~L~C~~-~~p~p~v~Wykq~~g~~~~~~~~~~~r~~~-------~~~~L~I~~~~~~DsG~Y~C~a~~~~ 76 (91)
T cd05871 5 VVYGVENNSTFLECLP-KSPQASVKWLFQRGGDQRKEEVKTEERLIH-------TERGLLLRSLQRSDAGVYTCTAVEHS 76 (91)
T ss_pred EEEEecCCcEEEEEEC-CCCCceEEEEEECCCCCccccccccccEEE-------ecCeEEEeeCChhHCEEEEEEEEccC
Confidence 3456789999999997 478899999983321110000001112211 12469999999999999999998 57
Q ss_pred CCceeEEEEEEEE
Q psy1672 342 AGIADANFTLQVT 354 (600)
Q Consensus 342 ~G~~~~~v~L~V~ 354 (600)
.+.....+.|+|.
T Consensus 77 ~~~~~~~~~l~v~ 89 (91)
T cd05871 77 FSQTLAKYTLHVI 89 (91)
T ss_pred CeEEEEEEEEEEe
Confidence 7767777888774
No 131
>cd05717 Ig1_Necl-1-3_like First (N-terminal) immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-3 (also known as cell adhesion molecules CADM3, CADM1, and CADM2 respectively). Ig1_Necl-1-3_like: N-terminal immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), and Necl-3 (CADM2). At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1, Necl-2, and Necl-3 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the form
Probab=98.45 E-value=8e-07 Score=74.79 Aligned_cols=89 Identities=22% Similarity=0.309 Sum_probs=58.9
Q ss_pred cccccccccccceeeeEeecCCCCeeEEEEcCeec-cCCc-ccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEE
Q psy1672 261 SRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLL-LNNT-AFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVA 338 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l-~~~~-~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a 338 (600)
++.+.+.+|+.++|.|.+.+.+.+.+.|++.++.+ .... ......++.+.... .....|.|.+++.+|+|.|+|.+
T Consensus 4 ~~~~~v~~G~~v~L~C~~~~~~~~~v~W~~p~~~~~~~~~~~~~~~~r~~~~~~~--~~~~~L~I~~v~~~DsG~Y~C~~ 81 (95)
T cd05717 4 TQDVTVVEGGTATLKCRVKNNDNSSLQWSNPNQQTLYFNDKRALRDNRIQLVNFS--ANELSISISNVSLSDEGRYTCSL 81 (95)
T ss_pred CCcEEEcCCCCEEEEEEECCCCCceEEEeCCCCcEEEeccccccccCcEEEEcCC--CCeeEEEEccCCcccCEEEEEEE
Confidence 46678889999999999998888999998643221 1000 00012333332211 12357999999999999999999
Q ss_pred ecCCCceeEEEEEE
Q psy1672 339 ENRAGIADANFTLQ 352 (600)
Q Consensus 339 ~N~~G~~~~~v~L~ 352 (600)
.+... .++.+.|.
T Consensus 82 ~~~~~-~~~~~~~~ 94 (95)
T cd05717 82 YTMPV-QTAKATVT 94 (95)
T ss_pred ecCCC-ceEEEEEE
Confidence 98753 35555554
No 132
>smart00408 IGc2 Immunoglobulin C-2 Type.
Probab=98.42 E-value=1.1e-06 Score=66.69 Aligned_cols=63 Identities=30% Similarity=0.549 Sum_probs=49.1
Q ss_pred ccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCC
Q psy1672 268 SSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAG 343 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G 343 (600)
+|+.++|.|.+.+.|.+.+.|++++..+.. ...... ....|.|.+++..|.|.|+|.+.|..|
T Consensus 1 ~g~~~~l~C~~~~~~~~~v~W~~~~~~~~~--------~~~~~~-----~~~~L~i~~~~~~d~G~Y~C~~~n~~g 63 (63)
T smart00408 1 EGQSVTLTCPAEGDPVPNITWLKDGKPLPE--------SNRLSA-----SGSTLTIKSVSLEDSGEYTCVAENSAG 63 (63)
T ss_pred CCceEEEEeeCccCCCCeEEEEECCEECCC--------CCEEec-----CCcEEEEeeCCcccCEEEEEEEecCCC
Confidence 478899999998889999999998876551 111111 124799999999999999999999865
No 133
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=98.42 E-value=4.7e-07 Score=80.49 Aligned_cols=127 Identities=22% Similarity=0.392 Sum_probs=73.8
Q ss_pred CCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCccCccc
Q psy1672 63 ILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGA 142 (600)
Q Consensus 63 ~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~ 142 (600)
.|+..+|. ++.+|+.+.+.+ .+..|...+|.++.+|+.+.+..+ +..+....|.++.+|+.+.+.. .+..+....
T Consensus 2 ~i~~~~F~--~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~ 76 (129)
T PF13306_consen 2 SIGNNAFY--NCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNA 76 (129)
T ss_dssp EE-TTTTT--T-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTT
T ss_pred EECHHHHh--CCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-ccccccccc
Confidence 35566676 677888888874 677888888888888888888775 8888888888887788888865 666677777
Q ss_pred ccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCcccccccccc
Q psy1672 143 FQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLLKL 197 (600)
Q Consensus 143 ~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L 197 (600)
|..+.+|+.+.+..+ +..+....|.+. +|+.+.+.. .+..++...|..+.+|
T Consensus 77 F~~~~~l~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l 128 (129)
T PF13306_consen 77 FSNCTNLKNIDIPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKL 128 (129)
T ss_dssp TTT-TTECEEEETTT--BEEHTTTTTT--T--EEE-TT-B-SS----GGG-----
T ss_pred ccccccccccccCcc-ccEEchhhhcCC-CceEEEECC-CccEECCccccccccC
Confidence 888888888888765 777777777777 888888775 5677777777766655
No 134
>cd07690 Ig1_CD4 First immunoglobulin (Ig) domain of CD4. Ig1_CD4; first immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=98.39 E-value=8.1e-07 Score=74.41 Aligned_cols=82 Identities=15% Similarity=0.218 Sum_probs=53.7
Q ss_pred ccccccccceeeeEeecCCCCeeEEEEcCeeccCCcc--c------CccceEEEeeCCceeeeeeEEEecCCCCCCeEEE
Q psy1672 264 VEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTA--F------SSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFY 335 (600)
Q Consensus 264 ~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~--~------~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~ 335 (600)
+.+..|+.|+|.|.+.+.+.+.|.|+++++....... + ....++.....+.......|+|.+++.+|+|+|+
T Consensus 2 v~~~~G~~VtL~C~~s~~~~~~i~W~~~~~k~~~g~~~~l~~~~~~~~~~r~~~~~~~~~~g~~~L~I~~l~~sDsgtY~ 81 (94)
T cd07690 2 VLGKKGDTAELPCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRNLWDQGSFPLIIKNLKIEDSDTYI 81 (94)
T ss_pred eEeeCCCCEEEEEEeCCCCCcEEEEEECCcEEccCcCCEEEEecccccCCCCceecccCCCCeEEEEECCCCHHHCEEEE
Confidence 3567899999999999999999999976533211110 0 0011111111110112357999999999999999
Q ss_pred EEEecCCCce
Q psy1672 336 CVAENRAGIA 345 (600)
Q Consensus 336 C~a~N~~G~~ 345 (600)
|.+.|..+..
T Consensus 82 C~v~~~~~~~ 91 (94)
T cd07690 82 CEVEDKKEEV 91 (94)
T ss_pred EEECCccceE
Confidence 9999987653
No 135
>KOG0531|consensus
Probab=98.38 E-value=5.2e-08 Score=104.95 Aligned_cols=149 Identities=29% Similarity=0.387 Sum_probs=100.7
Q ss_pred ceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEc
Q psy1672 51 TQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNL 130 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 130 (600)
++.+++..|.|..+....- .+.+|..|++.+|+|..+... +..+.+|++|+|++|.|+.+.. +..+..|+.|++
T Consensus 74 l~~l~l~~n~i~~~~~~l~---~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l 147 (414)
T KOG0531|consen 74 LKELNLRQNLIAKILNHLS---KLKSLEALDLYDNKIEKIENL-LSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNL 147 (414)
T ss_pred HHhhccchhhhhhhhcccc---cccceeeeeccccchhhcccc-hhhhhcchheeccccccccccc--hhhccchhhhee
Confidence 5666677777766333222 567888888888888777542 5667788888888888887765 556667888888
Q ss_pred cCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCcccccccccccEEEccCCcCcc
Q psy1672 131 ARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLLKLMMIELHDNPWVC 209 (600)
Q Consensus 131 s~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~l~~N~~~C 209 (600)
++|.|..+.. |..+..|+.+++++|++..+.......+.+|+.+++.+|.+..+. .+..+..+..+++.+|.+..
T Consensus 148 ~~N~i~~~~~--~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~--~~~~~~~l~~~~l~~n~i~~ 222 (414)
T KOG0531|consen 148 SGNLISDISG--LESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIE--GLDLLKKLVLLSLLDNKISK 222 (414)
T ss_pred ccCcchhccC--CccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhccc--chHHHHHHHHhhccccccee
Confidence 8888877633 455778888888888888775410356777778888888777664 23333444445666665543
No 136
>KOG1644|consensus
Probab=98.37 E-value=3.6e-07 Score=85.06 Aligned_cols=102 Identities=24% Similarity=0.368 Sum_probs=49.0
Q ss_pred cEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCcccCh-hhhcCCCCCCEEEcCC
Q psy1672 102 IEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISP-EAFTGAKSLESIKLNG 180 (600)
Q Consensus 102 ~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~-~~~~~l~~L~~L~Ls~ 180 (600)
..+||++|.|..+.. |..+++|.+|.|++|+|+.+.+..-..+++|..|.|.+|.|..+.. +-+..++.|++|.+-+
T Consensus 45 d~iDLtdNdl~~l~~--lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltll~ 122 (233)
T KOG1644|consen 45 DAIDLTDNDLRKLDN--LPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTLLG 122 (233)
T ss_pred ceecccccchhhccc--CCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceeeecC
Confidence 344444444444332 3444444444444444444444333334444444444444443321 1233455666666666
Q ss_pred CcCCCCC---cccccccccccEEEccCC
Q psy1672 181 NRLSHFP---VRSVEPLLKLMMIELHDN 205 (600)
Q Consensus 181 N~l~~l~---~~~~~~l~~L~~L~l~~N 205 (600)
|.+.... ...+..+++|++||+..-
T Consensus 123 Npv~~k~~YR~yvl~klp~l~~LDF~kV 150 (233)
T KOG1644|consen 123 NPVEHKKNYRLYVLYKLPSLRTLDFQKV 150 (233)
T ss_pred CchhcccCceeEEEEecCcceEeehhhh
Confidence 6555432 234556677777776653
No 137
>KOG3207|consensus
Probab=98.35 E-value=9.6e-08 Score=98.15 Aligned_cols=156 Identities=20% Similarity=0.264 Sum_probs=111.9
Q ss_pred ceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCc-cccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEE
Q psy1672 51 TQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDS-GALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLN 129 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~-~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~ 129 (600)
|+.|+|+.|.+..-..+... ..+.+|+.|.|+.|+|+.-+- .....+++|+.|+|..|....+....+.-+..|+.|+
T Consensus 174 Le~LNls~Nrl~~~~~s~~~-~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~Ld 252 (505)
T KOG3207|consen 174 LENLNLSSNRLSNFISSNTT-LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELD 252 (505)
T ss_pred chhcccccccccCCccccch-hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhcc
Confidence 99999999998743332221 257899999999999974322 2245789999999999964434333455677899999
Q ss_pred ccCCCCCccCc-ccccCCCCcceeeCCCCcCcccChhh------hcCCCCCCEEEcCCCcCCCCCc-ccccccccccEEE
Q psy1672 130 LARNPISKIEK-GAFQFVPGLVKLDMSESRLEHISPEA------FTGAKSLESIKLNGNRLSHFPV-RSVEPLLKLMMIE 201 (600)
Q Consensus 130 Ls~N~i~~l~~-~~~~~l~~L~~L~Ls~n~l~~i~~~~------~~~l~~L~~L~Ls~N~l~~l~~-~~~~~l~~L~~L~ 201 (600)
|++|.+-.... .....++.|+.|+++.+.+..+.--. ...+++|++|++..|++..++. ..+..+.+|+.+.
T Consensus 253 Ls~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~ 332 (505)
T KOG3207|consen 253 LSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLR 332 (505)
T ss_pred ccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhh
Confidence 99999876643 34567899999999999988764221 2467899999999999987652 3334445566665
Q ss_pred ccCCcC
Q psy1672 202 LHDNPW 207 (600)
Q Consensus 202 l~~N~~ 207 (600)
+..|++
T Consensus 333 ~~~n~l 338 (505)
T KOG3207|consen 333 ITLNYL 338 (505)
T ss_pred cccccc
Confidence 555554
No 138
>cd05845 Ig2_L1-CAM_like Second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig2_L1-CAM_like: domain similar to the second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=98.35 E-value=9.4e-07 Score=73.83 Aligned_cols=73 Identities=25% Similarity=0.380 Sum_probs=56.8
Q ss_pred ccccccccccceeeeE-eecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCe-EEEEEEe
Q psy1672 262 RYVEAVSSENATVVCR-VDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSG-RFYCVAE 339 (600)
Q Consensus 262 ~~~~v~~G~~v~L~C~-v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G-~Y~C~a~ 339 (600)
..+.+.+|+.+.|.|. ..|.|.|.|.|..++.... ....|+.+..+| .|.|.+++..|.| .|.|.|+
T Consensus 11 ~~v~V~eG~~~~L~C~pP~g~P~P~i~W~~~~~~~i-----~~~~Ri~~~~~G------nL~fs~v~~~D~g~~Y~C~a~ 79 (95)
T cd05845 11 RPVEVEEGDSVVLPCNPPKSAVPLRIYWMNSDLLHI-----TQDERVSMGQNG------NLYFANVEEQDSHPDYICHAH 79 (95)
T ss_pred ceeEEecCCCEEEEecCCCCCCCCEEEEECCCCccc-----cccccEEECCCc------eEEEEEEehhhCCCCeEEEEE
Confidence 5577889999999997 6799999999997653321 123455554444 8999999999999 7999999
Q ss_pred cCCCce
Q psy1672 340 NRAGIA 345 (600)
Q Consensus 340 N~~G~~ 345 (600)
|.+...
T Consensus 80 ~~~~~~ 85 (95)
T cd05845 80 FPGLRT 85 (95)
T ss_pred cccccc
Confidence 987543
No 139
>cd05885 Ig2_Necl-4 Second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Ig2_Necl-4: second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1-Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Ig domains are likely to participate in ligand binding and recognition. Necl-4 is expressed on Schwann cells, and plays a key part in initiating peripheral nervous system (PNS) myelination. In injured peripheral nerve cells, the mRNA signal for both Necl-4 and Necl-5 was observed to be elevated. Necl-4 participates in cell-cell adhesion and is proposed to play a role in tumor suppression.
Probab=98.34 E-value=2.6e-06 Score=68.73 Aligned_cols=67 Identities=16% Similarity=0.291 Sum_probs=51.5
Q ss_pred ceeeeEee-cCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCce
Q psy1672 272 ATVVCRVD-SIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIA 345 (600)
Q Consensus 272 v~L~C~v~-g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~ 345 (600)
+.|.|.+. |.|+++|.|+++++.+..... ....+..+...+.|.+......|.+.|+|.|.|.++..
T Consensus 2 ~~L~C~s~~skP~a~i~W~k~~~~l~~~~~-------~~~~~~~~t~~s~L~~~~~~~Ddg~~~~C~A~n~a~~~ 69 (80)
T cd05885 2 VELTCLSPRSKPAATLRWYRDRKELKGVIS-------QQENGKTVSVSNTIRFPVDRKDDGAILSCEASHPALVS 69 (80)
T ss_pred EEEEEeCCCccCCCeEEEEECCEECCCCcc-------cccCCceEEEEEEEEEEeeeccCCcEEEEEEEChhhCC
Confidence 67999887 789999999999998864321 01222334456789998888889899999999998764
No 140
>smart00409 IG Immunoglobulin.
Probab=98.33 E-value=7.2e-06 Score=66.05 Aligned_cols=82 Identities=35% Similarity=0.648 Sum_probs=62.2
Q ss_pred cccccccccceeeeEeecCCCCeeEEEEc-CeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecC
Q psy1672 263 YVEAVSSENATVVCRVDSIPPAAISWYWN-GRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 263 ~~~v~~G~~v~L~C~v~g~P~p~i~W~~~-g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~ 341 (600)
.+.+..|+.+.|.|.+.+.+.+.+.|+++ +..+... .+........ ...|.|.++...|.|.|+|.+.+.
T Consensus 3 ~~~~~~g~~~~l~C~~~~~~~~~~~W~~~~~~~v~~~------~~~~~~~~~~---~~~l~i~~~~~~d~G~Y~C~v~~~ 73 (86)
T smart00409 3 SVTVKEGESVTLSCEVSGSPPPEVTWYKQGGKLLAES------GRFSVSRSGS---NSTLTISNVTPEDSGTYTCAATNS 73 (86)
T ss_pred cEEEeCCCeEEEEEEEccCCCCeEEEEECCCEEcCCC------CcEEEEEcCC---eeEEEEEeeccccCeEEEEEEEcC
Confidence 45567899999999999888889999997 6665411 1222222221 458999999999999999999999
Q ss_pred CCceeEEEEEEE
Q psy1672 342 AGIADANFTLQV 353 (600)
Q Consensus 342 ~G~~~~~v~L~V 353 (600)
.+.....+.|.|
T Consensus 74 ~~~~~~~~~l~V 85 (86)
T smart00409 74 SGSASSTTTLTV 85 (86)
T ss_pred CCeEEEEEEEEE
Confidence 888777766655
No 141
>smart00410 IG_like Immunoglobulin like. IG domains that cannot be classified into one of IGv1, IGc1, IGc2, IG.
Probab=98.33 E-value=7.2e-06 Score=66.05 Aligned_cols=82 Identities=35% Similarity=0.648 Sum_probs=62.2
Q ss_pred cccccccccceeeeEeecCCCCeeEEEEc-CeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecC
Q psy1672 263 YVEAVSSENATVVCRVDSIPPAAISWYWN-GRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 263 ~~~v~~G~~v~L~C~v~g~P~p~i~W~~~-g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~ 341 (600)
.+.+..|+.+.|.|.+.+.+.+.+.|+++ +..+... .+........ ...|.|.++...|.|.|+|.+.+.
T Consensus 3 ~~~~~~g~~~~l~C~~~~~~~~~~~W~~~~~~~v~~~------~~~~~~~~~~---~~~l~i~~~~~~d~G~Y~C~v~~~ 73 (86)
T smart00410 3 SVTVKEGESVTLSCEVSGSPPPEVTWYKQGGKLLAES------GRFSVSRSGS---NSTLTISNVTPEDSGTYTCAATNS 73 (86)
T ss_pred cEEEeCCCeEEEEEEEccCCCCeEEEEECCCEEcCCC------CcEEEEEcCC---eeEEEEEeeccccCeEEEEEEEcC
Confidence 45567899999999999888889999997 6665411 1222222221 458999999999999999999999
Q ss_pred CCceeEEEEEEE
Q psy1672 342 AGIADANFTLQV 353 (600)
Q Consensus 342 ~G~~~~~v~L~V 353 (600)
.+.....+.|.|
T Consensus 74 ~~~~~~~~~l~V 85 (86)
T smart00410 74 SGSASSTTTLTV 85 (86)
T ss_pred CCeEEEEEEEEE
Confidence 888777766655
No 142
>KOG4579|consensus
Probab=98.33 E-value=2.4e-08 Score=87.15 Aligned_cols=134 Identities=23% Similarity=0.242 Sum_probs=76.3
Q ss_pred ccEEEeecccCcccCc--cccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeC
Q psy1672 77 LQKLFLARCHIGQIDS--GALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDM 154 (600)
Q Consensus 77 L~~L~L~~n~l~~i~~--~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~L 154 (600)
+..++|++|.|..|.. ..+.....|+..+|++|.+..+|+..-...+.+++|+|++|.|+.++.+ +..++.|+.|++
T Consensus 29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE-~Aam~aLr~lNl 107 (177)
T KOG4579|consen 29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEE-LAAMPALRSLNL 107 (177)
T ss_pred hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHH-HhhhHHhhhccc
Confidence 3344455554444321 1123334455556666666666654333444566666666666666544 666666777777
Q ss_pred CCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCcccccccccccEEEccCCcCcccccc
Q psy1672 155 SESRLEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLLKLMMIELHDNPWVCDCNM 213 (600)
Q Consensus 155 s~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~l~~N~~~C~C~l 213 (600)
+.|.+... +..+..+.+|..|+..+|.+..++.+.|.. ...-.+.+.++||.-.|..
T Consensus 108 ~~N~l~~~-p~vi~~L~~l~~Lds~~na~~eid~dl~~s-~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 108 RFNPLNAE-PRVIAPLIKLDMLDSPENARAEIDVDLFYS-SLPALIKLGNEPLGDETKK 164 (177)
T ss_pred ccCccccc-hHHHHHHHhHHHhcCCCCccccCcHHHhcc-ccHHHHHhcCCcccccCcc
Confidence 77666655 334444677777777777777777653322 2333345677887766643
No 143
>PF13895 Ig_2: Immunoglobulin domain; PDB: 2V5R_B 2V5M_A 2V5S_B 2GI7_A 3LAF_A 4DEP_C 3O4O_B 2EC8_A 2E9W_A 1J87_A ....
Probab=98.31 E-value=1.6e-06 Score=69.82 Aligned_cols=71 Identities=27% Similarity=0.574 Sum_probs=54.3
Q ss_pred ccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCC
Q psy1672 264 VEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAG 343 (600)
Q Consensus 264 ~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G 343 (600)
..+..|+.+.|.|.+.+.|.+.+.|++++..+.... ..+.+.+++..|.|.|+|.|.|..+
T Consensus 9 ~~v~~g~~~~l~C~~~~~p~~~~~w~~~~~~~~~~~-------------------~~~~~~~~~~~~~g~y~C~~~~~~~ 69 (80)
T PF13895_consen 9 QSVEEGDSVTLTCSVSGNPPPQVQWYKNGSPINSSQ-------------------NGLFIPNVSPEDSGNYTCRASNGSG 69 (80)
T ss_dssp SEEETTSEEEEEEEEESSSSSEEEEEETTEEEEEES-------------------SEEEESSEEGGGTEEEEEEEEETTE
T ss_pred eEEeCCCcEEEEEEEEcccceeeeeeeeeeeeeeee-------------------eeeeeeeeccccCEEEEEEEEeCCC
Confidence 457789999999999999889999999876554211 1266778889999999999999664
Q ss_pred -ceeEEEEEEE
Q psy1672 344 -IADANFTLQV 353 (600)
Q Consensus 344 -~~~~~v~L~V 353 (600)
..+..+.|+|
T Consensus 70 ~~~s~~~~v~V 80 (80)
T PF13895_consen 70 SNTSTSVNVTV 80 (80)
T ss_dssp EEEEEEEEEEE
T ss_pred CeEeeeEEeeC
Confidence 3455555554
No 144
>KOG4221|consensus
Probab=98.30 E-value=2.2e-06 Score=97.41 Aligned_cols=91 Identities=25% Similarity=0.460 Sum_probs=69.9
Q ss_pred ccccccccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEE
Q psy1672 256 EIRMDSRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFY 335 (600)
Q Consensus 256 ~i~~~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~ 335 (600)
.+...+....+.+|+.+.|.|.+.|.|+|.|.|.++|..+.-.+ .++.+. ..+.|.|.+++..|+|.|+
T Consensus 239 ~fl~~p~~~~v~~g~~v~leCvvs~~p~p~v~Wlrng~~i~~ds-----~rivl~------g~~slliS~a~~~dSg~Yt 307 (1381)
T KOG4221|consen 239 VFLDEPSNAVVVEGDDVVLECVVSGVPKPSVKWLRNGEKISVDS-----YRIVLV------GGSSLLISNATDDDSGKYT 307 (1381)
T ss_pred eeecCCCccccccCCcEEEEEEecCCCCCceEEeeCCeeeeecc-----eEEEEe------cccceEEeccccccCceEE
Confidence 34455677888999999999999999999999999998776432 122221 1358999999999999999
Q ss_pred EEEecCCCceeEEEEEEEEEcc
Q psy1672 336 CVAENRAGIADANFTLQVTYRG 357 (600)
Q Consensus 336 C~a~N~~G~~~~~v~L~V~~~~ 357 (600)
|.|.|......+.+.+.|...+
T Consensus 308 C~Atn~~D~idasaev~V~a~P 329 (1381)
T KOG4221|consen 308 CRATNTNDSIDASAEVTVLAPP 329 (1381)
T ss_pred EEecCCCcccccceEEEEEcCC
Confidence 9999966555666666665443
No 145
>KOG0531|consensus
Probab=98.30 E-value=1.1e-07 Score=102.46 Aligned_cols=150 Identities=25% Similarity=0.270 Sum_probs=116.9
Q ss_pred ceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEc
Q psy1672 51 TQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNL 130 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 130 (600)
.+.++..++.+...... .. .+..++.+.+..|.+..+.. .+..+.+|..|++.+|.|+.+.. .+..+++|+.|+|
T Consensus 51 ~~~~~~~~~~~~~~~~~-~~--~l~~l~~l~l~~n~i~~~~~-~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~l 125 (414)
T KOG0531|consen 51 LEEIDLIFNLDGSDEDL-VE--SLTSLKELNLRQNLIAKILN-HLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDL 125 (414)
T ss_pred hhhhcchhccccchhhh-HH--HhHhHHhhccchhhhhhhhc-ccccccceeeeeccccchhhccc-chhhhhcchheec
Confidence 66677777665544333 12 46788888899998887432 36788899999999999998875 2667889999999
Q ss_pred cCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCc-ccccccccccEEEccCCcCcc
Q psy1672 131 ARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPV-RSVEPLLKLMMIELHDNPWVC 209 (600)
Q Consensus 131 s~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~-~~~~~l~~L~~L~l~~N~~~C 209 (600)
++|.|+.+.. +..+..|+.|++++|.|..+ ..+..+..|+.+++++|++..+.. . ...+.+++.+++.+|.+..
T Consensus 126 s~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 126 SFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE 200 (414)
T ss_pred cccccccccc--hhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc
Confidence 9999998854 56777899999999999988 446668899999999999998875 2 4677888889999998665
Q ss_pred c
Q psy1672 210 D 210 (600)
Q Consensus 210 ~ 210 (600)
-
T Consensus 201 i 201 (414)
T KOG0531|consen 201 I 201 (414)
T ss_pred c
Confidence 3
No 146
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=98.29 E-value=3.9e-07 Score=111.98 Aligned_cols=78 Identities=28% Similarity=0.598 Sum_probs=67.4
Q ss_pred EcCCCcCCCCCcccccccccccEEEccCCcCccccccccchhhhcccCC-C--CCCCCCCCCccccccccccccccccCc
Q psy1672 177 KLNGNRLSHFPVRSVEPLLKLMMIELHDNPWVCDCNMRSIKMWLADKKN-V--PVQPACTGPERLSGKVFSDLHADDFAC 253 (600)
Q Consensus 177 ~Ls~N~l~~l~~~~~~~l~~L~~L~l~~N~~~C~C~l~~l~~w~~~~~~-~--~~~~~C~~p~~l~g~~l~~l~~~~~~C 253 (600)
||++|+|+.|+...|..+.+|+.|+|.+|||.|||++.||..|+.+... + .....|..|..++|+.+.++...+|.|
T Consensus 1 DLSnN~LstLp~g~F~~L~sL~~LdLsgNPw~CDC~L~WL~~WL~~~~v~v~~~~~i~CasP~~LrG~~L~~l~~~d~~C 80 (2740)
T TIGR00864 1 DISNNKISTIEEGICANLCNLSEIDLSGNPFECDCGLARLPRWAEEKGVKVRQPEAALCAGPGALAGQPLLGIPLLDSGC 80 (2740)
T ss_pred CCCCCcCCccChHHhccCCCceEEEeeCCccccccccHHHHHHHHhcCccccCCcccCCCCChHHCCCCcccCCcccCCC
Confidence 5789999999999999999999999999999999999999999985532 1 145689999999999999998877666
Q ss_pred c
Q psy1672 254 K 254 (600)
Q Consensus 254 ~ 254 (600)
.
T Consensus 81 ~ 81 (2740)
T TIGR00864 81 D 81 (2740)
T ss_pred C
Confidence 3
No 147
>PHA02785 IL-beta-binding protein; Provisional
Probab=98.27 E-value=5.6e-06 Score=86.10 Aligned_cols=85 Identities=27% Similarity=0.355 Sum_probs=60.9
Q ss_pred cccccccccccceeeeEeecCCC---CeeEEEEcCeeccCCcccCccceEEEee-----CCceeeeeeEEEecCCCCCCe
Q psy1672 261 SRYVEAVSSENATVVCRVDSIPP---AAISWYWNGRLLLNNTAFSSYQRIFVIE-----QGEYERKSSLVLTNAQESDSG 332 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P~---p~i~W~~~g~~l~~~~~~~~~~~~~~~~-----~g~~~~~s~L~I~~v~~~d~G 332 (600)
+..+++..|+.+.|.|.+.|.|. +.+.|.++|..+....... ..+..... ++.....+.|+|.+++.+|.|
T Consensus 227 p~~~~~~~G~~v~L~C~a~g~P~~~~~~v~W~kng~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~L~I~~V~~~D~G 305 (326)
T PHA02785 227 PEGVVTSIGSNLTIACRVSLRPPTTDADVFWISNGMYYEEDDEDG-DGRISVANKIYTTDKRRVITSRLNINPVKEEDAT 305 (326)
T ss_pred CCcEEecCCCcEEEEEEEECCCCCCCceEEEEECCEECCCcCCCC-ceeEEEecCccccccceeeeEEEEECCcchhcCe
Confidence 45667788999999999998886 4899999998875432111 12222211 111223568999999999999
Q ss_pred EEEEEEecCCCcee
Q psy1672 333 RFYCVAENRAGIAD 346 (600)
Q Consensus 333 ~Y~C~a~N~~G~~~ 346 (600)
.|+|.|.|..|...
T Consensus 306 ~Y~C~A~n~~~~~~ 319 (326)
T PHA02785 306 TFTCMAFTIPSISK 319 (326)
T ss_pred eeEEEEEeccCceE
Confidence 99999999986543
No 148
>KOG1644|consensus
Probab=98.24 E-value=1.7e-06 Score=80.65 Aligned_cols=135 Identities=20% Similarity=0.239 Sum_probs=104.5
Q ss_pred ccCCCCCCCCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccC
Q psy1672 41 TIPEAPESELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQ 120 (600)
Q Consensus 41 ~ip~~~~~~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~ 120 (600)
+.|..+....-+.++|.+.++..+...-. -+.+...++|++|.+..++. |..++.|..|.|++|+|+.|.+..-.
T Consensus 11 q~pqy~~~~~e~e~~LR~lkip~ienlg~---~~d~~d~iDLtdNdl~~l~~--lp~l~rL~tLll~nNrIt~I~p~L~~ 85 (233)
T KOG1644|consen 11 QAPQYINSVRERELDLRGLKIPVIENLGA---TLDQFDAIDLTDNDLRKLDN--LPHLPRLHTLLLNNNRITRIDPDLDT 85 (233)
T ss_pred hchhhhhhccccccccccccccchhhccc---cccccceecccccchhhccc--CCCccccceEEecCCcceeeccchhh
Confidence 34444444335778888888877665222 46688899999999988865 88999999999999999999987666
Q ss_pred CCCCCCEEEccCCCCCccCc-ccccCCCCcceeeCCCCcCcccC---hhhhcCCCCCCEEEcCC
Q psy1672 121 SVRFLRDLNLARNPISKIEK-GAFQFVPGLVKLDMSESRLEHIS---PEAFTGAKSLESIKLNG 180 (600)
Q Consensus 121 ~l~~L~~L~Ls~N~i~~l~~-~~~~~l~~L~~L~Ls~n~l~~i~---~~~~~~l~~L~~L~Ls~ 180 (600)
.+++|..|.|.+|.|+.+.. .-+..++.|+.|.+-+|.+.... ...+..+++|+.||++.
T Consensus 86 ~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~k 149 (233)
T KOG1644|consen 86 FLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQK 149 (233)
T ss_pred hccccceEEecCcchhhhhhcchhccCCccceeeecCCchhcccCceeEEEEecCcceEeehhh
Confidence 77889999999999887654 34677899999999999876542 23456789999998754
No 149
>cd05759 Ig2_KIRREL3-like Second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). Ig2_KIRREL3-like: domain similar to the second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=98.23 E-value=9e-06 Score=66.29 Aligned_cols=75 Identities=28% Similarity=0.492 Sum_probs=51.5
Q ss_pred ceeeeEeec-CCCCeeEEEEcCeeccCCcccCccceEEEeeCCc-eeeeeeEEEecCCCCCCeEEEEEEecCCCce--eE
Q psy1672 272 ATVVCRVDS-IPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGE-YERKSSLVLTNAQESDSGRFYCVAENRAGIA--DA 347 (600)
Q Consensus 272 v~L~C~v~g-~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~-~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~--~~ 347 (600)
+.|.|.+.| .|.+.|.|+++|+.+.... . ...+..++. +...+.|.+......|.|.|+|.|.|..... ++
T Consensus 2 ~~L~C~v~g~~P~~~v~W~~~g~~l~~~~----~-~~~~~~~~~~~~~~s~L~i~~~~~~~~~~y~C~a~n~~l~~~~~~ 76 (82)
T cd05759 2 YNLTCRARGAKPAAEIIWFRDGEVLDGAT----Y-SKELLKDGKRETTVSTLPITPSDHDTGRTFTCRARNEALPTGKET 76 (82)
T ss_pred EEEEEEEeCccCCCEEEEEECCEEccCce----e-eeeEecCCCeEEEEEEEEEeCceecCCCEEEEEEcCccCCCCcEE
Confidence 579999986 6888999999998875432 1 111222332 3345678888777778889999999987544 44
Q ss_pred EEEE
Q psy1672 348 NFTL 351 (600)
Q Consensus 348 ~v~L 351 (600)
+++|
T Consensus 77 s~~l 80 (82)
T cd05759 77 SVTL 80 (82)
T ss_pred EEEE
Confidence 4444
No 150
>PF00047 ig: Immunoglobulin domain The Prosite family only concerns antibodies and MHCs.; InterPro: IPR013151 Members of the immunoglobulin superfamily are found in hundreds of proteins of different functions. Examples include antibodies, the giant muscle kinase titin and receptor tyrosine kinases. Immunoglobulin-like domains may be involved in protein-protein and protein-ligand interactions. The Pfam alignments do not include the first and last strand of the immunoglobulin-like domain.; PDB: 1B6U_A 3O4O_C 3VH8_H 1BIH_A 2C9A_A 2V5Y_A 1BQH_K 2ATP_A 3B9K_A 1NEZ_H ....
Probab=98.18 E-value=6.3e-06 Score=63.51 Aligned_cols=63 Identities=27% Similarity=0.518 Sum_probs=44.5
Q ss_pred cccceeeeEe-ecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEE
Q psy1672 269 SENATVVCRV-DSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVA 338 (600)
Q Consensus 269 G~~v~L~C~v-~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a 338 (600)
|+.++|.|.+ .+.+...+.|+++++...... .......+.. ....|.|.+++.+|+|.|+|.|
T Consensus 1 G~~v~L~C~~~~~~~~~~~~W~~~~~~~~~~~------~~~~~~~~~~-~~~~L~i~~v~~~d~G~Y~C~v 64 (64)
T PF00047_consen 1 GSSVTLTCSVSSGPPPTTVTWSKNGQSLPEGS------TTNRSTNSVS-STSRLTISNVTPEDSGTYTCVV 64 (64)
T ss_dssp TSEEEEEEEEEESSSTSEEEEEETTTTTSEEE------EEEEEETTTE-EEEEEEESSCTGGGTEEEEEEE
T ss_pred CCeEEEEeecCCCCCCcEEEEEECCccccCcc------eeEeecccce-eeeEEEEccCCHHHCEEEEEEC
Confidence 6889999999 678888999999876543221 1112222211 1114999999999999999986
No 151
>KOG1859|consensus
Probab=98.16 E-value=3.5e-08 Score=106.71 Aligned_cols=131 Identities=28% Similarity=0.350 Sum_probs=102.4
Q ss_pred CCceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEE
Q psy1672 49 ELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDL 128 (600)
Q Consensus 49 ~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L 128 (600)
..|...+++.|.|..+....- -++.|+.|+|++|+++... ++..+++|++|||+.|.|+.+|......+. |..|
T Consensus 164 n~L~~a~fsyN~L~~mD~SLq---ll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L 237 (1096)
T KOG1859|consen 164 NKLATASFSYNRLVLMDESLQ---LLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLL 237 (1096)
T ss_pred hhHhhhhcchhhHHhHHHHHH---HHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heee
Confidence 347778888888887765543 4789999999999998886 588899999999999999998875544554 9999
Q ss_pred EccCCCCCccCcccccCCCCcceeeCCCCcCcccCh-hhhcCCCCCCEEEcCCCcCCCCC
Q psy1672 129 NLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISP-EAFTGAKSLESIKLNGNRLSHFP 187 (600)
Q Consensus 129 ~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~-~~~~~l~~L~~L~Ls~N~l~~l~ 187 (600)
+|++|.++.+. .+.++.+|+.||++.|-|.+... ..+..+..|+.|+|.+|.+---+
T Consensus 238 ~lrnN~l~tL~--gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 238 NLRNNALTTLR--GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred eecccHHHhhh--hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 99999988874 36788999999999997766432 22345678888999999876433
No 152
>cd05713 Ig_MOG_like Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). Ig_MOG_like: immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). MOG, a minor component of the myelin sheath, is an important CNS-specific autoantigen, linked to the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). It is a transmembrane protein having an extracellular Ig domain. MOG is expressed in the CNS on the outermost lamellae of the myelin sheath, and on the surface of oligodendrocytes, and may participate in the completion, compaction, and/or maintenance of myelin. This group also includes butyrophilin (BTN). BTN is the most abundant protein in bovine milk-fat globule membrane (MFGM).
Probab=98.13 E-value=1.8e-05 Score=67.14 Aligned_cols=85 Identities=18% Similarity=0.344 Sum_probs=52.9
Q ss_pred cccceeeeEeecCC---CCeeEEEEcC--eec---cCCcc-----cCc-cceEEEeeCCceeeeeeEEEecCCCCCCeEE
Q psy1672 269 SENATVVCRVDSIP---PAAISWYWNG--RLL---LNNTA-----FSS-YQRIFVIEQGEYERKSSLVLTNAQESDSGRF 334 (600)
Q Consensus 269 G~~v~L~C~v~g~P---~p~i~W~~~g--~~l---~~~~~-----~~~-~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y 334 (600)
|++++|.|...... ...+.|++.. ..+ ..... ... ..|+.+..+.......+|.|.+++.+|+|.|
T Consensus 1 G~~v~L~C~~~~~~~~~~~~v~W~k~~~~~~v~~~~~~~~~~~~~~~~~~~R~~~~~~~~~~~~~sL~I~~v~~~D~G~Y 80 (100)
T cd05713 1 GEDAELPCHLSPKMSAEHMEVRWFRSQFSPAVHLYRDGQDQYGEQMPEYRGRTELLKDAIAEGSVALRIHNVRASDEGLY 80 (100)
T ss_pred CCcEEEEeEEcCCCCCCeeEEEEEECCCceeEEEEcCCcccccccCccccceEEeecccccCCcEEEEEEcCChhhCEEE
Confidence 67899999886221 2368898843 111 00000 000 1233332221111245899999999999999
Q ss_pred EEEEecCCCceeEEEEEEE
Q psy1672 335 YCVAENRAGIADANFTLQV 353 (600)
Q Consensus 335 ~C~a~N~~G~~~~~v~L~V 353 (600)
+|.+.|..+..++.+.|.|
T Consensus 81 ~C~v~~~~~~~~~~i~l~v 99 (100)
T cd05713 81 TCFFQSDGFYEEATVELKV 99 (100)
T ss_pred EEEEecCCcEEEEEEEEEE
Confidence 9999998888888787776
No 153
>KOG4658|consensus
Probab=98.13 E-value=2.4e-06 Score=99.03 Aligned_cols=140 Identities=21% Similarity=0.285 Sum_probs=113.2
Q ss_pred CCCCccCCCCCCCCceEEEeeCCCCCCCChhhhcccCCCCccEEEeeccc--CcccCccccCCCCCccEEEccCC-CCCC
Q psy1672 37 KFLITIPEAPESELTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCH--IGQIDSGALDGLTNLIEIDLSDN-LLTS 113 (600)
Q Consensus 37 ~~L~~ip~~~~~~~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~--l~~i~~~~f~~l~~L~~L~Ls~N-~l~~ 113 (600)
.++..+|........+.+.+.+|.+..++... ..++|++|-+..|. +..+....|..++.|+.|||++| .+..
T Consensus 511 ~~~~~~~~~~~~~~~rr~s~~~~~~~~~~~~~----~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~ 586 (889)
T KOG4658|consen 511 VGLSEIPQVKSWNSVRRMSLMNNKIEHIAGSS----ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSK 586 (889)
T ss_pred cCccccccccchhheeEEEEeccchhhccCCC----CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCc
Confidence 46666777666655899999999998887655 45689999999996 78888888999999999999977 5677
Q ss_pred CCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCc
Q psy1672 114 IPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNR 182 (600)
Q Consensus 114 l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~ 182 (600)
+|. .++.+-+|++|+|++..+..++. .+.++..|.+|++..+.-....+.....+.+|++|.+..-.
T Consensus 587 LP~-~I~~Li~LryL~L~~t~I~~LP~-~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 587 LPS-SIGELVHLRYLDLSDTGISHLPS-GLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred CCh-HHhhhhhhhcccccCCCccccch-HHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 776 67889999999999999998854 57889999999999876555446777779999999987654
No 154
>PHA02826 IL-1 receptor-like protein; Provisional
Probab=98.10 E-value=1.4e-05 Score=78.33 Aligned_cols=71 Identities=24% Similarity=0.437 Sum_probs=53.9
Q ss_pred ccccccccceeeeEeec-----CCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEE
Q psy1672 264 VEAVSSENATVVCRVDS-----IPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVA 338 (600)
Q Consensus 264 ~~v~~G~~v~L~C~v~g-----~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a 338 (600)
..+.+|+.+.|.|.+.+ .|.|+|+|+++++.+.... +..+..++ +.|.|.+++.+|+|.|+|.|
T Consensus 139 ~~~~~G~~v~L~C~~~~~~~~~~p~p~I~WyKng~~l~~~~------r~~~~~~~-----~~L~I~~V~~~DsG~YtC~a 207 (227)
T PHA02826 139 YQFNSGKDSKLHCYGTDGISSTFKDYTLTWYKNGNIVLYTD------RIQLRNNN-----STLVIKSATHDDSGIYTCNL 207 (227)
T ss_pred ceEecCCCEEEEeeCCCCccccCCCceEEEEECCEECCCCC------CEEEeCCC-----CEEEECcCCHHhCEEEEEEE
Confidence 45567999999999863 4578999999999876432 33333222 37999999999999999999
Q ss_pred ecCCCce
Q psy1672 339 ENRAGIA 345 (600)
Q Consensus 339 ~N~~G~~ 345 (600)
+...+..
T Consensus 208 ~~~~~g~ 214 (227)
T PHA02826 208 RFNKNSN 214 (227)
T ss_pred EEeECCE
Confidence 9875443
No 155
>KOG4579|consensus
Probab=98.09 E-value=3e-07 Score=80.48 Aligned_cols=115 Identities=20% Similarity=0.272 Sum_probs=93.4
Q ss_pred ceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEc
Q psy1672 51 TQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNL 130 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 130 (600)
+..++|+.+.|-.|++..........|+.++|++|.+...++..-..++.++.|+|++|.|..+|.. +..++.|+.|++
T Consensus 29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE-~Aam~aLr~lNl 107 (177)
T KOG4579|consen 29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEE-LAAMPALRSLNL 107 (177)
T ss_pred hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHH-HhhhHHhhhccc
Confidence 5668888888887777665444667888889999999988877666777899999999999999986 888999999999
Q ss_pred cCCCCCccCcccccCCCCcceeeCCCCcCcccChhhh
Q psy1672 131 ARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAF 167 (600)
Q Consensus 131 s~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~ 167 (600)
+.|++...+. .+..+.+|..|+..+|.+..|+.+.|
T Consensus 108 ~~N~l~~~p~-vi~~L~~l~~Lds~~na~~eid~dl~ 143 (177)
T KOG4579|consen 108 RFNPLNAEPR-VIAPLIKLDMLDSPENARAEIDVDLF 143 (177)
T ss_pred ccCccccchH-HHHHHHhHHHhcCCCCccccCcHHHh
Confidence 9999887644 45558889999999999988876644
No 156
>PF13927 Ig_3: Immunoglobulin domain; PDB: 2D3V_A 1G0X_A 1VDG_A 1P7Q_D 3D2U_H 1UFU_A 1UGN_A 3VH8_H 3OQ3_B 4DKD_C ....
Probab=98.09 E-value=6.9e-06 Score=64.97 Aligned_cols=73 Identities=29% Similarity=0.586 Sum_probs=47.4
Q ss_pred cccccccccccccccccceeeeEeecCC-CCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeE
Q psy1672 255 PEIRMDSRYVEAVSSENATVVCRVDSIP-PAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGR 333 (600)
Q Consensus 255 p~i~~~~~~~~v~~G~~v~L~C~v~g~P-~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~ 333 (600)
|.+...+.......+. +.|.|.+.+.+ .+.+.|+ .... .............+.|.|.++..+|.|.
T Consensus 2 P~I~~~~~~~~~~~~~-~~l~C~~~~~~~~~~~~W~-~~~~-----------~~~~~~~~~~~~~~~L~i~~v~~~~~g~ 68 (75)
T PF13927_consen 2 PQISVPPPPVVTSGGS-VTLTCSAEGGPPPPSISWY-DSNP-----------SFNSNSRGSSSSNSTLTISNVTRSDNGT 68 (75)
T ss_dssp SEEEEESTSEEETTEE-EEEEEEESSEESSEEEEEE-TEEE-----------EEEEEEEEEEEEEEEEEESSCCGGGTEE
T ss_pred CEEEEcCCCcEeecee-EEEEEEEccccCCeEEEEE-ecCC-----------ceeeeeeeccceeeEEEEccCCHHhCcE
Confidence 3444444444443344 99999999877 7899999 1100 0111111122345689999999999999
Q ss_pred EEEEEec
Q psy1672 334 FYCVAEN 340 (600)
Q Consensus 334 Y~C~a~N 340 (600)
|+|+|+|
T Consensus 69 y~C~a~N 75 (75)
T PF13927_consen 69 YTCIASN 75 (75)
T ss_dssp EEEEEEE
T ss_pred EEEEEEC
Confidence 9999987
No 157
>cd05879 Ig_P0 Immunoglobulin (Ig)-like domain of Protein zero (P0). Ig_P0ex: immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin.
Probab=98.08 E-value=2.3e-05 Score=68.43 Aligned_cols=88 Identities=19% Similarity=0.306 Sum_probs=56.2
Q ss_pred ccccccccccccceeeeEeecC----CCCeeEEEEcCee-------c--cCCcccC-----ccceEEEeeCCceeeeeeE
Q psy1672 260 DSRYVEAVSSENATVVCRVDSI----PPAAISWYWNGRL-------L--LNNTAFS-----SYQRIFVIEQGEYERKSSL 321 (600)
Q Consensus 260 ~~~~~~v~~G~~v~L~C~v~g~----P~p~i~W~~~g~~-------l--~~~~~~~-----~~~~~~~~~~g~~~~~s~L 321 (600)
.+..+.+..|+.++|.|..... +..+|.|.+.... + .....+. ..+|+.+..+. ...+.+|
T Consensus 4 ~~~ev~a~~G~~v~L~C~f~~~~~~~~~~~v~W~~~~~~~~~~~~v~~y~~g~~~~~~~~~f~~Rv~f~g~~-~~~daSI 82 (116)
T cd05879 4 TDREVYGTVGSDVTLSCSFWSSEWISDDISFTWHYQPDGSRDAISIFHYGKGQPYIDDVGPFKERIEWVGNP-SRKDGSI 82 (116)
T ss_pred ccceEEEEcCCcEEEEEEEecCCCCCCcEEEEEEEcCCCCCccEEEEEeCCCceecccccCccCceEEeCCC-CcCeeEE
Confidence 3456788899999999998753 3458999552110 0 0001110 01234333322 2356789
Q ss_pred EEecCCCCCCeEEEEEEecCCCceeEE
Q psy1672 322 VLTNAQESDSGRFYCVAENRAGIADAN 348 (600)
Q Consensus 322 ~I~~v~~~d~G~Y~C~a~N~~G~~~~~ 348 (600)
.|.+++.+|+|.|+|.+.|..+.....
T Consensus 83 ~I~nv~~sD~G~Y~C~v~n~p~~~~~~ 109 (116)
T cd05879 83 VIHNLDYTDNGTFTCDVKNPPDIVGKS 109 (116)
T ss_pred EEccCCcccCEEEEEEEEcCCCcCCce
Confidence 999999999999999999998754333
No 158
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=98.07 E-value=9.1e-06 Score=72.16 Aligned_cols=117 Identities=18% Similarity=0.355 Sum_probs=76.3
Q ss_pred CceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEE
Q psy1672 50 LTQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLN 129 (600)
Q Consensus 50 ~l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~ 129 (600)
.++.+.+.. .+..|....|. ++.+|+.|.+.++ +..+...+|.++.+|+.+.+.+ .+..++...|..+.+|+.+.
T Consensus 13 ~l~~i~~~~-~~~~I~~~~F~--~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~l~~i~ 87 (129)
T PF13306_consen 13 NLESITFPN-TIKKIGENAFS--NCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTNLKNID 87 (129)
T ss_dssp T--EEEETS-T--EE-TTTTT--T-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TTECEEE
T ss_pred CCCEEEECC-CeeEeChhhcc--ccccccccccccc-ccccceeeeecccccccccccc-cccccccccccccccccccc
Confidence 388888875 68899999997 7889999999885 9999999999998999999976 78888888999999999999
Q ss_pred ccCCCCCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCC
Q psy1672 130 LARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLE 174 (600)
Q Consensus 130 Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 174 (600)
+..+ +..+....|.++ +|+.+.+.. .+..+....|.++++|+
T Consensus 88 ~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l~ 129 (129)
T PF13306_consen 88 IPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKLK 129 (129)
T ss_dssp ETTT--BEEHTTTTTT--T--EEE-TT-B-SS----GGG------
T ss_pred cCcc-ccEEchhhhcCC-CceEEEECC-CccEECCccccccccCC
Confidence 9876 888888889988 999998876 77788888888887764
No 159
>cd05897 Ig2_IL1R2_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). Ig2_IL1R2_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds the type II (IL1R2) represented in this group. Mature IL1R2 consists of three IG-like domains, a transmembrane domain, and a short cytoplasmic domain. It lacks the large cytoplasmic domain of Mature IL1R1, and does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=98.05 E-value=2.5e-05 Score=65.43 Aligned_cols=75 Identities=17% Similarity=0.347 Sum_probs=53.0
Q ss_pred cccccccceeeeEe-e----cCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEe
Q psy1672 265 EAVSSENATVVCRV-D----SIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAE 339 (600)
Q Consensus 265 ~v~~G~~v~L~C~v-~----g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~ 339 (600)
.+..|....|.|.- . ..+.+++.|+++++.+.... .+.....+ .+.|.|.++..+|.|.|+|.|.
T Consensus 6 ~~~~~~~~~l~Cp~~~~f~~~~~~~~v~WYKd~~~l~~~~-----~~~~~~~~-----~~~L~I~~v~~~D~G~YtC~~~ 75 (95)
T cd05897 6 ILFTSTSGKLVCPDLSDFTINRTDVELQWYKDSVLLDKDN-----EKFYSLKG-----STYLHIIDVSLNDSGYYTCKLQ 75 (95)
T ss_pred EeccccCcEEECCCHHHcccCCCCCcEEEccCCEECcCCC-----cceEecCC-----CCEEEEEEcChhhCEEEEEEEE
Confidence 45678888999952 2 34667999999998875332 11111122 2369999999999999999999
Q ss_pred cCCCceeEEE
Q psy1672 340 NRAGIADANF 349 (600)
Q Consensus 340 N~~G~~~~~v 349 (600)
|..|...-.+
T Consensus 76 ~~~~g~~y~v 85 (95)
T cd05897 76 FTHEGKKYNI 85 (95)
T ss_pred EeeCCEEEEE
Confidence 9987664433
No 160
>cd05872 Ig_Sema4B_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4B. Ig_Sema4B_like; Immunoglobulin (Ig)-like domain of Sema4B_like. Sema4B is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4B has extracellular Sema and Ig domains, a transmembrane domain and a short cytoplasmic domain. Sema4B has been shown to preferentially regulate the development of the postsynaptic specialization at the glutamatergic synapses. This cytoplasmic domain includes a PDZ-binding motif upon which the synaptic localization of Sem4B is dependent. Sema4B is a ligand of CLCP1, CLCP1 was identified in an expression profiling analysis, which compared a highly metastic lung cancer subline with its low metastic parental line. Sema4B was shown to promote CLCP1 endocytosis, and their interaction is a potential target for therapeutic intervention of metastasis.
Probab=97.97 E-value=4.1e-05 Score=62.69 Aligned_cols=71 Identities=21% Similarity=0.382 Sum_probs=53.2
Q ss_pred ccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecC
Q psy1672 262 RYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 262 ~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~ 341 (600)
+.+++..|..+.|.|...+. .+.+.|+++|..+... .++.....| |.|..++..|+|.|.|.+. .
T Consensus 4 ~~~tv~~g~~v~L~C~~~s~-~A~v~W~~ng~~l~~~------~r~~~~~~G-------LlI~~~~~~dsG~Y~C~s~-E 68 (85)
T cd05872 4 KNRTVAPGADVVLPCQLRSN-LASPVWLFNGTPLNAQ------FSYRVGTDG-------LLILVTSPEHSGTYRCYSE-E 68 (85)
T ss_pred eEEEEecCCCEEEECCCCCC-CccEEEEECCcccCCC------cceEEeCCC-------CEEEECCHhhCEEEEEEEe-c
Confidence 45678899999999999864 6799999999876532 233333333 7799999999999999988 3
Q ss_pred CCceeE
Q psy1672 342 AGIADA 347 (600)
Q Consensus 342 ~G~~~~ 347 (600)
.|....
T Consensus 69 ~gf~~~ 74 (85)
T cd05872 69 EGFQQL 74 (85)
T ss_pred CCCeEE
Confidence 354443
No 161
>cd05714 Ig_CSPGs_LP Immunoglobulin (Ig)-like domain of chondroitin sulfate proteoglycans (CSPGs), human cartilage link protein (LP) and similar proteins. Ig_CSPGs_LP: immunoglobulin (Ig)-like domain similar to that found in chondroitin sulfate proteoglycans (CSPGs) and human cartilage link protein (LP). Included in this group are the CSPGs aggrecan, versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue.
Probab=97.95 E-value=6.6e-05 Score=64.42 Aligned_cols=85 Identities=24% Similarity=0.306 Sum_probs=55.9
Q ss_pred ccccceeeeEeecCC------CCeeEEEEcC---e---ec-c-CCcc---cCcc-ceEEEeeCCceeeeeeEEEecCCCC
Q psy1672 268 SSENATVVCRVDSIP------PAAISWYWNG---R---LL-L-NNTA---FSSY-QRIFVIEQGEYERKSSLVLTNAQES 329 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P------~p~i~W~~~g---~---~l-~-~~~~---~~~~-~~~~~~~~g~~~~~s~L~I~~v~~~ 329 (600)
.|++|+|.|.....+ ...|.|++.. . .+ . .... ...+ .++... .......+|+|.+++.+
T Consensus 1 ~G~~V~L~C~~~~~~~~~~~~~~~i~W~k~~~~~~~~~~v~~~~~~~~~~~~~~~~r~~~~--~~~~~~~sL~I~~v~~s 78 (106)
T cd05714 1 LGGNVTLPCRFHLEPALSAPHGPRIKWTKLESDGAKEVDVLVAIGGRVKVYGSGRVRVPLY--PADPGDASLVITDLRLE 78 (106)
T ss_pred CCCCEEEeEEeECCcccCCCCCcEEEEEEeCCCCCceEEEEEEcCCEEEEcCCCceEEEee--CCCCCcceEEECCCCHH
Confidence 388999999987543 4689999952 1 00 0 0000 0000 111111 11124578999999999
Q ss_pred CCeEEEEEEecCCCceeEEEEEEEE
Q psy1672 330 DSGRFYCVAENRAGIADANFTLQVT 354 (600)
Q Consensus 330 d~G~Y~C~a~N~~G~~~~~v~L~V~ 354 (600)
|+|.|.|.+.+..+..++.+.|.|.
T Consensus 79 D~G~Y~C~v~~~~~~~~~~v~L~V~ 103 (106)
T cd05714 79 DSGRYRCEVIDGIEDEQDTVELEVR 103 (106)
T ss_pred HCEEEEEEEEcCCCceEEEEEEEEE
Confidence 9999999999988888888888875
No 162
>KOG1909|consensus
Probab=97.94 E-value=4.4e-06 Score=83.96 Aligned_cols=157 Identities=23% Similarity=0.271 Sum_probs=106.2
Q ss_pred CceEEEeeCCCCCC--CCh--hhhcccCCCCccEEEeecccCcccCccc-------------cCCCCCccEEEccCCCCC
Q psy1672 50 LTQVLDMSGNNLQI--LPK--EAFRRAGLLNLQKLFLARCHIGQIDSGA-------------LDGLTNLIEIDLSDNLLT 112 (600)
Q Consensus 50 ~l~~L~Ls~n~L~~--l~~--~~f~~~~l~~L~~L~L~~n~l~~i~~~~-------------f~~l~~L~~L~Ls~N~l~ 112 (600)
.+++|+||+|-|.. ++. ... ..+..|++|.|.||++....... ...-++|+.+...+|++.
T Consensus 93 ~L~~ldLSDNA~G~~g~~~l~~ll--~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrle 170 (382)
T KOG1909|consen 93 KLQKLDLSDNAFGPKGIRGLEELL--SSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLE 170 (382)
T ss_pred ceeEeeccccccCccchHHHHHHH--HhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccc
Confidence 38999999998862 222 122 25889999999999886543322 233468899999999887
Q ss_pred CCCc----cccCCCCCCCEEEccCCCCCcc----CcccccCCCCcceeeCCCCcCcccC----hhhhcCCCCCCEEEcCC
Q psy1672 113 SIPS----LTFQSVRFLRDLNLARNPISKI----EKGAFQFVPGLVKLDMSESRLEHIS----PEAFTGAKSLESIKLNG 180 (600)
Q Consensus 113 ~l~~----~~f~~l~~L~~L~Ls~N~i~~l----~~~~~~~l~~L~~L~Ls~n~l~~i~----~~~~~~l~~L~~L~Ls~ 180 (600)
.-+. ..|+..+.|+.+.+..|.|..- ....|..+++|+.|+|..|-++.-. ...+..+++|+.|++++
T Consensus 171 n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~d 250 (382)
T KOG1909|consen 171 NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGD 250 (382)
T ss_pred cccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccc
Confidence 5443 2466677888888888877532 1245667888888888888776533 34556677888888888
Q ss_pred CcCCCCCcccc-----cccccccEEEccCCcCc
Q psy1672 181 NRLSHFPVRSV-----EPLLKLMMIELHDNPWV 208 (600)
Q Consensus 181 N~l~~l~~~~~-----~~l~~L~~L~l~~N~~~ 208 (600)
|.+..-....| ...+.|+++.+.+|-+.
T Consensus 251 cll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 251 CLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred cccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 87775442222 23467788888777654
No 163
>cd05878 Ig_Aggrecan_like Immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG). Ig_Aggrecan_like: immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG)s. Included in this group are the Ig domains of other CSPGs: versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substi
Probab=97.93 E-value=6.1e-05 Score=65.20 Aligned_cols=88 Identities=20% Similarity=0.265 Sum_probs=57.1
Q ss_pred ccccceeeeEeecCC----------CCeeEEEEc--Ceecc-----CCc--ccCcc-ceEEEeeCCceeeeeeEEEecCC
Q psy1672 268 SSENATVVCRVDSIP----------PAAISWYWN--GRLLL-----NNT--AFSSY-QRIFVIEQGEYERKSSLVLTNAQ 327 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P----------~p~i~W~~~--g~~l~-----~~~--~~~~~-~~~~~~~~g~~~~~s~L~I~~v~ 327 (600)
.|++++|.|.....+ ...|.|++. ++... ... ..+.+ +|+.+..+........|+|.+++
T Consensus 1 ~G~~V~LpC~~~~~~~~~~~~~~~~~~~i~W~k~~~~~~~~v~~~~~~~~~~~~~f~gR~~~~~~~~~~~~asL~I~~l~ 80 (110)
T cd05878 1 LSSSVLLPCYFTLPPALPPPSNAPESPRIKWTKLSGQKEVTVLVAQDGVVKVGQEYQGRVSLPNYPENRGDASLEISRLR 80 (110)
T ss_pred CCCCEEEeeEeeCCccccccccCCCCCEEEEEEecCCCcEEEEEEECCEEEecccccCeEEeccCCCCCCcEEEEECCCC
Confidence 488999999887533 257999994 22111 000 00111 23333221111234679999999
Q ss_pred CCCCeEEEEEEecCCCceeEEEEEEEEE
Q psy1672 328 ESDSGRFYCVAENRAGIADANFTLQVTY 355 (600)
Q Consensus 328 ~~d~G~Y~C~a~N~~G~~~~~v~L~V~~ 355 (600)
.+|+|.|.|.+.......++.+.|.|..
T Consensus 81 ~sD~G~Y~C~v~~~~~~~~~~v~l~V~g 108 (110)
T cd05878 81 SSDSGVYRCEVMHGIEDEQDTVPLEVTG 108 (110)
T ss_pred hhhCEEEEEEEEeCCCcceEEEEEEEEE
Confidence 9999999999999877788888888853
No 164
>PHA02826 IL-1 receptor-like protein; Provisional
Probab=97.89 E-value=2.5e-05 Score=76.57 Aligned_cols=90 Identities=18% Similarity=0.267 Sum_probs=59.8
Q ss_pred ccccccccccceeeeEeecCC-----------CCeeEEEEcCeec--cCCcccCccceEEEeeCCceeeeeeEEEecCCC
Q psy1672 262 RYVEAVSSENATVVCRVDSIP-----------PAAISWYWNGRLL--LNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQE 328 (600)
Q Consensus 262 ~~~~v~~G~~v~L~C~v~g~P-----------~p~i~W~~~g~~l--~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~ 328 (600)
..+.+.+|+.+.|.|.+.+.| .+.+.|++.+... ...............+.+ .....|.|.+++.
T Consensus 30 ~~~~v~eGe~v~L~C~~~~~~~~~~~~~~~~~~~~V~W~k~~s~~~v~~~~~~~~~~~i~~~~~~--~r~~~L~I~~v~~ 107 (227)
T PHA02826 30 TPVYAKFGDPMVLLCTGKHYKKSIFFDKTFITSYNVTWSKTDSLAFVRDSGARTKIKKITHNEIG--DRSENLWIGNVIN 107 (227)
T ss_pred ceEEecCCCCEEEEccccccccccccccccCCCccEEEEeCCeEEEEEcCCCcccccccccccee--cCCCeEEECCCCh
Confidence 456788999999999987644 3489999976431 110000000000000000 1134899999999
Q ss_pred CCCeEEEEEEecCCCceeEEEEEEE
Q psy1672 329 SDSGRFYCVAENRAGIADANFTLQV 353 (600)
Q Consensus 329 ~d~G~Y~C~a~N~~G~~~~~v~L~V 353 (600)
+|+|.|+|.|.|..|..+..+.|.|
T Consensus 108 ~DsG~Y~C~a~N~~~~~~~~i~L~V 132 (227)
T PHA02826 108 IDEGIYICTISSGNICEESTIRLTF 132 (227)
T ss_pred HHCEEEEEEEEECCcceEEEEEEEE
Confidence 9999999999999988888887777
No 165
>cd05900 Ig_Aggrecan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. Ig_Aggrecan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. These aggregates contribute to the tissue's load bearing properties. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Aggrecan has a wide distribution in connective tissue and extracellular matrices. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=97.88 E-value=8.3e-05 Score=64.44 Aligned_cols=87 Identities=16% Similarity=0.275 Sum_probs=55.7
Q ss_pred ccccceeeeEeecCC------------CCeeEEEEc--Cee---ccC--Cc--ccCcc-ceEEEeeCCceeeeeeEEEec
Q psy1672 268 SSENATVVCRVDSIP------------PAAISWYWN--GRL---LLN--NT--AFSSY-QRIFVIEQGEYERKSSLVLTN 325 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P------------~p~i~W~~~--g~~---l~~--~~--~~~~~-~~~~~~~~g~~~~~s~L~I~~ 325 (600)
.|++++|.|...... .+.|.|++. ++. +.. .. ..+.+ .|+.+...........|+|.+
T Consensus 1 ~G~~VtLpC~~~~~~~~~~~~~~~~~~~~~I~W~k~~~g~~~~ii~~~~~~~~~~~~f~~R~sl~~~~~~~~~asL~I~n 80 (112)
T cd05900 1 LGSSLLIPCYFQDPIAKDPGAPTVAPLSPRIKWSFISKEKESVLLVATEGKVRVNTEYLDRVSLPNYPAIPSDATLEITE 80 (112)
T ss_pred CCCcEEEeeEEeCCcCccccccccCCCCCEEEEEEecCCCccEEEEEECCeEEECccccCeEEecccCCCCCCcEEEEee
Confidence 488999999887432 468999983 211 100 00 01112 244443211112356899999
Q ss_pred CCCCCCeEEEEEEecCCCceeEEEEEEEE
Q psy1672 326 AQESDSGRFYCVAENRAGIADANFTLQVT 354 (600)
Q Consensus 326 v~~~d~G~Y~C~a~N~~G~~~~~v~L~V~ 354 (600)
++.+|+|.|+|.+.+.....+..+.|.|.
T Consensus 81 l~~sDsG~Y~C~V~~g~~~~~~~v~l~v~ 109 (112)
T cd05900 81 LRSNDSGTYRCEVMHGIEDNYDTVEVQVK 109 (112)
T ss_pred cccccCEEEEEEEecCCCCceeEEEEEEE
Confidence 99999999999999887777777777763
No 166
>cd05881 Ig1_Necl-2 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig1_Necl-2: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-2, Necl-2 (also known as cell adhesion molecule 1 (CADM1), SynCAM1, IGSF4A, Tslc1, sgIGSF, and RA175). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-2 is expressed in a wide variety of tissues, and is a
Probab=97.87 E-value=8.4e-05 Score=62.26 Aligned_cols=79 Identities=22% Similarity=0.322 Sum_probs=55.6
Q ss_pred cccccccccccceeeeEeecCCCCeeEEEEcCeecc--CCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEE
Q psy1672 261 SRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLL--NNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVA 338 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~--~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a 338 (600)
..++++.+|++++|.|.+.+.....+.|++.++.+. .........|+...... .....|.|.+++.+|.|.|+|.+
T Consensus 4 ~~nvtv~~G~ta~L~C~v~~~~~~~v~w~~~~~~~i~~~~~~~~~d~Rf~~~~~~--~~~~tL~I~~vq~~D~G~Y~Cqv 81 (95)
T cd05881 4 TEDVTVVEGEVAIISCRVKNNDDSVIQLLNPNRQTIYFRDVRPLKDSRFQLVNFS--SNELRVSLSNVSLSDEGRYFCQL 81 (95)
T ss_pred cCceEEcCCCcEEEEEEEccCCccEEEEEecCCcEEEecCccccCCcCEEEEeCC--CCEEEEEECcCCcccCEEEEEEE
Confidence 356788999999999999987777899998664431 11111223455444311 12347999999999999999998
Q ss_pred ecC
Q psy1672 339 ENR 341 (600)
Q Consensus 339 ~N~ 341 (600)
...
T Consensus 82 ~t~ 84 (95)
T cd05881 82 YTD 84 (95)
T ss_pred Ecc
Confidence 764
No 167
>cd05877 Ig_LP_like Immunoglobulin (Ig)-like domain of human cartilage link protein (LP). Ig_LP_like: immunoglobulin (Ig)-like domain similar to that that found in human cartilage link protein (LP). In cartilage, chondroitin-keratan sulfate proteoglycan (CSPG), aggrecan, forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=97.87 E-value=9.8e-05 Score=63.32 Aligned_cols=85 Identities=22% Similarity=0.347 Sum_probs=56.5
Q ss_pred ccccceeeeEeecCC------CCeeEEEEcCe------e--ccCCc---ccCc-cceEEEeeCCceeeeeeEEEecCCCC
Q psy1672 268 SSENATVVCRVDSIP------PAAISWYWNGR------L--LLNNT---AFSS-YQRIFVIEQGEYERKSSLVLTNAQES 329 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P------~p~i~W~~~g~------~--l~~~~---~~~~-~~~~~~~~~g~~~~~s~L~I~~v~~~ 329 (600)
.|++++|.|.....| ...|.|++... . +.... .++. ..|..+... .....+|.|.+++.+
T Consensus 1 ~G~~vtL~C~~~~~~~~~~~~~~~v~W~k~~~~~~~~~~~~~~~~~~~~~~~~~~~R~~~~~~--~~~~~sL~I~~v~~~ 78 (106)
T cd05877 1 RGGNVTLPCRYHYEPELSAPRKIRVKWTKLESDYLKEEDVLVAIGTRHKSYGSYQGRVFLRRA--HDLDASLVITDLRLE 78 (106)
T ss_pred CCCcEEEEeEeECCCcCCCCccceEEEEEecCCCCeeEEEEEEcCcEEEeccCccCcEEecCC--CCCcEEEEEccCChH
Confidence 378999999887553 35799999421 0 01000 0011 123332211 123568999999999
Q ss_pred CCeEEEEEEecCCCceeEEEEEEEE
Q psy1672 330 DSGRFYCVAENRAGIADANFTLQVT 354 (600)
Q Consensus 330 d~G~Y~C~a~N~~G~~~~~v~L~V~ 354 (600)
|+|.|+|.+.+..+..+..+.|.|.
T Consensus 79 DsG~Y~C~v~~~~~~~~~~~~l~v~ 103 (106)
T cd05877 79 DYGRYRCEVIDGLEDESVVVALRLR 103 (106)
T ss_pred HCEEEEEEEEecccceEEEEEEEEE
Confidence 9999999999999988888888884
No 168
>cd05896 Ig1_IL1RAPL-1_like First immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). Ig1_ IL1RAPL-1_like: domain similar to the first immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). IL-1 alpha and IL-1 beta are cytokines which participates in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of
Probab=97.86 E-value=8.8e-05 Score=62.59 Aligned_cols=84 Identities=15% Similarity=0.251 Sum_probs=54.7
Q ss_pred cccccccccceeeeEee-----------cCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCC
Q psy1672 263 YVEAVSSENATVVCRVD-----------SIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDS 331 (600)
Q Consensus 263 ~~~v~~G~~v~L~C~v~-----------g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~ 331 (600)
...+.+|+.+.|.|... ......+.|++++..+....... ....++...+ ..|.|.++..+|+
T Consensus 9 ~~~~~~GE~v~l~C~~~~~~~~~~~~~~~~~~~~v~WyK~~~~~~~~~~~~-~~~~Ri~~~~-----~~Lwf~Pa~~eDS 82 (104)
T cd05896 9 KYMVLAGEPVRIKCALFYGYIRTNYSMAQSAGLSLMWYKSSGDGEEPIEII-FDGVRMSKEE-----DSIWFRPAELQDS 82 (104)
T ss_pred eEEEcCCCeEEEECCCccccccccccccccCCceEEEEECCCCCCCCCccc-ccceeEEEeC-----CEEEEEeCChhhC
Confidence 45677899999999762 11234799999874443322110 1111222222 3799999999999
Q ss_pred eEEEEEEecCCCceeEEEEEE
Q psy1672 332 GRFYCVAENRAGIADANFTLQ 352 (600)
Q Consensus 332 G~Y~C~a~N~~G~~~~~v~L~ 352 (600)
|.|+|++.|...-....+.|.
T Consensus 83 G~Y~C~~rN~t~C~~~~i~l~ 103 (104)
T cd05896 83 GLYTCVLRNSTYCMKVSMSLT 103 (104)
T ss_pred eEEEEEECCCCcceEEEEEEE
Confidence 999999999876555555444
No 169
>cd05888 Ig1_Nectin-4_like Frst immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor) and similar proteins. Ig1_Nectin-4_like: domain similar to the first immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor). Nectin-4 belongs to the nectin family, which is comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example nectin-4 trans-interacts with nectin-1. Nectin-4 has also been shown to interact with the actin filament-binding protein, afadin. Unlike the other nectins, which are widely expressed in adult tissues, nectin-4 is mainly expressed during embryogenesis, and is not detected in normal adult
Probab=97.85 E-value=0.00013 Score=61.88 Aligned_cols=82 Identities=24% Similarity=0.446 Sum_probs=52.2
Q ss_pred cceeeeEeecCC---CCeeEEEEc--Ce-e--c---c---CCcccCcc-ceEEEeeCCceeeeeeEEEecCCCCCCeEEE
Q psy1672 271 NATVVCRVDSIP---PAAISWYWN--GR-L--L---L---NNTAFSSY-QRIFVIEQGEYERKSSLVLTNAQESDSGRFY 335 (600)
Q Consensus 271 ~v~L~C~v~g~P---~p~i~W~~~--g~-~--l---~---~~~~~~~~-~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~ 335 (600)
+++|.|.....+ ...|.|++. +. . + . ....+..+ +|..+..+. ....+.|+|.+++.+|+|.|+
T Consensus 2 ~v~L~C~~~~~~~~~~~~v~W~k~~~~~~~~~i~~~~~~~~~~~~~~~~~Rv~f~~~~-~~~~~sL~I~nv~~sD~GtY~ 80 (100)
T cd05888 2 DTRLPCRYNVSDGETVVQVLWIRENAGGVEEEIALLHFKYGQTEFHAYEGRVRFETPN-PIADGALILRNAVQADEGKYK 80 (100)
T ss_pred CEEEEeEEecCCCCcEEEEEEEEccCCCCcEEEEEEeccCCcccCCCccCcEEEeCCC-CCCceEEEEecCccccceEEE
Confidence 688999887443 448999983 21 1 1 0 11112222 344433221 123568999999999999999
Q ss_pred EEEec-CCCceeEEEEEEE
Q psy1672 336 CVAEN-RAGIADANFTLQV 353 (600)
Q Consensus 336 C~a~N-~~G~~~~~v~L~V 353 (600)
|.+.+ +.|..++.+.|.|
T Consensus 81 C~v~~~p~g~~~~~~~L~V 99 (100)
T cd05888 81 CRVITFPAGNFEAELVLTV 99 (100)
T ss_pred EEEEeCCCCCeeeEEEEEe
Confidence 99998 6676777777765
No 170
>cd04983 IgV_TCR_alpha_like Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) alpha chain and similar proteins. IgV_TCR_alpha: immunoglobulin (Ig) variable domain of the alpha chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group represents the variable domain of the alpha chain of TCRs and also includes the variable domain of delta chains of TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=97.85 E-value=0.0001 Score=63.48 Aligned_cols=83 Identities=22% Similarity=0.268 Sum_probs=55.7
Q ss_pred ccccccccccccceeeeEeecCCCCeeEEEEcCe--ec----cC--CcccCccceEEEeeCCceeeeeeEEEecCCCCCC
Q psy1672 260 DSRYVEAVSSENATVVCRVDSIPPAAISWYWNGR--LL----LN--NTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDS 331 (600)
Q Consensus 260 ~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~--~l----~~--~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~ 331 (600)
.+..+.+..|++++|.|.+.+.+...+.|++... .. .. ........++.+..+. ......|.|.+++.+|+
T Consensus 4 ~~~~v~~~~G~~v~L~C~~~~~~~~~v~W~k~~~~~~~~~l~~~~~~~~~~~~~r~~~~~~~-~~~~~~L~I~~~~~~Ds 82 (109)
T cd04983 4 SPQSLSVQEGENVTLNCNYSTSTFYYLFWYRQYPGQGPQFLIYISSNGEEKEKGRFSATLDK-SRKSSSLHISAAQLSDS 82 (109)
T ss_pred cCCceEEcCCCCEEEEEEECCCCccEEEEEEECCCCCeEEEEEEecCCCcccCCcEEEEEcc-cCCEEEEEECCCCHHHC
Confidence 4567788999999999999977788999998431 10 00 0000112333333221 11346899999999999
Q ss_pred eEEEEEEecCCC
Q psy1672 332 GRFYCVAENRAG 343 (600)
Q Consensus 332 G~Y~C~a~N~~G 343 (600)
|.|.|.+.+..+
T Consensus 83 G~Y~C~~~~~~~ 94 (109)
T cd04983 83 AVYFCALSESGG 94 (109)
T ss_pred EEEEEEEecCCC
Confidence 999999998654
No 171
>cd05774 Ig_CEACAM_D1 First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). IG_CEACAM_D1: immunoglobulin (Ig)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the D
Probab=97.80 E-value=0.00011 Score=62.90 Aligned_cols=83 Identities=18% Similarity=0.203 Sum_probs=53.1
Q ss_pred ccccccccceeeeEeecCCCCeeEEEEcCeecc--------CC---ccc--CccceEEEeeCCceeeeeeEEEecCCCCC
Q psy1672 264 VEAVSSENATVVCRVDSIPPAAISWYWNGRLLL--------NN---TAF--SSYQRIFVIEQGEYERKSSLVLTNAQESD 330 (600)
Q Consensus 264 ~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~--------~~---~~~--~~~~~~~~~~~g~~~~~s~L~I~~v~~~d 330 (600)
..+.+|+++.|.|.........+.|++...... .. ... ...+|..++.+| +|.|.+++..|
T Consensus 8 ~~~~~G~~V~L~v~~~p~~~~~~~W~kg~~~~~~~~I~~y~~~~~~~~~gp~~~gR~~~~~ng------SL~I~~v~~~D 81 (105)
T cd05774 8 PQVAEGENVLLLVHNLPENLLAYAWYKGKTVSPNFLIASYIISTNSSTPGPAYSGRETIYPNG------SLLIQNVTQKD 81 (105)
T ss_pred CcccCCCCEEEEecCCCCCceEEEEEcCCCCCCCEEEEEEECCCcccccCcccCCcEEEeCCC------cEEEecCCccc
Confidence 446789999999966544445899999421110 00 000 012334444444 89999999999
Q ss_pred CeEEEEEEecCCC-ceeEEEEEE
Q psy1672 331 SGRFYCVAENRAG-IADANFTLQ 352 (600)
Q Consensus 331 ~G~Y~C~a~N~~G-~~~~~v~L~ 352 (600)
+|.|+|.+.|... ..+..+.|.
T Consensus 82 ~G~Y~~~v~~~~~~~~~~~v~l~ 104 (105)
T cd05774 82 TGFYTLQTITTNFQVEQATVHLQ 104 (105)
T ss_pred CEEEEEEEEeCCccEEEEEEEEE
Confidence 9999999999874 344444443
No 172
>cd05741 Ig_CEACAM_D1_like First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) and similar proteins. Ig_CEACAM_D1_like : immunoglobulin (IG)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily-like. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surf
Probab=97.80 E-value=8.6e-05 Score=61.74 Aligned_cols=78 Identities=22% Similarity=0.315 Sum_probs=51.2
Q ss_pred cccceeeeEeecCCCCeeEEEEcCeeccCCc----------cc--CccceEEEeeCCceeeeeeEEEecCCCCCCeEEEE
Q psy1672 269 SENATVVCRVDSIPPAAISWYWNGRLLLNNT----------AF--SSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYC 336 (600)
Q Consensus 269 G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~----------~~--~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C 336 (600)
|++|+|.|.........|.|++......... .. ....|..+.. .++|.|.+++.+|+|.|+|
T Consensus 1 G~~VtL~c~~~~~~~~~i~W~~~~~~~~~~~i~~~~~~~~~~~~~~~~~R~~~~~------~~sL~I~~l~~~DsG~Y~c 74 (92)
T cd05741 1 GESVTLPVSNLPENLQEITWYKGKDKSVEAEIASYIATNSTVFGPAYSGRETIYP------NGSLLIQNLTKEDSGTYTL 74 (92)
T ss_pred CCcEEEEcccCCCCCEEEEEECCCCCCcceEEEEEecCCceeECCCcCCeEEEcC------CceEEEccCCchhcEEEEE
Confidence 7899999988776667899999543211100 00 0012222222 3589999999999999999
Q ss_pred EEecCCCc-eeEEEEEE
Q psy1672 337 VAENRAGI-ADANFTLQ 352 (600)
Q Consensus 337 ~a~N~~G~-~~~~v~L~ 352 (600)
.+....|. ..+.+.|+
T Consensus 75 ~v~~~~~~~~~~~~~l~ 91 (92)
T cd05741 75 QIISTNGVTENAKFFLR 91 (92)
T ss_pred EEEcCCCcEEEEEEEEE
Confidence 99988754 34555554
No 173
>cd05718 Ig1_PVR_like First immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig1_PVR_like: domain similar to the first immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), that result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane, may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus "c
Probab=97.76 E-value=0.00022 Score=60.09 Aligned_cols=82 Identities=16% Similarity=0.290 Sum_probs=52.0
Q ss_pred ccceeeeEeecCC---CCeeEEEEcCee----c--cC---CcccCc--cceEEEeeCCceeeeeeEEEecCCCCCCeEEE
Q psy1672 270 ENATVVCRVDSIP---PAAISWYWNGRL----L--LN---NTAFSS--YQRIFVIEQGEYERKSSLVLTNAQESDSGRFY 335 (600)
Q Consensus 270 ~~v~L~C~v~g~P---~p~i~W~~~g~~----l--~~---~~~~~~--~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~ 335 (600)
++|+|.|.....+ ...|.|++.... + .. ...+.. ..|+.+..+. .....|.|.+++.+|+|.|.
T Consensus 1 ~~v~L~C~~~~~~~~~~~~v~W~k~~~~~~~~i~~~~~~~~~~~~~~~~~R~~~~~~~--~~~~sL~I~~v~~~D~G~Y~ 78 (98)
T cd05718 1 ESVTLECSFPVPGPVQITQVTWMKITGGSKQNIAVFHPQYGISIPPSYEGRVSFLNSS--LEDATISISNLRLEDEGNYI 78 (98)
T ss_pred CCEEEEeEeeCCCCceEEEEEEeeECCCCCEEEEEEecCCCcccCcCcCceEEEeCCC--CCceEEEEccCCcccCEEEE
Confidence 4689999887644 447999994321 0 00 000000 1222222211 14568999999999999999
Q ss_pred EEEec-CCCceeEEEEEEE
Q psy1672 336 CVAEN-RAGIADANFTLQV 353 (600)
Q Consensus 336 C~a~N-~~G~~~~~v~L~V 353 (600)
|.+.+ ..|..++.+.|.|
T Consensus 79 C~v~~~~~g~~~~~~~l~V 97 (98)
T cd05718 79 CEFATFPQGNRQKVTTLTV 97 (98)
T ss_pred EEEEeCCCCcEEEEEEEEe
Confidence 99875 6688888887776
No 174
>cd05751 Ig1_LILRB1_like First immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1) and similar proteins. Ig1_LILRB1_like: domain similar to the first immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1). This group includes, LILRA5 (LIR9), an activating natural cytotoxicity receptor NKp46, and the immune-type receptor glycoprotein VI (GPVI). LILRs are a family of immunoreceptors expressed on expressed on T and B cells, on monocytes, dendritic cells, and subgroups of natural killer (NK) cells. The human LILR family contains nine proteins (LILRA1-3,and 5, and LILRB1-5). From functional assays, and as the cytoplasmic domains of various LILRs, for example LILRB1 (LIR-1), LILRB2 (LIR-2), and LILRB3 (LIR-3) contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) it is thought that LIR proteins are inhibitory receptors. Of the eight LIR family proteins, only LIR-1(LILRB1), and LIR-2 (LILRB2),
Probab=97.75 E-value=0.00011 Score=61.23 Aligned_cols=66 Identities=14% Similarity=0.241 Sum_probs=48.9
Q ss_pred cccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecC
Q psy1672 263 YVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 263 ~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~ 341 (600)
...+..|++|+|.|... .+...+.|+++|....... .. .....+.+.|.+++.+|+|.|+|.+.|.
T Consensus 10 ~~vV~~G~~VtL~C~~~-~~~~~f~l~k~g~~~~~~~----------~~--~~~~~~~f~i~~v~~~~~G~Y~C~~~~~ 75 (91)
T cd05751 10 SSVVPLGKPVTLRCQGP-YGAVEYRLYREGSTFAVKK----------PP--EPQNKAKFFIPSMKREHAGRYRCYYRSG 75 (91)
T ss_pred CCccCCCCcEEEEEecC-CCCCEEEEEECCCCccccc----------cC--CCceeEEEEccCCChhHCEEEEEEEECC
Confidence 34677999999999886 6677899999886432110 00 0112357899999999999999999986
No 175
>PHA02785 IL-beta-binding protein; Provisional
Probab=97.73 E-value=0.00012 Score=76.27 Aligned_cols=80 Identities=23% Similarity=0.352 Sum_probs=60.6
Q ss_pred cccccccccceeeeEe-----ecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEE
Q psy1672 263 YVEAVSSENATVVCRV-----DSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCV 337 (600)
Q Consensus 263 ~~~v~~G~~v~L~C~v-----~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~ 337 (600)
...+..|+.+.+.|.+ .|.|.+++.|+++|.... +.....++ ..|.|.++..+|+|.|+|+
T Consensus 35 ~~~~~~ge~~~l~C~~~~~~~~g~p~~~i~W~K~g~~~~---------~~~~~~~g-----~~l~i~~~~~~DsG~Y~C~ 100 (326)
T PHA02785 35 SFMELENEPVILPCPQINTLSSGYNILDILWEKRGADND---------RIIPIDNG-----SNMLILNPTQSDSGIYICI 100 (326)
T ss_pred hhhhhcCCCEEEECCCccccccCCCCceEEEEECCCccc---------eEEEccCC-----ceEEEcccCcccCeEEEEE
Confidence 3445579999999987 688889999999874211 12222233 2477999999999999999
Q ss_pred EecCCCceeEEEEEEEEEc
Q psy1672 338 AENRAGIADANFTLQVTYR 356 (600)
Q Consensus 338 a~N~~G~~~~~v~L~V~~~ 356 (600)
|.|..|....++.|.|...
T Consensus 101 a~N~~g~~~~s~~L~V~~~ 119 (326)
T PHA02785 101 TKNETYCDMMSLNLTIVSV 119 (326)
T ss_pred EECCCcceEEEEEEEEEec
Confidence 9999998888888888654
No 176
>cd05880 Ig_EVA1 Immunoglobulin (Ig)-like domain of epithelial V-like antigen 1 (EVA). Ig_EVA: immunoglobulin (Ig) domain of epithelial V-like antigen 1 (EVA). EVA is also known as myelin protein zero-like 2. EVA is an adhesion molecule, which may play a role in structural organization of the thymus and early lymphocyte development.
Probab=97.72 E-value=0.0001 Score=64.41 Aligned_cols=84 Identities=23% Similarity=0.440 Sum_probs=52.1
Q ss_pred ccccccccccccceeeeEeecCC----CCeeEEEEc----Cee--cc---CCcc---cCcc-ceEEEeeCCceeeeeeEE
Q psy1672 260 DSRYVEAVSSENATVVCRVDSIP----PAAISWYWN----GRL--LL---NNTA---FSSY-QRIFVIEQGEYERKSSLV 322 (600)
Q Consensus 260 ~~~~~~v~~G~~v~L~C~v~g~P----~p~i~W~~~----g~~--l~---~~~~---~~~~-~~~~~~~~g~~~~~s~L~ 322 (600)
.+..+++..|++++|.|.....+ ...|.|++. +.. +. .... ...+ .|+.+..+ ......+|.
T Consensus 4 ~~~~v~~~~G~~v~L~C~~s~~~~~~~~~~i~W~~~~~~~~~~~~v~~~~~~~~~~~~~~f~~R~~~~~~-~~~~~~sL~ 82 (115)
T cd05880 4 TSKEVEAVNGTDVRLKCTFSSSAPIGDTLVITWNFRPLDGGREESVFYYHKRPYPPPDGRFKGRVVWDGN-IMRRDASIL 82 (115)
T ss_pred cCceEEEEcCCCEEEEEEEEeCCCCCCcEEEEEEEECCCCCceeEEEEECCCccccCcccccCeEEEecC-CcCCceEEE
Confidence 35678889999999999886433 236999862 111 10 0000 0000 12221111 112356799
Q ss_pred EecCCCCCCeEEEEEEecCCCc
Q psy1672 323 LTNAQESDSGRFYCVAENRAGI 344 (600)
Q Consensus 323 I~~v~~~d~G~Y~C~a~N~~G~ 344 (600)
|.+++.+|+|.|+|.+.|..+.
T Consensus 83 I~~v~~~D~G~Y~C~v~~~~~~ 104 (115)
T cd05880 83 IWQLQPTDNGTYTCQVKNPPDV 104 (115)
T ss_pred EeeCChhhCEEEEEEEEeCCCC
Confidence 9999999999999999998764
No 177
>KOG4658|consensus
Probab=97.71 E-value=3e-05 Score=90.15 Aligned_cols=140 Identities=21% Similarity=0.260 Sum_probs=105.6
Q ss_pred cCCCCCccCCCCCCCCceEEEeeCCC--CCCCChhhhcccCCCCccEEEeecc-cCcccCccccCCCCCccEEEccCCCC
Q psy1672 35 RDKFLITIPEAPESELTQVLDMSGNN--LQILPKEAFRRAGLLNLQKLFLARC-HIGQIDSGALDGLTNLIEIDLSDNLL 111 (600)
Q Consensus 35 ~~~~L~~ip~~~~~~~l~~L~Ls~n~--L~~l~~~~f~~~~l~~L~~L~L~~n-~l~~i~~~~f~~l~~L~~L~Ls~N~l 111 (600)
.+.....++.......+++|-+..|. +..++...|. .++.|+.|+|++| .+..+ |..++.|.+|++|+|++..+
T Consensus 531 ~~~~~~~~~~~~~~~~L~tLll~~n~~~l~~is~~ff~--~m~~LrVLDLs~~~~l~~L-P~~I~~Li~LryL~L~~t~I 607 (889)
T KOG4658|consen 531 MNNKIEHIAGSSENPKLRTLLLQRNSDWLLEISGEFFR--SLPLLRVLDLSGNSSLSKL-PSSIGELVHLRYLDLSDTGI 607 (889)
T ss_pred eccchhhccCCCCCCccceEEEeecchhhhhcCHHHHh--hCcceEEEECCCCCccCcC-ChHHhhhhhhhcccccCCCc
Confidence 34555566655554459999999997 8889988887 8999999999987 55666 55689999999999999999
Q ss_pred CCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCc--CcccChhhhcCCCCCCEEEc
Q psy1672 112 TSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESR--LEHISPEAFTGAKSLESIKL 178 (600)
Q Consensus 112 ~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~--l~~i~~~~~~~l~~L~~L~L 178 (600)
..+|. .+.++..|.+|++..+......+.....+.+|+.|.+.... .....-..+.++.+|+.|..
T Consensus 608 ~~LP~-~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 608 SHLPS-GLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred cccch-HHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence 99998 68899999999999887555556777779999999886543 22222233344555555544
No 178
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.67 E-value=3.9e-05 Score=54.44 Aligned_cols=37 Identities=32% Similarity=0.496 Sum_probs=14.7
Q ss_pred CccEEEeecccCcccCccccCCCCCccEEEccCCCCCC
Q psy1672 76 NLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTS 113 (600)
Q Consensus 76 ~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~ 113 (600)
+|++|+|++|+|+.+++ .|.+|++|++|++++|.|++
T Consensus 2 ~L~~L~l~~N~i~~l~~-~l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPP-ELSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp T-SEEEETSSS-SSHGG-HGTTCTTSSEEEETSSCCSB
T ss_pred cceEEEccCCCCcccCc-hHhCCCCCCEEEecCCCCCC
Confidence 34444444444444432 23444444444444444443
No 179
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.66 E-value=3.6e-05 Score=54.57 Aligned_cols=39 Identities=46% Similarity=0.718 Sum_probs=25.3
Q ss_pred CCccEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCcc
Q psy1672 99 TNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKI 138 (600)
Q Consensus 99 ~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l 138 (600)
++|++|+|++|+|+.+++ .+..+++|+.|++++|+|+.+
T Consensus 1 ~~L~~L~l~~N~i~~l~~-~l~~l~~L~~L~l~~N~i~~i 39 (44)
T PF12799_consen 1 KNLEELDLSNNQITDLPP-ELSNLPNLETLNLSNNPISDI 39 (44)
T ss_dssp TT-SEEEETSSS-SSHGG-HGTTCTTSSEEEETSSCCSBE
T ss_pred CcceEEEccCCCCcccCc-hHhCCCCCCEEEecCCCCCCC
Confidence 356777777777777665 466777777777777776654
No 180
>KOG4221|consensus
Probab=97.66 E-value=3.1e-05 Score=88.48 Aligned_cols=91 Identities=29% Similarity=0.456 Sum_probs=73.6
Q ss_pred ccccccccccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeE
Q psy1672 254 KPEIRMDSRYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGR 333 (600)
Q Consensus 254 ~p~i~~~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~ 333 (600)
.|.+...+..+.+.++.++.+.|.+.|.|.|.+.|+++|..+.... .+++..++ .|.|.-+-..|.|.
T Consensus 328 ~P~~~~~p~~l~A~e~~die~ec~~~g~p~p~v~w~kNgd~~ipsd------y~ki~~~~------~lrIlgi~~sdeg~ 395 (1381)
T KOG4221|consen 328 PPGFTKAPTTLVAHESMDIEFECPVSGKPIPTVRWYKNGDRIIPSD------YFKIVGGG------NLRILGIVKSDEGF 395 (1381)
T ss_pred CCCCCCCCcceeeeeccceeEeCCCCCCCcceEEEEecCcccCccc------ceEecCCC------CcEEEEEecccchh
Confidence 4666666778888899999999999999999999999998766532 23333333 47888888899999
Q ss_pred EEEEEecCCCceeEEEEEEEEEc
Q psy1672 334 FYCVAENRAGIADANFTLQVTYR 356 (600)
Q Consensus 334 Y~C~a~N~~G~~~~~v~L~V~~~ 356 (600)
|+|+++|.+|.+.+.+.+.+...
T Consensus 396 yQcvaen~~G~a~a~a~l~vv~~ 418 (1381)
T KOG4221|consen 396 YQCVAENDAGSAQAAAQLEVVPQ 418 (1381)
T ss_pred hhhhhccCcccccchhhheeccC
Confidence 99999999999999998877554
No 181
>cd00098 IgC Immunoglobulin Constant domain. IgC: Immunoglobulin constant domain (IgC). Members of the IgC family are components of immunoglobulin, T-cell receptors, CD1 cell surface glycoproteins, secretory glycoproteins A/C, and Major Histocompatibility Complex (MHC) class I/II molecules. In immunoglobulins, each chain is composed of one variable domain (IgV) and one or more IgC domains. These names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. The IgV domain is responsible for antigen binding, and the IgC domain is involved in oligomerization and molecular interactions.
Probab=97.65 E-value=0.00016 Score=60.40 Aligned_cols=75 Identities=19% Similarity=0.385 Sum_probs=55.9
Q ss_pred cccccceeeeEeecC-CC-CeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCc
Q psy1672 267 VSSENATVVCRVDSI-PP-AAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGI 344 (600)
Q Consensus 267 ~~G~~v~L~C~v~g~-P~-p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~ 344 (600)
..|+.++|.|.+.|. |. .+|+|+++|..+..... ........++.+...+.|.+......+.+.|+|.|.+....
T Consensus 11 ~~~~~~~L~C~a~g~~P~~~~i~W~~~g~~~~~~~~---~~~~~~~~~gt~~~~s~l~v~~~~~~~~~~y~C~v~h~~~~ 87 (95)
T cd00098 11 LLGGSVTLTCLATGFYPPDITVTWLKNGKELTSGVT---TTPPVPNSDGTYSVSSQLTVSPSDWNSGDTYTCVVTHESLP 87 (95)
T ss_pred HcCCCeEEEEEEeeEECCCcEEEEEECCEECCCcee---ccccccCCCCCEEEEEEEEECHHHhCCCCCEEEEEEeCCCC
Confidence 468899999999987 53 58999999988764431 12233345566677778888777777899999999998654
No 182
>cd05883 Ig2_Necl-2 Second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig2_Necl-2: second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Nectin-like molecules (Necls) have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is expressed in a wide variety of tissues, and is a putative tumour suppressor gene, which is downregulated in aggressive neuroblastoma. Ig domains are likely to participate in ligand binding and recognition.
Probab=97.65 E-value=0.00056 Score=55.45 Aligned_cols=77 Identities=22% Similarity=0.379 Sum_probs=50.2
Q ss_pred ceeeeEee-cCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCe-EEEEEEecCCCc-eeEE
Q psy1672 272 ATVVCRVD-SIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSG-RFYCVAENRAGI-ADAN 348 (600)
Q Consensus 272 v~L~C~v~-g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G-~Y~C~a~N~~G~-~~~~ 348 (600)
+.|.|.+. +.|.++|.|+++++.+..... ......+.+...+.|.+. ++.+|.| .|+|.|.|+.-. .+..
T Consensus 2 ~~L~C~s~gSkP~A~I~W~k~~~~l~~~~~------~~~~~~~~~t~~S~L~~~-p~~eDdG~~~~C~a~~~~l~~~~~~ 74 (82)
T cd05883 2 IELNCTAMASKPAATIRWFKGNKELTGKST------VEETWSRMFTVTSQLMLK-VTKEDDGVPVICLVDHPAVKDLQTQ 74 (82)
T ss_pred EEEEEEecCCCCCCEEEEEECCEECcCccc------ceeccCCCcEEEEEEEEE-CchhhCCCEEEEEEcCcccCCceee
Confidence 57899998 578899999999988865321 011122234455677774 4555555 899999997632 3555
Q ss_pred EEEEEEE
Q psy1672 349 FTLQVTY 355 (600)
Q Consensus 349 v~L~V~~ 355 (600)
+.|.|.+
T Consensus 75 ~~L~V~y 81 (82)
T cd05883 75 RYLEVQY 81 (82)
T ss_pred EEEEEEE
Confidence 6666643
No 183
>KOG1909|consensus
Probab=97.64 E-value=9.5e-06 Score=81.61 Aligned_cols=160 Identities=21% Similarity=0.217 Sum_probs=118.8
Q ss_pred CCceEEEeeCCCCCCCChhh-----hc------ccCCCCccEEEeecccCcccC----ccccCCCCCccEEEccCCCCCC
Q psy1672 49 ELTQVLDMSGNNLQILPKEA-----FR------RAGLLNLQKLFLARCHIGQID----SGALDGLTNLIEIDLSDNLLTS 113 (600)
Q Consensus 49 ~~l~~L~Ls~n~L~~l~~~~-----f~------~~~l~~L~~L~L~~n~l~~i~----~~~f~~l~~L~~L~Ls~N~l~~ 113 (600)
..|++|.|.+|.+...--.. |. .+.-++|+.+...+|++..-. ..+|...+.|+.+.++.|.|..
T Consensus 120 ~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~ 199 (382)
T KOG1909|consen 120 TDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRP 199 (382)
T ss_pred cCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccC
Confidence 34999999999987322211 11 135679999999999986543 3457777899999999998863
Q ss_pred C----CccccCCCCCCCEEEccCCCCCccC----cccccCCCCcceeeCCCCcCcccChhhh-----cCCCCCCEEEcCC
Q psy1672 114 I----PSLTFQSVRFLRDLNLARNPISKIE----KGAFQFVPGLVKLDMSESRLEHISPEAF-----TGAKSLESIKLNG 180 (600)
Q Consensus 114 l----~~~~f~~l~~L~~L~Ls~N~i~~l~----~~~~~~l~~L~~L~Ls~n~l~~i~~~~~-----~~l~~L~~L~Ls~ 180 (600)
- -...|..+++|+.|+|.+|.++.-. ..++..+++|+.|++++|.+..-...+| ...++|+.|.|.+
T Consensus 200 eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~g 279 (382)
T KOG1909|consen 200 EGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAG 279 (382)
T ss_pred chhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCc
Confidence 2 2235778999999999999887532 2456678899999999999987654443 2478999999999
Q ss_pred CcCCCCC----cccccccccccEEEccCCcCc
Q psy1672 181 NRLSHFP----VRSVEPLLKLMMIELHDNPWV 208 (600)
Q Consensus 181 N~l~~l~----~~~~~~l~~L~~L~l~~N~~~ 208 (600)
|.|+.-. .......+.|..|+|.+|.+-
T Consensus 280 NeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 280 NEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred chhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 9998532 123344678999999999983
No 184
>cd05899 IgV_TCR_beta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) bet a chain. IgV_TCR_beta: immunoglobulin (Ig) variable domain of the beta chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group includes the variable domain of the alpha chain of alpha/beta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=97.63 E-value=0.00014 Score=62.90 Aligned_cols=81 Identities=21% Similarity=0.327 Sum_probs=53.4
Q ss_pred ccccccccccccceeeeEeecCCCCeeEEEEcC--eeccCC------c--c--cCccceEEEeeCCceeeeeeEEEecCC
Q psy1672 260 DSRYVEAVSSENATVVCRVDSIPPAAISWYWNG--RLLLNN------T--A--FSSYQRIFVIEQGEYERKSSLVLTNAQ 327 (600)
Q Consensus 260 ~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g--~~l~~~------~--~--~~~~~~~~~~~~g~~~~~s~L~I~~v~ 327 (600)
.+..+.+.+|++++|.|.+.+ +.+.+.|++.. +.+..- . . .....+....... .....|.|.+++
T Consensus 4 ~p~~~~v~~G~~v~l~C~~~~-~~~~v~Wykq~~g~~~~~l~~~~~~~~~~~~~~~~~r~~~~~~~--~~~~~L~I~~~~ 80 (110)
T cd05899 4 SPRYLIKGRGQSVTLRCSQTS-GHDNMYWYRQDPGKGLQLLFYSNGGSLNEEEGDPKDRFSASRPS--LTRSSLTIKSAE 80 (110)
T ss_pred CCCceEEcCCCcEEEEEEECC-CCCEEEEEEECCCCCcEEEEEEcCCCceEecCccCCceEEECcC--CCccEEEECCCC
Confidence 456788899999999999987 67889999942 211100 0 0 0001222222211 134589999999
Q ss_pred CCCCeEEEEEEecCCC
Q psy1672 328 ESDSGRFYCVAENRAG 343 (600)
Q Consensus 328 ~~d~G~Y~C~a~N~~G 343 (600)
.+|+|.|.|.+.+..+
T Consensus 81 ~~Dsg~Y~Ca~~~~~~ 96 (110)
T cd05899 81 PEDSAVYLCASSLGGG 96 (110)
T ss_pred hhhCEEEEEEeeCCCC
Confidence 9999999999987643
No 185
>cd05901 Ig_Versican Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. Ig_Versican: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Like aggrecan, versican has a wide distribution in connective tissue and extracellular matrices. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA
Probab=97.62 E-value=0.00056 Score=59.38 Aligned_cols=86 Identities=21% Similarity=0.295 Sum_probs=56.0
Q ss_pred cccceeeeEeecCC-----------CCeeEEEEcC-----eeccCCcc----------c-CccceEEEeeCCceeeeeeE
Q psy1672 269 SENATVVCRVDSIP-----------PAAISWYWNG-----RLLLNNTA----------F-SSYQRIFVIEQGEYERKSSL 321 (600)
Q Consensus 269 G~~v~L~C~v~g~P-----------~p~i~W~~~g-----~~l~~~~~----------~-~~~~~~~~~~~g~~~~~s~L 321 (600)
|++++|.|.....| ...|.|++-. +....... . .-.+|+.+..+.......+|
T Consensus 2 ~g~v~LPC~f~~~p~~p~~~~~~~~~~rIkW~~~~~~~~g~~~~e~~Vlv~~~g~~~~~~~y~gRv~l~~~~~~~g~asL 81 (117)
T cd05901 2 SGSVVLPCRFSTLPTLPPSVITTSEFLRIKWTKIEVDKNGKDHKETTVLVAQNGIIKIGQEYMGRVSVPSHPEDQGDASL 81 (117)
T ss_pred CCCEEEeeEEEecCCCCCcccCCCCCcEEEEEEecccccccCCCccEEEEEECCEEEECCcccCcEEeeccCCcCCceEE
Confidence 67899999988443 2379998731 11000000 0 00123333322212235789
Q ss_pred EEecCCCCCCeEEEEEEecCCCceeEEEEEEEE
Q psy1672 322 VLTNAQESDSGRFYCVAENRAGIADANFTLQVT 354 (600)
Q Consensus 322 ~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L~V~ 354 (600)
.|.+++.+|+|.|.|.+.+.....+..+.|.|.
T Consensus 82 ~i~~v~~sD~G~Y~C~V~~g~~~~~~~v~L~V~ 114 (117)
T cd05901 82 TIVKLRASDAGVYRCEVMHGIEDTQDTVSLDVS 114 (117)
T ss_pred EEcccccccCEEEEEEEEECCcccEEEEEEEEE
Confidence 999999999999999999999888888888884
No 186
>cd05715 Ig_P0-like Immunoglobulin (Ig)-like domain of Protein zero (P0) and similar proteins. Ig_P0ex-like: domain similar to the immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an extracellular Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin. This group also contains the Ig domain of Sodium channel subunit beta-2
Probab=97.61 E-value=0.00041 Score=60.63 Aligned_cols=83 Identities=20% Similarity=0.404 Sum_probs=52.1
Q ss_pred cccccccccccceeeeEeecCC----CCeeEEEEcCe------ecc---CCcc----cCcc-ceEEEeeCCceeeeeeEE
Q psy1672 261 SRYVEAVSSENATVVCRVDSIP----PAAISWYWNGR------LLL---NNTA----FSSY-QRIFVIEQGEYERKSSLV 322 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P----~p~i~W~~~g~------~l~---~~~~----~~~~-~~~~~~~~g~~~~~s~L~ 322 (600)
+..+.+..|+.++|.|...... ...|.|++... .+. .... .+.+ .|+.+..+ ......+|+
T Consensus 5 p~~v~v~~G~~vtL~C~~s~~~~~~~~~~v~W~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~R~~~~~~-~~~~~~sL~ 83 (116)
T cd05715 5 PREVYAVNGSDVRLKCTFSSSEPISDDISVTWSFQPEGSGDTESIFHYHKGPYYPLKDGRFKDRVEWVGN-PSRKDASIV 83 (116)
T ss_pred CCeEEEEcCCCeEEEeEEeCCCCcCCceEEEEEEecCCCCCcEEEEEEcCCccccccCccccCcEEEecC-CcCCeeEEE
Confidence 5667888999999999886432 24699987221 110 0000 0011 22222211 112346899
Q ss_pred EecCCCCCCeEEEEEEecCCCc
Q psy1672 323 LTNAQESDSGRFYCVAENRAGI 344 (600)
Q Consensus 323 I~~v~~~d~G~Y~C~a~N~~G~ 344 (600)
|.+++.+|+|.|.|.+.|..+.
T Consensus 84 I~~v~~~D~G~Y~C~v~~~~~~ 105 (116)
T cd05715 84 IHNLQFTDNGTYTCDVKNPPDI 105 (116)
T ss_pred EeeCCcccCEEEEEEEEeCCCC
Confidence 9999999999999999998764
No 187
>cd05775 Ig_SLAM-CD84_like_N N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. Ig_SLAM-CD84_like_N: The N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. The SLAM family is a group of immune-cell specific receptors that can regulate both adaptive and innate immune responses. Members of this group include proteins such as CD84, SLAM (CD150), Ly-9 (CD229), NTB-A (ly-108, SLAM6), 19A (CRACC), and SLAMF9. The genes coding for the SLAM family are nested on chromosome 1, in humans at 1q23, and in mice at 1H2. The SLAM family is a subset of the CD2 family, which also includes CD2 and CD58 located on chromosome 1 at 1p13 in humans. In mice, CD2 is located on chromosome 3, and there is no CD58 homolog. The SLAM family proteins are organized as an extracellular domain with either two or four Ig-like domains, a single transmembrane segment, and a cytoplasmic region
Probab=97.61 E-value=0.00022 Score=60.24 Aligned_cols=82 Identities=21% Similarity=0.414 Sum_probs=54.2
Q ss_pred cccccceeeeEeec-CCCCeeEEEEcCeeccCCcc---------c-Ccc-ceEEEeeCCceeeeeeEEEecCCCCCCeEE
Q psy1672 267 VSSENATVVCRVDS-IPPAAISWYWNGRLLLNNTA---------F-SSY-QRIFVIEQGEYERKSSLVLTNAQESDSGRF 334 (600)
Q Consensus 267 ~~G~~v~L~C~v~g-~P~p~i~W~~~g~~l~~~~~---------~-~~~-~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y 334 (600)
..|++|+|.|.... .....+.|++....+..... + +.+ .|+.+.. ...+|+|.+++.+|+|.|
T Consensus 2 ~~G~sVtL~c~~~~~~~~~~v~W~~~~~~~i~~~~~~~~~~~~~~~~~f~~R~~~~~-----~~~sL~I~~~~~~DsG~Y 76 (97)
T cd05775 2 ILGGSVTLPLNIPDGTEIESITWSFNTSLAIITPGEETAPEIIVTDPSYKERVNFSQ-----NDYSLQISNLKMEDAGSY 76 (97)
T ss_pred ccCCeEEEeCCCCCCcEEEEEEEecCCEeEEEecCCCCCCccEEeCCCceeeEEecC-----CceeEEECCCchHHCEEE
Confidence 36999999998764 45568999986432211100 0 000 1222211 236899999999999999
Q ss_pred EEEEecCCCce-eEEEEEEE
Q psy1672 335 YCVAENRAGIA-DANFTLQV 353 (600)
Q Consensus 335 ~C~a~N~~G~~-~~~v~L~V 353 (600)
.|.+.+..|.. .+.+.|+|
T Consensus 77 ~c~v~~~~~~~~~~~f~L~v 96 (97)
T cd05775 77 RAEINTKNGVTITKEFTLHI 96 (97)
T ss_pred EEEEEcCCCCeEEEEEEEEe
Confidence 99999988765 66677765
No 188
>cd05886 Ig1_Nectin-1_like First immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111) and similar proteins. Ig1_Nectin-1_like: domain similar to the first immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111). Nectin-1 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. In addition nectins heterophilically trans-interact with other CAMs such as nectin-like molecules (Necls), nectin-1 for example, has been shown to trans-interact with Necl-1. Nectins also interact with various other proteins, including the actin filament (F-actin)-binding protein, afadin. Mutation in the human nectin-1 gene is
Probab=97.60 E-value=0.00033 Score=59.24 Aligned_cols=81 Identities=16% Similarity=0.340 Sum_probs=51.5
Q ss_pred cceeeeEeecC-CC---CeeEEEEcC--e--ec--cCC----cccC-ccceEEEeeCCceeeeeeEEEecCCCCCCeEEE
Q psy1672 271 NATVVCRVDSI-PP---AAISWYWNG--R--LL--LNN----TAFS-SYQRIFVIEQGEYERKSSLVLTNAQESDSGRFY 335 (600)
Q Consensus 271 ~v~L~C~v~g~-P~---p~i~W~~~g--~--~l--~~~----~~~~-~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~ 335 (600)
.++|.|..... |. ..|.|.+.. . .+ ... ...+ ...|+.+... ...+++|.|.+++.+|+|.|+
T Consensus 2 ~v~L~C~f~~~~~~~~~~~V~W~k~~~~~~~~va~y~~~~g~~~~~~f~~Rv~f~~~--~~~daSi~i~nl~~~D~G~Y~ 79 (99)
T cd05886 2 DVVLHCSFINPLPPVKITQVTWQKLTNGSKQNVAIYNPSMGVSVLPPYRERVTFKNP--SFEDGTISLSRLELEDEGVYI 79 (99)
T ss_pred cEEEEeEeecCCCCCCeEEEEEEECCCCCceEEEEECCcCCcccCccccCcEEEcCC--CCCcceEEEcCCccccCEEEE
Confidence 57899988742 22 268998831 1 11 000 0000 1123333211 124679999999999999999
Q ss_pred EEEec-CCCceeEEEEEEE
Q psy1672 336 CVAEN-RAGIADANFTLQV 353 (600)
Q Consensus 336 C~a~N-~~G~~~~~v~L~V 353 (600)
|.+.| +.|..++.+.|.|
T Consensus 80 C~v~t~P~g~~~~~~~L~V 98 (99)
T cd05886 80 CEFATFPTGNRESQLNLTV 98 (99)
T ss_pred EEEEeCCCCCeEEEEEEEE
Confidence 99999 6788888888876
No 189
>cd05902 Ig_Neurocan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. Ig_Neurocan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Unlike aggrecan which is widely distributed in connective tissue and extracellular matrices, neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many differen
Probab=97.59 E-value=0.00039 Score=60.01 Aligned_cols=87 Identities=21% Similarity=0.206 Sum_probs=56.1
Q ss_pred ccccceeeeEeecCC-------CCeeEEEEc--Ceecc-------CC-c--cc-CccceEEEeeCCceeeeeeEEEecCC
Q psy1672 268 SSENATVVCRVDSIP-------PAAISWYWN--GRLLL-------NN-T--AF-SSYQRIFVIEQGEYERKSSLVLTNAQ 327 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P-------~p~i~W~~~--g~~l~-------~~-~--~~-~~~~~~~~~~~g~~~~~s~L~I~~v~ 327 (600)
.|+.++|.|...-.| .+.|.|.+. +.... .. . .. .-.+|+.+..+.......+|.|.+++
T Consensus 1 ~~~~v~LpC~~~~~p~~~~~~~~~~I~W~k~~~~~~~~~~~v~v~~~~~~~~~~~y~gRvsl~~~~~~~~~asL~i~nv~ 80 (110)
T cd05902 1 LSSSVLLPCVFTLPPSASSPPEGPRIKWTKLRPASGQKQRPVLVARDNVVRVAKAFQGRVSLPGYPKNRYNASLVLSRLR 80 (110)
T ss_pred CCCcEEEeeEEEcCccccCCCCCCEEEEEEeCCCCCceEEEEEECCCCcEEEchhcccEEEeecCCCCCceEEEEECCCC
Confidence 378899999866322 368999983 11000 00 0 00 11234444433222346799999999
Q ss_pred CCCCeEEEEEEecCCCceeEEEEEEEE
Q psy1672 328 ESDSGRFYCVAENRAGIADANFTLQVT 354 (600)
Q Consensus 328 ~~d~G~Y~C~a~N~~G~~~~~v~L~V~ 354 (600)
.+|+|.|.|.+.......+..+.|.|.
T Consensus 81 ~~D~G~Y~C~v~~g~~~~~~~v~L~V~ 107 (110)
T cd05902 81 YSDSGTYRCEVVLGINDEQDTVPLEVT 107 (110)
T ss_pred HHHCEEEEEEEEECCcccEEEEEEEEE
Confidence 999999999999977667788888774
No 190
>cd04980 IgV_L_kappa Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. IgV_L_kappa: Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=97.58 E-value=0.00027 Score=60.64 Aligned_cols=81 Identities=17% Similarity=0.351 Sum_probs=52.2
Q ss_pred ccccccccccccccceeeeEeecCC-CCeeEEEEc--Cee---cc-CC--cccCccceEEEeeCCceeeeeeEEEecCCC
Q psy1672 258 RMDSRYVEAVSSENATVVCRVDSIP-PAAISWYWN--GRL---LL-NN--TAFSSYQRIFVIEQGEYERKSSLVLTNAQE 328 (600)
Q Consensus 258 ~~~~~~~~v~~G~~v~L~C~v~g~P-~p~i~W~~~--g~~---l~-~~--~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~ 328 (600)
...+..+.+.+|+.++|.|.+.+.. ...+.|++. |+. +. .. .......+.....+ .....|.|.+++.
T Consensus 4 ~Q~p~~~~v~~G~~v~L~C~~~~~~~~~~~~Wyrq~~g~~~~~l~~~~~~~~~~~~~r~~~~~~---~~~~~L~I~~~~~ 80 (106)
T cd04980 4 TQSPATLSVSPGESATISCKASQSVSSNYLAWYQQKPGQAPKLLIYGASTLASGTPSRFSGSGS---GTDFTLTISRVEP 80 (106)
T ss_pred EECCCcEEECCCCCEEEEEEECCCCCCCcEEEEEECCCCCcEEEEECccccCCCCCCCEEEecc---CCEEEEEECCCCh
Confidence 3446678889999999999997655 567999983 221 11 00 00001112222111 1345799999999
Q ss_pred CCCeEEEEEEecC
Q psy1672 329 SDSGRFYCVAENR 341 (600)
Q Consensus 329 ~d~G~Y~C~a~N~ 341 (600)
+|+|.|.|.+.+.
T Consensus 81 ~Dsg~Y~Ca~~~~ 93 (106)
T cd04980 81 EDAAVYYCQQYGT 93 (106)
T ss_pred HHCEEEEEEEeCC
Confidence 9999999998764
No 191
>cd05761 Ig2_Necl-1-4_like Second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-4 (also known as cell adhesion molecules CADM3, CADM1, CADM2, and CADM4, respectively). Ig2_Necl-1-4_like: domain similar to the second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), Necl-3 (CADM2) and Necl-4 (CADM4). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cel
Probab=97.52 E-value=0.00067 Score=55.25 Aligned_cols=69 Identities=19% Similarity=0.286 Sum_probs=46.8
Q ss_pred ceeeeEeec-CCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCce
Q psy1672 272 ATVVCRVDS-IPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIA 345 (600)
Q Consensus 272 v~L~C~v~g-~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~ 345 (600)
+.|.|.+.+ .|.++|.|+++++.+.... .......++.+...+.|.+......+.+.|+|.|.|.....
T Consensus 2 ~~L~C~~~~~~P~~~v~W~~~~~~l~~~~-----~~~~~~~~~~~~~~s~l~~~~~~~d~g~~~~C~v~h~~l~~ 71 (82)
T cd05761 2 VELTCTSSGSKPAATIRWFKGDKELKGVK-----LKEEDENGKTFTVTSSLRFQVDREDDGAPIICRVDHPALKS 71 (82)
T ss_pred EEEEEEecCcCcCCeEEEEECCEEccCce-----eeEecCCCCEEEEEEEEEEEcchhhCCCEEEEEEeChhcCC
Confidence 579999985 5889999999998875321 11111233445556677775555555569999999987653
No 192
>KOG4222|consensus
Probab=97.48 E-value=0.00017 Score=82.13 Aligned_cols=92 Identities=29% Similarity=0.450 Sum_probs=71.4
Q ss_pred ccccccccccccccceeeeEee-cCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEE
Q psy1672 258 RMDSRYVEAVSSENATVVCRVD-SIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYC 336 (600)
Q Consensus 258 ~~~~~~~~v~~G~~v~L~C~v~-g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C 336 (600)
...++.+.+..|+.+.|.|.-. |.|.|.+.|.++|+.+.... ..++.+...| .|.|.++..+|.|.|.|
T Consensus 135 rv~prd~~~a~ge~avlEcgpP~ghpeptvSw~Kdg~pl~~~~----~~~~~lisgG------~LlIsnvrksD~GtY~C 204 (1281)
T KOG4222|consen 135 RVSPRDVQAAVGEEAVLECGPPRGHPEPTVSWVKDGKPLDHYD----VPIIALISGG------NLLISNVRKSDEGTYAC 204 (1281)
T ss_pred ccCcccccccccceeEEeccCCCCCCCCcceeecCCCcccccc----ceeEEEecCC------cEEEeccccCCCceeee
Confidence 4445667788899999999765 89999999999999887221 2233344444 79999999999999999
Q ss_pred EEecCCCcee-EEEEEEEEEccCC
Q psy1672 337 VAENRAGIAD-ANFTLQVTYRGVG 359 (600)
Q Consensus 337 ~a~N~~G~~~-~~v~L~V~~~~~~ 359 (600)
+|.|.+|..+ ....|.|.+++..
T Consensus 205 VatNmvG~ReS~~A~lsv~e~P~f 228 (1281)
T KOG4222|consen 205 VATNMVGERESIPARLSVQEKPWF 228 (1281)
T ss_pred eecccccccccccceeeeccCCcc
Confidence 9999999864 4467777766543
No 193
>smart00082 LRRCT Leucine rich repeat C-terminal domain.
Probab=97.47 E-value=3.7e-05 Score=56.48 Aligned_cols=48 Identities=31% Similarity=0.828 Sum_probs=37.9
Q ss_pred CcCccccccccchhhhcccCCCC--CCCCCCCCccccccccccccccccCc
Q psy1672 205 NPWVCDCNMRSIKMWLADKKNVP--VQPACTGPERLSGKVFSDLHADDFAC 253 (600)
Q Consensus 205 N~~~C~C~l~~l~~w~~~~~~~~--~~~~C~~p~~l~g~~l~~l~~~~~~C 253 (600)
|||.|||++.||..|+.+...+. ..+.|..|..+. ..+.++..+++.|
T Consensus 1 NP~~CdC~l~~~~~w~~~~~~~~~~~~~~C~~P~~~~-~~l~~~~~~~~~C 50 (51)
T smart00082 1 NPFICDCELRWLLRWLQANEHLQDPVSLRCASPSSLR-GPLLELLHSEFKC 50 (51)
T ss_pred CCccCcCCchHHHHHHHhCCccCCCCCCEeCCcHHHH-hHHHcCCHhhCCC
Confidence 89999999999999998633322 468999999988 5577777767776
No 194
>KOG2982|consensus
Probab=97.42 E-value=7.9e-05 Score=73.54 Aligned_cols=109 Identities=21% Similarity=0.229 Sum_probs=60.0
Q ss_pred ceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCc--cccCCCCCccEEEccCCCCCCCCccccCCCCCCCEE
Q psy1672 51 TQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDS--GALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDL 128 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~--~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L 128 (600)
++.|-+.++.|..+.....-......++.|+|.+|.|+.... ..+.+|+.|+.|+|+.|.+.......-..+.+|+.|
T Consensus 47 ~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~l 126 (418)
T KOG2982|consen 47 LELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVL 126 (418)
T ss_pred hhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEE
Confidence 445666666665443322111245667777777777654422 224567777777777777664332111245567777
Q ss_pred EccCCCCCccCc-ccccCCCCcceeeCCCCcC
Q psy1672 129 NLARNPISKIEK-GAFQFVPGLVKLDMSESRL 159 (600)
Q Consensus 129 ~Ls~N~i~~l~~-~~~~~l~~L~~L~Ls~n~l 159 (600)
.|.+..+.+... ..+..++.+++|+++.|.+
T Consensus 127 VLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~ 158 (418)
T KOG2982|consen 127 VLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL 158 (418)
T ss_pred EEcCCCCChhhhhhhhhcchhhhhhhhccchh
Confidence 776666544332 2344566666666666633
No 195
>cd00099 IgV Immunoglobulin variable domain (IgV). IgV: Immunoglobulin variable domain (IgV). Members of the IgV family are components of immunoglobulin (Ig) and T cell receptors. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. Within the variable domain, there are regions of even more variability called the hypervariable or complementarity-determining regions (CDRs) which are responsible for antigen binding. A predominant feature of most Ig domains is the disulfide bridge connecting 2 beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=97.40 E-value=0.00039 Score=59.20 Aligned_cols=78 Identities=21% Similarity=0.313 Sum_probs=51.4
Q ss_pred cccccccceeeeEeecC-CCCeeEEEEcCe--e---ccC--Cc----ccCccceEEEeeCCceeeeeeEEEecCCCCCCe
Q psy1672 265 EAVSSENATVVCRVDSI-PPAAISWYWNGR--L---LLN--NT----AFSSYQRIFVIEQGEYERKSSLVLTNAQESDSG 332 (600)
Q Consensus 265 ~v~~G~~v~L~C~v~g~-P~p~i~W~~~g~--~---l~~--~~----~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G 332 (600)
.+..|+.++|.|.+.+. +...+.|++... . +.. .. ......+..+..+. ......|+|.+++.+|+|
T Consensus 2 ~v~~G~~v~L~C~~~~~~~~~~v~W~k~~~~~~~~~i~~~~~~~~~~~~~~~~r~~~~~~~-~~~~~sL~I~~v~~~D~G 80 (105)
T cd00099 2 SVSEGESVTLSCTYSGSFSSYYIFWYRQKPGKGPELLIYISSNGSQYAGGVKGRFSGTRDS-SKSSFTLTISSLQPEDSA 80 (105)
T ss_pred eecCCCCEEEEEEEeCCcCcceEEEEEECCCCCCEEEEEEeCCCCccCccCCCcEEEEEec-cCCEEEEEECCCCHHHCE
Confidence 56789999999999876 667899998332 1 100 00 00111233332222 113468999999999999
Q ss_pred EEEEEEecCCC
Q psy1672 333 RFYCVAENRAG 343 (600)
Q Consensus 333 ~Y~C~a~N~~G 343 (600)
.|.|.+.+..+
T Consensus 81 ~Y~C~v~~~~~ 91 (105)
T cd00099 81 VYYCAVSLSGG 91 (105)
T ss_pred EEEEEEecCCC
Confidence 99999998765
No 196
>cd04984 IgV_L_lambda Immunoglobulin (Ig) lambda light chain variable (V) domain. IgV_L_lambda: Immunoglobulin (Ig) light chain, lambda type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=97.40 E-value=0.00074 Score=56.96 Aligned_cols=74 Identities=22% Similarity=0.365 Sum_probs=47.7
Q ss_pred cccccccceeeeEeecC--CCCeeEEEEc--CeeccC----C--cccCccceEEEeeCCceeeeeeEEEecCCCCCCeEE
Q psy1672 265 EAVSSENATVVCRVDSI--PPAAISWYWN--GRLLLN----N--TAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRF 334 (600)
Q Consensus 265 ~v~~G~~v~L~C~v~g~--P~p~i~W~~~--g~~l~~----~--~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y 334 (600)
.+..|++++|.|.+.+. ....+.|++. ++.... . .......+.....++ ....|+|.+++.+|+|.|
T Consensus 2 ~v~~G~~v~l~C~~~~~~~~~~~i~Wy~q~~g~~~~~l~~~~~~~~~~~~~rf~~~~~~---~~~~L~I~~~~~~Dsg~Y 78 (98)
T cd04984 2 SVSPGETVTITCTGSSGNISGNYVNWYQQKPGSAPRYLIYEDSDRPSGIPDRFSGSKSG---NTASLTISGAQTEDEADY 78 (98)
T ss_pred ccCCCCCEEEEEEEcCCCcCCCCEEEEEECCCCCccEEEEeccccCCCCCCCEEEEccC---CEEEEEECCCChhhCEEE
Confidence 57789999999998765 4567999983 221110 0 000011233322222 345799999999999999
Q ss_pred EEEEecC
Q psy1672 335 YCVAENR 341 (600)
Q Consensus 335 ~C~a~N~ 341 (600)
.|.+.+.
T Consensus 79 ~C~~~~~ 85 (98)
T cd04984 79 YCQVWDS 85 (98)
T ss_pred EEEEccC
Confidence 9998753
No 197
>KOG3665|consensus
Probab=97.38 E-value=9.7e-05 Score=83.77 Aligned_cols=132 Identities=20% Similarity=0.200 Sum_probs=95.3
Q ss_pred CceEEEeeCCCCC--CCChhhhcccCCCCccEEEeecccCcccC-ccccCCCCCccEEEccCCCCCCCCccccCCCCCCC
Q psy1672 50 LTQVLDMSGNNLQ--ILPKEAFRRAGLLNLQKLFLARCHIGQID-SGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLR 126 (600)
Q Consensus 50 ~l~~L~Ls~n~L~--~l~~~~f~~~~l~~L~~L~L~~n~l~~i~-~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~ 126 (600)
+|+.|++++...- ..+..... -+++|+.|.+.+-.+..-+ ...+..+++|..||+|+.+++.+. .++.|++|+
T Consensus 123 nL~~LdI~G~~~~s~~W~~kig~--~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl~--GIS~LknLq 198 (699)
T KOG3665|consen 123 NLQHLDISGSELFSNGWPKKIGT--MLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNLS--GISRLKNLQ 198 (699)
T ss_pred hhhhcCccccchhhccHHHHHhh--hCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCcH--HHhccccHH
Confidence 4889999987743 55656655 7999999999887653321 233568899999999999999883 478899999
Q ss_pred EEEccCCCCCcc-CcccccCCCCcceeeCCCCcCcccC------hhhhcCCCCCCEEEcCCCcCCC
Q psy1672 127 DLNLARNPISKI-EKGAFQFVPGLVKLDMSESRLEHIS------PEAFTGAKSLESIKLNGNRLSH 185 (600)
Q Consensus 127 ~L~Ls~N~i~~l-~~~~~~~l~~L~~L~Ls~n~l~~i~------~~~~~~l~~L~~L~Ls~N~l~~ 185 (600)
.|.+.+=.+..- .-..+.+|++|+.||+|........ -+....+++|+.||.+++.+..
T Consensus 199 ~L~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~~ 264 (699)
T KOG3665|consen 199 VLSMRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDINE 264 (699)
T ss_pred HHhccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcchhH
Confidence 998877665542 1134567999999999876544332 1223458999999999876653
No 198
>cd07705 Ig2_Necl-1 Second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig2_Necl-1: second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue and is important to the formation of synapses, axon bundles, and myel
Probab=97.37 E-value=0.0015 Score=53.31 Aligned_cols=69 Identities=17% Similarity=0.277 Sum_probs=47.8
Q ss_pred ceeeeEeec-CCCCeeEEEEcCeeccCCcccCccceEEEeeC-CceeeeeeEEEecCCCCCCeEEEEEEecCCCce
Q psy1672 272 ATVVCRVDS-IPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQ-GEYERKSSLVLTNAQESDSGRFYCVAENRAGIA 345 (600)
Q Consensus 272 v~L~C~v~g-~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~-g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~ 345 (600)
+.|.|.+.+ .|.+.|.|+++|+.+.... ..+....+ +.+...+.|.+......+...|+|.|.+.....
T Consensus 2 ~~LtC~a~g~~P~~~ItW~k~g~~l~~~~-----~~~~~~~~~~t~~~~s~l~~~~~~~d~g~~~tC~v~h~~l~~ 72 (83)
T cd07705 2 AKLRCTSSGSKPAANIKWRKGDQELEGAP-----TSVLEDGNGKTFTVSSSVEFQVTREDDGAEITCSVGHESLHD 72 (83)
T ss_pred EEEEEEecCccCCCEeEEEECCEECCCcc-----eeEEECCCCCEEEEEEEEEEEecchhCCCEEEEEEECcccCC
Confidence 579999995 5889999999998875432 12222223 345556777776555666679999999987544
No 199
>PF07686 V-set: Immunoglobulin V-set domain; InterPro: IPR013106 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the V-set domains, which are Ig-like domains resembling the antibody variable domain. V-set domains are found in diverse protein families, including immunoglobulin light and heavy chains; in several T-cell receptors such as CD2 (Cluster of Differentiation 2), CD4, CD80, and CD86; in myelin membrane adhesion molecules; in junction adhesion molecules (JAM); in tyrosine-protein kinase receptors; and in the programmed cell death protein 1 (PD1).; PDB: 1PY9_A 2NXY_D 1U9K_B 3RNK_A 3BP6_A 3BIK_B 3SBW_A 1NPU_A 3BP5_A 3RNQ_A ....
Probab=97.37 E-value=0.00041 Score=59.60 Aligned_cols=93 Identities=24% Similarity=0.367 Sum_probs=56.7
Q ss_pred ccccccccccccceeeeEee-cCCCCeeEEEEcCe-----ecc--CCc------ccCccceEEEeeCCceeeeeeEEEec
Q psy1672 260 DSRYVEAVSSENATVVCRVD-SIPPAAISWYWNGR-----LLL--NNT------AFSSYQRIFVIEQGEYERKSSLVLTN 325 (600)
Q Consensus 260 ~~~~~~v~~G~~v~L~C~v~-g~P~p~i~W~~~g~-----~l~--~~~------~~~~~~~~~~~~~g~~~~~s~L~I~~ 325 (600)
.+..+.+..|+.+.|.|... ......+.|++... .+. ... ......+..+..+.. .....|.|.+
T Consensus 7 ~~~~v~~~~G~~v~L~C~~~~~~~~~~v~W~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~r~~~~~~~~-~~~~sL~i~~ 85 (114)
T PF07686_consen 7 PPSPVTVQEGESVTLPCSYSSSSNQSSVYWYRQSPGQGPQLIIRYSLSSTNETPTPSYSGRFTFSGNGS-QNNFSLTIKN 85 (114)
T ss_dssp EESEEEEETTSEEEEEEEEESSSSGSEEEEEEEETTSEEEEEEEEETTEEEEEEETTETTTEEEEEETT-TTEEEEEESS
T ss_pred eCCeEEEecCCCEEEEEEEeCCCCcceEEEEEECccccceeeeeeccceeeeccccceeeeeeeeeccc-CCeEEEEECC
Confidence 36678899999999999998 45566899999322 111 000 000011122222111 1245799999
Q ss_pred CCCCCCeEEEEEEecCC-CceeEEEEEEE
Q psy1672 326 AQESDSGRFYCVAENRA-GIADANFTLQV 353 (600)
Q Consensus 326 v~~~d~G~Y~C~a~N~~-G~~~~~v~L~V 353 (600)
++.+|+|.|.|.+.... ......+.|+|
T Consensus 86 l~~~DsG~Y~C~v~~~~~~~~~~~~~L~V 114 (114)
T PF07686_consen 86 LQPSDSGTYFCQVSTSNEQSFGNGTKLTV 114 (114)
T ss_dssp ESGGGEEEEEEEEEESSEEEEEEEEEEEE
T ss_pred CCcCcCEEEEEEEEECCCCEECCcEEEEC
Confidence 99999999999999872 22334444443
No 200
>cd05887 Ig1_Nectin-3_like First immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and similar proteins. Ig1_Nectin-3_like: domain similar to the first immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3). Nectin-3 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example, during spermatid development, the nectin-3,-2 trans-interaction is required for the formation of Sertoli cell-spermatid junctions in testis, and during morphogenesis of the ciliary body, the nectin-3,-1 trans-interaction is important for apex-apex adhesion between the pigment and non-pigment layers of the ciliary epithelia. Nectins also
Probab=97.33 E-value=0.0011 Score=55.70 Aligned_cols=82 Identities=22% Similarity=0.295 Sum_probs=52.1
Q ss_pred ccceeeeEeecC-CCCeeEEEEcC----eecc-CCccc-----Cc-cceEEEeeCCceeeeeeEEEecCCCCCCeEEEEE
Q psy1672 270 ENATVVCRVDSI-PPAAISWYWNG----RLLL-NNTAF-----SS-YQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCV 337 (600)
Q Consensus 270 ~~v~L~C~v~g~-P~p~i~W~~~g----~~l~-~~~~~-----~~-~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~ 337 (600)
++++|.|..... ....|+|.+.. ..+. ....+ +. ..|+.+... ...+++|.|.+++.+|+|.|+|.
T Consensus 1 ~~vtL~C~~~~~~~~~qV~W~k~~~~~~~~ia~y~~~~g~~~~~~y~~Rv~~~~~--~~~d~sl~i~nv~~~D~G~Y~C~ 78 (96)
T cd05887 1 KNVTLKCRIQVNETITQSSWEKIHGKGSVTLAVHHPMYGISIQPDYQGRVSFKNY--SLLDATIMLENVGFSDIGVYICK 78 (96)
T ss_pred CCEEEEEEecCCCcEEEEEEEEcCCCCcEEEEEEcccCCcccChhhCCcEEEcCC--CCCccEEEEeCCCccccEEEEEE
Confidence 368899988732 33589998832 1111 00000 01 123433321 23467999999999999999999
Q ss_pred Eec-CCCceeEEEEEEE
Q psy1672 338 AEN-RAGIADANFTLQV 353 (600)
Q Consensus 338 a~N-~~G~~~~~v~L~V 353 (600)
+.+ +.|+.++++.|.|
T Consensus 79 v~tfP~G~~~~~~~l~~ 95 (96)
T cd05887 79 AVTFPLGNTQSSTTVTV 95 (96)
T ss_pred EEeCCCCCeeEEEEEEE
Confidence 764 6688888888876
No 201
>PF08205 C2-set_2: CD80-like C2-set immunoglobulin domain ; InterPro: IPR013162 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the C2-set type domains found in the T-cell antigen CD80, as well as in related proteins. CD80 (B7-1) is a glycoprotein expressed on antigen-presenting cells []. The shared ligands on CD80 and CD86 (B7-2) deliver the co-stimulatory signal through CD28 and CTLA-4 on T-cells, where CD28 augments the T-cell response and CTLA-4 attenuates it [].; PDB: 3S58_A 3O3U_N 3CJJ_A 3S59_A 2PF6_B 2PET_A 3ALP_A 3SKU_D 3U83_A 3U82_B ....
Probab=97.32 E-value=0.00093 Score=55.16 Aligned_cols=73 Identities=25% Similarity=0.464 Sum_probs=47.2
Q ss_pred cccceeeeEee-cCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCce
Q psy1672 269 SENATVVCRVD-SIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIA 345 (600)
Q Consensus 269 G~~v~L~C~v~-g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~ 345 (600)
|+.+.+.|.+. +.|.|.|.|+.++..+.... ........++.+...+.|.+......+...++|.|.+..-..
T Consensus 14 ~~~~~~~C~s~~~~P~~~i~W~~~~~~~~~~~----~~~~~~~~~~~~~~~S~l~~~~~~~~~~~~~~C~~~~~~~~~ 87 (89)
T PF08205_consen 14 GEEVTLTCSSSGGYPPPQITWYLDGGPVVASN----TTQSSSPDNGLFTVSSTLTLTPTREDHGKTLTCRASHPALSQ 87 (89)
T ss_dssp TEEEEEEEEEEEEBS-EEEEEEETTCEECEEE----EEEEEETTTTTEEEEEEEEEETTGGGTTEEEEEEEEETTCCE
T ss_pred ceEEEEEEEeCCeECCeEEEEEECCCceeeee----eeeeeccCCCcceEEEEEEEEcChHHCCeEEEEEEECCccCC
Confidence 77999999777 78999999999887661110 011112223334455678776555455568999999986443
No 202
>cd05884 Ig2_Necl-3 Second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig2_Necl-3: second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-3 has been shown to accumulate in tissues of the central and peripheral nervous system, where it is expressed in ependymal cells and myelinated axons. It is observed at the interface between the axon shaft and the myelin sheath. Ig domains are likely to participate in ligand binding and recognition.
Probab=97.30 E-value=0.0011 Score=54.05 Aligned_cols=69 Identities=16% Similarity=0.324 Sum_probs=46.9
Q ss_pred ceeeeEeec-CCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCc
Q psy1672 272 ATVVCRVDS-IPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGI 344 (600)
Q Consensus 272 v~L~C~v~g-~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~ 344 (600)
++|.|.+.| .|...|.|+++|+.+.... ........++++...+.|.+......+...|+|.|.+..-.
T Consensus 2 ~~LtC~a~gf~P~~~itW~kng~~l~~~~----~~~~~~~~~~t~~~~s~L~~~~~~~d~g~~ytC~v~h~~l~ 71 (83)
T cd05884 2 MQLTCKTSGSKPAADIRWFKNDKEIKDVK----YLKEEDANRKTFTVSSTLDFRVDRSDDGVAIICRVDHESLN 71 (83)
T ss_pred EEEEEEeCCccCCCEEEEEECCEECcCce----eeEeeCCCCCEEEEEEEEEEEcccccCCCEEEEEEechhcC
Confidence 579999985 6778999999999875432 11122223455566778888644444445899999998644
No 203
>cd05846 Ig1_MRC-OX-2_like First immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200) and similar proteins. Ig1_ MRC-OX-2_like: domain similar to the first immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200). MRC OX-2 is a membrane glycoprotein expressed in a variety of lymphoid and non-lymphoid cells in rats. It has a similar broad distribution pattern in humans. MRC OX-2 may regulate myeloid cell activity. The protein has an extracellular portion containing two Ig-like domains, a transmembrane portion, and a cytoplasmic portion.
Probab=97.29 E-value=0.0017 Score=54.65 Aligned_cols=83 Identities=17% Similarity=0.268 Sum_probs=50.9
Q ss_pred cccceeeeEeecCCC-CeeEEEEcCe----ecc-----CCcc-cCc-cceEEEeeCCceeeeeeEEEecCCCCCCeEEEE
Q psy1672 269 SENATVVCRVDSIPP-AAISWYWNGR----LLL-----NNTA-FSS-YQRIFVIEQGEYERKSSLVLTNAQESDSGRFYC 336 (600)
Q Consensus 269 G~~v~L~C~v~g~P~-p~i~W~~~g~----~l~-----~~~~-~~~-~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C 336 (600)
|++++|.|....... -.|.|++... .+. .... ... ..+..+... ....++|.|.+++.+|+|.|+|
T Consensus 1 G~~vtL~C~~~~~~~~~~v~W~k~~~~~~~~i~~~~~~~~~~~~~~~~~r~~~~~~--~~~~~sL~I~nv~~~D~G~Y~C 78 (97)
T cd05846 1 GGNVTLSCNLTLPEEVLQVTWQKIQGSSPENIATYSEKYGVKIQPSYFRRRSITSL--GLNSTSITIWNVTLEDEGCYKC 78 (97)
T ss_pred CCcEEEEEEeCCCCeeEEEEEEEcCCCCceEEEEEcccCCcccCCCccCeEEEcCC--CCCccEEEEeCCceeeeEEEEE
Confidence 688999998764332 3699998321 100 0000 001 112222211 1245789999999999999999
Q ss_pred EEec-CCCceeEEEEEEE
Q psy1672 337 VAEN-RAGIADANFTLQV 353 (600)
Q Consensus 337 ~a~N-~~G~~~~~v~L~V 353 (600)
.... +.|..+..+.|.|
T Consensus 79 ~~~~~p~g~~~~~~~L~v 96 (97)
T cd05846 79 IFNTFPDGSKSGTMCLTV 96 (97)
T ss_pred EEEeCCCCCeeeEEEEEE
Confidence 9875 5567777777766
No 204
>cd04982 IgV_TCR_gamma Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) gamma chain. IgV_TCR_gamma: immunoglobulin (Ig) variable (V) domain of the gamma chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=97.27 E-value=0.00073 Score=58.89 Aligned_cols=81 Identities=20% Similarity=0.388 Sum_probs=52.8
Q ss_pred ccccccccccccceeeeEeec--CCCCeeEEEEc--Ceecc------CCcc-----cCccceEEEeeCCceeeeeeEEEe
Q psy1672 260 DSRYVEAVSSENATVVCRVDS--IPPAAISWYWN--GRLLL------NNTA-----FSSYQRIFVIEQGEYERKSSLVLT 324 (600)
Q Consensus 260 ~~~~~~v~~G~~v~L~C~v~g--~P~p~i~W~~~--g~~l~------~~~~-----~~~~~~~~~~~~g~~~~~s~L~I~ 324 (600)
.+..+.+..|+.++|.|.+.+ .+.+.+.|++. +.... .... .....++.+..+.. .....|+|.
T Consensus 4 ~p~~~~~~~G~~v~l~C~~~~~~~~~~~v~Wyrq~~g~~~~~l~~~~~~~~~~~~~~~~~~r~~~~~~~~-~~~~~L~I~ 82 (116)
T cd04982 4 PQLSITREESKSVTISCKVSGIDFSTTYIHWYRQKPGQALERLLYVSSTSTQRKLSGGTKNKFEARKDVG-KSTSTLTIQ 82 (116)
T ss_pred cCCeEEeCCCCCEEEEEEEeCCCccccEEEEEEECCCCCCEEEEEEecCCCcEEeCcccCCCEEEEEECC-CCEEEEEEE
Confidence 456778899999999999987 67788999993 22110 0000 00112333322210 134579999
Q ss_pred cCCCCCCeEEEEEEecC
Q psy1672 325 NAQESDSGRFYCVAENR 341 (600)
Q Consensus 325 ~v~~~d~G~Y~C~a~N~ 341 (600)
+++.+|+|.|.|.+...
T Consensus 83 ~~~~~Dsg~Y~C~~~~~ 99 (116)
T cd04982 83 NLEKEDSATYYCAYWES 99 (116)
T ss_pred ECCHHHCEEEEEEEecC
Confidence 99999999999998753
No 205
>cd05771 IgC_Tapasin_R Tapasin-R immunoglobulin-like domain. IgC_Tapasin_R: Immunoglobulin-like domain on Tapasin-R. Tapasin is a V-C1 (variable-constant) immunoglobulin superfamily molecule present in the endoplasmic reticulum (ER), where it links MHC class I molecules to the transporter associated with antigen processing (TAP). Tapasin-R is a tapasin-related protein that contains similar structural motifs to Tapasin, with some marked differences, especially in the V domain, transmembrane and cytoplasmic regions. The majority of Tapasin-R is located within the ER; however, there may be some expression of Tapasin-R at the cell surface. Tapasin-R lacks an obvious ER retention signal.
Probab=97.13 E-value=0.0019 Score=58.35 Aligned_cols=90 Identities=17% Similarity=0.288 Sum_probs=55.3
Q ss_pred ccccccccccccccccccceeeeEeecC-CC-CeeEEEEcCeeccCC---cccCccceEEEeeCCceeeeeeEEEecCCC
Q psy1672 254 KPEIRMDSRYVEAVSSENATVVCRVDSI-PP-AAISWYWNGRLLLNN---TAFSSYQRIFVIEQGEYERKSSLVLTNAQE 328 (600)
Q Consensus 254 ~p~i~~~~~~~~v~~G~~v~L~C~v~g~-P~-p~i~W~~~g~~l~~~---~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~ 328 (600)
.|.+...+.......|+.++|.|.+.|. |. .+|.|+++|...... .............++++...+.|.+.....
T Consensus 38 ~P~v~~~~~~~~~~~~~~~~L~C~a~g~~P~~~~i~W~~~g~~~~~~~~~~~~~~~~~~~~~~dgt~~~~s~L~v~~~~~ 117 (139)
T cd05771 38 PPRVRLSLEKLVSMIEEPQTLICHIAGYYPLDVQVEWTREPPGDSPPPVSLSNVSFSSHRQHQDGTYSLSSHLTLEPGTE 117 (139)
T ss_pred CCceEEeCCCceeecCCcEEEEEEECCCCCCCeEEEEEECCCCCccceeccCCeEecceEeCCCCCEEEEEEEEecCCcc
Confidence 4544444444444468889999999986 44 489999987542210 000001122344567777778888875555
Q ss_pred CCCeEEEEEEecCCC
Q psy1672 329 SDSGRFYCVAENRAG 343 (600)
Q Consensus 329 ~d~G~Y~C~a~N~~G 343 (600)
.+.+.|+|.+.+..-
T Consensus 118 ~~g~~ytC~V~H~~l 132 (139)
T cd05771 118 DAGATYTCRVSHVSL 132 (139)
T ss_pred CCCCEEEEEEEcCCC
Confidence 455589999987643
No 206
>KOG2982|consensus
Probab=97.10 E-value=0.0004 Score=68.72 Aligned_cols=83 Identities=18% Similarity=0.138 Sum_probs=33.4
Q ss_pred ceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCC-CccccCCCCCCCEEE
Q psy1672 51 TQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSI-PSLTFQSVRFLRDLN 129 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l-~~~~f~~l~~L~~L~ 129 (600)
++.|||.+|.|+.+..-......|+.|+.|+|+.|.+..-....-..+.+|+.|-|.+..+..- ....+..++.++.|.
T Consensus 73 v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelH 152 (418)
T KOG2982|consen 73 VKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELH 152 (418)
T ss_pred hhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhh
Confidence 4445555555544332211112455555555555544322111002334555555544433211 111223344445555
Q ss_pred ccCC
Q psy1672 130 LARN 133 (600)
Q Consensus 130 Ls~N 133 (600)
++.|
T Consensus 153 mS~N 156 (418)
T KOG2982|consen 153 MSDN 156 (418)
T ss_pred hccc
Confidence 5544
No 207
>cd05711 Ig_FcalphaRI Immunoglobulin (IG)-like domain of of FcalphaRI. IG_FcalphaRI : immunoglobulin (IG)-like domain of of FcalphaRI. FcalphaRI (CD89) is an IgA-specific receptor that is expressed on monocytes, eosinophils, neutrophils and macrophages. FcalphaRI mediates IgA-induced immune effector responses such as phagocytosis, antibody-dependent cell-mediated cytotoxicity and respiratory burst. Both monomeric and dimeric IgA can bind to FcalphaRI, and monomeric or dimeric IgA immune complexes can activate phagocytosis and other immune responses through the clustering of FcalphaRI. The Fc RI ectodomain is comprised of two Ig-like domains oriented at about 90 degree to each another.
Probab=97.08 E-value=0.0022 Score=53.70 Aligned_cols=68 Identities=21% Similarity=0.215 Sum_probs=46.7
Q ss_pred ccccccccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEe
Q psy1672 262 RYVEAVSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAE 339 (600)
Q Consensus 262 ~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~ 339 (600)
....+..|++|+|.|.... ....+.|+++|...... ...........+.+.|..++..|+|.|.|...
T Consensus 8 p~~vV~~G~~VTL~C~~~~-~~~~f~l~k~g~~~~~~---------~~~~~~~~~~~a~f~I~~~~~~~~G~Y~C~~~ 75 (94)
T cd05711 8 PSPVVPSGENVTLQCHSDI-RFDRFILYKEGRSKPVL---------HLYEKHHGGFQASFPLGPVTPAHAGTYRCYGS 75 (94)
T ss_pred CCCccCCCCeEEEEEecCC-CCCEEEEEECCCCCCce---------ecccccCCeEEEEEEecCCCcccCEEEEEEEE
Confidence 4556779999999998864 55679999977542210 00000011234578999999999999999975
No 208
>cd00096 Ig Immunoglobulin domain. Ig: immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of this group are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as, T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as, butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=97.08 E-value=0.0043 Score=46.90 Aligned_cols=67 Identities=33% Similarity=0.571 Sum_probs=46.5
Q ss_pred ceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCC
Q psy1672 272 ATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAG 343 (600)
Q Consensus 272 v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G 343 (600)
+.|.|.+.+.+...+.|++++......... ..............|.|.++...|.|.|.|.+.+..+
T Consensus 1 ~~l~C~~~~~~~~~~~W~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~i~~~~~~d~g~y~C~~~~~~~ 67 (74)
T cd00096 1 VTLTCLASGPPPPTITWLKNGKPLPSSVLT-----RVRSSRGTSSGSSTLTISNVTLEDSGTYTCVASNSAG 67 (74)
T ss_pred CEEEEEecCCCCCcEEEEECCEECCCcccE-----EeccccCcceeEEEEEECccCcccCcEEEEEEecCcC
Confidence 468999988777899999977654432210 0111122233456799999999999999999998763
No 209
>cd05889 Ig1_DNAM-1_like First immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226) and similar proteins. Ig1_DNAM-1_like: domain similar to the first immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226). DNAM-1 is a transmembrane protein having two Ig-like domains. It is an adhesion molecule which plays a part in tumor-directed cytotoxicity and adhesion in natural killer (NK) cells and T lymphocytes. It has been shown to regulate the NK cell killing of several tumor types, including myeloma cells and ovarian carcinoma cells. DNAM-1 interacts specifically with poliovirus receptor (PVR; CD155) and nectin -2 (CD211), other members of the Ig superfamily. DNAM-1 is expressed in most peripheral T cells, NK cells, monocytes and a subset of B lymphocytes.
Probab=97.03 E-value=0.0036 Score=52.54 Aligned_cols=79 Identities=16% Similarity=0.268 Sum_probs=47.8
Q ss_pred cceeeeEeec-CCCCeeEEEEcCe----eccC-----Cccc-Cc-cceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEE
Q psy1672 271 NATVVCRVDS-IPPAAISWYWNGR----LLLN-----NTAF-SS-YQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVA 338 (600)
Q Consensus 271 ~v~L~C~v~g-~P~p~i~W~~~g~----~l~~-----~~~~-~~-~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a 338 (600)
.++|.|.... .....++|.+... .+.- ...+ +. ..|+.+.... ..+++|.|.+++.+|+|.|+|..
T Consensus 2 ~vtL~C~~~~~~~~~qV~W~k~~~~~~~~iavy~~~~g~~~~~~y~~Rv~f~~~~--~~d~sI~i~nvt~~D~G~Y~C~~ 79 (96)
T cd05889 2 KMKLECVYPKTGVLIQVSWTKHNGSHKENIAVYHPIYGMHIEDKYRGRVYFLNST--REDMSLSFNNATEEDVGLYCCSL 79 (96)
T ss_pred CEEEEeEcCCCCcEEEEEEEEcCCCCCceEEEEECCCCCEECccccCeEEEecCC--CCccEEEEcCCCcccCEEEEEEE
Confidence 5789998763 2356788998321 1100 0000 01 1233333221 24578999999999999999999
Q ss_pred ecC-CCceeEEEEE
Q psy1672 339 ENR-AGIADANFTL 351 (600)
Q Consensus 339 ~N~-~G~~~~~v~L 351 (600)
... .|..++.+.+
T Consensus 80 ~t~P~g~~~~~i~~ 93 (96)
T cd05889 80 VTYPQGSWEKVIEV 93 (96)
T ss_pred EeCCCCCeEEEEEE
Confidence 875 5766666554
No 210
>smart00407 IGc1 Immunoglobulin C-Type.
Probab=96.99 E-value=0.0049 Score=49.17 Aligned_cols=68 Identities=22% Similarity=0.449 Sum_probs=46.4
Q ss_pred ceeeeEeecC-CC-CeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCC
Q psy1672 272 ATVVCRVDSI-PP-AAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRA 342 (600)
Q Consensus 272 v~L~C~v~g~-P~-p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~ 342 (600)
++|.|.+.|. |. ..+.|+++|+.+..... ........+|.+...+.|.+......+...|+|.+....
T Consensus 2 ~~L~C~a~gf~P~~i~v~W~k~g~~~~~~~~---~~~~~~~~~gt~~~~s~L~v~~~~~~~~~~~tC~V~H~~ 71 (75)
T smart00407 2 ATLVCLVSGFYPPDITVTWLRNGQEVTSGVS---TTDPLKNSDGTYFLSSYLTVSASTWESGDTYTCQVTHEG 71 (75)
T ss_pred eEEEEEEEeEeCCCCEEEEEECCEECCCCEE---ECceEECCCCCEEEEEEEEEccccCCCCCEEEEEEEEcC
Confidence 6799999975 44 48999999986543321 111222346677778888887666556668999998764
No 211
>PRK15386 type III secretion protein GogB; Provisional
Probab=96.99 E-value=0.0047 Score=65.25 Aligned_cols=131 Identities=18% Similarity=0.322 Sum_probs=62.5
Q ss_pred ceEEEeeCCCCCCCChhhhcccCCCCccEEEeecc-cCcccCccccCCCCCccEEEccCC-CCCCCCccccCCCCCCCEE
Q psy1672 51 TQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARC-HIGQIDSGALDGLTNLIEIDLSDN-LLTSIPSLTFQSVRFLRDL 128 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n-~l~~i~~~~f~~l~~L~~L~Ls~N-~l~~l~~~~f~~l~~L~~L 128 (600)
++.|++++|.|+.+|. + ..+|+.|.+++| .++.++ +.+ ..+|++|+|++| .+..+|. .|+.|
T Consensus 54 l~~L~Is~c~L~sLP~--L----P~sLtsL~Lsnc~nLtsLP-~~L--P~nLe~L~Ls~Cs~L~sLP~-------sLe~L 117 (426)
T PRK15386 54 SGRLYIKDCDIESLPV--L----PNELTEITIENCNNLTTLP-GSI--PEGLEKLTVCHCPEISGLPE-------SVRSL 117 (426)
T ss_pred CCEEEeCCCCCcccCC--C----CCCCcEEEccCCCCcccCC-chh--hhhhhheEccCccccccccc-------ccceE
Confidence 6667777777776661 1 345777777664 444433 222 246677777766 5554443 35566
Q ss_pred EccCCCCCccCcccccCCCCcceeeCCCCc-CcccChhhhcCCCCCCEEEcCCCcCCCCCcccccccccccEEEccCC
Q psy1672 129 NLARNPISKIEKGAFQFVPGLVKLDMSESR-LEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLLKLMMIELHDN 205 (600)
Q Consensus 129 ~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~-l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~l~~N 205 (600)
++..+.+..+.. -.++|+.|.+.+++ ........ .-..+|+.|++++|....++.. +. .+|+.|.+..+
T Consensus 118 ~L~~n~~~~L~~----LPssLk~L~I~~~n~~~~~~lp~-~LPsSLk~L~Is~c~~i~LP~~-LP--~SLk~L~ls~n 187 (426)
T PRK15386 118 EIKGSATDSIKN----VPNGLTSLSINSYNPENQARIDN-LISPSLKTLSLTGCSNIILPEK-LP--ESLQSITLHIE 187 (426)
T ss_pred EeCCCCCccccc----CcchHhheecccccccccccccc-ccCCcccEEEecCCCcccCccc-cc--ccCcEEEeccc
Confidence 665554332210 11245555553322 10000000 0124566666666655443321 11 35555665544
No 212
>KOG2123|consensus
Probab=96.98 E-value=3.4e-05 Score=75.42 Aligned_cols=100 Identities=22% Similarity=0.287 Sum_probs=55.8
Q ss_pred CCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCccCc-ccccCCCCccee
Q psy1672 74 LLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEK-GAFQFVPGLVKL 152 (600)
Q Consensus 74 l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~-~~~~~l~~L~~L 152 (600)
+.+.++|++.+|+|..|.- ...|+.|+.|.||-|.|+++.+ |..+.+|++|+|..|.|..+.. .-+.++++|+.|
T Consensus 18 l~~vkKLNcwg~~L~DIsi--c~kMp~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~L 93 (388)
T KOG2123|consen 18 LENVKKLNCWGCGLDDISI--CEKMPLLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTL 93 (388)
T ss_pred HHHhhhhcccCCCccHHHH--HHhcccceeEEeeccccccchh--HHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhH
Confidence 4455666666666666543 3456666666666666666654 5556666666666666655533 224456666666
Q ss_pred eCCCCcCcccC-----hhhhcCCCCCCEEE
Q psy1672 153 DMSESRLEHIS-----PEAFTGAKSLESIK 177 (600)
Q Consensus 153 ~Ls~n~l~~i~-----~~~~~~l~~L~~L~ 177 (600)
.|..|....-. ...+.-+++|+.||
T Consensus 94 WL~ENPCc~~ag~nYR~~VLR~LPnLkKLD 123 (388)
T KOG2123|consen 94 WLDENPCCGEAGQNYRRKVLRVLPNLKKLD 123 (388)
T ss_pred hhccCCcccccchhHHHHHHHHcccchhcc
Confidence 66655433222 12344456666554
No 213
>PHA02987 Ig domain OX-2-like protein; Provisional
Probab=96.96 E-value=0.0034 Score=58.36 Aligned_cols=89 Identities=17% Similarity=0.320 Sum_probs=60.0
Q ss_pred ccccccccccceeeeEee-cCCCCeeEEEEcCeeccCCcccCccc---------eEEEeeCCceeeeeeEEEecCCCCCC
Q psy1672 262 RYVEAVSSENATVVCRVD-SIPPAAISWYWNGRLLLNNTAFSSYQ---------RIFVIEQGEYERKSSLVLTNAQESDS 331 (600)
Q Consensus 262 ~~~~v~~G~~v~L~C~v~-g~P~p~i~W~~~g~~l~~~~~~~~~~---------~~~~~~~g~~~~~s~L~I~~v~~~d~ 331 (600)
..++|.+|++++|.|... +...+.+.|.+..+.+. .+..++ |+.+...+ ...+.|+|.+++.+|+
T Consensus 23 ~~v~V~ege~VtLsCs~t~s~~~~qVtWkK~~~~Ia---tY~~~g~~i~~~Fk~Rve~mS~s--~~~StItIknVt~sDe 97 (189)
T PHA02987 23 VKITVSEHVNVKISCNKTSSFNSILITWKKNNKTIA---GYGPCGPVIVDKFKNKIEYLSKS--FNESTILIKNVSLKDN 97 (189)
T ss_pred EEEEEcCCCCEEEEEecCCCCccceEEEEEcCCCEE---EEecCCcEEChhhcCeEEEeccC--CCcceEEEEeCChhhC
Confidence 356788999999999985 55678899999543221 111111 22111111 1357899999999999
Q ss_pred eEEEEEEecC-CC-ceeEEEEEEEEE
Q psy1672 332 GRFYCVAENR-AG-IADANFTLQVTY 355 (600)
Q Consensus 332 G~Y~C~a~N~-~G-~~~~~v~L~V~~ 355 (600)
|.|+|...-. .| ..+....|.|+.
T Consensus 98 GcY~C~F~tfp~G~~~~gt~CLtVt~ 123 (189)
T PHA02987 98 GCYTCIFNTLLSKNNEKGVVCLNVTT 123 (189)
T ss_pred eEEEEEEEecCCCCCceeEEEEEEEc
Confidence 9999998754 35 667777787754
No 214
>PRK15386 type III secretion protein GogB; Provisional
Probab=96.96 E-value=0.0041 Score=65.62 Aligned_cols=132 Identities=20% Similarity=0.274 Sum_probs=83.0
Q ss_pred EEEccCCCCCccCCCCCCCCceEEEeeC-CCCCCCChhhhcccCCCCccEEEeecc-cCcccCccccCCCCCccEEEccC
Q psy1672 31 WMECRDKFLITIPEAPESELTQVLDMSG-NNLQILPKEAFRRAGLLNLQKLFLARC-HIGQIDSGALDGLTNLIEIDLSD 108 (600)
Q Consensus 31 ~v~C~~~~L~~ip~~~~~~~l~~L~Ls~-n~L~~l~~~~f~~~~l~~L~~L~L~~n-~l~~i~~~~f~~l~~L~~L~Ls~ 108 (600)
.++-.+..|+.+|. ++.. ++.|.+++ +.++.+|... ..+|+.|.|++| .+..++ ..|+.|+|+.
T Consensus 56 ~L~Is~c~L~sLP~-LP~s-LtsL~Lsnc~nLtsLP~~L-----P~nLe~L~Ls~Cs~L~sLP-------~sLe~L~L~~ 121 (426)
T PRK15386 56 RLYIKDCDIESLPV-LPNE-LTEITIENCNNLTTLPGSI-----PEGLEKLTVCHCPEISGLP-------ESVRSLEIKG 121 (426)
T ss_pred EEEeCCCCCcccCC-CCCC-CcEEEccCCCCcccCCchh-----hhhhhheEccCcccccccc-------cccceEEeCC
Confidence 45555668899984 5554 99999987 4567777533 358999999998 666554 3578888887
Q ss_pred CCCCCCCccccCCCCCCCEEEccCCC-CCccCcccccCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCC
Q psy1672 109 NLLTSIPSLTFQSVRFLRDLNLARNP-ISKIEKGAFQFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLS 184 (600)
Q Consensus 109 N~l~~l~~~~f~~l~~L~~L~Ls~N~-i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~ 184 (600)
+.+..+.. + .++|+.|.+.++. ........ .-..+|+.|++++|....++ ..+ ..+|+.|+++.+...
T Consensus 122 n~~~~L~~--L--PssLk~L~I~~~n~~~~~~lp~-~LPsSLk~L~Is~c~~i~LP-~~L--P~SLk~L~ls~n~~~ 190 (426)
T PRK15386 122 SATDSIKN--V--PNGLTSLSINSYNPENQARIDN-LISPSLKTLSLTGCSNIILP-EKL--PESLQSITLHIEQKT 190 (426)
T ss_pred CCCccccc--C--cchHhheecccccccccccccc-ccCCcccEEEecCCCcccCc-ccc--cccCcEEEecccccc
Confidence 76554332 1 1357777775432 21110000 11257999999988766443 222 368899998876433
No 215
>cd07706 IgV_TCR_delta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) delta chain. IgV_TCR_delta: immunoglobulin (Ig) variable (V) domain of the delta chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=96.94 E-value=0.0024 Score=55.64 Aligned_cols=82 Identities=21% Similarity=0.324 Sum_probs=52.2
Q ss_pred cccccccccccccceeeeEeecC-CCCeeEEEEc--Ceecc----CCccc--CccceEEEeeCCceeeeeeEEEecCCCC
Q psy1672 259 MDSRYVEAVSSENATVVCRVDSI-PPAAISWYWN--GRLLL----NNTAF--SSYQRIFVIEQGEYERKSSLVLTNAQES 329 (600)
Q Consensus 259 ~~~~~~~v~~G~~v~L~C~v~g~-P~p~i~W~~~--g~~l~----~~~~~--~~~~~~~~~~~g~~~~~s~L~I~~v~~~ 329 (600)
..+..+.+..|+.++|.|..... ....+.|++. +..+. ..... ....|+.+..+. ......|.|.+++.+
T Consensus 4 q~~~~v~~~~G~~v~L~C~~~~~~~~~~v~Wyrq~~~~~~~~l~~~~~~~~~~~~~R~~~~~~~-~~~~~sL~I~~~~~~ 82 (116)
T cd07706 4 QAQPDVSVQVGEEVTLNCRYETSWTNYYIFWYKQLPSGEMTFLIRQKSIYGNATKGRYSVNFQK-AQKSISLTISALQLE 82 (116)
T ss_pred EeCCceEEcCCCCEEEEEEEeCCCCceEEEEEEECCCCceEEEEEecCccCCccCCeEEEEEec-cCCEEEEEECCCCHH
Confidence 34567888999999999998753 4567999983 22110 00000 111333332111 112457999999999
Q ss_pred CCeEEEEEEecC
Q psy1672 330 DSGRFYCVAENR 341 (600)
Q Consensus 330 d~G~Y~C~a~N~ 341 (600)
|+|.|.|.+...
T Consensus 83 Dsg~Y~C~~~~~ 94 (116)
T cd07706 83 DSAKYFCALSTL 94 (116)
T ss_pred HCEEEEEEEECC
Confidence 999999999854
No 216
>KOG2739|consensus
Probab=96.90 E-value=0.0005 Score=67.08 Aligned_cols=60 Identities=23% Similarity=0.334 Sum_probs=28.4
Q ss_pred CCCccEEEeecccCcccCccccCCCCCccEEEccCCCCC---CCCccccCCCCCCCEEEccCCCCC
Q psy1672 74 LLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLT---SIPSLTFQSVRFLRDLNLARNPIS 136 (600)
Q Consensus 74 l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~---~l~~~~f~~l~~L~~L~Ls~N~i~ 136 (600)
+.+|+.|.+.+..++.+.. |-.|++|+.|.++.|.+. .+.. ....+++|++|+|++|+|+
T Consensus 42 ~~~le~ls~~n~gltt~~~--~P~Lp~LkkL~lsdn~~~~~~~l~v-l~e~~P~l~~l~ls~Nki~ 104 (260)
T KOG2739|consen 42 FVELELLSVINVGLTTLTN--FPKLPKLKKLELSDNYRRVSGGLEV-LAEKAPNLKVLNLSGNKIK 104 (260)
T ss_pred ccchhhhhhhccceeeccc--CCCcchhhhhcccCCccccccccee-hhhhCCceeEEeecCCccc
Confidence 4455555555555555433 445555566666555222 1111 1122355555555555544
No 217
>cd07698 IgC_MHC_I_alpha3 Class I major histocompatibility complex (MHC) alpha chain immunoglobulin domain. IgC_MHC_I_alpha3; Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class I alpha chain. Class I MHC proteins bind antigenic peptide fragments and present them to CD8+ T lymphocytes. Class I molecules consist of a transmembrane alpha chain and a small chain called the beta2 microglobulin. The alpha chain contains three extracellular domains, two of which fold together to form the peptide-binding cleft (alpha1 and alpha2), and one which has an Ig fold (alpha3). Peptide binding to class I molecules occurs in the endoplasmic reticulum (ER) and involves both chaperones and dedicated factors to assist in peptide loading. Class I MHC molecules are expressed on most nucleated cells.
Probab=96.90 E-value=0.008 Score=50.14 Aligned_cols=69 Identities=19% Similarity=0.415 Sum_probs=45.7
Q ss_pred cccceeeeEeecC-CCC-eeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCC
Q psy1672 269 SENATVVCRVDSI-PPA-AISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAG 343 (600)
Q Consensus 269 G~~v~L~C~v~g~-P~p-~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G 343 (600)
++.++|.|.+.|. |.. .+.|.++|..+..... ........++.+...+.|.+... +.+.|+|.+.+..-
T Consensus 14 ~~~~~L~C~a~gF~P~~i~v~W~~~g~~~~~~~~---~~~~~~~~d~ty~~~s~l~v~~~---~~~~ytC~V~H~~~ 84 (93)
T cd07698 14 DGSLTLSCHATGFYPRDIEVTWLRDGEDSVDDVE---SGEILPNGDGTYQLWVTLEVPPE---DKARYSCRVEHSGL 84 (93)
T ss_pred CCcEEEEEEEEEEeCCCcEEEEEECCEECccccc---ccceEECCCCeEEEEEEEEECCC---CCCEEEEEEEeCCC
Confidence 6789999999986 443 8899999864333221 11222334555666667766553 66799999988654
No 218
>cd05755 Ig2_ICAM-1_like Second immunoglobulin (Ig)-like domain of intercellular cell adhesion molecule-1 (ICAM-1, CD54) and similar proteins. Ig2_ ICAM-1_like: domain similar to the second immunoglobulin (Ig)-like domain of intercellular cell adhesion molecule-1 (ICAM-1, CD54). During the inflammation process, these molecules recruit leukocytes onto the vascular endothelium before extravasation to the injured tissues. ICAM-1 may be involved in organ targeted tumor metastasis. The interaction of ICAM-1 with leukocyte function-associated antigen-1 (LFA-1) plays a part in leukocyte-endothelial cell recognition. This group also contains ICAM-2, which also interacts with LFA-1. Transmigration of immature dendritic cells across resting endothelium is dependent on the interaction of ICAM-2 with, yet unidentified, ligand(s) on the dendritic cells. ICAM-1 has five Ig-like domains and ICAM-2 has two. ICAM-1 may also act as host receptor for viruses and parasites.
Probab=96.85 E-value=0.0061 Score=51.45 Aligned_cols=73 Identities=16% Similarity=0.211 Sum_probs=49.5
Q ss_pred cccccccceeeeEeec-CCCCe--eEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCe-EEEEEEec
Q psy1672 265 EAVSSENATVVCRVDS-IPPAA--ISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSG-RFYCVAEN 340 (600)
Q Consensus 265 ~v~~G~~v~L~C~v~g-~P~p~--i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G-~Y~C~a~N 340 (600)
.+.+|+.++|.|.+.| .|.+. |.|++.++.+...... . .........+.+.+. +...|.| .|+|.|++
T Consensus 12 ~~~eG~~~tL~C~v~g~~P~a~L~i~W~rG~~~l~~~~~~-~------~~~~~~~~~stlt~~-~~r~D~g~~~sC~A~l 83 (100)
T cd05755 12 WQPVGKNYTLQCDVPGVAPRQNLTVVLLRGNETLSRQPFG-D------NTKSPVNAPATITIT-VDREDHGANFSCETEL 83 (100)
T ss_pred cccCCCcEEEEEEEcCcCCCCcEEEEEeeCCEEcccceec-c------ccCCCceeEEEEEEe-cchhhCCcEEEEEEEe
Confidence 3578999999999995 67776 7999998887543210 0 011122344566664 5567777 89999999
Q ss_pred CCCce
Q psy1672 341 RAGIA 345 (600)
Q Consensus 341 ~~G~~ 345 (600)
..+..
T Consensus 84 ~l~~~ 88 (100)
T cd05755 84 DLRPE 88 (100)
T ss_pred ccCcc
Confidence 87653
No 219
>KOG2739|consensus
Probab=96.83 E-value=0.00048 Score=67.18 Aligned_cols=105 Identities=19% Similarity=0.269 Sum_probs=72.9
Q ss_pred cCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEccCC--CCCccCcccccCCCCcceeeCCCCcCcccCh-hhhcCCC
Q psy1672 95 LDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARN--PISKIEKGAFQFVPGLVKLDMSESRLEHISP-EAFTGAK 171 (600)
Q Consensus 95 f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N--~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~-~~~~~l~ 171 (600)
+..+..|+.|.+.+..++++.. |..|++|+.|.++.| ++..-..-....+++|++|+|++|+|+.+.. ..+..+.
T Consensus 39 ~d~~~~le~ls~~n~gltt~~~--~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~lstl~pl~~l~ 116 (260)
T KOG2739|consen 39 TDEFVELELLSVINVGLTTLTN--FPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKDLSTLRPLKELE 116 (260)
T ss_pred cccccchhhhhhhccceeeccc--CCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccccccccchhhhhc
Confidence 3455677788888888777654 667899999999999 4433222223456899999999998875421 2344677
Q ss_pred CCCEEEcCCCcCCCCC---cccccccccccEEE
Q psy1672 172 SLESIKLNGNRLSHFP---VRSVEPLLKLMMIE 201 (600)
Q Consensus 172 ~L~~L~Ls~N~l~~l~---~~~~~~l~~L~~L~ 201 (600)
+|..|++.+|..+.+. ...|.-+++|+.|+
T Consensus 117 nL~~Ldl~n~~~~~l~dyre~vf~ll~~L~~LD 149 (260)
T KOG2739|consen 117 NLKSLDLFNCSVTNLDDYREKVFLLLPSLKYLD 149 (260)
T ss_pred chhhhhcccCCccccccHHHHHHHHhhhhcccc
Confidence 8888899888777654 24455567777766
No 220
>cd05716 Ig_pIgR Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). Ig_pIgR: Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). pIgR delivers dimeric IgA and pentameric IgM to mucosal secretions. Polymeric immunoglobulin (pIgs) are the first defense against pathogens and toxins. IgA and IgM can form polymers via an 18-residue extension at their c-termini referred to as the tailpiece. pIgR transports pIgs across mucosal epithelia into mucosal secretions. Human pIgR is a glycosylated type I transmembrane protein, comprised of a 620 residue extracellular region, a 23 residue transmembrane region, and a 103 residue cytoplasmic tail. The extracellular region contains five domains that share sequence similarity with Ig variable (v) regions.
Probab=96.81 E-value=0.0043 Score=52.18 Aligned_cols=78 Identities=13% Similarity=0.259 Sum_probs=48.9
Q ss_pred ccccccccceeeeEeec-CCCCeeEEEEcCe-----ecc-CCccc-CccceEEEeeCCceeeeeeEEEecCCCCCCeEEE
Q psy1672 264 VEAVSSENATVVCRVDS-IPPAAISWYWNGR-----LLL-NNTAF-SSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFY 335 (600)
Q Consensus 264 ~~v~~G~~v~L~C~v~g-~P~p~i~W~~~g~-----~l~-~~~~~-~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~ 335 (600)
+.+..|++++|.|.... .....+.|++... .+. ..... ....+..+..+. ......|+|.+++.+|+|.|.
T Consensus 2 v~~~~G~~vtl~C~~~~~~~~~~~~W~r~~~~~~~~~l~~~~~~~~~~~~r~~~~~~~-~~~~~~L~I~~v~~~DsG~Y~ 80 (98)
T cd05716 2 VTGELGGSVTIPCPYPPKNRSYEKYWCKWGSAGCCLIIVSEGSVQSQYEGRVSLTDDP-DNGVFTVTLNQLRKEDAGWYW 80 (98)
T ss_pred EEEEeCCeEEEEeeCCCCCCCcEeEeECCCCCCCCeEEECCCccccccCCCEEEEecC-CCCEEEEEEcCCCHHHCEEEE
Confidence 35678999999998874 3456789998431 111 00000 111233332211 123468999999999999999
Q ss_pred EEEecCC
Q psy1672 336 CVAENRA 342 (600)
Q Consensus 336 C~a~N~~ 342 (600)
|.+....
T Consensus 81 C~~~~~~ 87 (98)
T cd05716 81 CGVGDDG 87 (98)
T ss_pred EEcccCC
Confidence 9988764
No 221
>cd05712 Ig_Siglec_N Immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Ig_Siglec_N: immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Siglec refers to a structurally related protein family that specifically recognizes sialic acid in oligosaccharide chains of glycoproteins and glycolipids. Siglecs are type I transmembrane proteins, organized as an extracellular module composed of Ig-like domains (an N-terminal variable set of Ig-like carbohydrate recognition domains, and 1 to 16 constant Ig-like domains), followed by transmembrane and short cytoplasmic domains. Human siglecs are classified into two subgroups, one subgroup is comprised of sialoadhesin (Siglec-1), CD22 (Siglec-2), and MAG, the other subgroup is comprised of CD33-related Siglecs which include CD33 (Siglec-3) and human Siglecs 5-11.
Probab=96.79 E-value=0.0056 Score=53.67 Aligned_cols=81 Identities=19% Similarity=0.244 Sum_probs=50.4
Q ss_pred ccccccccccccceeeeEeecCC------CCeeEEEEc--Ce---ecc---C-Cccc--CccceEEEeeCCceeeeeeEE
Q psy1672 260 DSRYVEAVSSENATVVCRVDSIP------PAAISWYWN--GR---LLL---N-NTAF--SSYQRIFVIEQGEYERKSSLV 322 (600)
Q Consensus 260 ~~~~~~v~~G~~v~L~C~v~g~P------~p~i~W~~~--g~---~l~---~-~~~~--~~~~~~~~~~~g~~~~~s~L~ 322 (600)
.+..+.+..|+.|+|.|...... ...+.|++. +. .+. . .... ...+|+.+..+ .......|.
T Consensus 5 ~P~~v~~~~G~~VtL~C~f~~~~~~~~~~~~~~~Wykq~~g~~~~~~~~~~~~~~~~~~~f~gR~~~~~~-~~~~~~sL~ 83 (119)
T cd05712 5 MPKSVSVQEGLCVLIPCSFSYPADWPVSNGVHGIWYKGHPYPKNRPPVATNNRSRLVHESTRGRFRLLGD-LGKKNCSLL 83 (119)
T ss_pred CCCEEEEeccccEEEEEEeeCcccccCCCceEEEEEeCCCCCCCCCcEEEcCCCccccccccccEEEecC-CCCCEEEEE
Confidence 35667889999999999875221 245899983 21 110 0 0000 01123333211 123456899
Q ss_pred EecCCCCCCeEEEEEEecC
Q psy1672 323 LTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 323 I~~v~~~d~G~Y~C~a~N~ 341 (600)
|.+++.+|+|.|.|.+...
T Consensus 84 I~~l~~~Dsg~Y~C~~~~~ 102 (119)
T cd05712 84 ISDAQPEDSGKYFFRVELG 102 (119)
T ss_pred EccCChhhCeEEEEEEEcC
Confidence 9999999999999988764
No 222
>KOG4222|consensus
Probab=96.73 E-value=0.007 Score=69.55 Aligned_cols=94 Identities=28% Similarity=0.378 Sum_probs=65.2
Q ss_pred cccccccccccccccccceeeeEeecCCCCeeEEEEcCee-ccC-CcccCccceEEEeeCCceeeeeeEEEecCCCCCCe
Q psy1672 255 PEIRMDSRYVEAVSSENATVVCRVDSIPPAAISWYWNGRL-LLN-NTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSG 332 (600)
Q Consensus 255 p~i~~~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g~~-l~~-~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G 332 (600)
|.+...+....+..|..++|.|.+.|.|+|.+.|.+.|.. +.. ..-+....+..+.- ++.|+|.+++..|.|
T Consensus 316 P~f~kkp~dq~v~lg~~vt~pc~~~gnP~PavfW~keg~q~llf~~~p~~~~~r~svs~------~g~L~it~v~~~d~g 389 (1281)
T KOG4222|consen 316 PSFGKKPRDQKVALGGTVTFPCETLGNPPPAVFWLKEGSQDLLFSASPPSSNGRGSVSP------TGTLTITNVRQSDEG 389 (1281)
T ss_pred cccccccCccccccCceEEeeeecCCCCCcceEEeccCcceecccCCCCCcCccceecC------CCCcccccccccccc
Confidence 3333344555677788999999999999999999996542 222 12222333333333 348999999999999
Q ss_pred EEEEEEecCCCceeEEEEEEEE
Q psy1672 333 RFYCVAENRAGIADANFTLQVT 354 (600)
Q Consensus 333 ~Y~C~a~N~~G~~~~~v~L~V~ 354 (600)
.|.|...+.+|.......+.++
T Consensus 390 ~Yvcq~~~~~~ss~~~a~~~qt 411 (1281)
T KOG4222|consen 390 YYVCQTQTSAGSSLTKAYLEQT 411 (1281)
T ss_pred eEeecccccccccccceeEEEE
Confidence 9999999988876555444444
No 223
>cd05720 Ig_CD8_alpha Immunoglobulin (Ig) like domain of CD8 alpha chain. Ig_CD8_alpha: immunoglobulin (Ig)-like domain in CD8 alpha. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alphaalpha or alphabeta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a v-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain. The Ig domain of CD8 alpha binds to antibodies.
Probab=96.70 E-value=0.0058 Score=52.20 Aligned_cols=73 Identities=21% Similarity=0.398 Sum_probs=45.6
Q ss_pred cccccccceeeeEeecCCCCeeEEEEc--C--eec---cCC----c-ccC----ccceEEEeeCCceeeeeeEEEecCCC
Q psy1672 265 EAVSSENATVVCRVDSIPPAAISWYWN--G--RLL---LNN----T-AFS----SYQRIFVIEQGEYERKSSLVLTNAQE 328 (600)
Q Consensus 265 ~v~~G~~v~L~C~v~g~P~p~i~W~~~--g--~~l---~~~----~-~~~----~~~~~~~~~~g~~~~~s~L~I~~v~~ 328 (600)
.+..|+.|+|.|.+.......+.|++. | ..+ ... . ... ...+.....+ .....|+|.+++.
T Consensus 2 ~v~~G~~vtL~C~~~~~~~~~v~Wyrq~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~rf~~~~~---~~~~~L~I~~~~~ 78 (104)
T cd05720 2 DAELGQKVELKCEVLNSSPTGCSWLFQPPGSAPQPTFLVYLSGSSKITWDEEELSSKRFSGSRS---SNSFVLTLKNFQK 78 (104)
T ss_pred cccCCCeEEEEEEecCCCCCcEEEEEeCCCCCCCCEEEEEEeCCCCeeeccccCCCceEEEEec---CCEEEEEECCCCH
Confidence 367899999999986555567999993 3 211 100 0 000 0112222111 1355799999999
Q ss_pred CCCeEEEEEEec
Q psy1672 329 SDSGRFYCVAEN 340 (600)
Q Consensus 329 ~d~G~Y~C~a~N 340 (600)
+|+|.|.|.+.+
T Consensus 79 sDsgtY~Ca~~~ 90 (104)
T cd05720 79 ENEGYYFCSVAS 90 (104)
T ss_pred HHCEEEEEEEcc
Confidence 999999998764
No 224
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=96.67 E-value=0.0017 Score=63.64 Aligned_cols=159 Identities=25% Similarity=0.235 Sum_probs=108.3
Q ss_pred ceEEEeeCCCCCCCChhhhc--ccCCCCccEEEeecccCccc----------CccccCCCCCccEEEccCCCCCCCCcc-
Q psy1672 51 TQVLDMSGNNLQILPKEAFR--RAGLLNLQKLFLARCHIGQI----------DSGALDGLTNLIEIDLSDNLLTSIPSL- 117 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~--~~~l~~L~~L~L~~n~l~~i----------~~~~f~~l~~L~~L~Ls~N~l~~l~~~- 117 (600)
+..++|++|.|..--..... .++-.+|+..+++.-..... .-.++.++++|+.++||.|.+..-.+.
T Consensus 32 ~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~~e~ 111 (388)
T COG5238 32 LVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEFPEE 111 (388)
T ss_pred eeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCcccchH
Confidence 88999999998632111111 12566788888776433221 124577899999999999988743221
Q ss_pred ---ccCCCCCCCEEEccCCCCCccCccccc-------------CCCCcceeeCCCCcCcccChhh----hcCCCCCCEEE
Q psy1672 118 ---TFQSVRFLRDLNLARNPISKIEKGAFQ-------------FVPGLVKLDMSESRLEHISPEA----FTGAKSLESIK 177 (600)
Q Consensus 118 ---~f~~l~~L~~L~Ls~N~i~~l~~~~~~-------------~l~~L~~L~Ls~n~l~~i~~~~----~~~l~~L~~L~ 177 (600)
.+.....|..|.|++|.+..+...-+. .-+.|+.+....|++..-+... +..-.+|+.+.
T Consensus 112 L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk~vk 191 (388)
T COG5238 112 LGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHENLKEVK 191 (388)
T ss_pred HHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHHhhcCceeEE
Confidence 345567899999999988765433222 3467999999999998765432 23336889999
Q ss_pred cCCCcCCCCCc-----ccccccccccEEEccCCcCcc
Q psy1672 178 LNGNRLSHFPV-----RSVEPLLKLMMIELHDNPWVC 209 (600)
Q Consensus 178 Ls~N~l~~l~~-----~~~~~l~~L~~L~l~~N~~~C 209 (600)
+..|.|.--.. ..+..+++|++|++.+|.|+-
T Consensus 192 i~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~ 228 (388)
T COG5238 192 IQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTL 228 (388)
T ss_pred eeecCcCcchhHHHHHHHHHHhCcceeeeccccchhh
Confidence 99998764322 233456899999999998764
No 225
>cd07694 Ig2_CD4 Second immunoglobulin (Ig) domain of CD4. Ig2_CD4; second immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=96.56 E-value=0.014 Score=47.58 Aligned_cols=71 Identities=20% Similarity=0.287 Sum_probs=47.2
Q ss_pred cccccccceeeeEeecCCC--CeeEEEEcCee-ccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecC
Q psy1672 265 EAVSSENATVVCRVDSIPP--AAISWYWNGRL-LLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 265 ~v~~G~~v~L~C~v~g~P~--p~i~W~~~g~~-l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~ 341 (600)
.+..|++++|.|.....+. +.|+|.-.+.. ..... .+ .-.|.+..+...|+|.++|++.-.
T Consensus 10 ~lL~G~sLtLtl~~~s~s~p~~~i~w~~P~n~~~~~~~-----------~~-----~ktL~~~qv~~qdSG~WtC~V~~~ 73 (88)
T cd07694 10 HVLSGTNLTLTLHGSSNSLPAFKVEWRGPGNKSKQILN-----------QD-----KKTLNLVQLGPNDSGTWDCIVSVN 73 (88)
T ss_pred eeecCCcEEEEEecCCCCCCCccEEEeCCCCccceecc-----------CC-----ccEEEeceeCcccCCEEEEEEEEC
Confidence 4568999999999975444 49999874422 11100 01 126889999999999999999733
Q ss_pred CCceeEEEEEEE
Q psy1672 342 AGIADANFTLQV 353 (600)
Q Consensus 342 ~G~~~~~v~L~V 353 (600)
.....+.+.|
T Consensus 74 --~k~~~~~~~V 83 (88)
T cd07694 74 --SSEKTLKLDI 83 (88)
T ss_pred --ceEEEEEeeE
Confidence 3333444444
No 226
>KOG3665|consensus
Probab=96.55 E-value=0.0016 Score=74.11 Aligned_cols=131 Identities=17% Similarity=0.137 Sum_probs=85.5
Q ss_pred CCCccEEEeecccCc--ccCccccCCCCCccEEEccCCCCCCCC-ccccCCCCCCCEEEccCCCCCccCcccccCCCCcc
Q psy1672 74 LLNLQKLFLARCHIG--QIDSGALDGLTNLIEIDLSDNLLTSIP-SLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLV 150 (600)
Q Consensus 74 l~~L~~L~L~~n~l~--~i~~~~f~~l~~L~~L~Ls~N~l~~l~-~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~ 150 (600)
-.+|++|++++...- ......-.-||.|+.|.+++-.+..-. .....++++|..||+++..++.+ ..++.+++|+
T Consensus 121 r~nL~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq 198 (699)
T KOG3665|consen 121 RQNLQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQ 198 (699)
T ss_pred HHhhhhcCccccchhhccHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHH
Confidence 457888888775432 111122345788888888776554221 12355778899999999988877 4467888888
Q ss_pred eeeCCCCcCccc-ChhhhcCCCCCCEEEcCCCcCCCCC------cccccccccccEEEccCCc
Q psy1672 151 KLDMSESRLEHI-SPEAFTGAKSLESIKLNGNRLSHFP------VRSVEPLLKLMMIELHDNP 206 (600)
Q Consensus 151 ~L~Ls~n~l~~i-~~~~~~~l~~L~~L~Ls~N~l~~l~------~~~~~~l~~L~~L~l~~N~ 206 (600)
.|.+.+=.+..- .-..+-+|.+|+.||+|........ .+....+++|+.||.++..
T Consensus 199 ~L~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTd 261 (699)
T KOG3665|consen 199 VLSMRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTD 261 (699)
T ss_pred HHhccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcc
Confidence 888877665542 1234457899999999876554433 1233447888888877654
No 227
>PF01462 LRRNT: Leucine rich repeat N-terminal domain; InterPro: IPR000372 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. LRRs are often flanked by cysteine-rich domains: an N-terminal LRR domain and a C-terminal LRR domain (IPR000483 from INTERPRO). This entry represents the N-terminal LRR domain. ; PDB: 3E6J_A 1W8A_A 2V9S_C 2V9T_B 3TWI_D 3ZYN_A 3ZYO_A 1OOK_G 1QYY_G 1SQ0_B ....
Probab=96.52 E-value=0.0018 Score=40.99 Aligned_cols=28 Identities=25% Similarity=0.731 Sum_probs=22.4
Q ss_pred CCCCCCeecccCCceEEEccCCCCCccCCCCC
Q psy1672 16 SCPSTCICKWKGGKQWMECRDKFLITIPEAPE 47 (600)
Q Consensus 16 ~Cp~~C~C~~~~~~~~v~C~~~~L~~ip~~~~ 47 (600)
.||..|.|. ..+|+|++++|+++|..++
T Consensus 1 ~CP~~C~C~----~~~V~C~~~~L~~vP~~lP 28 (28)
T PF01462_consen 1 ACPRPCTCS----GLTVDCSGRGLTAVPSDLP 28 (28)
T ss_dssp SSETTSEEE----TTEEEETTSS-SSS-STS-
T ss_pred CcCCCCEec----CCEeECCCCCCCccCCCCc
Confidence 599999999 5789999999999998653
No 228
>cd07700 IgV_CD8_beta Immunoglobulin (Ig) like domain of CD8 beta chain. IgV_CD8_beta: immunoglobulin (Ig)-like domain in CD8 beta. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alpha/alpha or alpha/beta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a V-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain.
Probab=96.48 E-value=0.011 Score=50.82 Aligned_cols=75 Identities=12% Similarity=0.312 Sum_probs=44.5
Q ss_pred cccccccceeeeEeecCC-CCeeEEEEc--C---eecc----CCc----ccCc---cceEEEeeCCceeeeeeEEEecCC
Q psy1672 265 EAVSSENATVVCRVDSIP-PAAISWYWN--G---RLLL----NNT----AFSS---YQRIFVIEQGEYERKSSLVLTNAQ 327 (600)
Q Consensus 265 ~v~~G~~v~L~C~v~g~P-~p~i~W~~~--g---~~l~----~~~----~~~~---~~~~~~~~~g~~~~~s~L~I~~v~ 327 (600)
.+..|+.++|.|.+.+.. ...+.|++. | +.+. ... .+.. ..+..+.... ......|+|.+++
T Consensus 2 ~v~~G~~vtL~C~~~~~~~~~~~~Wyrq~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~rf~~~~~~-~~~~~~L~I~~~~ 80 (107)
T cd07700 2 LVQTNNTVKLSCEAKGISENTRIYWLRWRQAPKDSHFEFLALWSPLGGATYGEEVSQEKFSIRVTS-DSSRYRLHINRVK 80 (107)
T ss_pred EEcCCCCEEEEEEEecCCCCCeEEEEEECCCCCCCccEEEEEEcCCCCeEEccccccCcEEEEEEC-CCCEEEEEECCCC
Confidence 467899999999987543 457999983 2 1100 000 0000 0111111100 0123579999999
Q ss_pred CCCCeEEEEEEec
Q psy1672 328 ESDSGRFYCVAEN 340 (600)
Q Consensus 328 ~~d~G~Y~C~a~N 340 (600)
.+|+|.|.|...+
T Consensus 81 ~~Dsg~YyCa~~~ 93 (107)
T cd07700 81 PEDSGTYFCMTVG 93 (107)
T ss_pred HHHCEEEEEeEcC
Confidence 9999999999863
No 229
>KOG2120|consensus
Probab=96.43 E-value=0.00021 Score=70.66 Aligned_cols=150 Identities=19% Similarity=0.187 Sum_probs=86.7
Q ss_pred ceEEEeeCCCCCCCC-hhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCC-CCCCCCc-cccCCCCCCCE
Q psy1672 51 TQVLDMSGNNLQILP-KEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDN-LLTSIPS-LTFQSVRFLRD 127 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~-~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N-~l~~l~~-~~f~~l~~L~~ 127 (600)
+++|||++..|+.-. ..+.. .+.+|+.|.|.++++..-....++...+|+.|||+.+ .+++..- -.|.++..|..
T Consensus 187 lq~lDLS~s~it~stl~~iLs--~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~ 264 (419)
T KOG2120|consen 187 LQHLDLSNSVITVSTLHGILS--QCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDE 264 (419)
T ss_pred hHHhhcchhheeHHHHHHHHH--HHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhh
Confidence 889999998887311 12222 5788999999999887655566788889999999876 4543221 23567788888
Q ss_pred EEccCCCCCccCccc-cc-CCCCcceeeCCCCc--C--cccChhhhcCCCCCCEEEcCCCc-CCCCCcccccccccccEE
Q psy1672 128 LNLARNPISKIEKGA-FQ-FVPGLVKLDMSESR--L--EHISPEAFTGAKSLESIKLNGNR-LSHFPVRSVEPLLKLMMI 200 (600)
Q Consensus 128 L~Ls~N~i~~l~~~~-~~-~l~~L~~L~Ls~n~--l--~~i~~~~~~~l~~L~~L~Ls~N~-l~~l~~~~~~~l~~L~~L 200 (600)
|+|+++.+..-.... .. --.+|..|+|+++. + ..+ ..-...+++|.+|||++|. |+.--...|.+++.|++|
T Consensus 265 LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~-~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~l 343 (419)
T KOG2120|consen 265 LNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHL-STLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHL 343 (419)
T ss_pred cCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHH-HHHHHhCCceeeeccccccccCchHHHHHHhcchheee
Confidence 888888654211110 00 12356666666542 1 111 1112356677777777653 222111233344555555
Q ss_pred Ecc
Q psy1672 201 ELH 203 (600)
Q Consensus 201 ~l~ 203 (600)
.+.
T Consensus 344 Sls 346 (419)
T KOG2120|consen 344 SLS 346 (419)
T ss_pred ehh
Confidence 544
No 230
>cd05847 IgC_CH2_IgE CH2 domain (second constant Ig domain of the heavy chain) in immunoglobulin E (IgE). IgC_CH2_IgE: The second constant domain of the heavy chain of immunoglobulin E (IgE). The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma, and mu, all consisting of a variable domain (VH) and three (in alpha, delta, and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). The different classes of antibodies vary in their heavy chains; the IgE class has the epsilon type. This domain (Cepsilon2) of IgE is in place of the flexible hinge region found in IgG.
Probab=96.38 E-value=0.018 Score=48.23 Aligned_cols=76 Identities=16% Similarity=0.303 Sum_probs=48.1
Q ss_pred ccccceeeeEeecCCC--CeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCce
Q psy1672 268 SSENATVVCRVDSIPP--AAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIA 345 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P~--p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~ 345 (600)
....++|.|.+.|.-+ ..|.|.++|..+..... ........++++...+.|.+....-.+...|+|.+.......
T Consensus 13 ~~~~~~L~C~a~gFyP~~I~vtW~~dg~~~~~~~~---~s~~~~~~~~Ty~~~S~L~v~~~~w~~~~~ytC~V~H~~~~~ 89 (94)
T cd05847 13 TSETIQLLCLISGYTPGTIEVEWLVDGQVATLVAA---STAPQKEEGSTFSTTSELNVTQEDWKSGKTYTCKVTHQGTTF 89 (94)
T ss_pred CCCCEEEEEEEEeEECCCCEEEEEECCEECcCcee---ecccEECCCCcEEEEEEEEEchHHhcCCCeEEEEEEECCeee
Confidence 4456899999998544 37799999987633211 011122345566667777776443334458999999876544
Q ss_pred e
Q psy1672 346 D 346 (600)
Q Consensus 346 ~ 346 (600)
+
T Consensus 90 ~ 90 (94)
T cd05847 90 E 90 (94)
T ss_pred e
Confidence 3
No 231
>KOG2123|consensus
Probab=96.36 E-value=0.00021 Score=70.05 Aligned_cols=97 Identities=27% Similarity=0.318 Sum_probs=75.7
Q ss_pred ceEEEeeCCCCCCCChhhhcccCCCCccEEEeecccCcccCccccCCCCCccEEEccCCCCCCCCcc-ccCCCCCCCEEE
Q psy1672 51 TQVLDMSGNNLQILPKEAFRRAGLLNLQKLFLARCHIGQIDSGALDGLTNLIEIDLSDNLLTSIPSL-TFQSVRFLRDLN 129 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~-~f~~l~~L~~L~ 129 (600)
++.|++.++.|..|.-. . .|+.|+.|.|+-|+|+.+.+ |..+++|++|.|..|.|.++..- .+.++++|+.|-
T Consensus 21 vkKLNcwg~~L~DIsic--~--kMp~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~LW 94 (388)
T KOG2123|consen 21 VKKLNCWGCGLDDISIC--E--KMPLLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTLW 94 (388)
T ss_pred hhhhcccCCCccHHHHH--H--hcccceeEEeeccccccchh--HHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhHh
Confidence 67788888888877532 2 68999999999999999876 88899999999999999887652 357889999999
Q ss_pred ccCCCCCccCcc-----cccCCCCcceee
Q psy1672 130 LARNPISKIEKG-----AFQFVPGLVKLD 153 (600)
Q Consensus 130 Ls~N~i~~l~~~-----~~~~l~~L~~L~ 153 (600)
|..|+.-.-... .+.-|++|+.||
T Consensus 95 L~ENPCc~~ag~nYR~~VLR~LPnLkKLD 123 (388)
T KOG2123|consen 95 LDENPCCGEAGQNYRRKVLRVLPNLKKLD 123 (388)
T ss_pred hccCCcccccchhHHHHHHHHcccchhcc
Confidence 999986543322 244577777764
No 232
>cd05772 IgC_SIRP Signal-regulatory protein (SIRP) immunoglobulin-like domain. IgC_SIRP: Immunoglobulin-like domain of signal-regulatory proteins (SIRP); the signal-regulatory proteins (SIRP) are Ig-like cell surface receptors detected in hematopoietic and non-hematopoietic cells. While their extracellular domains are similar, SIRP are classified as alpha or beta based on the length of the intracytoplasmic domain. Those having a 110- to 113-amino acid tail are classified as SIRP-alpha, and those having a 5-amino acid tail as SIRP-beta. SIRP-alpha and SIRP-beta molecules are thought to have complementary roles in signal regulation: SIRP-alpha inhibit signalling via their immunoreceptor tyrosine (IT)-based inhibition motifs while SIRP-beta are activating. SIRP-beta lack the cytoplasmic domainof SIRP-alpha, and associate with at least one other transmembrane protein (DAP-12 or KARAP). The IT-based activation motifs within DAP-12's cytoplasmic domain may link SIRP-beta to the activating
Probab=96.35 E-value=0.035 Score=48.00 Aligned_cols=73 Identities=19% Similarity=0.335 Sum_probs=48.8
Q ss_pred cccccccceeeeEeecC-CC-CeeEEEEcCeeccCCcccCccceEEEeeC-CceeeeeeEEEecCCCCCCe-EEEEEEec
Q psy1672 265 EAVSSENATVVCRVDSI-PP-AAISWYWNGRLLLNNTAFSSYQRIFVIEQ-GEYERKSSLVLTNAQESDSG-RFYCVAEN 340 (600)
Q Consensus 265 ~v~~G~~v~L~C~v~g~-P~-p~i~W~~~g~~l~~~~~~~~~~~~~~~~~-g~~~~~s~L~I~~v~~~d~G-~Y~C~a~N 340 (600)
+...|+.++|.|.+.|. |. ..++|++||+.+.... .......+ +++..++.|.+... ..|.| .|+|.+..
T Consensus 17 ~~~~g~~~tL~C~a~gF~P~~i~v~W~kng~~~~~~~-----~~~~p~~d~~ty~~~S~L~~~~~-~~d~~~~ytC~V~H 90 (111)
T cd05772 17 RANPGQSVNFTCSAHGFSPRDITVKWLKNGNELSAEQ-----PNITPEGDSVSYNVTSTVQVKLT-EDDVHSQVTCEVQH 90 (111)
T ss_pred ccCCCCCEEEEEEEeeEeCCCCEEEEEECCEECcccc-----cceeeCCCCCcEEEEEEEEEECc-cccccCceEEEEEe
Confidence 34568889999999975 43 4889999999875421 12222233 35666777877753 44444 59999998
Q ss_pred CCC
Q psy1672 341 RAG 343 (600)
Q Consensus 341 ~~G 343 (600)
...
T Consensus 91 ~~l 93 (111)
T cd05772 91 RTL 93 (111)
T ss_pred CCC
Confidence 753
No 233
>cd07699 IgC_L Immunoglobulin Constant domain. IgC_L: Immunoglobulin (Ig) light chain constant (C) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=96.31 E-value=0.013 Score=49.69 Aligned_cols=75 Identities=21% Similarity=0.340 Sum_probs=50.3
Q ss_pred cccccccceeeeEeecC-C-CCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCC
Q psy1672 265 EAVSSENATVVCRVDSI-P-PAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRA 342 (600)
Q Consensus 265 ~v~~G~~v~L~C~v~g~-P-~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~ 342 (600)
....++.++|.|.+.|. | ..+|.|.++|..+..... ........++++...+.|.+....-.+...|+|.+....
T Consensus 13 ~~~~~~~~~L~C~~~gfyP~~i~v~W~~~g~~~~~~~~---~~~~~~~~dgty~~~s~L~v~~~~w~~~~~~sC~V~H~~ 89 (100)
T cd07699 13 ELEKSGKATLVCLINDFYPGFATVQWKVDGATVSSGVQ---TSTTEQQSDNTYSLSSYLTLTKSDWNKHKVYTCEVTHEG 89 (100)
T ss_pred HHccCCCcEEEEEEEeEECCCCEEEEEECCEECcccEe---ccccEECCCCCEEEEEEEEEcHHHhCCCCeEEEEEEecC
Confidence 34456789999999974 4 347899999988754321 112222346777777788776555444568999999764
No 234
>cd05719 Ig2_PVR_like Second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig2_PVR_like: domain similar to the second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), these result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus
Probab=96.26 E-value=0.033 Score=46.67 Aligned_cols=69 Identities=19% Similarity=0.215 Sum_probs=43.1
Q ss_pred ccceeeeEee-cCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCe-EEEEEEecCCCcee
Q psy1672 270 ENATVVCRVD-SIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSG-RFYCVAENRAGIAD 346 (600)
Q Consensus 270 ~~v~L~C~v~-g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G-~Y~C~a~N~~G~~~ 346 (600)
....+.|.+. |.|.++|.|+++. .... ........+|.+...+.|.+.. +.+|.| .|+|.|.|..-...
T Consensus 16 ~~~va~C~s~~gkP~a~ItW~~~~---~~~~----~~~~~~~~~g~~tv~S~l~~~p-~~~d~G~~~tC~v~h~~l~~~ 86 (95)
T cd05719 16 PVTVATCVSANGKPPATISWETTL---GGEA----ETQSKENPNGTVTVTSEYRLVP-SREANGKELTCVVSHPTLQEP 86 (95)
T ss_pred ccEEEEEECCCCcCCCEEEEEeCC---CCcc----eeEeecCCCCCEEEEEEEEEec-CHHHCCCEEEEEEeCcccCCC
Confidence 3456789985 8999999999861 1110 0112223345455566777644 445555 89999999875443
No 235
>cd05768 IgC_CH4 CH4 domain (fourth constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH4: The fourth immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=96.23 E-value=0.012 Score=50.08 Aligned_cols=77 Identities=23% Similarity=0.337 Sum_probs=47.3
Q ss_pred cccccccceeeeEeecCCCC--eeEEEEcCeeccCCcccCccceEEEe--eCCceeeeeeEEEecCCCCCCeEEEEEEec
Q psy1672 265 EAVSSENATVVCRVDSIPPA--AISWYWNGRLLLNNTAFSSYQRIFVI--EQGEYERKSSLVLTNAQESDSGRFYCVAEN 340 (600)
Q Consensus 265 ~v~~G~~v~L~C~v~g~P~p--~i~W~~~g~~l~~~~~~~~~~~~~~~--~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N 340 (600)
.+..+..++|.|.+.|..+. .+.|.++|+.+........ ..... .++++...+.|.+..-.-.+...|+|.+..
T Consensus 12 ~~~~~~~~tL~C~a~gFyP~~i~v~W~k~g~~~~~~~~~~~--~~~~~~~~dgTy~~~s~L~v~~~~w~~~~~ytC~V~H 89 (102)
T cd05768 12 ELSLQETATLTCLVKGFSPSDIFVKWLQNGQPLSKQKYVTT--APMQEPGGNESYFLYSKLTVSAEDWNAGDVFTCVVGH 89 (102)
T ss_pred HhCcCCceEEEEEEeeEeCCCCEEEEEECCEECCccccccc--CcccccCCCCeEEEEEEEEEcHHHhcCCCcEEEEeEe
Confidence 33456789999999986554 5699999987654321000 00011 146666677787744322333479999997
Q ss_pred CCC
Q psy1672 341 RAG 343 (600)
Q Consensus 341 ~~G 343 (600)
...
T Consensus 90 ~~l 92 (102)
T cd05768 90 EAL 92 (102)
T ss_pred CCC
Confidence 643
No 236
>cd04981 IgV_H Immunoglobulin (Ig) heavy chain (H), variable (V) domain. IgV_H: Immunoglobulin (Ig) heavy chain (H), variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which can associate with any of the heavy chains. This family includes alpha, gamma, delta, epsilon, and mu heavy chains.
Probab=96.16 E-value=0.016 Score=50.61 Aligned_cols=79 Identities=15% Similarity=0.287 Sum_probs=47.9
Q ss_pred cccccccccccceeeeEeecCC--CCeeEEEEc--Ceecc------CC--cc-c--CccceEEEeeCCceeeeeeEEEec
Q psy1672 261 SRYVEAVSSENATVVCRVDSIP--PAAISWYWN--GRLLL------NN--TA-F--SSYQRIFVIEQGEYERKSSLVLTN 325 (600)
Q Consensus 261 ~~~~~v~~G~~v~L~C~v~g~P--~p~i~W~~~--g~~l~------~~--~~-~--~~~~~~~~~~~g~~~~~s~L~I~~ 325 (600)
+..+.+..|+.++|.|...+.. ...+.|++. |+.+. .. .. . ....+.....+. ......|+|.+
T Consensus 4 ~~~~~v~~G~~vtL~C~~~~~~~~~~~~~WYkQ~~g~~p~~l~~~~~~~~~~~~~~~~~~rf~~~~~~-~~~~~~L~I~~ 82 (117)
T cd04981 4 SGPGLVKPGQSLKLSCKASGFTFTSYGVNWVRQAPGKGLEWIGFINPGGGETYYADSVKGRFTITRDT-SKSTVYLQLNS 82 (117)
T ss_pred CCCeEEcCCCCEEEEEEEeCCCcccceEEEEEECCCCCcEEEEEEecCCCceEeCcccCCcEEEEEEc-cCCEEEEEECC
Confidence 4567788999999999876433 456999982 22110 00 00 0 001122221111 11234699999
Q ss_pred CCCCCCeEEEEEEec
Q psy1672 326 AQESDSGRFYCVAEN 340 (600)
Q Consensus 326 v~~~d~G~Y~C~a~N 340 (600)
++.+|+|.|.|.+..
T Consensus 83 ~~~~Dsa~YyCa~~~ 97 (117)
T cd04981 83 LTPEDTAVYYCARGL 97 (117)
T ss_pred CCHHHCEEEEEEEEc
Confidence 999999999998875
No 237
>PF07654 C1-set: Immunoglobulin C1-set domain; InterPro: IPR003597 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C1-set domains, which are classical Ig-like domains resembling the antibody constant domain. C1-set domains are found almost exclusively in molecules involved in the immune system, such as in immunoglobulin light and heavy chains, in the major histocompatibility complex (MHC) class I and II complex molecules [, ], and in various T-cell receptors.; PDB: 3BVN_D 3BXN_A 3PWV_E 3L9R_F 2XFX_B 1BMG_A 1K8I_A 3M1B_G 3M17_C 1EXU_A ....
Probab=96.16 E-value=0.029 Score=45.61 Aligned_cols=71 Identities=20% Similarity=0.323 Sum_probs=48.9
Q ss_pred ccccceeeeEeecCCCC--eeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCc
Q psy1672 268 SSENATVVCRVDSIPPA--AISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGI 344 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P~p--~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~ 344 (600)
.+..++|.|.+.+.-+. .|.|.++|..+..... ........+|++...+.|.+. ..+...|+|.+......
T Consensus 7 ~~~~~~L~C~v~~f~P~~i~v~W~~~~~~~~~~~~---~~~~~~~~dgty~~~s~l~v~---~~~~~~ysC~V~H~~l~ 79 (83)
T PF07654_consen 7 LGGSVTLTCLVSGFYPKDITVTWLKNGKEVTEGVE---TTPPPPNSDGTYSVTSSLTVT---WNSGDEYSCRVTHESLP 79 (83)
T ss_dssp STSEEEEEEEEEEEBSSTEEEEEEETTEEETTTEE---EEEEEEETTSEEEEEEEEEEE---TTTTGGEEEEEEETTSS
T ss_pred CCCCEEEEEEEEEEECCCcEEEEEeccceeeeeee---ecccccccccceeeeEEEEec---CCCCCEEEEEEEECCCC
Confidence 48899999999975433 6899999988765431 111122467777778888887 33344899999987543
No 238
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=96.15 E-value=0.0036 Score=61.38 Aligned_cols=156 Identities=22% Similarity=0.215 Sum_probs=93.5
Q ss_pred ceEEEeeCCCCC-CCChhhhc-ccCCCCccEEEeecccCcccCcccc-------------CCCCCccEEEccCCCCCCCC
Q psy1672 51 TQVLDMSGNNLQ-ILPKEAFR-RAGLLNLQKLFLARCHIGQIDSGAL-------------DGLTNLIEIDLSDNLLTSIP 115 (600)
Q Consensus 51 l~~L~Ls~n~L~-~l~~~~f~-~~~l~~L~~L~L~~n~l~~i~~~~f-------------~~l~~L~~L~Ls~N~l~~l~ 115 (600)
++.++|+.|.+. ..+..... .....+|.+|.|++|++..+...-+ ..-+.|+.+....|++..-+
T Consensus 94 l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs 173 (388)
T COG5238 94 LQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGS 173 (388)
T ss_pred ceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCc
Confidence 788888888875 22221111 1256788888888888765533222 23467888888888877544
Q ss_pred cc----ccCCCCCCCEEEccCCCCCccCc-----ccccCCCCcceeeCCCCcCcccCh----hhhcCCCCCCEEEcCCCc
Q psy1672 116 SL----TFQSVRFLRDLNLARNPISKIEK-----GAFQFVPGLVKLDMSESRLEHISP----EAFTGAKSLESIKLNGNR 182 (600)
Q Consensus 116 ~~----~f~~l~~L~~L~Ls~N~i~~l~~-----~~~~~l~~L~~L~Ls~n~l~~i~~----~~~~~l~~L~~L~Ls~N~ 182 (600)
.. .|....+|+++.+..|.|..-.- ..+..+.+|+.|+|..|-++.... .++..++.|+.|.+.+|.
T Consensus 174 ~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDCl 253 (388)
T COG5238 174 KELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCL 253 (388)
T ss_pred HHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchh
Confidence 32 23344577888888887653211 112346778888888887765432 345566777888888887
Q ss_pred CCCCCcccc-c-----ccccccEEEccCCc
Q psy1672 183 LSHFPVRSV-E-----PLLKLMMIELHDNP 206 (600)
Q Consensus 183 l~~l~~~~~-~-----~l~~L~~L~l~~N~ 206 (600)
++.-....+ . ..++|..|-+..|.
T Consensus 254 ls~~G~~~v~~~f~e~~~p~l~~L~~~Yne 283 (388)
T COG5238 254 LSNEGVKSVLRRFNEKFVPNLMPLPGDYNE 283 (388)
T ss_pred hccccHHHHHHHhhhhcCCCccccccchhh
Confidence 765442211 1 12455556565554
No 239
>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane. Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.
Probab=95.94 E-value=0.01 Score=51.57 Aligned_cols=34 Identities=26% Similarity=0.419 Sum_probs=26.1
Q ss_pred ccCcchhHHHHHHHHHHHHHHHHHHHHHhHhcCC
Q psy1672 363 LGGGHINGISLALFFLIILILIIIIYLLIRMRTI 396 (600)
Q Consensus 363 ~~~~~i~gi~~g~~l~l~lillii~~~~~rkrr~ 396 (600)
+..+.|+||++|+++++++++++|+|+++|+||+
T Consensus 61 fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk 94 (122)
T PF01102_consen 61 FSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKK 94 (122)
T ss_dssp SS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred ccccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence 4557899999999999999888888887777654
No 240
>smart00013 LRRNT Leucine rich repeat N-terminal domain.
Probab=95.94 E-value=0.0091 Score=39.36 Aligned_cols=30 Identities=23% Similarity=0.682 Sum_probs=26.5
Q ss_pred CCCCCCeecccCCceEEEccCCCCCccCCCCCCC
Q psy1672 16 SCPSTCICKWKGGKQWMECRDKFLITIPEAPESE 49 (600)
Q Consensus 16 ~Cp~~C~C~~~~~~~~v~C~~~~L~~ip~~~~~~ 49 (600)
.||..|.|. ...|+|.+++|+.||..++..
T Consensus 1 ~CP~~C~C~----~~~V~C~~~~L~~vP~~iP~~ 30 (33)
T smart00013 1 ACPAPCNCS----GTAVDCSGRGLTEVPLDLPPD 30 (33)
T ss_pred CcCCCCEEC----CCEeEeCCCCcCccCCCCCcc
Confidence 499999998 468999999999999988764
No 241
>cd07696 IgC_CH3 CH3 domain (third constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH3: The third immunoglobulin constant domain (IgC) of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=95.91 E-value=0.039 Score=46.37 Aligned_cols=76 Identities=12% Similarity=0.217 Sum_probs=47.0
Q ss_pred ccccccccceeeeEeecC-CCC--eeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEec
Q psy1672 264 VEAVSSENATVVCRVDSI-PPA--AISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAEN 340 (600)
Q Consensus 264 ~~v~~G~~v~L~C~v~g~-P~p--~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N 340 (600)
..+..++.++|.|.+.|. -++ .++|.++++...... ........++++...+.|.+..-.-.+.-.|+|.+..
T Consensus 9 ~~l~~~~~~tLtC~v~gf~yP~~i~v~W~r~~~~~~~~~----~~~~~~~~dgty~~~s~l~v~~~~w~~g~~ysC~V~H 84 (96)
T cd07696 9 KQLLLTKSVKLTCLVTNLTSPEGVNVTWTRGSGEPVKAS----IQPPESHNNATLSVTSTLNVSTDDWISGDTFQCKVTH 84 (96)
T ss_pred HHhccCCCeEEEEEEeCCCCCCCcEEEEEECCeEeeeEE----ecccccCCCCCEEEEEEEEeCHHHccCCCcEEEEEEC
Confidence 345568899999999988 333 679999864322111 0111233456666677777765332223379999998
Q ss_pred CCC
Q psy1672 341 RAG 343 (600)
Q Consensus 341 ~~G 343 (600)
..-
T Consensus 85 ~~l 87 (96)
T cd07696 85 PDL 87 (96)
T ss_pred CCC
Confidence 653
No 242
>smart00406 IGv Immunoglobulin V-Type.
Probab=95.90 E-value=0.015 Score=46.40 Aligned_cols=67 Identities=21% Similarity=0.431 Sum_probs=39.0
Q ss_pred cceeeeEeecCCCC--eeEEEEcCe--e---ccC----Cccc---CccceEEEeeCCceeeeeeEEEecCCCCCCeEEEE
Q psy1672 271 NATVVCRVDSIPPA--AISWYWNGR--L---LLN----NTAF---SSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYC 336 (600)
Q Consensus 271 ~v~L~C~v~g~P~p--~i~W~~~g~--~---l~~----~~~~---~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C 336 (600)
++.|.|.+.....+ .+.|++... . +.. ...+ ....|+.+.... ......|.|.+++.+|+|.|.|
T Consensus 1 ~v~l~C~~~~~~~~~~~v~W~~~~~~~~~~~l~~~~~~~~~~~~~~~~~R~~~~~~~-~~~~~~L~i~~~~~~D~G~Y~C 79 (81)
T smart00406 1 SVTLSCKASGFTFSSYYVSWVRQPPGKGLEWLGYIGSSGSTYYQQSYKGRVTISKDT-SKNDVSLTISNLRVEDTGTYYC 79 (81)
T ss_pred CEEEEEEEeccccceeEEEEEEeCCCCCeEEEEEEcCCCcEEECcccCCcEEEEecC-cCCEEEEEEcCCCHHHCEEEEE
Confidence 36799988755443 789998431 1 110 0000 011233333221 1234679999999999999999
Q ss_pred EE
Q psy1672 337 VA 338 (600)
Q Consensus 337 ~a 338 (600)
.+
T Consensus 80 ~v 81 (81)
T smart00406 80 AV 81 (81)
T ss_pred cC
Confidence 63
No 243
>cd07703 Ig2_Nectin-2_like Second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112) and similar proteins. Ig2_Nectin-2_like: domain similar to the second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112). Nectin-2 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectin-2 and nectin-3 localize at Sertoli-spermatid junctions where they form heterophilic trans-interactions between the cells that are essential for the formation and maintenance of the junctions and for spermatid development.
Probab=95.90 E-value=0.054 Score=45.37 Aligned_cols=75 Identities=19% Similarity=0.205 Sum_probs=45.9
Q ss_pred ccceeeeEee-cCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCe-EEEEEEecCCCceeE
Q psy1672 270 ENATVVCRVD-SIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSG-RFYCVAENRAGIADA 347 (600)
Q Consensus 270 ~~v~L~C~v~-g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G-~Y~C~a~N~~G~~~~ 347 (600)
....+.|.+. |.|.++|.|+.+.. ... ........++++...+.|.+.. +.+|.| .|+|.|+|..-....
T Consensus 16 ~~~va~C~s~~gkPaa~IsW~~~~~---g~~----~~~~~~~~~gt~tv~S~l~~~P-~~~d~Gk~ltC~v~h~al~~~~ 87 (95)
T cd07703 16 PVPVAKCVSANGRPPARISWSSTLG---GNA----NTTSKENGDGTVTVTSEYSLVP-TPEANGKEVTCKVEHETLQEPQ 87 (95)
T ss_pred ccEEEEEEcCCCCCCcEEEEEcCCC---CCe----eEEEEeCCCCCEEEEEEEEEec-CHHHCCCEEEEEEeCcccCCCe
Confidence 3457899887 89999999998621 100 0111222344555566777644 444555 899999998755554
Q ss_pred EEEEE
Q psy1672 348 NFTLQ 352 (600)
Q Consensus 348 ~v~L~ 352 (600)
.+.+.
T Consensus 88 ~~~~~ 92 (95)
T cd07703 88 LLPVT 92 (95)
T ss_pred EEEEE
Confidence 44443
No 244
>PHA03376 BARF1; Provisional
Probab=95.82 E-value=0.06 Score=50.04 Aligned_cols=87 Identities=20% Similarity=0.206 Sum_probs=52.5
Q ss_pred cccccccccceeeeEee---cCCCCeeEEEEcCe----ecc-CC------cccCccceEEEeeCCceeeeeeEEEecCCC
Q psy1672 263 YVEAVSSENATVVCRVD---SIPPAAISWYWNGR----LLL-NN------TAFSSYQRIFVIEQGEYERKSSLVLTNAQE 328 (600)
Q Consensus 263 ~~~v~~G~~v~L~C~v~---g~P~p~i~W~~~g~----~l~-~~------~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~ 328 (600)
.+.+..|+.+.|.|.-. ..+.-.|.|++.+. .+. -. ..+...+++.++.+. ..-+|.|.+++.
T Consensus 20 pVta~VGEda~LsC~lnp~ssa~~MrIrWqKs~p~~~~VvL~~~ggdVv~~QmEyRGrtD~~~~~---gnvsLvI~~l~l 96 (221)
T PHA03376 20 AVTAFLGERVTLTSYWRRVSLGPEIEVSWFKLGPGEEQVLIGRMHHDVIFIEWPFRGFFDIHRSA---NTFFLVVTAANI 96 (221)
T ss_pred chhheeCCcEEEEecccCccCCCceEEEEEecCCCCCCEEEEEcCCeeeeeeeccccEEEEEecC---CeEEEEEEeeee
Confidence 56678899999999665 22345789999431 111 00 011111222222222 245799999999
Q ss_pred CCCeEEEEEEecCCCceeEEEEEE
Q psy1672 329 SDSGRFYCVAENRAGIADANFTLQ 352 (600)
Q Consensus 329 ~d~G~Y~C~a~N~~G~~~~~v~L~ 352 (600)
+|.|.|+|..+-.-....+.-.|.
T Consensus 97 SDdGtY~C~fQkge~~~~k~ehLt 120 (221)
T PHA03376 97 SHDGNYLCRMKLGETEVTKQEHLS 120 (221)
T ss_pred cCCceEEEEEEcCCCceeeeeeee
Confidence 999999999997654444443333
No 245
>cd05767 IgC_MHC_II_alpha Class II major histocompatibility complex (MHC) alpha chain immunoglobulin domain. IgC_MHC_II_alpha: Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class II alpha chain. MHC class II molecules play a key role in the initiation of the antigen-specific immune reponse. In both humans and in mice these molecules have been shown to be expressed constitutively on the cell surface of professional antigen-presenting cells (APCs), for example on B-lymphocytes, monocytes, and macrophages. The expression of these molecules has been shown to be induced in nonprofessional APCs such as keratinocyctes, and they are expressed on the surface of activated human T cells and on T cells from other species. The MHC II molecules present antigenic peptides to CD4(+) T-lymphocytes. These peptides derive mostly from protelytic processing via the endocytic pathway, of antigens internalized by the APC. These peptides bind to the MHC class II molecules in the endosom
Probab=95.80 E-value=0.074 Score=44.44 Aligned_cols=69 Identities=22% Similarity=0.439 Sum_probs=46.5
Q ss_pred ccccceeeeEeecCCCC--eeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCC
Q psy1672 268 SSENATVVCRVDSIPPA--AISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRA 342 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P~p--~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~ 342 (600)
.+..++|.|.+.|.-+. .++|.++|..+..... ........++++...+.|.+..- +...|+|.+....
T Consensus 14 ~~~~~tL~C~a~gFyP~~I~v~W~~~g~~~~~~~~---~~~~~~~~Dgty~~~s~L~v~~~---~~~~ytC~V~H~~ 84 (94)
T cd05767 14 LGEPNTLICFVDNFFPPVLNVTWLKNGVPVTDGVS---ETRYYPRQDLSFQKFSYLNFTPE---EGDIYSCIVEHWG 84 (94)
T ss_pred CCCCeEEEEEEEEEECCcCEEEEEECCeEccCceE---EeeeEeCCCCcEEEEEEEEEECC---CCCeEEEEEEeCC
Confidence 45567999999985443 6799999988754321 12233445677777778877642 3448999998764
No 246
>cd05766 IgC_MHC_II_beta Class II major histocompatibility complex (MHC) beta chain immunoglobulin domain. IgC_MHC_II_beta: Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class II beta chain. MHC class II molecules play a key role in the initiation of the antigen-specific immune reponse. In both humans and in mice these molecules have been shown to be expressed constitutively on the cell surface of professional antigen-presenting cells (APCs), for example on B-lymphocytes, monocytes, and macrophages. The expression of these molecules has been shown to be induced in nonprofessional APCs such as keratinocyctes, and they are expressed on the surface of activated human T cells and on T cells from other species. The MHC II molecules present antigenic peptides to CD4(+) T-lymphocytes. These peptides derive mostly from protelytic processing via the endocytic pathway, of antigens internalized by the APC. These peptides bind to the MHC class II molecules in the endosome be
Probab=95.79 E-value=0.093 Score=43.86 Aligned_cols=71 Identities=21% Similarity=0.301 Sum_probs=47.1
Q ss_pred ccccceeeeEeecCCCC--eeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCc
Q psy1672 268 SSENATVVCRVDSIPPA--AISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGI 344 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P~p--~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~ 344 (600)
.|+.++|.|.+.|.-++ .+.|.++|+.+..... .....-..++++...+.|.+.. .+...|+|.+......
T Consensus 13 ~~~~~~L~C~~~gFyP~~i~v~W~~~g~~~~~~~~---~~~~~~~~dgTy~~~s~L~~~~---~~~~~ysC~V~H~~l~ 85 (94)
T cd05766 13 LSHPHLLVCHVWGFYPPEITVKWFKNGQEETEGVV---STELIPNGDWTYQILVMLETTP---SRGDTYTCVVEHSSLQ 85 (94)
T ss_pred CCCCeEEEEEEeeecCCCCEEEEEECCeecCCCce---ecceEECCCCcEEEEEEEEEcC---CCCCEEEEEEEeCCCC
Confidence 57889999999985443 6799999988765421 1122233445666667776643 3445899999986543
No 247
>KOG1026|consensus
Probab=95.59 E-value=0.031 Score=62.96 Aligned_cols=117 Identities=22% Similarity=0.373 Sum_probs=64.9
Q ss_pred CCCCEEEcCCCc---CCCCCcccccccccccEEEccCCcCccccccccchhhhcccCCCC-CCCCCCCCccccccccccc
Q psy1672 171 KSLESIKLNGNR---LSHFPVRSVEPLLKLMMIELHDNPWVCDCNMRSIKMWLADKKNVP-VQPACTGPERLSGKVFSDL 246 (600)
Q Consensus 171 ~~L~~L~Ls~N~---l~~l~~~~~~~l~~L~~L~l~~N~~~C~C~l~~l~~w~~~~~~~~-~~~~C~~p~~l~g~~l~~l 246 (600)
+.+....+..+. +..++...++.+.. ..+.+..|++.|.|..+|+..|-......+ ....|..... +..+...
T Consensus 109 ~~~~~~~~~~~~~~~~~~~~~~~~e~~~~-~~l~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~c~~~~~--~~~~~~~ 185 (774)
T KOG1026|consen 109 SRLRRDNLSTNDTGVLGSLSTNGFETLSL-TELSLVGNPFTCSCSIRWLDRYREDGFCVPYRGLACLNFLS--NGTVANE 185 (774)
T ss_pred ccccccccchhhhcccccccccccccccc-chhhhccCCCCcchhhhHHhhhcccCCCCCchhhHHHhhcC--Cceehhh
Confidence 334444444444 33333334444332 333444499999999999886655332222 2334553322 1222211
Q ss_pred cccccCc-ccccccccccccccccccceeeeEeecCCCCeeEEEEcC
Q psy1672 247 HADDFAC-KPEIRMDSRYVEAVSSENATVVCRVDSIPPAAISWYWNG 292 (600)
Q Consensus 247 ~~~~~~C-~p~i~~~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~~g 292 (600)
... .| .+..........+..+..+++.|.+.+.|.+.+.|+.+.
T Consensus 186 ~~~--~~~~~~~~~~~~~~~v~~~~~~~~~c~~~~~~vp~~~~~~~~ 230 (774)
T KOG1026|consen 186 SIQ--LCGEIENRIRAANLTVEEGSSITLKCSQAGIPVPCHYWFPNC 230 (774)
T ss_pred hhh--hhcchhhhhhhhhhhhcccchheeeeecccCCCcceeeeccc
Confidence 111 13 223333334567788999999999999999999998643
No 248
>cd05770 IgC_beta2m Class I major histocompatibility complex (MHC) beta2-microglobulin. IgC_beta2m: Immunoglobulin-like domain in beta2-Microglobulin (beta2m). Beta2m is the non-covalently bound light chain of the human class I major histocompatibility complex (MHC-I). Beta2m is structured as a beta-sandwich domain composed of two facing beta-sheets (four stranded and three stranded), that is typical of the C-type immunoglobulin superfamily. This structure is stabilized by an intramolecular disulfide bridge connecting two Cys residues in the facing beta -sheets. In vivo, MHC-I continuously exposes beta2m on the cell surface, where it may be released to plasmatic fluids, transported to the kidneys, degraded and then excreted.
Probab=95.59 E-value=0.11 Score=43.37 Aligned_cols=69 Identities=13% Similarity=0.201 Sum_probs=47.2
Q ss_pred cccccceeeeEeecCCCC--eeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCC
Q psy1672 267 VSSENATVVCRVDSIPPA--AISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRA 342 (600)
Q Consensus 267 ~~G~~v~L~C~v~g~P~p--~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~ 342 (600)
..|...+|.|.+.|.-++ .++|.++|..+. ... ........++++...+.|.+.. .+...|+|.+....
T Consensus 13 ~~g~~~~L~C~a~gFyP~~i~v~W~~dg~~~~-~~~---~~~~~p~~d~tyq~~s~l~~~~---~~~~~ysC~V~H~~ 83 (93)
T cd05770 13 ENGKPNVLNCYVTGFHPPDIEIRLLKNGVKIP-KVE---QSDLSFSKDWTFYLLKSTEFTP---TKGDEYACRVRHNS 83 (93)
T ss_pred cCCCceEEEEEEEEEeCCCCEEEEEECCEECC-CcE---ECcEEECCCCCEEEEEEEEECC---CCCCeEEEEEEECC
Confidence 346667899999985544 679999999876 331 2234445567777677776663 34457999999753
No 249
>cd05769 IgC_TCR_beta T cell receptor (TCR) beta chain constant immunoglobulin domain. IgC_TCR_beta: Constant domain of the beta chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group includes the variable domain of the beta chain. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The antigen binding site is formed by the variable domains of the alpha and beta chains, located at the N-terminus of each chain. Alpha/beta TCRs recognize antigens differently from gamma/delta TCRs.
Probab=95.45 E-value=0.074 Score=46.23 Aligned_cols=81 Identities=22% Similarity=0.371 Sum_probs=52.1
Q ss_pred cccccccceeeeEeecCCCC--eeEEEEcCeeccCCcccCccceEEEee-CCceeeeeeEEEecCCCCC-CeEEEEEEec
Q psy1672 265 EAVSSENATVVCRVDSIPPA--AISWYWNGRLLLNNTAFSSYQRIFVIE-QGEYERKSSLVLTNAQESD-SGRFYCVAEN 340 (600)
Q Consensus 265 ~v~~G~~v~L~C~v~g~P~p--~i~W~~~g~~l~~~~~~~~~~~~~~~~-~g~~~~~s~L~I~~v~~~d-~G~Y~C~a~N 340 (600)
+...+..++|.|.+.+.-+. .|.|.++|+.+...... ....... ++++...+.|.+....-.+ ...|+|.+..
T Consensus 14 e~~~~~~~tL~Cla~gFyP~~I~V~W~kng~~l~~g~~~---~~~~~~~~~gTYs~~S~L~v~~~~w~~~~~~ytC~V~H 90 (115)
T cd05769 14 EIRNKRKATLVCLATGFYPDHVSLSWKVNGKEVTDGVAT---DPQALRENTSTYSISSRLRVSATEWFNPRNTFTCIVQF 90 (115)
T ss_pred HhccCCCcEEEEEEEeEeCCCcEEEEEECCEECCCCccc---ccceecCCCCeEEEEEEEEEChHHhccCCCeEEEEEEE
Confidence 33356678999999975443 78999999887654311 0111222 2566777888887654434 3479999998
Q ss_pred CCCceeEE
Q psy1672 341 RAGIADAN 348 (600)
Q Consensus 341 ~~G~~~~~ 348 (600)
........
T Consensus 91 ~g~~~~~~ 98 (115)
T cd05769 91 YGGTDTDK 98 (115)
T ss_pred eCCcccee
Confidence 76555443
No 250
>cd07697 IgC_TCR_gamma T cell receptor (TCR) gamma chain constant immunoglobulin domain. IgC_TCR_gamma; immunoglobulin (Ig) constant (C) domain of the gamma chain of gamma-delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha-beta TCRs but a small subset contain gamma-delta TCRs. Alpha-beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma-delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma-delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds.
Probab=95.08 E-value=0.15 Score=42.77 Aligned_cols=70 Identities=13% Similarity=0.260 Sum_probs=43.9
Q ss_pred cccccceeeeEeecCCCC--eeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCC
Q psy1672 267 VSSENATVVCRVDSIPPA--AISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRA 342 (600)
Q Consensus 267 ~~G~~v~L~C~v~g~P~p--~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~ 342 (600)
..+..++|.|.|.|.-++ .++|.++|..+..... ... ....++++...+.|.+..-.. ...|+|.+....
T Consensus 14 ~~~~~~tL~C~a~gFyP~~I~v~W~kng~~~~~~~~---~~~-~~~~~dty~~~S~L~vt~~~~--~~~ysC~V~H~g 85 (96)
T cd07697 14 EKQGQGIYLCLLENFFPDVIQVHWREGNSPSILGSQ---KSE-KDKDNDVYSTTSWLTVTKDSL--GKKFRCIYKHEG 85 (96)
T ss_pred ccCCCEEEEEEEEEEeCCCeEEEEEECCEECcCCeE---ecc-EecCCCEEEEEEEEEECchhC--CCeEEEEEEECC
Confidence 345678999999985444 6799999987654321 111 122334566677777664422 235999998743
No 251
>cd05771 IgC_Tapasin_R Tapasin-R immunoglobulin-like domain. IgC_Tapasin_R: Immunoglobulin-like domain on Tapasin-R. Tapasin is a V-C1 (variable-constant) immunoglobulin superfamily molecule present in the endoplasmic reticulum (ER), where it links MHC class I molecules to the transporter associated with antigen processing (TAP). Tapasin-R is a tapasin-related protein that contains similar structural motifs to Tapasin, with some marked differences, especially in the V domain, transmembrane and cytoplasmic regions. The majority of Tapasin-R is located within the ER; however, there may be some expression of Tapasin-R at the cell surface. Tapasin-R lacks an obvious ER retention signal.
Probab=95.07 E-value=0.029 Score=50.56 Aligned_cols=37 Identities=24% Similarity=0.337 Sum_probs=33.4
Q ss_pred eEEEecCCCCCCeEEEEEEecCCCceeEEEEEEEEEc
Q psy1672 320 SLVLTNAQESDSGRFYCVAENRAGIADANFTLQVTYR 356 (600)
Q Consensus 320 ~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L~V~~~ 356 (600)
+|.|.+++..|.|.|+|.+.+..|.....+.|.|...
T Consensus 2 sL~i~~v~~~D~G~Y~C~~~~~~~~~~~~~~l~v~~~ 38 (139)
T cd05771 2 SLTLPGLTVHDEGTYICSVSTPPHQAQQIIQLSVSEP 38 (139)
T ss_pred eEEECCCCHHHCEEEEEEEEccCcceeeEEEEEEecC
Confidence 6899999999999999999999999988888888644
No 252
>cd07692 Ig_CD3_epsilon Immunoglobulin (Ig)-like domain of CD3 epsilon chain. Ig_CD3_epsilon; immunoglobulin (Ig)-like domain of CD3 epsilon chain. CD3 is a T cell surface receptor that is associated with alpha/beta T cell receptors (TCRs). The CD3 complex consists of one gamma, one delta, two epsilon, and two zeta chains. The CD3 subunits form heterodimers as gamma/epsilon, delta/epsilon, and zeta/zeta. The gamma, delta, and epsilon chains each contain an extracellular Ig domain, whereas the extracellular domains of the zeta chains are very small and have unknown structure. The CD3 domain participates in intracellular signalling once the TCR has bound an MHC/antigen complex.
Probab=94.60 E-value=0.064 Score=41.10 Aligned_cols=52 Identities=27% Similarity=0.474 Sum_probs=34.1
Q ss_pred cccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecC
Q psy1672 267 VSSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 267 ~~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~ 341 (600)
..|..|+|+|...+ ..+.|.+++..+.... ..+.+.+-. +++|.|.|.+.+.
T Consensus 5 isGTtVtlTCP~~~---~~i~W~~n~~~~~g~~-------------------~~~~~~~~~-e~~G~Y~C~~~~~ 56 (65)
T cd07692 5 ISGTTVTVTCPLSG---DDIKWKKNDQVSQGSD-------------------EKYLSLNHF-SSSGYYHCTADNA 56 (65)
T ss_pred EeccEEEEECCCCC---CCceEEeCCccCCCCC-------------------ceEEeeccC-CCCceEEEEeCCC
Confidence 46889999997652 2399999875443211 023333444 8899999999754
No 253
>cd04985 IgC_CH1 CH1 domain (first constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH1: The first immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fab antigen-binding fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=94.47 E-value=0.2 Score=41.94 Aligned_cols=71 Identities=21% Similarity=0.443 Sum_probs=44.8
Q ss_pred ccccceeeeEeecCCCC--eeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCC
Q psy1672 268 SSENATVVCRVDSIPPA--AISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRA 342 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P~p--~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~ 342 (600)
.++.++|.|.+.|.-+. .|+|.++|+. .... ...... ...++++...+.|.+....-.....|+|.+....
T Consensus 15 ~~~~~~L~C~a~gFyP~~i~vtW~k~g~~-~~~~--~~~~~~-~~~dgty~~~s~L~v~~~~w~~~~~ytC~V~H~~ 87 (95)
T cd04985 15 SSDSVTLGCLATGFLPEPVTFTWNSGSNS-TSGV--KTYPAV-LQSGGLYTASSQLTVPASEWKGKESFYCKVEHPS 87 (95)
T ss_pred CCCcEEEEEEEeeEECCCcEEEEeECCEE-CCCc--EECCCE-eCCCCCEEEEEEEEEeHHHcCCCCcEEEEEEeCC
Confidence 35578999999985443 6789999987 3321 111111 1226777777778776543222346999999864
No 254
>KOG4597|consensus
Probab=94.46 E-value=0.06 Score=56.48 Aligned_cols=90 Identities=16% Similarity=0.120 Sum_probs=65.9
Q ss_pred ccccccccccccceeeeEeecCCCCeeEEEE---cCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEE
Q psy1672 260 DSRYVEAVSSENATVVCRVDSIPPAAISWYW---NGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYC 336 (600)
Q Consensus 260 ~~~~~~v~~G~~v~L~C~v~g~P~p~i~W~~---~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C 336 (600)
.+....+..+++..++|-+.|.+.+.|.|.+ ++..+.- . ....+++-..+....|.|-+.+..|.|.|+|
T Consensus 202 cpa~w~vg~wetcS~tCg~~G~q~r~V~c~qv~anr~~vv~---~----~nq~~e~p~vtstcql~ic~ewq~~a~w~tC 274 (560)
T KOG4597|consen 202 CPAEWFVGDWETCSSTCGVQGRQYRVVTCEQVFANRENVVM---R----PNQTVENPVVTSTCQLVICNEWQADAGWYTC 274 (560)
T ss_pred CcchhhcccchhhcccccccCCcCceeeeehhhccccceee---c----CccccCCcceeeeeeEEEcchhhcCCCceee
Confidence 3445567788999999999999999999976 2222110 0 1112222223445689999999999999999
Q ss_pred EEecCCCceeEEEEEEEEEc
Q psy1672 337 VAENRAGIADANFTLQVTYR 356 (600)
Q Consensus 337 ~a~N~~G~~~~~v~L~V~~~ 356 (600)
.|.|.+|..++.|.+.+...
T Consensus 275 s~rcg~g~~~rdv~c~s~~g 294 (560)
T KOG4597|consen 275 SARCGAGFLRRDVPCSSVKG 294 (560)
T ss_pred ccccccceeeccceeeeecc
Confidence 99999999999998887543
No 255
>cd07691 Ig_CD3_gamma_delta Immunoglobulin (Ig)-like domain of CD3 gamma and delta chains. Ig_CD3_gamma_delta; immunoglobulin (Ig)-like domain of CD3 gamma and delta chains. CD3 is a T cell surface receptor that is associated with alpha/beta T cell receptors (TCRs). The CD3 complex consists of one gamma, one delta, two epsilon, and two zeta chains. The CD3 subunits form heterodimers as gamma/epsilon, delta/epsilon, and zeta/zeta. The gamma, delta, and epsilon chains each contain an extracellular Ig domain, whereas the extracellular domains of the zeta chains are very small and have unknown structure. The CD3 domain participates in intracellular signalling once the TCR has bound an MHC/antigen complex.
Probab=94.33 E-value=0.1 Score=40.28 Aligned_cols=61 Identities=25% Similarity=0.429 Sum_probs=40.2
Q ss_pred ccccceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeE
Q psy1672 268 SSENATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADA 347 (600)
Q Consensus 268 ~G~~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~ 347 (600)
..+.|.|.|.+. .+|.|++ |..+.... ...|.+......-.|.|.|.+++ ...
T Consensus 5 ~~~~V~L~C~~~----tsi~W~k-G~~~~~~~------------------~~tlnLGs~~~DPRG~Y~C~~s~----~~~ 57 (69)
T cd07691 5 SEGKVFLKCNGA----TNITWKK-GKEILEVS------------------NTLLDLGSRINDPRGTYSCKESE----PNK 57 (69)
T ss_pred cCceEEEEecCC----CcEEEec-Cccccccc------------------ccEEeccCcccCCCcceEecCcc----CCC
Confidence 345789999662 5699999 54332111 12577888888889999999887 233
Q ss_pred EEEEEEEE
Q psy1672 348 NFTLQVTY 355 (600)
Q Consensus 348 ~v~L~V~~ 355 (600)
...|.|.+
T Consensus 58 ~~~LQVyY 65 (69)
T cd07691 58 EKTLQVYY 65 (69)
T ss_pred cEEEEEEE
Confidence 44555543
No 256
>cd07704 Ig2_Nectin-3-4_like Second immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3), nectin-4 (poliovirus receptor related protein 4) and similar proteins. Ig2_Nectin-3-4_like: domain similar to the second immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and nectin-4 (poliovirus receptor related protein 4). Nectin-3 and nectin-4 belong to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectin-2 and nectin-3 localize at Sertoli-spermatid junctions where they form heterophilic trans-interactions between the cells that are essential for the formation and maintenance of the junctions and for spermatid development. Nect
Probab=94.09 E-value=0.23 Score=41.62 Aligned_cols=74 Identities=15% Similarity=0.162 Sum_probs=48.9
Q ss_pred ccccccccccee-eeEee-cCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEec
Q psy1672 263 YVEAVSSENATV-VCRVD-SIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAEN 340 (600)
Q Consensus 263 ~~~v~~G~~v~L-~C~v~-g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N 340 (600)
.+.+.+|..+.+ .|.+. |.|.++|.|+.+..-.. ........+|++...+.+.+......|--.++|.+..
T Consensus 10 ~~~~~~g~~~~vA~C~sa~gkPaa~IsW~~~~~G~~-------~~~~~~~~ngT~TV~S~~~l~p~r~d~G~~vtC~V~H 82 (97)
T cd07704 10 SLLIDGGNGTTLAACCAAEGRPAADVTWETNVYGTS-------ESHSQEHPNGTTTVTSEYIWVPSRHANGHPLTCVVSH 82 (97)
T ss_pred eeEeecCcceeEEEEEccCCccCCEeEEeCCCCCcc-------ceeeecCCCCCEEEEEEEEEEeCHHHCCcEEEEEEeC
Confidence 345667788888 88776 89999999997532111 1122334456777777787755544444489999998
Q ss_pred CCC
Q psy1672 341 RAG 343 (600)
Q Consensus 341 ~~G 343 (600)
..-
T Consensus 83 ~al 85 (97)
T cd07704 83 PAL 85 (97)
T ss_pred ccc
Confidence 754
No 257
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=94.05 E-value=0.017 Score=34.17 Aligned_cols=16 Identities=69% Similarity=0.744 Sum_probs=7.8
Q ss_pred ccEEEccCCCCCCCCc
Q psy1672 101 LIEIDLSDNLLTSIPS 116 (600)
Q Consensus 101 L~~L~Ls~N~l~~l~~ 116 (600)
|++|||++|+|+.+|+
T Consensus 2 L~~Ldls~n~l~~ip~ 17 (22)
T PF00560_consen 2 LEYLDLSGNNLTSIPS 17 (22)
T ss_dssp ESEEEETSSEESEEGT
T ss_pred ccEEECCCCcCEeCCh
Confidence 4445555555544444
No 258
>PHA02633 hypothetical protein; Provisional
Probab=93.98 E-value=0.14 Score=38.56 Aligned_cols=38 Identities=26% Similarity=0.527 Sum_probs=32.0
Q ss_pred eeEEEecCCCCCCeEEEEEEecCCCceeEEEEEEEEEc
Q psy1672 319 SSLVLTNAQESDSGRFYCVAENRAGIADANFTLQVTYR 356 (600)
Q Consensus 319 s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L~V~~~ 356 (600)
..|.|-++..+|+|.|.|+.+|..--...++.+.|...
T Consensus 18 ~nLwilpa~~sDSGiYiC~~rn~t~c~~~si~l~V~~~ 55 (63)
T PHA02633 18 NNMLILNPTQSDSGIYMCITKNETYSDMMKFDLCICLR 55 (63)
T ss_pred ccEEEeccccccCcEEEEEEcCCCeeEEEEEEEEEeec
Confidence 37899999999999999999998766777788877544
No 259
>PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []. This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.
Probab=93.86 E-value=0.14 Score=34.34 Aligned_cols=21 Identities=24% Similarity=0.423 Sum_probs=12.6
Q ss_pred hhHHHHHHHHHHHHHHHHHHH
Q psy1672 368 INGISLALFFLIILILIIIIY 388 (600)
Q Consensus 368 i~gi~~g~~l~l~lillii~~ 388 (600)
.++|++|++++++++++.+++
T Consensus 5 ~IaIIv~V~vg~~iiii~~~~ 25 (38)
T PF02439_consen 5 TIAIIVAVVVGMAIIIICMFY 25 (38)
T ss_pred hhhHHHHHHHHHHHHHHHHHH
Confidence 456666666666666555544
No 260
>cd04986 IgC_CH2 CH2 domain (second constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH2: The second immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=93.21 E-value=0.28 Score=41.32 Aligned_cols=71 Identities=21% Similarity=0.339 Sum_probs=45.3
Q ss_pred ccccccceeeeEeecCC-C--CeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCe-EEEEEEecC
Q psy1672 266 AVSSENATVVCRVDSIP-P--AAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSG-RFYCVAENR 341 (600)
Q Consensus 266 v~~G~~v~L~C~v~g~P-~--p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G-~Y~C~a~N~ 341 (600)
...+..++|.|.+.+.- + ..|.|.++|.. . .. ........++++...+.|.+.. ..-..| .|+|.+...
T Consensus 16 l~~~~~atLtClV~~f~~P~~i~V~W~~~g~~-~-~~----~t~~~~~~dgTys~~S~L~v~~-~~W~~g~~ytC~V~H~ 88 (99)
T cd04986 16 LLLGSSASLTCTLSGLRDPEGAVFTWTPSGGK-E-AV----QTSAESDQCGCYSVSSVLPGCA-EEWNKGEPFACTVTHP 88 (99)
T ss_pred hCcCCccEEEEEEeccCCCCCeEEEEEECCcc-C-cE----EcCcccCCCCCEEEEEEEEeCH-HHhcCCCeEEEEEECC
Confidence 44678899999999754 2 37899998865 1 11 0111123456677777787663 233445 599999987
Q ss_pred CC
Q psy1672 342 AG 343 (600)
Q Consensus 342 ~G 343 (600)
..
T Consensus 89 ~l 90 (99)
T cd04986 89 EG 90 (99)
T ss_pred Cc
Confidence 54
No 261
>KOG2120|consensus
Probab=92.91 E-value=0.0027 Score=63.03 Aligned_cols=131 Identities=21% Similarity=0.150 Sum_probs=83.4
Q ss_pred CccEEEeecccCcccC-ccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEccCCC-CCccCc-ccccCCCCccee
Q psy1672 76 NLQKLFLARCHIGQID-SGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNP-ISKIEK-GAFQFVPGLVKL 152 (600)
Q Consensus 76 ~L~~L~L~~n~l~~i~-~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~-i~~l~~-~~~~~l~~L~~L 152 (600)
.|++|+|++..|+.-. ...+..+.+|+.|.|.++++..-.-..+..-.+|+.|+|+.+. ++.... -.|..++.|++|
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L 265 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL 265 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence 5888888887764321 2235667788888888888876444456667789999998753 544322 346678889999
Q ss_pred eCCCCcCcccChhh-hc-CCCCCCEEEcCCCcCC--CCCc-ccccccccccEEEccCCc
Q psy1672 153 DMSESRLEHISPEA-FT-GAKSLESIKLNGNRLS--HFPV-RSVEPLLKLMMIELHDNP 206 (600)
Q Consensus 153 ~Ls~n~l~~i~~~~-~~-~l~~L~~L~Ls~N~l~--~l~~-~~~~~l~~L~~L~l~~N~ 206 (600)
+|+.+.+..-.... .. --++|..|+|+++.-. .-.. .....++.|..|||+++.
T Consensus 266 NlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v 324 (419)
T KOG2120|consen 266 NLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSV 324 (419)
T ss_pred CchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeecccccc
Confidence 99888664321111 11 1357788888876321 1111 122456889999998865
No 262
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=92.47 E-value=0.096 Score=32.22 Aligned_cols=21 Identities=52% Similarity=0.776 Sum_probs=11.6
Q ss_pred CCccEEEccCCCCCCCCcccc
Q psy1672 99 TNLIEIDLSDNLLTSIPSLTF 119 (600)
Q Consensus 99 ~~L~~L~Ls~N~l~~l~~~~f 119 (600)
.+|++|+|++|+|+.++...|
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f 22 (26)
T smart00369 2 PNLRELDLSNNQLSSLPPGAF 22 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHc
Confidence 445555555555555555444
No 263
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=92.47 E-value=0.096 Score=32.22 Aligned_cols=21 Identities=52% Similarity=0.776 Sum_probs=11.6
Q ss_pred CCccEEEccCCCCCCCCcccc
Q psy1672 99 TNLIEIDLSDNLLTSIPSLTF 119 (600)
Q Consensus 99 ~~L~~L~Ls~N~l~~l~~~~f 119 (600)
.+|++|+|++|+|+.++...|
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f 22 (26)
T smart00370 2 PNLRELDLSNNQLSSLPPGAF 22 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHc
Confidence 445555555555555555444
No 264
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=92.21 E-value=0.061 Score=31.80 Aligned_cols=16 Identities=31% Similarity=0.293 Sum_probs=8.3
Q ss_pred ccEEEeecccCcccCc
Q psy1672 77 LQKLFLARCHIGQIDS 92 (600)
Q Consensus 77 L~~L~L~~n~l~~i~~ 92 (600)
|++|+|++|+|+.|++
T Consensus 2 L~~Ldls~n~l~~ip~ 17 (22)
T PF00560_consen 2 LEYLDLSGNNLTSIPS 17 (22)
T ss_dssp ESEEEETSSEESEEGT
T ss_pred ccEEECCCCcCEeCCh
Confidence 4555555555554443
No 265
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D ....
Probab=91.75 E-value=0.1 Score=28.79 Aligned_cols=13 Identities=62% Similarity=0.710 Sum_probs=4.4
Q ss_pred ccEEEccCCCCCC
Q psy1672 101 LIEIDLSDNLLTS 113 (600)
Q Consensus 101 L~~L~Ls~N~l~~ 113 (600)
|+.|+|++|+|++
T Consensus 3 L~~L~l~~n~L~~ 15 (17)
T PF13504_consen 3 LRTLDLSNNRLTS 15 (17)
T ss_dssp -SEEEETSS--SS
T ss_pred cCEEECCCCCCCC
Confidence 4444444444443
No 266
>cd05721 IgV_CTLA-4 Immunoglobulin (Ig) domain of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). IgV_CTLA-4: domain similar to the variable(v)-type immunoglobulin (Ig) domain found in cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). CTLA-4 is involved in the regulation of T cell response, acting as an inhibitor of intracellular signalling. CTLA-4 is similar to CD28, a T cell co-receptor protein that recognizes the B7 proteins (CD80 and CD86). CD28 binding of the B7 proteins occurs after the presentation of antigen to the T cell receptor (TCR) via the peptide-MHC complex on the surface of an antigen presenting cell (APC). CTLA-4 also binds the B7 molecules with a higher affinity than does CD28. The B7/CTLA-4 interaction generates inhibitory signals down-regulating the response, and may prevent T cell activation by weak TCR signals. CD28 and CTLA-4 then elicit opposing signals in the regulation of T cell responsiveness and homeostasis. T cell activation leads to increased
Probab=91.33 E-value=0.64 Score=40.14 Aligned_cols=75 Identities=17% Similarity=0.135 Sum_probs=44.4
Q ss_pred cccccccccceeeeEeecCCC---CeeEEEE--cCeecc------CC--cccCccceEEEeeCCceeeeeeEEEecCCCC
Q psy1672 263 YVEAVSSENATVVCRVDSIPP---AAISWYW--NGRLLL------NN--TAFSSYQRIFVIEQGEYERKSSLVLTNAQES 329 (600)
Q Consensus 263 ~~~v~~G~~v~L~C~v~g~P~---p~i~W~~--~g~~l~------~~--~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~ 329 (600)
...+..|..++|.|++.|... -.++|.+ ++ .+. .. .......+.....+ .......|+|.+++.+
T Consensus 7 ~~lv~p~~sv~LsC~~sg~~~s~e~~~~wvRq~pg-~lE~c~~~~~~g~~~~~~~~r~tcs~~-~s~ntv~L~l~~L~a~ 84 (115)
T cd05721 7 PVLASSNGAASLVCEYTYNGFSKEFRASLLKGADS-AVEVCAVTGNMSNQLQTSLDGFNCDGT-LGNEQVNFTLQNLRAN 84 (115)
T ss_pred CeEEcCCCCEEEEEEecCCccccEEEEEEEEeCCC-CcEEEEEEeCCCccccccCCCeEEeEe-CCCCEEEEEEcCCCHH
Confidence 344566778999999976443 3578888 33 211 00 00011122222211 1234568999999999
Q ss_pred CCeEEEEEEe
Q psy1672 330 DSGRFYCVAE 339 (600)
Q Consensus 330 d~G~Y~C~a~ 339 (600)
|++.|.|..+
T Consensus 85 DTa~Y~Ca~e 94 (115)
T cd05721 85 QTDIYFCKIE 94 (115)
T ss_pred HCeEEEEEee
Confidence 9999999653
No 267
>KOG1480|consensus
Probab=91.03 E-value=0.13 Score=57.07 Aligned_cols=71 Identities=23% Similarity=0.376 Sum_probs=53.4
Q ss_pred cccccccccceeeeEee-cCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecC
Q psy1672 263 YVEAVSSENATVVCRVD-SIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 263 ~~~v~~G~~v~L~C~v~-g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~ 341 (600)
...+..++...+.|+.. +.|...+.|++++..+.... ..... ....+++..+...|.|.|+|+|.|.
T Consensus 138 ~q~V~~~s~~~l~cr~pe~~paae~~w~k~e~~~~pd~------n~~~~------~d~~li~~~arlsd~~nytc~a~ni 205 (909)
T KOG1480|consen 138 GQEVQEETTLQLPCRPPEGDPKAEVEWLKNEVVIDPDA------NVIRA------SDHNLIISQARLSDSGNYTCEATNI 205 (909)
T ss_pred hheecccccccccccCcccchhhhhhccccCCCCCccc------cchhh------hcCCccccchhhhhcccceeeeehh
Confidence 34566677888888765 88999999999887666522 11111 2236889999999999999999999
Q ss_pred CCce
Q psy1672 342 AGIA 345 (600)
Q Consensus 342 ~G~~ 345 (600)
++..
T Consensus 206 ~~~r 209 (909)
T KOG1480|consen 206 VAKR 209 (909)
T ss_pred hccc
Confidence 9865
No 268
>PF08374 Protocadherin: Protocadherin; InterPro: IPR013585 The structure of protocadherins is similar to that of classic cadherins (IPR002126 from INTERPRO), but they also have some unique features associated with the cytoplasmic domains. They are expressed in a variety of organisms and are found in high concentrations in the brain where they seem to be localised mainly at cell-cell contact sites. Their expression seems to be developmentally regulated [].
Probab=90.50 E-value=0.49 Score=44.90 Aligned_cols=24 Identities=17% Similarity=0.383 Sum_probs=13.7
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHH
Q psy1672 366 GHINGISLALFFLIILILIIIIYL 389 (600)
Q Consensus 366 ~~i~gi~~g~~l~l~lillii~~~ 389 (600)
.+++||++|++.++++|++++++.
T Consensus 38 ~I~iaiVAG~~tVILVI~i~v~vR 61 (221)
T PF08374_consen 38 KIMIAIVAGIMTVILVIFIVVLVR 61 (221)
T ss_pred eeeeeeecchhhhHHHHHHHHHHH
Confidence 355666666666555555554443
No 269
>PF06365 CD34_antigen: CD34/Podocalyxin family; InterPro: IPR013836 This family consists of several mammalian CD34 antigen proteins. The CD34 antigen is a human leukocyte membrane protein expressed specifically by lymphohematopoietic progenitor cells. CD34 is a phosphoprotein. Activation of protein kinase C (PKC) has been found to enhance CD34 phosphorylation [, ]. This family contains several eukaryotic podocalyxin proteins. Podocalyxin is a major membrane protein of the glomerular epithelium and is thought to be involved in maintenance of the architecture of the foot processes and filtration slits characteristic of this unique epithelium by virtue of its high negative charge. Podocalyxin functions as an anti-adhesin that maintains an open filtration pathway between neighbouring foot processes in the glomerular epithelium by charge repulsion [].
Probab=90.41 E-value=1.1 Score=42.64 Aligned_cols=48 Identities=17% Similarity=0.194 Sum_probs=25.1
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHhHhcCCCCCCCCCCCcceeeccCC
Q psy1672 367 HINGISLALFFLIILILIIIIYLLIRMRTITYPNSKNPAQIEVMANGN 414 (600)
Q Consensus 367 ~i~gi~~g~~l~l~lillii~~~~~rkrr~~~~~~~~~~~~~~~~~~~ 414 (600)
.+|++++.+.+++++++++..|+++.||....+..+-.++.+...++.
T Consensus 101 ~lI~lv~~g~~lLla~~~~~~Y~~~~Rrs~~~~~~rl~Ee~~~vEng~ 148 (202)
T PF06365_consen 101 TLIALVTSGSFLLLAILLGAGYCCHQRRSWSKKGQRLGEELYTVENGY 148 (202)
T ss_pred EEEehHHhhHHHHHHHHHHHHHHhhhhccCCcchhhhccCceecccCc
Confidence 344555444344444444455555555544455555666666665543
No 270
>PTZ00382 Variant-specific surface protein (VSP); Provisional
Probab=90.32 E-value=0.058 Score=45.17 Aligned_cols=33 Identities=21% Similarity=0.324 Sum_probs=19.9
Q ss_pred ccCcchhHHHHHHHHHHHHHHHHHHHHHhHhcC
Q psy1672 363 LGGGHINGISLALFFLIILILIIIIYLLIRMRT 395 (600)
Q Consensus 363 ~~~~~i~gi~~g~~l~l~lillii~~~~~rkrr 395 (600)
+..+.|+||++|+++++..++.+++++|++|||
T Consensus 63 ls~gaiagi~vg~~~~v~~lv~~l~w~f~~r~k 95 (96)
T PTZ00382 63 LSTGAIAGISVAVVAVVGGLVGFLCWWFVCRGK 95 (96)
T ss_pred cccccEEEEEeehhhHHHHHHHHHhheeEEeec
Confidence 344678888888776665555444444444443
No 271
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=90.20 E-value=0.21 Score=30.66 Aligned_cols=22 Identities=27% Similarity=0.460 Sum_probs=13.0
Q ss_pred CCccEEEeecccCcccCccccC
Q psy1672 75 LNLQKLFLARCHIGQIDSGALD 96 (600)
Q Consensus 75 ~~L~~L~L~~n~l~~i~~~~f~ 96 (600)
.+|+.|+|++|+|+.+++++|.
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f~ 23 (26)
T smart00369 2 PNLRELDLSNNQLSSLPPGAFQ 23 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHcc
Confidence 4566666666666666555553
No 272
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=90.20 E-value=0.21 Score=30.66 Aligned_cols=22 Identities=27% Similarity=0.460 Sum_probs=13.0
Q ss_pred CCccEEEeecccCcccCccccC
Q psy1672 75 LNLQKLFLARCHIGQIDSGALD 96 (600)
Q Consensus 75 ~~L~~L~L~~n~l~~i~~~~f~ 96 (600)
.+|+.|+|++|+|+.+++++|.
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f~ 23 (26)
T smart00370 2 PNLRELDLSNNQLSSLPPGAFQ 23 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHcc
Confidence 4566666666666666555553
No 273
>PF14991 MLANA: Protein melan-A; PDB: 2GTZ_F 2GT9_F 3MRO_P 2GUO_C 3MRQ_P 2GTW_C 3L6F_C 3MRP_P.
Probab=89.95 E-value=0.063 Score=45.21 Aligned_cols=22 Identities=23% Similarity=0.211 Sum_probs=0.0
Q ss_pred HHHHHHHHHHHHHhHhcCCCCC
Q psy1672 378 LIILILIIIIYLLIRMRTITYP 399 (600)
Q Consensus 378 ~l~lillii~~~~~rkrr~~~~ 399 (600)
+|+.+++++-+||+|||..++.
T Consensus 34 VILgiLLliGCWYckRRSGYk~ 55 (118)
T PF14991_consen 34 VILGILLLIGCWYCKRRSGYKT 55 (118)
T ss_dssp ----------------------
T ss_pred HHHHHHHHHhheeeeecchhhh
Confidence 3444455566777776666543
No 274
>PF01034 Syndecan: Syndecan domain; InterPro: IPR001050 The syndecans are transmembrane proteoglycans which are involved in the organisation of cytoskeleton and/or actin microfilaments, and have important roles as cell surface receptors during cell-cell and/or cell-matrix interactions [, ]. Structurally, these proteins consist of four separate domains: A signal sequence; An extracellular domain (ectodomain) of variable length whose sequence is not evolutionary conserved in the various forms of syndecans. The ectodomain contains the sites of attachment of the heparan sulphate glycosaminoglycan side chains; A transmembrane region; A highly conserved cytoplasmic domain of about 30 to 35 residues, which could interact with cytoskeletal proteins. The proteins known to belong to this family are: Syndecan 1. Syndecan 2 or fibroglycan. Syndecan 3 or neuroglycan or N-syndecan. Syndecan 4 or amphiglycan or ryudocan. Drosophila syndecan. Caenorhabditis elegans probable syndecan (F57C7.3). Syndecan-4, a transmembrane heparan sulphate proteoglycan, is a coreceptor with integrins in cell adhesion. It has been suggested to form a ternary signalling complex with protein kinase Calpha and phosphatidylinositol 4,5-bisphosphate (PIP2). Structural studies have demonstrated that the cytoplasmic domain undergoes a conformational transition and forms a symmetric dimer in the presence of phospholipid activator PIP2, and whose overall structure in solution exhibits a twisted clamp shape having a cavity in the centre of dimeric interface. In addition, it has been observed that the syndecan-4 variable domain interacts, strongly, not only with fatty acyl groups but also the anionic head group of PIP2. These findings indicate that PIP2 promotes oligomerisation of the syndecan-4 cytoplasmic domain for transmembrane signalling and cell-matrix adhesion [, ].; GO: 0008092 cytoskeletal protein binding, 0016020 membrane; PDB: 1EJQ_B 1EJP_B 1YBO_C 1OBY_Q.
Probab=89.60 E-value=0.11 Score=39.34 Aligned_cols=26 Identities=19% Similarity=0.502 Sum_probs=0.4
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHhHhc
Q psy1672 369 NGISLALFFLIILILIIIIYLLIRMR 394 (600)
Q Consensus 369 ~gi~~g~~l~l~lillii~~~~~rkr 394 (600)
+|+++|+++++++++++|.++.+|.|
T Consensus 12 aavIaG~Vvgll~ailLIlf~iyR~r 37 (64)
T PF01034_consen 12 AAVIAGGVVGLLFAILLILFLIYRMR 37 (64)
T ss_dssp -------------------------S
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 44444444433433333333333443
No 275
>PHA03042 CD47-like protein; Provisional
Probab=89.49 E-value=2.1 Score=42.28 Aligned_cols=70 Identities=21% Similarity=0.460 Sum_probs=44.2
Q ss_pred cccceeeeEeecC-----CCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCC
Q psy1672 269 SENATVVCRVDSI-----PPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAG 343 (600)
Q Consensus 269 G~~v~L~C~v~g~-----P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G 343 (600)
.+++.++|.+... ..-.+.|..+++..-. .+++ +.++|.+.... .-.|+|+|.|.+...
T Consensus 31 N~TV~IpC~v~n~~~~ni~~~~V~Wkf~~~~If~-------------~n~t--n~aSL~~~f~~-~l~GNYTCEv~~l~n 94 (286)
T PHA03042 31 NKTIVIVCNLNLLIYYNISNIHINWKFNNKVIFK-------------KNNT--NTSSLKFNFSK-NLSGNYTCEAINKFN 94 (286)
T ss_pred CceEEEEeecCChhhcCccceEEEEEeCCeeEEE-------------ecCC--cceEEEEeccc-cCCCceeEEEeeccc
Confidence 3567889988642 3456899998765421 1222 23467665544 457999999998765
Q ss_pred ceeEEEEEEEE
Q psy1672 344 IADANFTLQVT 354 (600)
Q Consensus 344 ~~~~~v~L~V~ 354 (600)
.....+.|...
T Consensus 95 ~gk~~IeLk~~ 105 (286)
T PHA03042 95 KIKNTIELQYV 105 (286)
T ss_pred CccEEEEEEEE
Confidence 55555555554
No 276
>KOG0473|consensus
Probab=89.30 E-value=0.0093 Score=57.31 Aligned_cols=62 Identities=18% Similarity=0.258 Sum_probs=30.1
Q ss_pred cCCCCcceeeCCCCcCcccChhhhcCCCCCCEEEcCCCcCCCCCcccccccccccEEEccCCcC
Q psy1672 144 QFVPGLVKLDMSESRLEHISPEAFTGAKSLESIKLNGNRLSHFPVRSVEPLLKLMMIELHDNPW 207 (600)
Q Consensus 144 ~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~l~~N~~ 207 (600)
..++.|..|+++.|++... +..++.+..+.++++..|.++..| ..+..++.++.+++.+|+|
T Consensus 62 s~~t~~~rl~~sknq~~~~-~~d~~q~~e~~~~~~~~n~~~~~p-~s~~k~~~~k~~e~k~~~~ 123 (326)
T KOG0473|consen 62 SILTRLVRLDLSKNQIKFL-PKDAKQQRETVNAASHKNNHSQQP-KSQKKEPHPKKNEQKKTEF 123 (326)
T ss_pred HHHHHHHHHhccHhhHhhC-hhhHHHHHHHHHHHhhccchhhCC-ccccccCCcchhhhccCcc
Confidence 3344444444444444444 233444444455555555555554 2345555555666666553
No 277
>PF08204 V-set_CD47: CD47 immunoglobulin-like domain; InterPro: IPR013270 This family represents the CD47 leukocyte antigen V-set like Ig domain [, ].; PDB: 2VSC_B 2JJS_D 2JJT_C.
Probab=89.18 E-value=0.73 Score=40.71 Aligned_cols=82 Identities=11% Similarity=0.309 Sum_probs=44.1
Q ss_pred cccceeeeEeecC-----CCCeeEEEEcCeeccCC--cc----cCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEE
Q psy1672 269 SENATVVCRVDSI-----PPAAISWYWNGRLLLNN--TA----FSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCV 337 (600)
Q Consensus 269 G~~v~L~C~v~g~-----P~p~i~W~~~g~~l~~~--~~----~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~ 337 (600)
.++|.++|.+... +.-.|.|.++|+.+-.. .. ...+....+ ..-.....+|.+...+.- .|+|+|.
T Consensus 27 N~tV~IPC~v~n~~~~ni~~m~VkWk~~~~~If~~dg~~~~~~~~~f~sa~i--~~l~kG~aSL~~~~~~a~-~GnYTCe 103 (130)
T PF08204_consen 27 NDTVVIPCFVNNLEANNISEMYVKWKFKNKDIFIFDGTNNKSTSDNFPSAKI--SELLKGNASLKMDKSDAV-EGNYTCE 103 (130)
T ss_dssp -SEEEE--BBSS---SSGGGEEEEEEETTEEEEEEETTTTEEEEGGGTT-BE--GGGGGTB--EEEEHHHHH--EEEEEE
T ss_pred CCCEEEEeEeccccccccceEEEEEEECCeEEEEEcCccceecccCccccch--hHhhCCCEEEEEcchhcc-ccceEEE
Confidence 5678899988642 23358999988754211 00 000111111 111123456888876654 8999999
Q ss_pred EecCCCceeEEEEEEE
Q psy1672 338 AENRAGIADANFTLQV 353 (600)
Q Consensus 338 a~N~~G~~~~~v~L~V 353 (600)
+.......+..+.|..
T Consensus 104 Vt~~~~ege~~i~Lk~ 119 (130)
T PF08204_consen 104 VTELSREGETTIELKY 119 (130)
T ss_dssp EEETTEEEEEEEEEEE
T ss_pred EEecCCCceEEEEEEE
Confidence 9988777777777766
No 278
>KOG0473|consensus
Probab=88.21 E-value=0.015 Score=55.93 Aligned_cols=93 Identities=15% Similarity=0.193 Sum_probs=76.7
Q ss_pred CcccCccccCCCCCccEEEccCCCCCCCCccccCCCCCCCEEEccCCCCCccCcccccCCCCcceeeCCCCcCcccChhh
Q psy1672 87 IGQIDSGALDGLTNLIEIDLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEKGAFQFVPGLVKLDMSESRLEHISPEA 166 (600)
Q Consensus 87 l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~l~~i~~~~ 166 (600)
+++|+-..+......+.||++.|++..+.. .|+-+..|..|+++.|.+..++ ..+.++..+..+++..|.+... |..
T Consensus 30 ~s~~~v~ei~~~kr~tvld~~s~r~vn~~~-n~s~~t~~~rl~~sknq~~~~~-~d~~q~~e~~~~~~~~n~~~~~-p~s 106 (326)
T KOG0473|consen 30 LSEIPVREIASFKRVTVLDLSSNRLVNLGK-NFSILTRLVRLDLSKNQIKFLP-KDAKQQRETVNAASHKNNHSQQ-PKS 106 (326)
T ss_pred hcccchhhhhccceeeeehhhhhHHHhhcc-chHHHHHHHHHhccHhhHhhCh-hhHHHHHHHHHHHhhccchhhC-Ccc
Confidence 456665666777889999999999888766 5777888999999999998885 4467778888899999998888 567
Q ss_pred hcCCCCCCEEEcCCCc
Q psy1672 167 FTGAKSLESIKLNGNR 182 (600)
Q Consensus 167 ~~~l~~L~~L~Ls~N~ 182 (600)
++..+.++++++.+|.
T Consensus 107 ~~k~~~~k~~e~k~~~ 122 (326)
T KOG0473|consen 107 QKKEPHPKKNEQKKTE 122 (326)
T ss_pred ccccCCcchhhhccCc
Confidence 8899999999888775
No 279
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D ....
Probab=87.99 E-value=0.33 Score=26.68 Aligned_cols=15 Identities=33% Similarity=0.693 Sum_probs=6.4
Q ss_pred CCCEEEcCCCcCCCC
Q psy1672 172 SLESIKLNGNRLSHF 186 (600)
Q Consensus 172 ~L~~L~Ls~N~l~~l 186 (600)
+|+.|+|++|+|+.+
T Consensus 2 ~L~~L~l~~n~L~~l 16 (17)
T PF13504_consen 2 NLRTLDLSNNRLTSL 16 (17)
T ss_dssp T-SEEEETSS--SSE
T ss_pred ccCEEECCCCCCCCC
Confidence 455555555555544
No 280
>PF02480 Herpes_gE: Alphaherpesvirus glycoprotein E; InterPro: IPR003404 Glycoprotein E (gE) of Alphaherpesvirus forms a complex with glycoprotein I (gI), functioning as an immunoglobulin G (IgG) Fc binding protein. gE is involved in virus spread but is not essential for propagation [].; GO: 0016020 membrane; PDB: 2GJ7_F 2GIY_B.
Probab=87.69 E-value=0.35 Score=52.12 Aligned_cols=20 Identities=45% Similarity=0.494 Sum_probs=15.6
Q ss_pred eEEEecCCCCCCeEEEEEEe
Q psy1672 320 SLVLTNAQESDSGRFYCVAE 339 (600)
Q Consensus 320 ~L~I~~v~~~d~G~Y~C~a~ 339 (600)
.|++.++...++|.|.|++.
T Consensus 270 ~l~f~~a~~~~sGLYv~V~~ 289 (439)
T PF02480_consen 270 DLQFTNAPESASGLYVFVVY 289 (439)
T ss_dssp SEEESS--GGG-EEEEEEEE
T ss_pred ceEecCCCcccCceEEEEEE
Confidence 68999999999999999987
No 281
>PF07354 Sp38: Zona-pellucida-binding protein (Sp38); InterPro: IPR010857 This family contains a number of zona-pellucida-binding proteins that seem to be restricted to mammals. These are sperm proteins that bind to the 90 kDa family of zona pellucida glycoproteins in a calcium-dependent manner []. These represent some of the specific molecules that mediate the first steps of gamete interaction, allowing fertilisation to occur [].; GO: 0007339 binding of sperm to zona pellucida, 0005576 extracellular region
Probab=87.50 E-value=0.86 Score=44.81 Aligned_cols=49 Identities=31% Similarity=0.485 Sum_probs=36.9
Q ss_pred CCCeeEEEE-cCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCC
Q psy1672 282 PPAAISWYW-NGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRA 342 (600)
Q Consensus 282 P~p~i~W~~-~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~ 342 (600)
..|.+.|.- +|+.+...+ .+.+.+.| .|.+.+...+++|.|+|+.+-..
T Consensus 11 iDP~y~W~GP~g~~l~gn~------~~nIT~TG------~L~~~~F~esmSG~YTCtLsYk~ 60 (271)
T PF07354_consen 11 IDPTYLWTGPNGKPLSGNS------YVNITETG------KLMFKNFQESMSGSYTCTLSYKP 60 (271)
T ss_pred CCCceEEECCCCcccCCCC------eEEEccCc------eEEeeccccccCCceEEEEEEEe
Confidence 457899998 566555332 45555555 79999999999999999987554
No 282
>PHA03286 envelope glycoprotein E; Provisional
Probab=86.95 E-value=0.82 Score=48.10 Aligned_cols=20 Identities=45% Similarity=0.566 Sum_probs=18.3
Q ss_pred eEEEecCCCCCCeEEEEEEe
Q psy1672 320 SLVLTNAQESDSGRFYCVAE 339 (600)
Q Consensus 320 ~L~I~~v~~~d~G~Y~C~a~ 339 (600)
+|.+.|+...++|.|.|++.
T Consensus 308 nL~f~nA~~s~SGLYVfVl~ 327 (492)
T PHA03286 308 SFRLANAQPTDAGLYVVVAL 327 (492)
T ss_pred ceeecCCCcccCceEEEEEE
Confidence 48899999999999999987
No 283
>PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region. The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway [].
Probab=86.93 E-value=0.098 Score=46.92 Aligned_cols=24 Identities=13% Similarity=0.350 Sum_probs=13.0
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHH
Q psy1672 367 HINGISLALFFLIILILIIIIYLL 390 (600)
Q Consensus 367 ~i~gi~~g~~l~l~lillii~~~~ 390 (600)
.++|+++|+.+.+++++++++|+|
T Consensus 50 IVIGvVVGVGg~ill~il~lvf~~ 73 (154)
T PF04478_consen 50 IVIGVVVGVGGPILLGILALVFIF 73 (154)
T ss_pred EEEEEEecccHHHHHHHHHhheeE
Confidence 566777666555555444444433
No 284
>PHA02982 hypothetical protein; Provisional
Probab=86.91 E-value=1.2 Score=42.15 Aligned_cols=83 Identities=16% Similarity=0.279 Sum_probs=52.0
Q ss_pred ccccccccccceeeeEee-cCCCCeeEEEE-cCeeccCCcccC-----------ccce-EEEeeCCceeeeeeEEEecCC
Q psy1672 262 RYVEAVSSENATVVCRVD-SIPPAAISWYW-NGRLLLNNTAFS-----------SYQR-IFVIEQGEYERKSSLVLTNAQ 327 (600)
Q Consensus 262 ~~~~v~~G~~v~L~C~v~-g~P~p~i~W~~-~g~~l~~~~~~~-----------~~~~-~~~~~~g~~~~~s~L~I~~v~ 327 (600)
..+.+..++.|.|.|... +.......|.. ++..+.....-+ ++.. ..+.-+ ...|+|+|.++.
T Consensus 32 ~dv~a~vd~~V~L~C~~~~~~~i~~~~W~~~~~~~la~~~~~~~~iN~~~y~~~~~kd~y~~sv~---g~~STLTIkk~~ 108 (251)
T PHA02982 32 ADVNATVDQEVKLQCLFKDADEISRAMWKGDAGFMLAQEANGGTGINAFNYVPGPYKDKYALSVS---GNSSTFTMKKPD 108 (251)
T ss_pred hhhhccCCCcEEEEecCCCcchhhhheeeCCCCeEEEeeecCcceeccccccCCccceeEEEEEe---ccceeEEeccCC
Confidence 345567799999999864 33445678987 333333211100 0000 111111 246799999999
Q ss_pred CCCCeEEEEEEecCCCceeE
Q psy1672 328 ESDSGRFYCVAENRAGIADA 347 (600)
Q Consensus 328 ~~d~G~Y~C~a~N~~G~~~~ 347 (600)
.+..|-|+|.|....+..+.
T Consensus 109 i~N~GCYtc~~ks~~~k~E~ 128 (251)
T PHA02982 109 PQNLGCFTCEAKDAEGKEET 128 (251)
T ss_pred cccCCceEEEEecCCCchhe
Confidence 99999999999998766544
No 285
>KOG3515|consensus
Probab=86.62 E-value=0.78 Score=51.99 Aligned_cols=77 Identities=27% Similarity=0.454 Sum_probs=49.0
Q ss_pred cccccccceeeeEeecCCC-CeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCC
Q psy1672 265 EAVSSENATVVCRVDSIPP-AAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAG 343 (600)
Q Consensus 265 ~v~~G~~v~L~C~v~g~P~-p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G 343 (600)
.+..|+.|.|.|.+.+.|+ ++++|++.++.+.. +.... ....+.........-+.|.|.|.|..|
T Consensus 18 ~~~~g~~v~l~C~v~~~pp~~~~eW~h~~~~~~~--------~~~~~------~~~~~~~~~~~~~~~~~~~c~a~ns~~ 83 (741)
T KOG3515|consen 18 GLRLGEDVPLPCRVNSNPPEIDVEWYHSTSGEHG--------RYATI------ADPTLVTTGDVRDTVAELNCRAFNSVG 83 (741)
T ss_pred hhccCCcceeeeecCCCCCCcceEEEecCccccc--------ccccc------cCCceeeecchhhhhhhhhhhhccccc
Confidence 6788999999999997665 68999997654431 11111 122455666666666678888888766
Q ss_pred ce-eEEEEEEEEE
Q psy1672 344 IA-DANFTLQVTY 355 (600)
Q Consensus 344 ~~-~~~v~L~V~~ 355 (600)
.. .....+.+.+
T Consensus 84 ~~~~~~~~l~v~~ 96 (741)
T KOG3515|consen 84 MPSRCPMILDVDY 96 (741)
T ss_pred Cceecceeecccc
Confidence 53 3334444433
No 286
>PF15050 SCIMP: SCIMP protein
Probab=83.61 E-value=2.5 Score=36.09 Aligned_cols=29 Identities=7% Similarity=0.104 Sum_probs=12.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhHhcCCCC
Q psy1672 370 GISLALFFLIILILIIIIYLLIRMRTITY 398 (600)
Q Consensus 370 gi~~g~~l~l~lillii~~~~~rkrr~~~ 398 (600)
.++++++++-+.+.+|++++|+|+.|.++
T Consensus 11 iLAVaII~vS~~lglIlyCvcR~~lRqGk 39 (133)
T PF15050_consen 11 ILAVAIILVSVVLGLILYCVCRWQLRQGK 39 (133)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHccc
Confidence 33444333333333344445665555443
No 287
>KOG3515|consensus
Probab=83.40 E-value=3.5 Score=46.92 Aligned_cols=77 Identities=23% Similarity=0.379 Sum_probs=48.5
Q ss_pred ccccccccceeeeEee--cCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecC
Q psy1672 264 VEAVSSENATVVCRVD--SIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 264 ~~v~~G~~v~L~C~v~--g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~ 341 (600)
.....+..+.+.|.+. +.|.+.+.|..+++.......-...... ....+.....+.+.+......+.|.|+|.|.|.
T Consensus 107 ~~~~~~~vvqi~c~~~~~~~P~~nlrW~~n~r~e~~~~~~~~~~~~-~a~gss~t~~s~l~~~v~Rka~~g~~tC~A~nr 185 (741)
T KOG3515|consen 107 IFQVDKGVVQIICSAKVAGRPNPNLRWGFNNRAELNAVNQRGRVGA-GALGSSYTEPSLLKQTVSRKADNGNYTCPANNR 185 (741)
T ss_pred hhhhcCCeEEEEEeecCCCCCCcceeeeeccEEeecccCCcccccc-cccCceeccccceeeEEEEecCCceeEcccccc
Confidence 3445678888999665 6778899999988765443210000000 001111122346778888899999999999995
No 288
>KOG3864|consensus
Probab=82.30 E-value=0.25 Score=46.86 Aligned_cols=82 Identities=17% Similarity=0.239 Sum_probs=44.4
Q ss_pred CCEEEccCCCCCccCcccccCCCCcceeeCCCCc-CcccChhhhc-CCCCCCEEEcCCC-cCCCCCcccccccccccEEE
Q psy1672 125 LRDLNLARNPISKIEKGAFQFVPGLVKLDMSESR-LEHISPEAFT-GAKSLESIKLNGN-RLSHFPVRSVEPLLKLMMIE 201 (600)
Q Consensus 125 L~~L~Ls~N~i~~l~~~~~~~l~~L~~L~Ls~n~-l~~i~~~~~~-~l~~L~~L~Ls~N-~l~~l~~~~~~~l~~L~~L~ 201 (600)
++.++.++..|....-..+.+++.++.|.+.++. +....-+-++ -.++|+.|+|++| +|++-....+.++++|+.|.
T Consensus 103 IeaVDAsds~I~~eGle~L~~l~~i~~l~l~~ck~~dD~~L~~l~~~~~~L~~L~lsgC~rIT~~GL~~L~~lknLr~L~ 182 (221)
T KOG3864|consen 103 IEAVDASDSSIMYEGLEHLRDLRSIKSLSLANCKYFDDWCLERLGGLAPSLQDLDLSGCPRITDGGLACLLKLKNLRRLH 182 (221)
T ss_pred EEEEecCCchHHHHHHHHHhccchhhhheeccccchhhHHHHHhcccccchheeeccCCCeechhHHHHHHHhhhhHHHH
Confidence 5666666666655544445555556665555542 1111111111 2467777777765 45555555666666676666
Q ss_pred ccCCc
Q psy1672 202 LHDNP 206 (600)
Q Consensus 202 l~~N~ 206 (600)
+.+=+
T Consensus 183 l~~l~ 187 (221)
T KOG3864|consen 183 LYDLP 187 (221)
T ss_pred hcCch
Confidence 65544
No 289
>PF01299 Lamp: Lysosome-associated membrane glycoprotein (Lamp); InterPro: IPR002000 Lysosome-associated membrane glycoproteins (lamp) [] are integral membrane proteins, specific to lysosomes, and whose exact biological function is not yet clear. Structurally, the lamp proteins consist of two internally homologous lysosome-luminal domains separated by a proline-rich hinge region; at the C-terminal extremity there is a transmembrane region (TM) followed by a very short cytoplasmic tail (C). In each of the duplicated domains, there are two conserved disulphide bonds. This structure is schematically represented in the figure below. +-----+ +-----+ +-----+ +-----+ | | | | | | | | xCxxxxxCxxxxxxxxxxxxCxxxxxCxxxxxxxxxCxxxxxCxxxxxxxxxxxxCxxxxxCxxxxxxxx +--------------------------++Hinge++--------------------------++TM++C+ In mammals, there are two closely related types of lamp: lamp-1 and lamp-2, which form major components of the lysosome membrane. In chicken lamp-1 is known as LEP100. Also included in this entry is the macrophage protein CD68 (or macrosialin) [] is a heavily glycosylated integral membrane protein whose structure consists of a mucin-like domain followed by a proline-rich hinge; a single lamp-like domain; a transmembrane region and a short cytoplasmic tail. Similar to CD68, mammalian lamp-3, which is expressed in lymphoid organs, dendritic cells and in lung, contains all the C-terminal regions but lacks the N-terminal lamp-like region []. In a lamp-family protein from nematodes [] only the part C-terminal to the hinge is conserved. ; GO: 0016020 membrane
Probab=81.11 E-value=1 Score=46.40 Aligned_cols=30 Identities=20% Similarity=0.430 Sum_probs=22.0
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHhHhcC
Q psy1672 366 GHINGISLALFFLIILILIIIIYLLIRMRT 395 (600)
Q Consensus 366 ~~i~gi~~g~~l~l~lillii~~~~~rkrr 395 (600)
..++-|++|++|+.++++++|.|++.|||+
T Consensus 270 ~~~vPIaVG~~La~lvlivLiaYli~Rrr~ 299 (306)
T PF01299_consen 270 SDLVPIAVGAALAGLVLIVLIAYLIGRRRS 299 (306)
T ss_pred cchHHHHHHHHHHHHHHHHHHhheeEeccc
Confidence 467888888877777777777777766664
No 290
>cd07689 Ig2_VCAM-1 Second immunoglobulin (Ig)-like domain of vascular endothelial cell adhesion molecule-1 (VCAM-1, CD106) and intercellular cell adhesion molecule-1 (ICAM-1, CD54) and similar proteins. Ig2_ VCAM-1_like: domain similar to the second immunoglobulin (Ig)-like domain of vascular endothelial cell adhesion molecule-1 (VCAM-1, CD106). During the inflammation process, these molecules recruit leukocytes onto the vascular endothelium before extravasation to the injured tissues. The interaction of VCAM-1 binding to the beta1 integrin very late antigen (VLA-4) expressed by lymphocytes and monocytes mediates the adhesion of leucocytes to blood vessel walls, and regulates migration across the endothelium. During metastasis, some circulating cancer cells extravasate to a secondary site by a similar process. VCAM-1 may be involved in organ targeted tumor metastasis and may also act as host receptors for viruses and parasites. VCAM-1 contains seven Ig domains.
Probab=79.77 E-value=5.6 Score=33.40 Aligned_cols=71 Identities=20% Similarity=0.227 Sum_probs=41.4
Q ss_pred ccccccceeeeEeec-CCC--CeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCe-EEEEEEecC
Q psy1672 266 AVSSENATVVCRVDS-IPP--AAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSG-RFYCVAENR 341 (600)
Q Consensus 266 v~~G~~v~L~C~v~g-~P~--p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G-~Y~C~a~N~ 341 (600)
+..|..+++.|.+.+ .|. ..|.|++....+.... |... + ..+....+.+.+++.- +.+|.| .|+|.|.=.
T Consensus 12 l~~G~~vtv~C~v~~v~P~~~l~v~LlkG~~~l~~~~-f~~~--~--~~ks~~~~~~~vtftp-treD~g~~fsC~A~L~ 85 (99)
T cd07689 12 LEEGKPVTVKCEVPDVYPFDRLEIELLKGETLLPSKS-FLED--M--DKKSLETKSLEVTFTP-TIEDIGKVLVCRAKLH 85 (99)
T ss_pred ccCCceEEEEEEecCcccCCceEEEEecCcceecccc-cccc--c--ccCCCCCcceeEEEec-chhhCCcEEEEEEEEe
Confidence 468999999999984 444 4789988655554433 1100 0 0000001223455554 477888 899998754
Q ss_pred C
Q psy1672 342 A 342 (600)
Q Consensus 342 ~ 342 (600)
+
T Consensus 86 l 86 (99)
T cd07689 86 I 86 (99)
T ss_pred e
Confidence 4
No 291
>PF07213 DAP10: DAP10 membrane protein; InterPro: IPR009861 This family consists of several mammalian DAP10 membrane proteins. In activated mouse natural killer (NK) cells, the NKG2D receptor associates with two intracellular adaptors, DAP10 and DAP12, which trigger phosphatidyl inositol 3 kinase (PI3K) and Syk family protein tyrosine kinases, respectively. It has been suggested that the DAP10-PI3K pathway is sufficient to initiate NKG2D-mediated killing of target cells [].
Probab=79.31 E-value=2.3 Score=33.76 Aligned_cols=26 Identities=31% Similarity=0.529 Sum_probs=19.3
Q ss_pred cCcchhHHHHHHHHHHHHHHHHHHHH
Q psy1672 364 GGGHINGISLALFFLIILILIIIIYL 389 (600)
Q Consensus 364 ~~~~i~gi~~g~~l~l~lillii~~~ 389 (600)
..+..+||++|=+++.++|+++++++
T Consensus 32 s~g~LaGiV~~D~vlTLLIv~~vy~c 57 (79)
T PF07213_consen 32 SPGLLAGIVAADAVLTLLIVLVVYYC 57 (79)
T ss_pred CHHHHHHHHHHHHHHHHHHHHHHHhh
Confidence 34578999998888888777766554
No 292
>PF02439 Adeno_E3_CR2: Adenovirus E3 region protein CR2; InterPro: IPR003470 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []. This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D adenovirus) 49 kDa protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.
Probab=78.94 E-value=3.6 Score=27.72 Aligned_cols=30 Identities=13% Similarity=0.163 Sum_probs=18.4
Q ss_pred cCcchhHHHHHHHHHHHHHHHHHHHHHhHhc
Q psy1672 364 GGGHINGISLALFFLIILILIIIIYLLIRMR 394 (600)
Q Consensus 364 ~~~~i~gi~~g~~l~l~lillii~~~~~rkr 394 (600)
..+.|+|+++|.++.++.++..+ ++|+|.+
T Consensus 5 ~IaIIv~V~vg~~iiii~~~~Ya-Ccykk~~ 34 (38)
T PF02439_consen 5 TIAIIVAVVVGMAIIIICMFYYA-CCYKKHR 34 (38)
T ss_pred hhhHHHHHHHHHHHHHHHHHHHH-HHHcccc
Confidence 34567787777777666665554 4554433
No 293
>PF03302 VSP: Giardia variant-specific surface protein; InterPro: IPR005127 During infection, the intestinal protozoan parasite Giardia lamblia virus undergoes continuous antigenic variation which is determined by diversification of the parasite's major surface antigen, named VSP (variant surface protein).
Probab=78.88 E-value=1.1 Score=47.94 Aligned_cols=34 Identities=24% Similarity=0.299 Sum_probs=24.1
Q ss_pred ccccCcchhHHHHHHHHHHHHHHHHHHHHHhHhc
Q psy1672 361 PFLGGGHINGISLALFFLIILILIIIIYLLIRMR 394 (600)
Q Consensus 361 ~~~~~~~i~gi~~g~~l~l~lillii~~~~~rkr 394 (600)
..+..+.|+||+||++++|.-++.++.+||..|.
T Consensus 362 s~LstgaIaGIsvavvvvVgglvGfLcWwf~crg 395 (397)
T PF03302_consen 362 SGLSTGAIAGISVAVVVVVGGLVGFLCWWFICRG 395 (397)
T ss_pred ccccccceeeeeehhHHHHHHHHHHHhhheeecc
Confidence 3466789999999998887766665555555444
No 294
>PF05790 C2-set: Immunoglobulin C2-set domain; InterPro: IPR008424 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C2-set domains, which are Ig-like domains resembling the antibody constant domain. C2-set domains are found primarily in the mammalian T-cell surface antigens CD2 (Cluster of Differentiation 2), CD4 and CD80, as well as in vascular (VCAM) and intercellular (ICAM) cell adhesion molecules. CD2 mediates T-cell adhesion via its ectodomain, and signal transduction utilising its 117-amino acid cytoplasmic tail []. CD2 displays structural and functional similarities with African swine fever virus (ASFV) LMW8-DR, a protein that is involved in cell-cell adhesion and immune response modulation, suggesting a possible role in the pathogenesis of ASFV infection []. CD4 is the primary receptor for HIV-1. CD4 has four immunoglobulin-like domains in its extracellular region that share the same structure, but can differ in sequence. Certain extracellular domains may be involved in dimerisation [].; GO: 0007155 cell adhesion, 0016021 integral to membrane; PDB: 1CID_A 1CDU_A 1WIQ_B 2NY4_B 2NY2_B 1WIP_B 1WIO_A 3S4S_G 1CDY_A 3S5L_G ....
Probab=78.58 E-value=12 Score=30.22 Aligned_cols=34 Identities=21% Similarity=0.381 Sum_probs=23.1
Q ss_pred eEEEecCCCCCCeEEEEEE-ecCCCceeEEEEEEE
Q psy1672 320 SLVLTNAQESDSGRFYCVA-ENRAGIADANFTLQV 353 (600)
Q Consensus 320 ~L~I~~v~~~d~G~Y~C~a-~N~~G~~~~~v~L~V 353 (600)
.......+..|+|.++|.| .+..-.....+.+.|
T Consensus 44 ~~~~~~~~~~d~G~w~C~a~~~~~k~~~s~~~i~v 78 (80)
T PF05790_consen 44 LVSTFTPTTEDSGTWVCTASDNEPKERESKIEILV 78 (80)
T ss_dssp EEEEESBTCGGSEEEEEEEEECTTEEEEEEEEEEE
T ss_pred EEEEecCCCCCCEEEEEEEcCCceEEEEEEEEEEc
Confidence 4456677789999999999 565544444444443
No 295
>PF02009 Rifin_STEVOR: Rifin/stevor family; InterPro: IPR002858 Malaria is still a major cause of mortality in many areas of the world. Plasmodium falciparum causes the most severe human form of the disease and is responsible for most fatalities. Severe cases of malaria can occur when the parasite invades and then proliferates within red blood cell erythrocytes. The parasite produces many variant antigenic proteins, encoded by multigene families, which are present on the surface of the infected erythrocyte and play important roles in virulence. A crucial survival mechanism for the malaria parasite is its ability to evade the immune response by switching these variant surface antigens. The high virulence of P. falciparum relative to other malarial parasites is in large part due to the fact that in this organism many of these surface antigens mediate the binding of infected erythrocytes to the vascular endothelium (cytoadherence) and non-infected erythrocytes (rosetting). This can lead to the accumulation of infected cells in the vasculature of a variety of organs, blocking the blood flow and reducing the oxygen supply. Clinical symptoms of severe infection can include fever, progressive anaemia, multi-organ dysfunction and coma. For more information see []. Several multicopy gene families have been described in Plasmodium falciparum, including the stevor family of subtelomeric open reading frames and the rif interspersed repetitive elements. Both families contain three predicted transmembrane segments. It has been proposed that stevor and rif are members of a larger superfamily that code for variant surface antigens [].
Probab=76.97 E-value=1.8 Score=44.04 Aligned_cols=13 Identities=46% Similarity=0.838 Sum_probs=4.9
Q ss_pred HHHHHHHHHHHHh
Q psy1672 379 IILILIIIIYLLI 391 (600)
Q Consensus 379 l~lillii~~~~~ 391 (600)
++++.+||.++++
T Consensus 268 IVLIMvIIYLILR 280 (299)
T PF02009_consen 268 IVLIMVIIYLILR 280 (299)
T ss_pred HHHHHHHHHHHHH
Confidence 3333333333333
No 296
>PF13908 Shisa: Wnt and FGF inhibitory regulator
Probab=76.67 E-value=3.4 Score=38.87 Aligned_cols=7 Identities=29% Similarity=0.415 Sum_probs=2.7
Q ss_pred hhHHHHH
Q psy1672 368 INGISLA 374 (600)
Q Consensus 368 i~gi~~g 374 (600)
++||+++
T Consensus 81 ivgvi~~ 87 (179)
T PF13908_consen 81 IVGVICG 87 (179)
T ss_pred eeehhhH
Confidence 3344433
No 297
>PHA03282 envelope glycoprotein E; Provisional
Probab=75.95 E-value=27 Score=37.31 Aligned_cols=20 Identities=35% Similarity=0.639 Sum_probs=18.8
Q ss_pred eEEEecCCCCCCeEEEEEEe
Q psy1672 320 SLVLTNAQESDSGRFYCVAE 339 (600)
Q Consensus 320 ~L~I~~v~~~d~G~Y~C~a~ 339 (600)
.|++.|+...++|.|.|++.
T Consensus 334 dL~F~nAp~saSGLYVfVl~ 353 (540)
T PHA03282 334 NLQLRDASEASGGLYVCVVY 353 (540)
T ss_pred ceEecCCCcccCceEEEEEE
Confidence 68999999999999999987
No 298
>PF05454 DAG1: Dystroglycan (Dystrophin-associated glycoprotein 1); InterPro: IPR008465 Dystroglycan is one of the dystrophin-associated glycoproteins, which is encoded by a 5.5 kb transcript in Homo sapiens. The protein product is cleaved into two non-covalently associated subunits, [alpha] (N-terminal) and [beta] (C-terminal). In skeletal muscle the dystroglycan complex works as a transmembrane linkage between the extracellular matrix and the cytoskeleton [alpha]-dystroglycan is extracellular and binds to merosin ([alpha]-2 laminin) in the basement membrane, while [beta]-dystroglycan is a transmembrane protein and binds to dystrophin, which is a large rod-like cytoskeletal protein, absent in Duchenne muscular dystrophy patients. Dystrophin binds to intracellular actin cables. In this way, the dystroglycan complex, which links the extracellular matrix to the intracellular actin cables, is thought to provide structural integrity in muscle tissues. The dystroglycan complex is also known to serve as an agrin receptor in muscle, where it may regulate agrin-induced acetylcholine receptor clustering at the neuromuscular junction. There is also evidence which suggests the function of dystroglycan as a part of the signal transduction pathway because it is shown that Grb2, a mediator of the Ras-related signal pathway, can interact with the cytoplasmic domain of dystroglycan. In general, aberrant expression of dystrophin-associated protein complex underlies the pathogenesis of Duchenne muscular dystrophy, Becker muscular dystrophy and severe childhood autosomal recessive muscular dystrophy. Interestingly, no genetic disease has been described for either [alpha]- or [beta]-dystroglycan. Dystroglycan is widely distributed in non-muscle tissues as well as in muscle tissues. During epithelial morphogenesis of kidney, the dystroglycan complex is shown to act as a receptor for the basement membrane. Dystroglycan expression in Mus musculus brain and neural retina has also been reported. However, the physiological role of dystroglycan in non-muscle tissues has remained unclear [].; PDB: 1EG4_P.
Probab=75.47 E-value=0.9 Score=45.90 Aligned_cols=24 Identities=25% Similarity=0.222 Sum_probs=0.0
Q ss_pred HHHHHHHHHHHHHHHHhHhcCCCC
Q psy1672 375 LFFLIILILIIIIYLLIRMRTITY 398 (600)
Q Consensus 375 ~~l~l~lillii~~~~~rkrr~~~ 398 (600)
++++++|++++|+++|+||||.++
T Consensus 154 VI~~iLLIA~iIa~icyrrkR~GK 177 (290)
T PF05454_consen 154 VIAAILLIAGIIACICYRRKRKGK 177 (290)
T ss_dssp ------------------------
T ss_pred HHHHHHHHHHHHHHHhhhhhhccc
Confidence 333344444455555555555544
No 299
>PF05568 ASFV_J13L: African swine fever virus J13L protein; InterPro: IPR008385 This family consists of several African swine fever virus (ASFV) j13L proteins [, , ].
Probab=74.75 E-value=5.7 Score=35.15 Aligned_cols=32 Identities=28% Similarity=0.455 Sum_probs=16.0
Q ss_pred ccCcchhHHHHHHHHHHHHHHHHHHHHHhHhc
Q psy1672 363 LGGGHINGISLALFFLIILILIIIIYLLIRMR 394 (600)
Q Consensus 363 ~~~~~i~gi~~g~~l~l~lillii~~~~~rkr 394 (600)
+.......|.++++++++.+.++|.++-.|||
T Consensus 26 ffsthm~tILiaIvVliiiiivli~lcssRKk 57 (189)
T PF05568_consen 26 FFSTHMYTILIAIVVLIIIIIVLIYLCSSRKK 57 (189)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhH
Confidence 33345556666666655555544443333333
No 300
>PHA03281 envelope glycoprotein E; Provisional
Probab=74.64 E-value=18 Score=39.20 Aligned_cols=21 Identities=33% Similarity=0.418 Sum_probs=18.9
Q ss_pred eeEEEecCCCCCCeEEEEEEe
Q psy1672 319 SSLVLTNAQESDSGRFYCVAE 339 (600)
Q Consensus 319 s~L~I~~v~~~d~G~Y~C~a~ 339 (600)
..|.+.++...++|.|.|++.
T Consensus 475 vdL~F~nApasaSGLYVfVl~ 495 (642)
T PHA03281 475 SALKFVDAAESLSGLYVFIIH 495 (642)
T ss_pred cceEeccCCcccCceEEEEEE
Confidence 368899999999999999987
No 301
>PTZ00370 STEVOR; Provisional
Probab=74.45 E-value=3.6 Score=41.06 Aligned_cols=26 Identities=31% Similarity=0.655 Sum_probs=12.6
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhHhcCC
Q psy1672 370 GISLALFFLIILILIIIIYLLIRMRTI 396 (600)
Q Consensus 370 gi~~g~~l~l~lillii~~~~~rkrr~ 396 (600)
||++. |++++.+++||.|+|.+|||+
T Consensus 258 giaal-vllil~vvliilYiwlyrrRK 283 (296)
T PTZ00370 258 GIAAL-VLLILAVVLIILYIWLYRRRK 283 (296)
T ss_pred HHHHH-HHHHHHHHHHHHHHHHHHhhc
Confidence 55443 344444445555555555544
No 302
>TIGR01478 STEVOR variant surface antigen, stevor family. This model represents the stevor branch of the rifin/stevor family (pfam02009) of predicted variant surface antigens as found in Plasmodium falciparum. This model is based on a set of stevor sequences kindly provided by Matt Berriman from the Sanger Center. This is a global model and assesses a penalty for incomplete sequence. Additional fragmentary sequences may be found with the fragment model and a cutoff of 8 bits.
Probab=74.08 E-value=4.4 Score=40.37 Aligned_cols=26 Identities=27% Similarity=0.660 Sum_probs=12.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhHhcCC
Q psy1672 370 GISLALFFLIILILIIIIYLLIRMRTI 396 (600)
Q Consensus 370 gi~~g~~l~l~lillii~~~~~rkrr~ 396 (600)
||++.+ ++++.+++||.|+|.+|||+
T Consensus 262 giaalv-llil~vvliiLYiWlyrrRK 287 (295)
T TIGR01478 262 GIAALV-LIILTVVLIILYIWLYRRRK 287 (295)
T ss_pred HHHHHH-HHHHHHHHHHHHHHHHHhhc
Confidence 554433 44444445555555555544
No 303
>smart00365 LRR_SD22 Leucine-rich repeat, SDS22-like subfamily.
Probab=73.98 E-value=2.6 Score=26.07 Aligned_cols=14 Identities=50% Similarity=0.667 Sum_probs=6.6
Q ss_pred CccEEEccCCCCCC
Q psy1672 100 NLIEIDLSDNLLTS 113 (600)
Q Consensus 100 ~L~~L~Ls~N~l~~ 113 (600)
+|+.|+|++|.|+.
T Consensus 3 ~L~~L~L~~NkI~~ 16 (26)
T smart00365 3 NLEELDLSQNKIKK 16 (26)
T ss_pred ccCEEECCCCccce
Confidence 44444454444443
No 304
>PF14575 EphA2_TM: Ephrin type-A receptor 2 transmembrane domain; PDB: 3KUL_A 2XVD_A 2VX1_A 2VWV_A 2VX0_A 2VWY_A 2VWZ_A 2VWW_A 2VWU_A 2VWX_A ....
Probab=72.05 E-value=2.3 Score=33.83 Aligned_cols=11 Identities=18% Similarity=0.522 Sum_probs=4.5
Q ss_pred hHHHHHHHHHH
Q psy1672 369 NGISLALFFLI 379 (600)
Q Consensus 369 ~gi~~g~~l~l 379 (600)
+++++|+++++
T Consensus 4 ~~~~~g~~~ll 14 (75)
T PF14575_consen 4 ASIIVGVLLLL 14 (75)
T ss_dssp HHHHHHHHHHH
T ss_pred ehHHHHHHHHH
Confidence 34444443333
No 305
>PF02124 Marek_A: Marek's disease glycoprotein A; InterPro: IPR001038 Equid herpesvirus 1 (Equine herpesvirus 1, EHV-1) glycoprotein 13 (EHV-1 gp13) has the characteristic features of a membrane-spanning protein: an N-terminal signal sequence; a hydrophobic membrane anchor region; a charged C-terminal cytoplasmic tail; and an exterior domain with nine potential N-glycosylation sites []. EHV-1 gp13 is the structural homologue of the gC-like glycoproteins of the Human herpesvirus 1 (HHV-1) and Human herpesvirus 2 (HHV-2) (gC-1 and gC-2 respectively), Pseudorabies virus (strain Indiana-Funkhauser/Becker) (PRV) (gIII) and Human herpesvirus 3 (HHV-3) (gp66). Secretory glycoprotein GP57-65 precursor (glycoprotein A - GA) is similar to Herpesvirus glycoprotein C, and belongs to the immunoglobulin gene superfamily [, ]. GA is thought to play an immunoevasive role in the pathogenesis of Marek's disease. It is a candidate for causing the early-stage immunosuppression that occurs after MDHV infection.
Probab=72.01 E-value=9.8 Score=36.56 Aligned_cols=23 Identities=17% Similarity=0.494 Sum_probs=16.5
Q ss_pred ceeeeEeecCCC--CeeEEEEcCee
Q psy1672 272 ATVVCRVDSIPP--AAISWYWNGRL 294 (600)
Q Consensus 272 v~L~C~v~g~P~--p~i~W~~~g~~ 294 (600)
-...|.+.-.|. -.+.|..++..
T Consensus 92 g~AVC~A~CVP~~~v~l~W~v~d~~ 116 (211)
T PF02124_consen 92 GYAVCTARCVPRGNVTLRWSVGDDP 116 (211)
T ss_pred CEEEEEcceeeCCCeEEEEEECCcc
Confidence 356788887774 47899986654
No 306
>smart00364 LRR_BAC Leucine-rich repeats, bacterial type.
Probab=71.67 E-value=2.6 Score=26.04 Aligned_cols=17 Identities=47% Similarity=0.767 Sum_probs=11.7
Q ss_pred CccEEEccCCCCCCCCc
Q psy1672 100 NLIEIDLSDNLLTSIPS 116 (600)
Q Consensus 100 ~L~~L~Ls~N~l~~l~~ 116 (600)
+|++|++++|+|+++|.
T Consensus 3 ~L~~L~vs~N~Lt~LPe 19 (26)
T smart00364 3 SLKELNVSNNQLTSLPE 19 (26)
T ss_pred ccceeecCCCccccCcc
Confidence 56677777777776665
No 307
>PF01034 Syndecan: Syndecan domain; InterPro: IPR001050 The syndecans are transmembrane proteoglycans which are involved in the organisation of cytoskeleton and/or actin microfilaments, and have important roles as cell surface receptors during cell-cell and/or cell-matrix interactions [, ]. Structurally, these proteins consist of four separate domains: A signal sequence; An extracellular domain (ectodomain) of variable length whose sequence is not evolutionary conserved in the various forms of syndecans. The ectodomain contains the sites of attachment of the heparan sulphate glycosaminoglycan side chains; A transmembrane region; A highly conserved cytoplasmic domain of about 30 to 35 residues, which could interact with cytoskeletal proteins. The proteins known to belong to this family are: Syndecan 1. Syndecan 2 or fibroglycan. Syndecan 3 or neuroglycan or N-syndecan. Syndecan 4 or amphiglycan or ryudocan. Drosophila syndecan. Caenorhabditis elegans probable syndecan (F57C7.3). Syndecan-4, a transmembrane heparan sulphate proteoglycan, is a coreceptor with integrins in cell adhesion. It has been suggested to form a ternary signalling complex with protein kinase Calpha and phosphatidylinositol 4,5-bisphosphate (PIP2). Structural studies have demonstrated that the cytoplasmic domain undergoes a conformational transition and forms a symmetric dimer in the presence of phospholipid activator PIP2, and whose overall structure in solution exhibits a twisted clamp shape having a cavity in the centre of dimeric interface. In addition, it has been observed that the syndecan-4 variable domain interacts, strongly, not only with fatty acyl groups but also the anionic head group of PIP2. These findings indicate that PIP2 promotes oligomerisation of the syndecan-4 cytoplasmic domain for transmembrane signalling and cell-matrix adhesion [, ].; GO: 0008092 cytoskeletal protein binding, 0016020 membrane; PDB: 1EJQ_B 1EJP_B 1YBO_C 1OBY_Q.
Probab=71.45 E-value=1.3 Score=33.58 Aligned_cols=31 Identities=32% Similarity=0.505 Sum_probs=0.7
Q ss_pred CcchhHHHHHHHHHHHHHHHHHHHHHhHhcCC
Q psy1672 365 GGHINGISLALFFLIILILIIIIYLLIRMRTI 396 (600)
Q Consensus 365 ~~~i~gi~~g~~l~l~lillii~~~~~rkrr~ 396 (600)
.++|+|+++|++++++++++++ |.+++|-..
T Consensus 12 aavIaG~Vvgll~ailLIlf~i-yR~rkkdEG 42 (64)
T PF01034_consen 12 AAVIAGGVVGLLFAILLILFLI-YRMRKKDEG 42 (64)
T ss_dssp --------------------------S-----
T ss_pred HHHHHHHHHHHHHHHHHHHHHH-HHHHhcCCC
Confidence 4678888888877777776554 566777754
No 308
>PF02038 ATP1G1_PLM_MAT8: ATP1G1/PLM/MAT8 family; InterPro: IPR000272 The FXYD protein family contains at least seven members in mammals []. Two other family members that are not obvious orthologs of any identified mammalian FXYD protein exist in zebrafish. All these proteins share a signature sequence of six conserved amino acids comprising the FXYD motif in the NH2-terminus, and two glycines and one serine residue in the transmembrane domain. FXYD proteins are widely distributed in mammalian tissues with prominent expression in tissues that perform fluid and solute transport or that are electrically excitable. Initial functional characterisation suggested that FXYD proteins act as channels or as modulators of ion channels however studies have revealed that most FXYD proteins have another specific function and act as tissue-specific regulatory subunits of the Na,K-ATPase. Each of these auxiliary subunits produces a distinct functional effect on the transport characteristics of the Na,K-ATPase that is adjusted to the specific functional demands of the tissue in which the FXYD protein is expressed. FXYD proteins appear to preferentially associate with Na,K-ATPase alpha1-beta isozymes, and affect their function in a way that render them operationally complementary or supplementary to coexisting isozymes.; GO: 0005216 ion channel activity, 0006811 ion transport, 0016020 membrane; PDB: 2JO1_A 2JP3_A 2ZXE_G 3A3Y_G 3N23_E 3B8E_H 3KDP_G 3N2F_E.
Probab=70.37 E-value=5 Score=28.93 Aligned_cols=25 Identities=32% Similarity=0.323 Sum_probs=16.8
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHH
Q psy1672 366 GHINGISLALFFLIILILIIIIYLL 390 (600)
Q Consensus 366 ~~i~gi~~g~~l~l~lillii~~~~ 390 (600)
..+.|++.|++++++.+++++--.+
T Consensus 14 LrigGLi~A~vlfi~Gi~iils~kc 38 (50)
T PF02038_consen 14 LRIGGLIFAGVLFILGILIILSGKC 38 (50)
T ss_dssp HHHHHHHHHHHHHHHHHHHHCTTHH
T ss_pred hhccchHHHHHHHHHHHHHHHcCcc
Confidence 4677888888887777765544333
No 309
>KOG3864|consensus
Probab=70.30 E-value=0.72 Score=43.81 Aligned_cols=32 Identities=28% Similarity=0.418 Sum_probs=13.2
Q ss_pred CCcceeeCCCC-cCcccChhhhcCCCCCCEEEc
Q psy1672 147 PGLVKLDMSES-RLEHISPEAFTGAKSLESIKL 178 (600)
Q Consensus 147 ~~L~~L~Ls~n-~l~~i~~~~~~~l~~L~~L~L 178 (600)
++|+.|+|++| +|++-.-..+..+++|+.|.|
T Consensus 151 ~~L~~L~lsgC~rIT~~GL~~L~~lknLr~L~l 183 (221)
T KOG3864|consen 151 PSLQDLDLSGCPRITDGGLACLLKLKNLRRLHL 183 (221)
T ss_pred cchheeeccCCCeechhHHHHHHHhhhhHHHHh
Confidence 34444444433 333333333334444444444
No 310
>PHA03099 epidermal growth factor-like protein (EGF-like protein); Provisional
Probab=69.73 E-value=7.2 Score=33.94 Aligned_cols=20 Identities=25% Similarity=0.478 Sum_probs=10.3
Q ss_pred eEEEEEEecCC-CceeEEEEE
Q psy1672 332 GRFYCVAENRA-GIADANFTL 351 (600)
Q Consensus 332 G~Y~C~a~N~~-G~~~~~v~L 351 (600)
..+.|.=.+.. |..=..+.|
T Consensus 65 ~~~~CrC~~GYtGeRCEh~dL 85 (139)
T PHA03099 65 DGMYCRCSHGYTGIRCQHVVL 85 (139)
T ss_pred CCceeECCCCcccccccceee
Confidence 45778766544 443333444
No 311
>PHA03052 Hypothetical protein; Provisional
Probab=65.39 E-value=12 Score=28.88 Aligned_cols=35 Identities=26% Similarity=0.426 Sum_probs=27.2
Q ss_pred ccccccccccceeeeEee-cCC--CCeeEEEEcCeecc
Q psy1672 262 RYVEAVSSENATVVCRVD-SIP--PAAISWYWNGRLLL 296 (600)
Q Consensus 262 ~~~~v~~G~~v~L~C~v~-g~P--~p~i~W~~~g~~l~ 296 (600)
..+++..|..+++.|+|. |.+ .+.+.|.-|+....
T Consensus 5 ~~i~~slGs~ltI~Ckv~lg~g~~~a~V~W~~N~~~~e 42 (69)
T PHA03052 5 EGIVTSLGSNLTITCKVSLRPPTTDADVFWISNGMYYE 42 (69)
T ss_pred ccEEEEccCCceEeEEEEecCCCcceEEEEEeCCcEEe
Confidence 567888999999999998 443 45788888886663
No 312
>PF15069 FAM163: FAM163 family
Probab=64.18 E-value=49 Score=29.60 Aligned_cols=18 Identities=33% Similarity=0.434 Sum_probs=9.5
Q ss_pred chhHHHHHHHHHHHHHHH
Q psy1672 367 HINGISLALFFLIILILI 384 (600)
Q Consensus 367 ~i~gi~~g~~l~l~lill 384 (600)
+|.|.+.|.++++++|++
T Consensus 7 VItGgILAtVILLcIIaV 24 (143)
T PF15069_consen 7 VITGGILATVILLCIIAV 24 (143)
T ss_pred EEechHHHHHHHHHHHHH
Confidence 455666555555554443
No 313
>PF01463 LRRCT: Leucine rich repeat C-terminal domain; InterPro: IPR000483 Leucine-rich repeats (LRR, see IPR001611 from INTERPRO) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions []. Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response. LRRs are often flanked by cysteine-rich domains: an N-terminal LRR domain (IPR000372 from INTERPRO) and a C-terminal LRR domain. This entry represents the C-terminal LRR domain. ; PDB: 3RFE_B 3REZ_D 2WFH_A 2V70_B 2V9S_C 2V9T_B 1W8A_A.
Probab=64.07 E-value=3 Score=25.42 Aligned_cols=24 Identities=38% Similarity=0.826 Sum_probs=17.3
Q ss_pred CCCCCCccccccccccccccccCcc
Q psy1672 230 PACTGPERLSGKVFSDLHADDFACK 254 (600)
Q Consensus 230 ~~C~~p~~l~g~~l~~l~~~~~~C~ 254 (600)
..|+.|..++| .+.++...+|.|.
T Consensus 2 ~~Ca~P~~lrg-~l~~~~~~~f~C~ 25 (25)
T PF01463_consen 2 ARCASPPELRG-PLLDLPPSDFKCS 25 (25)
T ss_dssp -BEEESGGGTT-BGGGSSGGG----
T ss_pred CccCCChHHcC-cHhhCCcccCcCC
Confidence 57999999999 9998888888873
No 314
>PF11669 WBP-1: WW domain-binding protein 1; InterPro: IPR021684 This family of proteins represents WBP-1, a ligand of the WW domain of Yes-associated protein. This protein has a proline-rich domain. WBP-1 does not bind to the SH3 domain [].
Probab=63.57 E-value=14 Score=31.22 Aligned_cols=9 Identities=44% Similarity=0.840 Sum_probs=6.5
Q ss_pred CCCCccccc
Q psy1672 441 PPPSYHSTE 449 (600)
Q Consensus 441 ~pPr~~~~~ 449 (600)
+||.+.++.
T Consensus 83 ~pP~Y~ev~ 91 (102)
T PF11669_consen 83 KPPSYSEVV 91 (102)
T ss_pred CCCCcHHhc
Confidence 688887753
No 315
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=63.19 E-value=5.2 Score=51.74 Aligned_cols=36 Identities=22% Similarity=0.298 Sum_probs=24.6
Q ss_pred EccCCCCCCCCccccCCCCCCCEEEccCCCCCccCc
Q psy1672 105 DLSDNLLTSIPSLTFQSVRFLRDLNLARNPISKIEK 140 (600)
Q Consensus 105 ~Ls~N~l~~l~~~~f~~l~~L~~L~Ls~N~i~~l~~ 140 (600)
||++|+|+.|++..|..+.+|+.|+|++|++.+-+.
T Consensus 1 DLSnN~LstLp~g~F~~L~sL~~LdLsgNPw~CDC~ 36 (2740)
T TIGR00864 1 DISNNKISTIEEGICANLCNLSEIDLSGNPFECDCG 36 (2740)
T ss_pred CCCCCcCCccChHHhccCCCceEEEeeCCccccccc
Confidence 466777777777777777777777777777666544
No 316
>PF07204 Orthoreo_P10: Orthoreovirus membrane fusion protein p10; InterPro: IPR009854 This family consists of several Orthoreovirus membrane fusion protein p10 sequences. p10 is thought to be a multifunctional protein that plays a key role in virus-host interaction [].
Probab=62.91 E-value=3.9 Score=33.45 Aligned_cols=15 Identities=40% Similarity=0.499 Sum_probs=9.3
Q ss_pred CeEEEEEEe-cCCCce
Q psy1672 331 SGRFYCVAE-NRAGIA 345 (600)
Q Consensus 331 ~G~Y~C~a~-N~~G~~ 345 (600)
.|...|.|. |..|.+
T Consensus 16 fg~vhcqa~~nsaGgd 31 (98)
T PF07204_consen 16 FGNVHCQASQNSAGGD 31 (98)
T ss_pred ccchheeccccCCCCC
Confidence 466777754 666654
No 317
>PF05273 Pox_RNA_Pol_22: Poxvirus RNA polymerase 22 kDa subunit; InterPro: IPR007937 Vaccinia viral RNA synthesis is carried out by a virus coded, multi-subunit, eukaryotic-like RNA polymerase. RNA polymerase subunits are synthesized throughout infection and the assembled RNA polymerase is packaged into nascent virions late in infection. The RNA polymerase exists in two different forms, one specific for early genes and one specific for late genes. Both forms of the RNA polymerase have in common eight subunits, ranging in size from 147 to 7 kDa This family consists of several poxvirus DNA-dependent RNA polymerase 22 kDa subunits.; GO: 0003677 DNA binding, 0003899 DNA-directed RNA polymerase activity, 0019083 viral transcription
Probab=62.04 E-value=5.3 Score=36.01 Aligned_cols=36 Identities=22% Similarity=0.140 Sum_probs=29.3
Q ss_pred CCCCCCCCCCccccCCccccCCCCCCCCcceeeeec
Q psy1672 532 DDNYPPDYGLPIVGQGQNELLPNNIHPNAKTLRVWQ 567 (600)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 567 (600)
-++-+.|||=||+-+.-.|+=||++|.+.--+-|-.
T Consensus 71 YsP~e~DYGePIiiTs~lq~gHnKfPi~~lyIDvVa 106 (185)
T PF05273_consen 71 YSPLEDDYGEPIIITSFLQPGHNKFPINMLYIDVVA 106 (185)
T ss_pred eccccccCCCcEEEEecccccccccceeeEEeeeee
Confidence 567789999999977766899999999987766543
No 318
>PTZ00046 rifin; Provisional
Probab=61.87 E-value=6.6 Score=40.74 Aligned_cols=12 Identities=50% Similarity=0.982 Sum_probs=5.2
Q ss_pred HHHHHHhHhcCC
Q psy1672 385 IIIYLLIRMRTI 396 (600)
Q Consensus 385 ii~~~~~rkrr~ 396 (600)
+|+|+..|.||+
T Consensus 332 vIIYLILRYRRK 343 (358)
T PTZ00046 332 VIIYLILRYRRK 343 (358)
T ss_pred HHHHHHHHhhhc
Confidence 444444444443
No 319
>PHA02865 MHC-like TNF binding protein; Provisional
Probab=61.84 E-value=23 Score=36.67 Aligned_cols=68 Identities=19% Similarity=0.268 Sum_probs=38.7
Q ss_pred cceeeeEeecCCCC--eeEEEEcCeecc----------CCcccC--ccce------EEEeeC-CceeeeeeEEEecCCCC
Q psy1672 271 NATVVCRVDSIPPA--AISWYWNGRLLL----------NNTAFS--SYQR------IFVIEQ-GEYERKSSLVLTNAQES 329 (600)
Q Consensus 271 ~v~L~C~v~g~P~p--~i~W~~~g~~l~----------~~~~~~--~~~~------~~~~~~-g~~~~~s~L~I~~v~~~ 329 (600)
.++|.|.|.|.-+. .+.|.++ +.+. .....+ ...+ +.-..+ |++..+..+.+ ...
T Consensus 216 ~~tL~C~A~GFYP~~I~v~W~kd-~~~~~~~~~g~e~~e~~~n~d~e~ge~~~~~~~~pn~DggTfQ~~~~v~v---~~~ 291 (338)
T PHA02865 216 NTTLFCTFDSHYPSSVAAKWYNS-EDFAPEYRYGRYYPELGRDTDYEPGEPGFPTNTKKDNDKNTFSSTPSVRV---PTD 291 (338)
T ss_pred CceEEEEEEeEeCCccEEEEEec-ccccccccCCccccccccCCCccccccccccceeeCCCCCeeEEEEEEEe---CCC
Confidence 57999999987655 5679998 2221 000000 0011 222335 36666666643 344
Q ss_pred CCeEEEEEEecCC
Q psy1672 330 DSGRFYCVAENRA 342 (600)
Q Consensus 330 d~G~Y~C~a~N~~ 342 (600)
+...|+|.+....
T Consensus 292 ~~~~Y~C~V~Hsg 304 (338)
T PHA02865 292 MSNQIVCVVFHST 304 (338)
T ss_pred CCCCcEEEEEeCC
Confidence 6667999998753
No 320
>TIGR01477 RIFIN variant surface antigen, rifin family. This model represents the rifin branch of the rifin/stevor family (pfam02009) of predicted variant surface antigens as found in Plasmodium falciparum. This model is based on a set of rifin sequences kindly provided by Matt Berriman from the Sanger Center. This is a global model and assesses a penalty for incomplete sequence. Additional fragmentary sequences may be found with the fragment model and a cutoff of 20 bits.
Probab=61.39 E-value=6.8 Score=40.52 Aligned_cols=11 Identities=55% Similarity=1.135 Sum_probs=4.7
Q ss_pred HHHHHHhHhcC
Q psy1672 385 IIIYLLIRMRT 395 (600)
Q Consensus 385 ii~~~~~rkrr 395 (600)
+|+|+..|.||
T Consensus 327 vIIYLILRYRR 337 (353)
T TIGR01477 327 VIIYLILRYRR 337 (353)
T ss_pred HHHHHHHHhhh
Confidence 44444444443
No 321
>PF11465 Receptor_2B4: Natural killer cell receptor 2B4; InterPro: IPR024303 2B4 is a transmembrane receptor which is expressed primarily on natural killer (NK) cells. It plays a role in activating NK-mediated cytotoxicity through its interaction with CD48 on target cells in a subset of CD8 T cells []. The structure of 2B4 consists of an immunoglobulin variable domain fold and contains two beta-sheets. One of the beta-sheets, the six-stranded sheet, contains structural features that may have a role in ligand recognition and receptor function []. This entry represents the 2B4 immunoglobulin domain.; GO: 0005488 binding; PDB: 2PTU_D 2PTT_B 1Z2K_A.
Probab=61.39 E-value=25 Score=29.86 Aligned_cols=35 Identities=31% Similarity=0.481 Sum_probs=26.7
Q ss_pred eeEEEecCCCCCCeEEEEEEecCCCce-eEEEEEEE
Q psy1672 319 SSLVLTNAQESDSGRFYCVAENRAGIA-DANFTLQV 353 (600)
Q Consensus 319 s~L~I~~v~~~d~G~Y~C~a~N~~G~~-~~~v~L~V 353 (600)
..|.|..++..|+|.|.-.+.|..|.. ...+.+.|
T Consensus 71 laLlIkaAq~qDSG~Y~LEvT~~sG~V~~~~FqVsV 106 (108)
T PF11465_consen 71 LALLIKAAQPQDSGLYCLEVTNESGKVCTKNFQVSV 106 (108)
T ss_dssp TEEEESS-SGGG-EEEEEEEEETTSCEEEEEEEEEE
T ss_pred ceEEEeecCcccCceEEEEEEcCCCcEEEEEEEEEe
Confidence 379999999999999999999999986 34455544
No 322
>KOG4308|consensus
Probab=60.95 E-value=0.21 Score=54.60 Aligned_cols=38 Identities=24% Similarity=0.207 Sum_probs=18.8
Q ss_pred ceEEEeeCCCCCCCChhhhc--ccCCCCccEEEeecccCc
Q psy1672 51 TQVLDMSGNNLQILPKEAFR--RAGLLNLQKLFLARCHIG 88 (600)
Q Consensus 51 l~~L~Ls~n~L~~l~~~~f~--~~~l~~L~~L~L~~n~l~ 88 (600)
+..|.|.+|.+..-...... ......|..|++++|.+.
T Consensus 89 l~~L~L~~~~l~~~~~~~l~~~l~t~~~L~~L~l~~n~l~ 128 (478)
T KOG4308|consen 89 LLHLSLANNRLGDRGAEELAQALKTLPTLGQLDLSGNNLG 128 (478)
T ss_pred HHHhhhhhCccccchHHHHHHHhcccccHhHhhcccCCCc
Confidence 55566666666532211111 124556666666666654
No 323
>PF13908 Shisa: Wnt and FGF inhibitory regulator
Probab=60.27 E-value=14 Score=34.78 Aligned_cols=22 Identities=27% Similarity=0.513 Sum_probs=15.0
Q ss_pred cchhHHHHHHHHHHHHHHHHHH
Q psy1672 366 GHINGISLALFFLIILILIIII 387 (600)
Q Consensus 366 ~~i~gi~~g~~l~l~lillii~ 387 (600)
+.+++|++++++++++|+++|+
T Consensus 75 ~~~~~iivgvi~~Vi~Iv~~Iv 96 (179)
T PF13908_consen 75 YFITGIIVGVICGVIAIVVLIV 96 (179)
T ss_pred cceeeeeeehhhHHHHHHHhHh
Confidence 3567888888887776655444
No 324
>KOG1947|consensus
Probab=60.17 E-value=3.5 Score=44.83 Aligned_cols=13 Identities=46% Similarity=0.411 Sum_probs=6.6
Q ss_pred CCCCCccEEEccC
Q psy1672 96 DGLTNLIEIDLSD 108 (600)
Q Consensus 96 ~~l~~L~~L~Ls~ 108 (600)
...+.|+.|++++
T Consensus 211 ~~~~~L~~L~l~~ 223 (482)
T KOG1947|consen 211 LKCPNLEELDLSG 223 (482)
T ss_pred hhCchhheecccC
Confidence 3445555555544
No 325
>PF10873 DUF2668: Protein of unknown function (DUF2668); InterPro: IPR022640 Members in this family of proteins are annotated as cysteine and tyrosine-rich protein 1, however currently no function is known [].
Probab=60.15 E-value=20 Score=32.00 Aligned_cols=32 Identities=25% Similarity=0.476 Sum_probs=21.9
Q ss_pred cCcchhHHHHHHHHHHHHHHHHHHHHHhHhcC
Q psy1672 364 GGGHINGISLALFFLIILILIIIIYLLIRMRT 395 (600)
Q Consensus 364 ~~~~i~gi~~g~~l~l~lillii~~~~~rkrr 395 (600)
....|+||+.|+++++.+++.+.++++...|+
T Consensus 59 sgtAIaGIVfgiVfimgvva~i~icvCmc~kn 90 (155)
T PF10873_consen 59 SGTAIAGIVFGIVFIMGVVAGIAICVCMCMKN 90 (155)
T ss_pred ccceeeeeehhhHHHHHHHHHHHHHHhhhhhc
Confidence 34578888888877777776666665555543
No 326
>PF11770 GAPT: GRB2-binding adapter (GAPT); InterPro: IPR021082 This entry represents a family of transmembrane proteins which bind the growth factor receptor-bound protein 2 (GRB2) in B cells []. In contrast to other transmembrane adaptor proteins, GAPT, which this entry represents, is not phosphorylated upon BCR ligation. It associates with GRB2 constitutively through its proline-rich region [].
Probab=59.94 E-value=3.8 Score=36.61 Aligned_cols=28 Identities=21% Similarity=0.194 Sum_probs=18.6
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHhHhcCC
Q psy1672 369 NGISLALFFLIILILIIIIYLLIRMRTI 396 (600)
Q Consensus 369 ~gi~~g~~l~l~lillii~~~~~rkrr~ 396 (600)
+++++|+.++++|++..|.++++||+|.
T Consensus 10 v~i~igi~Ll~lLl~cgiGcvwhwkhr~ 37 (158)
T PF11770_consen 10 VAISIGISLLLLLLLCGIGCVWHWKHRD 37 (158)
T ss_pred HHHHHHHHHHHHHHHHhcceEEEeeccC
Confidence 4666777777766666666666666654
No 327
>cd05890 Ig2_Nectin-1_like Second immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111) and similar proteins. Ig2_Nectin-1_like: domain similar to the second immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111). Nectin-1 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectins also heterophilically trans-interact with other CAMs such as nectin-like molecules (necls); nectin-1 for example, has been shown to trans-interact with necl-1. Nectins also interact with various other proteins, including the actin filament (F-actin)-binding protein, afadin. Mutation in the human nectin-1 gene is associ
Probab=59.77 E-value=28 Score=28.96 Aligned_cols=71 Identities=18% Similarity=0.330 Sum_probs=43.5
Q ss_pred ceeeeE-eecCCCCeeEEEE--cCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeEE
Q psy1672 272 ATVVCR-VDSIPPAAISWYW--NGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADAN 348 (600)
Q Consensus 272 v~L~C~-v~g~P~p~i~W~~--~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~ 348 (600)
+.-.|. +.|.|++.|.|.- +|.. . ....-..+|+....+.+.+-.....|--..+|+++..--.....
T Consensus 23 ~VA~CiSa~GrPpa~ItW~t~l~G~~-e--------tq~~~~~~GT~TV~S~y~lVPs~~~~gk~lTCvV~h~~~~~~~~ 93 (98)
T cd05890 23 LVATCVSANGKPPSVVRWDTRLKGEA-E--------FQEIRNQNGTVTVISRYRLVPSREAHKQKLTCIVNYRNDRFTDS 93 (98)
T ss_pred EEEEEEcCCCcCCcEeEEEccCCCce-e--------eeeeCCCCCCEEEEEEEEEeECHHHcCCEeEEEEEecccccccc
Confidence 345797 5599999999985 2321 0 01112234556666677666666667668999998764333444
Q ss_pred EEE
Q psy1672 349 FTL 351 (600)
Q Consensus 349 v~L 351 (600)
+.|
T Consensus 94 ~~L 96 (98)
T cd05890 94 VTL 96 (98)
T ss_pred EEe
Confidence 444
No 328
>PF05961 Chordopox_A13L: Chordopoxvirus A13L protein; InterPro: IPR009236 This family consists of A13L proteins from the Chordopoxviruses. A13L or p8 is one of the three most abundant membrane proteins of the intracellular mature Vaccinia virus [].
Probab=58.26 E-value=22 Score=27.25 Aligned_cols=25 Identities=16% Similarity=0.275 Sum_probs=12.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhHhc
Q psy1672 370 GISLALFFLIILILIIIIYLLIRMR 394 (600)
Q Consensus 370 gi~~g~~l~l~lillii~~~~~rkr 394 (600)
|..+.++++++++.+++..+|.|++
T Consensus 3 ~d~iLi~ICVaii~lIlY~iYnr~~ 27 (68)
T PF05961_consen 3 GDFILIIICVAIIGLILYGIYNRKK 27 (68)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhccc
Confidence 3444444555555555444554444
No 329
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A ....
Probab=58.01 E-value=4.1 Score=24.27 Aligned_cols=11 Identities=55% Similarity=0.700 Sum_probs=3.9
Q ss_pred CccEEEccCCC
Q psy1672 100 NLIEIDLSDNL 110 (600)
Q Consensus 100 ~L~~L~Ls~N~ 110 (600)
+|++|+|++|.
T Consensus 3 ~L~~L~l~~n~ 13 (24)
T PF13516_consen 3 NLETLDLSNNQ 13 (24)
T ss_dssp T-SEEE-TSSB
T ss_pred CCCEEEccCCc
Confidence 34444444443
No 330
>KOG3763|consensus
Probab=57.49 E-value=5.1 Score=43.73 Aligned_cols=64 Identities=23% Similarity=0.285 Sum_probs=33.8
Q ss_pred CCCCccEEEccCCCCCCCCcc--ccCCCCCCCEEEccCC--CCCccCc-ccccCCCCcceeeCCCCcCcc
Q psy1672 97 GLTNLIEIDLSDNLLTSIPSL--TFQSVRFLRDLNLARN--PISKIEK-GAFQFVPGLVKLDMSESRLEH 161 (600)
Q Consensus 97 ~l~~L~~L~Ls~N~l~~l~~~--~f~~l~~L~~L~Ls~N--~i~~l~~-~~~~~l~~L~~L~Ls~n~l~~ 161 (600)
+.+.+..++|++|+|..+..- .-+..++|..|+|++| .+..... ..+. ...|++|-|.+|.+..
T Consensus 216 n~p~i~sl~lsnNrL~~Ld~~sslsq~apklk~L~LS~N~~~~~~~~el~K~k-~l~Leel~l~GNPlc~ 284 (585)
T KOG3763|consen 216 NFPEILSLSLSNNRLYHLDALSSLSQIAPKLKTLDLSHNHSKISSESELDKLK-GLPLEELVLEGNPLCT 284 (585)
T ss_pred CCcceeeeecccchhhchhhhhHHHHhcchhheeecccchhhhcchhhhhhhc-CCCHHHeeecCCcccc
Confidence 445666667777766554321 1123466777777777 3322111 1122 2346777777776653
No 331
>PF15471 TMEM171: Transmembrane protein family 171
Probab=57.25 E-value=63 Score=32.04 Aligned_cols=15 Identities=7% Similarity=-0.104 Sum_probs=8.9
Q ss_pred CCCCccCCCccccCC
Q psy1672 489 NDDVLFQNNYWNQNI 503 (600)
Q Consensus 489 ~~~~~~~~~~~~~~~ 503 (600)
.+-|+|..|.....+
T Consensus 252 sY~SIFn~g~t~~e~ 266 (319)
T PF15471_consen 252 SYYSIFNYGRTTPEG 266 (319)
T ss_pred CcchhccCCCcCccc
Confidence 346677777764444
No 332
>PHA03283 envelope glycoprotein E; Provisional
Probab=56.78 E-value=33 Score=37.33 Aligned_cols=20 Identities=35% Similarity=0.426 Sum_probs=18.3
Q ss_pred eEEEecCCCCCCeEEEEEEe
Q psy1672 320 SLVLTNAQESDSGRFYCVAE 339 (600)
Q Consensus 320 ~L~I~~v~~~d~G~Y~C~a~ 339 (600)
.|.+.++...++|.|.|++.
T Consensus 316 ~L~f~nap~~~SGLYVfVv~ 335 (542)
T PHA03283 316 DLLFKNAPASASGLYVFVLL 335 (542)
T ss_pred ceEeccCCcccCceEEEEEE
Confidence 68899999999999999987
No 333
>PF05808 Podoplanin: Podoplanin; InterPro: IPR008783 This family consists of several mammalian podoplanin-like proteins which are thought to control specifically the unique shape of podocytes [].; GO: 0016021 integral to membrane; PDB: 3IET_X.
Probab=56.69 E-value=3.6 Score=37.44 Aligned_cols=29 Identities=28% Similarity=0.285 Sum_probs=0.0
Q ss_pred ccCcchhHHHHHHHHHHHHHHHHHHHHHh
Q psy1672 363 LGGGHINGISLALFFLIILILIIIIYLLI 391 (600)
Q Consensus 363 ~~~~~i~gi~~g~~l~l~lillii~~~~~ 391 (600)
+.-..++||++|+++.+.++..||+++.+
T Consensus 126 L~T~tLVGIIVGVLlaIG~igGIIivvvR 154 (162)
T PF05808_consen 126 LSTVTLVGIIVGVLLAIGFIGGIIIVVVR 154 (162)
T ss_dssp -----------------------------
T ss_pred cceeeeeeehhhHHHHHHHHhheeeEEee
Confidence 34457899999999999988877776544
No 334
>PHA03273 envelope glycoprotein C; Provisional
Probab=55.55 E-value=32 Score=36.78 Aligned_cols=20 Identities=30% Similarity=0.722 Sum_probs=14.6
Q ss_pred eeeeEeecCCC--CeeEEEEcC
Q psy1672 273 TVVCRVDSIPP--AAISWYWNG 292 (600)
Q Consensus 273 ~L~C~v~g~P~--p~i~W~~~g 292 (600)
...|.+.-.|. -.+.|..+.
T Consensus 355 ~AVCtA~CVP~egV~l~W~v~D 376 (486)
T PHA03273 355 DAVCTAKCVPSTGVFVSWSVND 376 (486)
T ss_pred EEEEecccccCCCeeEEEEccC
Confidence 34688887776 578898754
No 335
>PHA03049 IMV membrane protein; Provisional
Probab=53.82 E-value=29 Score=26.50 Aligned_cols=25 Identities=12% Similarity=0.265 Sum_probs=11.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhHhc
Q psy1672 370 GISLALFFLIILILIIIIYLLIRMR 394 (600)
Q Consensus 370 gi~~g~~l~l~lillii~~~~~rkr 394 (600)
|.++.++++++++.+++..+|.|++
T Consensus 3 ~d~~l~iICVaIi~lIvYgiYnkk~ 27 (68)
T PHA03049 3 GDIILVIICVVIIGLIVYGIYNKKT 27 (68)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhccc
Confidence 3344444555555444444544443
No 336
>KOG0196|consensus
Probab=52.62 E-value=1.2e+02 Score=35.09 Aligned_cols=29 Identities=17% Similarity=0.312 Sum_probs=16.6
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHhHhc
Q psy1672 366 GHINGISLALFFLIILILIIIIYLLIRMR 394 (600)
Q Consensus 366 ~~i~gi~~g~~l~l~lillii~~~~~rkr 394 (600)
.+|+|.++++++++++++++.+++.++|+
T Consensus 548 ~~i~g~~~~~v~~lll~~vv~~~~~~~r~ 576 (996)
T KOG0196|consen 548 PLIIGSILAGVVFLLLAAVVVVAIVCSRK 576 (996)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHhheeecc
Confidence 46667666666666655555444444444
No 337
>PHA03265 envelope glycoprotein D; Provisional
Probab=52.24 E-value=6 Score=40.44 Aligned_cols=12 Identities=25% Similarity=0.664 Sum_probs=5.0
Q ss_pred HHHHHHhHhcCC
Q psy1672 385 IIIYLLIRMRTI 396 (600)
Q Consensus 385 ii~~~~~rkrr~ 396 (600)
+|+|+++|+||.
T Consensus 366 ~il~~~~rr~k~ 377 (402)
T PHA03265 366 VILYVCLRRKKE 377 (402)
T ss_pred HHHHHHhhhhhh
Confidence 334444444433
No 338
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type.
Probab=52.17 E-value=12 Score=23.39 Aligned_cols=12 Identities=58% Similarity=0.769 Sum_probs=5.5
Q ss_pred CccEEEccCCCC
Q psy1672 100 NLIEIDLSDNLL 111 (600)
Q Consensus 100 ~L~~L~Ls~N~l 111 (600)
+|++|||++|.|
T Consensus 3 ~L~~LdL~~N~i 14 (28)
T smart00368 3 SLRELDLSNNKL 14 (28)
T ss_pred ccCEEECCCCCC
Confidence 344444444444
No 339
>PHA03271 envelope glycoprotein C; Provisional
Probab=51.30 E-value=31 Score=36.38 Aligned_cols=21 Identities=14% Similarity=0.718 Sum_probs=13.4
Q ss_pred eeeEeecCCC-CeeEEEEcCee
Q psy1672 274 VVCRVDSIPP-AAISWYWNGRL 294 (600)
Q Consensus 274 L~C~v~g~P~-p~i~W~~~g~~ 294 (600)
..|.+.-.|. -.+.|......
T Consensus 365 AVCtA~CVP~gV~lrWlVgD~p 386 (490)
T PHA03271 365 AICTIECVPSGITVRWLVHDEP 386 (490)
T ss_pred EEEeccccCCCcEEEEEecCCC
Confidence 4577776653 37889875543
No 340
>KOG1219|consensus
Probab=51.07 E-value=1.6e+02 Score=38.44 Aligned_cols=14 Identities=21% Similarity=0.280 Sum_probs=9.8
Q ss_pred ccccCCCCcccCcc
Q psy1672 448 TEMISPNGQLPNKT 461 (600)
Q Consensus 448 ~~~~~~~~~~~~~~ 461 (600)
+..++|+...+||+
T Consensus 4087 vcSvapnlp~pspc 4100 (4289)
T KOG1219|consen 4087 VCSVAPNLPPPSPC 4100 (4289)
T ss_pred eeccCCCCCCCCCC
Confidence 34678887777766
No 341
>PF12877 DUF3827: Domain of unknown function (DUF3827); InterPro: IPR024606 The function of the proteins in this entry is not currently known, but one of the human proteins (Q9HCM3 from SWISSPROT) has been implicated in pilocytic astrocytomas [, , ]. In the majority of cases of pilocytic astrocytomas a tandem duplication produces an in-frame fusion of the gene encoding this protein and the BRAF oncogene. The resulting fusion protein has constitutive BRAF kinase activity and is capable of transforming cells.
Probab=50.97 E-value=17 Score=40.50 Aligned_cols=33 Identities=24% Similarity=0.444 Sum_probs=17.3
Q ss_pred cCcchhHHHHHHHHHHHHHHHHHHHHHhHhcCCC
Q psy1672 364 GGGHINGISLALFFLIILILIIIIYLLIRMRTIT 397 (600)
Q Consensus 364 ~~~~i~gi~~g~~l~l~lillii~~~~~rkrr~~ 397 (600)
..|+|+|+++.++++ ++|++++.+++||+.|..
T Consensus 268 NlWII~gVlvPv~vV-~~Iiiil~~~LCRk~K~e 300 (684)
T PF12877_consen 268 NLWIIAGVLVPVLVV-LLIIIILYWKLCRKNKLE 300 (684)
T ss_pred CeEEEehHhHHHHHH-HHHHHHHHHHHhcccccC
Confidence 456667776544443 334444444555666543
No 342
>KOG3763|consensus
Probab=50.47 E-value=6.1 Score=43.14 Aligned_cols=64 Identities=22% Similarity=0.307 Sum_probs=42.4
Q ss_pred CCCCccEEEeecccCcccCc--cccCCCCCccEEEccCC--CCCCCCc-cccCCCCCCCEEEccCCCCCc
Q psy1672 73 GLLNLQKLFLARCHIGQIDS--GALDGLTNLIEIDLSDN--LLTSIPS-LTFQSVRFLRDLNLARNPISK 137 (600)
Q Consensus 73 ~l~~L~~L~L~~n~l~~i~~--~~f~~l~~L~~L~Ls~N--~l~~l~~-~~f~~l~~L~~L~Ls~N~i~~ 137 (600)
+.+.+..|.|++|+|..++. ..-...++|+.|+|++| .+....+ ..+++++ |++|-|.+|++..
T Consensus 216 n~p~i~sl~lsnNrL~~Ld~~sslsq~apklk~L~LS~N~~~~~~~~el~K~k~l~-Leel~l~GNPlc~ 284 (585)
T KOG3763|consen 216 NFPEILSLSLSNNRLYHLDALSSLSQIAPKLKTLDLSHNHSKISSESELDKLKGLP-LEELVLEGNPLCT 284 (585)
T ss_pred CCcceeeeecccchhhchhhhhHHHHhcchhheeecccchhhhcchhhhhhhcCCC-HHHeeecCCcccc
Confidence 67788888888888766643 11234578999999998 4443222 1234444 8899999998754
No 343
>PF14979 TMEM52: Transmembrane 52
Probab=50.28 E-value=1.2e+02 Score=27.36 Aligned_cols=9 Identities=11% Similarity=0.069 Sum_probs=4.3
Q ss_pred CCCCccCCC
Q psy1672 489 NDDVLFQNN 497 (600)
Q Consensus 489 ~~~~~~~~~ 497 (600)
.|.|+|+.+
T Consensus 110 Paysl~a~e 118 (154)
T PF14979_consen 110 PAYSLYALE 118 (154)
T ss_pred CcccccCCC
Confidence 344555443
No 344
>PF12273 RCR: Chitin synthesis regulation, resistance to Congo red; InterPro: IPR020999 RCR proteins are ER membrane proteins that regulate chitin deposition in fungal cell walls. Although chitin, a linear polymer of beta-1,4-linked N-acetylglucosamine, constitutes only 2% of the cell wall it plays a vital role in the overall protection of the cell wall against stress, noxious chemicals and osmotic pressure changes. Congo red is a cell wall-disrupting benzidine-type dye extensively used in many cell wall mutant studies that specifically targets chitin in yeast cells and inhibits growth. RCR proteins render the yeasts resistant to Congo red by diminishing the content of chitin in the cell wall []. RCR proteins are probably regulating chitin synthase III interact directly with ubiquitin ligase Rsp5, and the VPEY motif is necessary for this, via interaction with the WW domains of Rsp5 [].
Probab=50.27 E-value=9.1 Score=33.95 Aligned_cols=7 Identities=29% Similarity=-0.002 Sum_probs=4.6
Q ss_pred HHhHhcC
Q psy1672 389 LLIRMRT 395 (600)
Q Consensus 389 ~~~rkrr 395 (600)
--+|+||
T Consensus 23 ~rRR~r~ 29 (130)
T PF12273_consen 23 NRRRRRR 29 (130)
T ss_pred HHHHhhc
Confidence 4577776
No 345
>PF12301 CD99L2: CD99 antigen like protein 2; InterPro: IPR022078 This family of proteins is found in eukaryotes. Proteins in this family are typically between 165 and 237 amino acids in length. CD99L2 and CD99 are involved in trans-endothelial migration of neutrophils in vitro and in the recruitment of neutrophils into inflamed peritoneum.
Probab=49.25 E-value=31 Score=32.07 Aligned_cols=32 Identities=19% Similarity=0.422 Sum_probs=17.7
Q ss_pred CcchhHHHHHHHHHHHHHHHHHHHHHhHhcCCCC
Q psy1672 365 GGHINGISLALFFLIILILIIIIYLLIRMRTITY 398 (600)
Q Consensus 365 ~~~i~gi~~g~~l~l~lillii~~~~~rkrr~~~ 398 (600)
.+.|+||+.+++++++- .+--|+-++|||.-+
T Consensus 114 ~g~IaGIvsav~valvG--AvsSyiaYqkKKlCF 145 (169)
T PF12301_consen 114 AGTIAGIVSAVVVALVG--AVSSYIAYQKKKLCF 145 (169)
T ss_pred cchhhhHHHHHHHHHHH--HHHHHHHHHhhccce
Confidence 45677877655444333 233455556666544
No 346
>KOG1094|consensus
Probab=48.93 E-value=3e+02 Score=31.02 Aligned_cols=6 Identities=33% Similarity=0.966 Sum_probs=3.4
Q ss_pred CCCCee
Q psy1672 18 PSTCIC 23 (600)
Q Consensus 18 p~~C~C 23 (600)
|..|+-
T Consensus 22 ~~~C~~ 27 (807)
T KOG1094|consen 22 PAKCRY 27 (807)
T ss_pred HHHhhh
Confidence 566644
No 347
>PF04689 S1FA: DNA binding protein S1FA; InterPro: IPR006779 S1FA is an unusual small plant peptide of only 70 amino acids with a basic domain which contains a nuclear localization signal and a putative DNA binding helix. S1FA is highly conserved between dicotyledonous and monocotyledonous plants and may be a DNA-binding protein that specifically recognises the negative promoter element S1F [].; GO: 0003677 DNA binding, 0006355 regulation of transcription, DNA-dependent, 0005634 nucleus
Probab=48.92 E-value=31 Score=26.11 Aligned_cols=32 Identities=22% Similarity=0.339 Sum_probs=22.3
Q ss_pred ccCcchhHHHHHHHHHHHHHHHHHHHHHhHhc
Q psy1672 363 LGGGHINGISLALFFLIILILIIIIYLLIRMR 394 (600)
Q Consensus 363 ~~~~~i~gi~~g~~l~l~lillii~~~~~rkr 394 (600)
+..+.|+-|+++.++++.++...+.|.|.+|.
T Consensus 10 lnPGlIVLlvV~g~ll~flvGnyvlY~Yaqk~ 41 (69)
T PF04689_consen 10 LNPGLIVLLVVAGLLLVFLVGNYVLYVYAQKT 41 (69)
T ss_pred CCCCeEEeehHHHHHHHHHHHHHHHHHHHhhc
Confidence 34467777888877777777777777776554
No 348
>PF14575 EphA2_TM: Ephrin type-A receptor 2 transmembrane domain; PDB: 3KUL_A 2XVD_A 2VX1_A 2VWV_A 2VX0_A 2VWY_A 2VWZ_A 2VWW_A 2VWU_A 2VWX_A ....
Probab=47.98 E-value=21 Score=28.33 Aligned_cols=16 Identities=19% Similarity=0.569 Sum_probs=7.4
Q ss_pred HHHHHHHHHHHHHHHH
Q psy1672 371 ISLALFFLIILILIII 386 (600)
Q Consensus 371 i~~g~~l~l~lillii 386 (600)
|+++++++++++++++
T Consensus 2 ii~~~~~g~~~ll~~v 17 (75)
T PF14575_consen 2 IIASIIVGVLLLLVLV 17 (75)
T ss_dssp HHHHHHHHHHHHHHHH
T ss_pred EEehHHHHHHHHHHhh
Confidence 3444555554444433
No 349
>PF06697 DUF1191: Protein of unknown function (DUF1191); InterPro: IPR010605 This family contains hypothetical plant proteins of unknown function.
Probab=47.95 E-value=8.6 Score=38.51 Aligned_cols=8 Identities=13% Similarity=0.273 Sum_probs=4.6
Q ss_pred EEEEEEec
Q psy1672 333 RFYCVAEN 340 (600)
Q Consensus 333 ~Y~C~a~N 340 (600)
.|.|.+..
T Consensus 175 ~nvC~~~~ 182 (278)
T PF06697_consen 175 PNVCSTSR 182 (278)
T ss_pred Cceeeeec
Confidence 46666653
No 350
>PF10577 UPF0560: Uncharacterised protein family UPF0560; InterPro: IPR018890 This family of proteins has no known function.
Probab=45.65 E-value=23 Score=40.57 Aligned_cols=28 Identities=11% Similarity=0.230 Sum_probs=12.1
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHhHhc
Q psy1672 367 HINGISLALFFLIILILIIIIYLLIRMR 394 (600)
Q Consensus 367 ~i~gi~~g~~l~l~lillii~~~~~rkr 394 (600)
...+|.+|.++++++++.+++|.|+||+
T Consensus 274 fLl~ILG~~~livl~lL~vLl~yCrrkc 301 (807)
T PF10577_consen 274 FLLAILGGTALIVLILLCVLLCYCRRKC 301 (807)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhhccc
Confidence 3455555544444433333333344433
No 351
>PF04971 Lysis_S: Lysis protein S ; InterPro: IPR007054 The lysis S protein is a cytotoxic protein forming holes in membranes causing cell lysis. The action of Lysis S is independent of the proportion of acidic phospholipids in the membrane [].
Probab=45.39 E-value=28 Score=26.91 Aligned_cols=22 Identities=18% Similarity=0.214 Sum_probs=12.4
Q ss_pred CcchhHHHHHHHHHHHHHHHHH
Q psy1672 365 GGHINGISLALFFLIILILIII 386 (600)
Q Consensus 365 ~~~i~gi~~g~~l~l~lillii 386 (600)
.+..+|+++++++.++-.+.-+
T Consensus 32 qW~aIGvi~gi~~~~lt~ltN~ 53 (68)
T PF04971_consen 32 QWAAIGVIGGIFFGLLTYLTNL 53 (68)
T ss_pred cchhHHHHHHHHHHHHHHHhHh
Confidence 3556677776665555444433
No 352
>PF06328 Lep_receptor_Ig: Ig-like C2-type domain; InterPro: IPR010457 This entry represents a ligand-binding domain that displays similarity to C2-set immunoglobulin domains (antibody constant domain 2) []. The two cysteine residues form a disulphide bridge.; PDB: 3L5H_A 1P9M_A 1I1R_A 2D9Q_B.
Probab=45.18 E-value=1.1e+02 Score=25.16 Aligned_cols=67 Identities=22% Similarity=0.353 Sum_probs=38.7
Q ss_pred ccccccccccccceeeeEeec-----CCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEE
Q psy1672 260 DSRYVEAVSSENATVVCRVDS-----IPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRF 334 (600)
Q Consensus 260 ~~~~~~v~~G~~v~L~C~v~g-----~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y 334 (600)
.+....+..|++++..|.... .....|.|..++..+... +.....++ .+.+++.+......-.|
T Consensus 9 ~p~~pvv~lGS~vtasC~l~~~c~~~~~a~~I~Wkln~~~iP~~-------qy~~in~~----~SsVT~~~~~~~~~~L~ 77 (89)
T PF06328_consen 9 SPPSPVVSLGSNVTASCVLKQNCSHSVNASQIVWKLNGEKIPGS-------QYRVINDT----VSSVTLPNLNPTGATLF 77 (89)
T ss_dssp ECSSSEEETTS-EEEEEEE-CCCHCT-STTCEEEECSSCESTCG-------CEEEESTT----EEEEEESS--SSEEEEE
T ss_pred ecCCCEEeCCCCEEEEEEEECCCCCCcccceEEEEECCEECChh-------HcceeCCe----EEEEEEccCCCCCceEE
Confidence 345566789999999998862 245689999988755432 22233333 25667766655544456
Q ss_pred EEE
Q psy1672 335 YCV 337 (600)
Q Consensus 335 ~C~ 337 (600)
-|.
T Consensus 78 cC~ 80 (89)
T PF06328_consen 78 CCK 80 (89)
T ss_dssp EEE
T ss_pred EEE
Confidence 565
No 353
>KOG1947|consensus
Probab=44.91 E-value=9.2 Score=41.49 Aligned_cols=110 Identities=19% Similarity=0.152 Sum_probs=68.9
Q ss_pred CCCCccEEEccCC-CCCCCC-ccccCCCCCCCEEEccCC-C-CCccC---cccccCCCCcceeeCCCCc-CcccChhhhc
Q psy1672 97 GLTNLIEIDLSDN-LLTSIP-SLTFQSVRFLRDLNLARN-P-ISKIE---KGAFQFVPGLVKLDMSESR-LEHISPEAFT 168 (600)
Q Consensus 97 ~l~~L~~L~Ls~N-~l~~l~-~~~f~~l~~L~~L~Ls~N-~-i~~l~---~~~~~~l~~L~~L~Ls~n~-l~~i~~~~~~ 168 (600)
..+.|+.|.+.+. .++... .......+.|+.|+++++ . +.... ......+.+|+.|+++.+. ++.+.-..+.
T Consensus 186 ~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~L~~l~l~~~~~isd~~l~~l~ 265 (482)
T KOG1947|consen 186 SCPLLKRLSLSGCSKITDDSLDALALKCPNLEELDLSGCCLLITLSPLLLLLLLSICRKLKSLDLSGCGLVTDIGLSALA 265 (482)
T ss_pred hCchhhHhhhcccccCChhhHHHHHhhCchhheecccCcccccccchhHhhhhhhhcCCcCccchhhhhccCchhHHHHH
Confidence 4678888888766 344311 123456788999999873 1 11111 1233456788999998887 6655444443
Q ss_pred -CCCCCCEEEcCCCc-CCCCCc-ccccccccccEEEccCCc
Q psy1672 169 -GAKSLESIKLNGNR-LSHFPV-RSVEPLLKLMMIELHDNP 206 (600)
Q Consensus 169 -~l~~L~~L~Ls~N~-l~~l~~-~~~~~l~~L~~L~l~~N~ 206 (600)
.+++|+.|.+.++. ++.... .....++.|+.|++....
T Consensus 266 ~~c~~L~~L~l~~c~~lt~~gl~~i~~~~~~L~~L~l~~c~ 306 (482)
T KOG1947|consen 266 SRCPNLETLSLSNCSNLTDEGLVSIAERCPSLRELDLSGCH 306 (482)
T ss_pred hhCCCcceEccCCCCccchhHHHHHHHhcCcccEEeeecCc
Confidence 37899999987776 554332 223456779999988544
No 354
>PF12768 Rax2: Cortical protein marker for cell polarity
Probab=44.88 E-value=31 Score=34.97 Aligned_cols=28 Identities=36% Similarity=0.463 Sum_probs=11.7
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHhHhc
Q psy1672 367 HINGISLALFFLIILILIIIIYLLIRMR 394 (600)
Q Consensus 367 ~i~gi~~g~~l~l~lillii~~~~~rkr 394 (600)
+.+++++|+.++++++++.+++.+.|||
T Consensus 230 VlIslAiALG~v~ll~l~Gii~~~~~r~ 257 (281)
T PF12768_consen 230 VLISLAIALGTVFLLVLIGIILAYIRRR 257 (281)
T ss_pred EEEehHHHHHHHHHHHHHHHHHHHHHhh
Confidence 3445555444444444443333333333
No 355
>PF06832 BiPBP_C: Penicillin-Binding Protein C-terminus Family; InterPro: IPR009647 This conserved region of approximately 90 residues is found in a sub-group of bacterial Penicillin-Binding Proteins (PBPs). A variable length loop region separates this region from the transpeptidase unit (IPR001460 from INTERPRO). It is predicted to be a beta fold.
Probab=43.90 E-value=1.3e+02 Score=24.26 Aligned_cols=56 Identities=14% Similarity=0.237 Sum_probs=36.2
Q ss_pred cceeeeEeecCCCCeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCceeE
Q psy1672 271 NATVVCRVDSIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIADA 347 (600)
Q Consensus 271 ~v~L~C~v~g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~ 347 (600)
...+..++.+. ...+.|+.||+.+...... . .+.+ .....|.|+-++....|....
T Consensus 31 ~~~l~l~a~~~-~~~~~W~vdg~~~g~~~~~---~--------------~~~~---~~~~~G~h~l~vvD~~G~~~~ 86 (89)
T PF06832_consen 31 RQPLVLKAAGG-RGPVYWFVDGEPLGTTQPG---H--------------QLFW---QPDRPGEHTLTVVDAQGRSAS 86 (89)
T ss_pred cceEEEEEeCC-CCcEEEEECCEEcccCCCC---C--------------eEEe---CCCCCeeEEEEEEcCCCCEEE
Confidence 56677777765 5599999999988433211 0 1211 123568999999888887543
No 356
>KOG4341|consensus
Probab=41.65 E-value=8.9 Score=40.56 Aligned_cols=112 Identities=21% Similarity=0.141 Sum_probs=46.8
Q ss_pred CCCCccEEEccCCC-CCCCC-ccccCCCCCCCEEEccCCC-CCccCcccc-cCCCCcceeeCCCCcCcccC--hhhhcCC
Q psy1672 97 GLTNLIEIDLSDNL-LTSIP-SLTFQSVRFLRDLNLARNP-ISKIEKGAF-QFVPGLVKLDMSESRLEHIS--PEAFTGA 170 (600)
Q Consensus 97 ~l~~L~~L~Ls~N~-l~~l~-~~~f~~l~~L~~L~Ls~N~-i~~l~~~~~-~~l~~L~~L~Ls~n~l~~i~--~~~~~~l 170 (600)
+...|+.|+.++.. ++... +...++..+|+.|.++.++ ++...-..+ .+.+.|+.+++..+.+..-. ...-.++
T Consensus 292 ~c~~lq~l~~s~~t~~~d~~l~aLg~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C 371 (483)
T KOG4341|consen 292 GCHALQVLCYSSCTDITDEVLWALGQHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRNC 371 (483)
T ss_pred hhhHhhhhcccCCCCCchHHHHHHhcCCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccCC
Confidence 34455666555442 22111 1112234556666655553 222111111 23455666655554322110 1111245
Q ss_pred CCCCEEEcCCCcCCCCC-----cccccccccccEEEccCCcCc
Q psy1672 171 KSLESIKLNGNRLSHFP-----VRSVEPLLKLMMIELHDNPWV 208 (600)
Q Consensus 171 ~~L~~L~Ls~N~l~~l~-----~~~~~~l~~L~~L~l~~N~~~ 208 (600)
+.|+.|.|+++.+.+-. ...-..+..|..+++++.|..
T Consensus 372 ~~lr~lslshce~itD~gi~~l~~~~c~~~~l~~lEL~n~p~i 414 (483)
T KOG4341|consen 372 PRLRVLSLSHCELITDEGIRHLSSSSCSLEGLEVLELDNCPLI 414 (483)
T ss_pred chhccCChhhhhhhhhhhhhhhhhccccccccceeeecCCCCc
Confidence 56666666655433221 111123345566666666544
No 357
>PF03229 Alpha_GJ: Alphavirus glycoprotein J; InterPro: IPR004913 The exact function of the herpesvirus glycoprotein J is unknown, but it appears to play a role in the inhibition of apotosis of the host cell [].; GO: 0019050 suppression by virus of host apoptosis
Probab=41.48 E-value=27 Score=29.87 Aligned_cols=29 Identities=14% Similarity=-0.030 Sum_probs=17.7
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHhHhc
Q psy1672 366 GHINGISLALFFLIILILIIIIYLLIRMR 394 (600)
Q Consensus 366 ~~i~gi~~g~~l~l~lillii~~~~~rkr 394 (600)
..+.++++|.+.++++..+..+++++|++
T Consensus 83 d~aLp~VIGGLcaL~LaamGA~~LLrR~c 111 (126)
T PF03229_consen 83 DFALPLVIGGLCALTLAAMGAGALLRRCC 111 (126)
T ss_pred ccchhhhhhHHHHHHHHHHHHHHHHHHHH
Confidence 45667777776667766665555544443
No 358
>PF15176 LRR19-TM: Leucine-rich repeat family 19 TM domain
Probab=41.15 E-value=46 Score=27.81 Aligned_cols=27 Identities=11% Similarity=0.151 Sum_probs=16.4
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHhHh
Q psy1672 367 HINGISLALFFLIILILIIIIYLLIRM 393 (600)
Q Consensus 367 ~i~gi~~g~~l~l~lillii~~~~~rk 393 (600)
..+|+++++++.-+||++.+-+-.++|
T Consensus 19 ~LVGVv~~al~~SlLIalaaKC~~~~k 45 (102)
T PF15176_consen 19 FLVGVVVTALVTSLLIALAAKCPVWYK 45 (102)
T ss_pred hHHHHHHHHHHHHHHHHHHHHhHHHHH
Confidence 567777777666666666655433333
No 359
>PF15069 FAM163: FAM163 family
Probab=40.75 E-value=16 Score=32.63 Aligned_cols=25 Identities=24% Similarity=0.288 Sum_probs=17.5
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHhH
Q psy1672 368 INGISLALFFLIILILIIIIYLLIR 392 (600)
Q Consensus 368 i~gi~~g~~l~l~lillii~~~~~r 392 (600)
.+.|.+|++..++|+.+|++.+|+|
T Consensus 5 TvVItGgILAtVILLcIIaVLCYCR 29 (143)
T PF15069_consen 5 TVVITGGILATVILLCIIAVLCYCR 29 (143)
T ss_pred eEEEechHHHHHHHHHHHHHHHHHh
Confidence 3456677777777777777777765
No 360
>PHA02914 Immunoglobulin-like domain protein; Provisional
Probab=40.69 E-value=65 Score=33.90 Aligned_cols=89 Identities=11% Similarity=0.112 Sum_probs=53.9
Q ss_pred cccccccccceeeeEeec---CCCCeeEEEEcCeeccCCc-----------ccCccceEEEeeC---CceeeeeeEEEec
Q psy1672 263 YVEAVSSENATVVCRVDS---IPPAAISWYWNGRLLLNNT-----------AFSSYQRIFVIEQ---GEYERKSSLVLTN 325 (600)
Q Consensus 263 ~~~v~~G~~v~L~C~v~g---~P~p~i~W~~~g~~l~~~~-----------~~~~~~~~~~~~~---g~~~~~s~L~I~~ 325 (600)
.+.++.|..+.+.|.... ..-..+.|+-.|-.+.... .|.......+..- ....+.|+|+|.+
T Consensus 273 ~~~~~~g~~v~~~c~~s~~~~e~i~~~~w~~t~~~~~~~~g~~~~~~~v~~~~~~~~~~~i~~~~~~s~dlk~STLTIkk 352 (500)
T PHA02914 273 EVMLEVGKRVDIECFFSMCGNENISNAKWIDTGFEIGPLIGTVKSKDIVEGDFAEDDDFMISAHANYSDDLKNSTLTIKK 352 (500)
T ss_pred eeEeccCcEEEEEEEEeecCCcccccceEEecCCcccceeEEEEecceeecccccCCceEEEEecccccchhhceEEeee
Confidence 456778999999998874 2345788987554332110 0111111111111 1113568999999
Q ss_pred CCCCCCeEEEEEEecCCCceeEEEEE
Q psy1672 326 AQESDSGRFYCVAENRAGIADANFTL 351 (600)
Q Consensus 326 v~~~d~G~Y~C~a~N~~G~~~~~v~L 351 (600)
+.....|-|+|.|....-..++..-+
T Consensus 353 a~I~N~GCY~~~a~~g~~~~ec~~Cl 378 (500)
T PHA02914 353 AHINNAGCYEAQAFMGKFKEECRHCF 378 (500)
T ss_pred EEEEcCCceEEEEecCcchhhhhhhe
Confidence 99999999999999875444444333
No 361
>PHA03269 envelope glycoprotein C; Provisional
Probab=40.55 E-value=41 Score=36.22 Aligned_cols=113 Identities=13% Similarity=0.089 Sum_probs=0.0
Q ss_pred eeEeecCCC--CeeEEEEcCeeccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCe--EEEEEEec-CCCceeEEE
Q psy1672 275 VCRVDSIPP--AAISWYWNGRLLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSG--RFYCVAEN-RAGIADANF 349 (600)
Q Consensus 275 ~C~v~g~P~--p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G--~Y~C~a~N-~~G~~~~~v 349 (600)
.|.+.-.|. -.+.|..+.....+....-...-.....-. ++.=........| +|+|.... +.+--.-+.
T Consensus 449 VCtA~CVP~~~V~l~WlVgD~p~~~~~t~itG~C~ehPGLV------NLRS~~pLS~~dgpveYTCrL~GYP~~lP~Fsd 522 (566)
T PHA03269 449 VCLAKCVPRGVVHFNWWINDIPIEHENSEILGVCDNNKRFV------NLQSSCDTSELDGPITYSCHLDGYPKKFPPFSA 522 (566)
T ss_pred EEecccccCCCceEEEEecCCCCCCccceeeccCCCCCCce------eecccccccccCCceeEEEEEeecCCCCCccce
Q ss_pred EEEEEEccCCCccccCcchhHHHHHHHHHHHHHHHHHHHHHhHh
Q psy1672 350 TLQVTYRGVGLPFLGGGHINGISLALFFLIILILIIIIYLLIRM 393 (600)
Q Consensus 350 ~L~V~~~~~~~~~~~~~~i~gi~~g~~l~l~lillii~~~~~rk 393 (600)
.-.....+..........|+|++++++++.+++++...++++.|
T Consensus 523 t~~YDASP~a~~~PvV~~IigV~~~~~algliilItAlCfyc~k 566 (566)
T PHA03269 523 VYTYDASSSASTFPLIAAIIGIISIIGILGLIALIATLCIRCCK 566 (566)
T ss_pred eeeecCCCcccCCceeeeehHHHHHHHHHHHHHhheeEEEEecC
No 362
>PF12669 P12: Virus attachment protein p12 family
Probab=39.96 E-value=33 Score=25.77 Aligned_cols=6 Identities=0% Similarity=0.207 Sum_probs=2.2
Q ss_pred HHhHhc
Q psy1672 389 LLIRMR 394 (600)
Q Consensus 389 ~~~rkr 394 (600)
+++++|
T Consensus 20 ~~k~~K 25 (58)
T PF12669_consen 20 FIKDKK 25 (58)
T ss_pred HHHHhh
Confidence 333333
No 363
>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane. Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.
Probab=39.66 E-value=28 Score=30.52 Aligned_cols=11 Identities=18% Similarity=0.437 Sum_probs=4.7
Q ss_pred HHHHHhHhcCC
Q psy1672 386 IIYLLIRMRTI 396 (600)
Q Consensus 386 i~~~~~rkrr~ 396 (600)
|++++++.||.
T Consensus 81 Illi~y~irR~ 91 (122)
T PF01102_consen 81 ILLISYCIRRL 91 (122)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 33344444443
No 364
>PF05545 FixQ: Cbb3-type cytochrome oxidase component FixQ; InterPro: IPR008621 This family consists of several Cbb3-type cytochrome oxidase components (FixQ/CcoQ). FixQ is found in nitrogen fixing bacteria. Since nitrogen fixation is an energy-consuming process, effective symbioses depend on operation of a respiratory chain with a high affinity for O2, closely coupled to ATP production. This requirement is fulfilled by a special three-subunit terminal oxidase (cytochrome terminal oxidase cbb3), which was first identified in Bradyrhizobium japonicum as the product of the fixNOQP operon [].
Probab=36.12 E-value=42 Score=24.04 Aligned_cols=7 Identities=29% Similarity=0.553 Sum_probs=2.8
Q ss_pred HHHHHHh
Q psy1672 385 IIIYLLI 391 (600)
Q Consensus 385 ii~~~~~ 391 (600)
++++.++
T Consensus 25 i~~w~~~ 31 (49)
T PF05545_consen 25 IVIWAYR 31 (49)
T ss_pred HHHHHHc
Confidence 3344443
No 365
>COG1470 Predicted membrane protein [Function unknown]
Probab=35.50 E-value=1.5e+02 Score=32.17 Aligned_cols=39 Identities=21% Similarity=0.296 Sum_probs=27.8
Q ss_pred eeeEEEecCCCCCCeEEEEEEecCCCceeEEEEEEEEEc
Q psy1672 318 KSSLVLTNAQESDSGRFYCVAENRAGIADANFTLQVTYR 356 (600)
Q Consensus 318 ~s~L~I~~v~~~d~G~Y~C~a~N~~G~~~~~v~L~V~~~ 356 (600)
+..++|.-.....+|.|.-..+-.....+..-+++|.+.
T Consensus 445 tV~ltI~vP~~a~aGdY~i~i~~ksDq~s~e~tlrV~V~ 483 (513)
T COG1470 445 TVSLTITVPEDAGAGDYRITITAKSDQASSEDTLRVVVG 483 (513)
T ss_pred eEEEEEEcCCCCCCCcEEEEEEEeeccccccceEEEEEe
Confidence 346788888888889898877766666666666666544
No 366
>PF07213 DAP10: DAP10 membrane protein; InterPro: IPR009861 This family consists of several mammalian DAP10 membrane proteins. In activated mouse natural killer (NK) cells, the NKG2D receptor associates with two intracellular adaptors, DAP10 and DAP12, which trigger phosphatidyl inositol 3 kinase (PI3K) and Syk family protein tyrosine kinases, respectively. It has been suggested that the DAP10-PI3K pathway is sufficient to initiate NKG2D-mediated killing of target cells [].
Probab=33.42 E-value=1e+02 Score=24.61 Aligned_cols=44 Identities=5% Similarity=0.094 Sum_probs=25.3
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHhHhcCCCCCCCCCCCccee
Q psy1672 366 GHINGISLALFFLIILILIIIIYLLIRMRTITYPNSKNPAQIEV 409 (600)
Q Consensus 366 ~~i~gi~~g~~l~l~lillii~~~~~rkrr~~~~~~~~~~~~~~ 409 (600)
.+-.|..+|+++.=+++.++|....++.-|.+...++.+.+.++
T Consensus 30 ~ls~g~LaGiV~~D~vlTLLIv~~vy~car~r~r~~~~~~kvYi 73 (79)
T PF07213_consen 30 PLSPGLLAGIVAADAVLTLLIVLVVYYCARPRRRPTQEDDKVYI 73 (79)
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHHHHhhcccccCCcccCCEEEE
Confidence 45678888888877777666555444444443333333444443
No 367
>PF14851 FAM176: FAM176 family
Probab=32.61 E-value=48 Score=30.27 Aligned_cols=18 Identities=17% Similarity=0.482 Sum_probs=12.8
Q ss_pred cchhHHHHHHHHHHHHHH
Q psy1672 366 GHINGISLALFFLIILIL 383 (600)
Q Consensus 366 ~~i~gi~~g~~l~l~lil 383 (600)
..+.|+++|+++.+++++
T Consensus 25 YFv~gVC~GLlLtLcllV 42 (153)
T PF14851_consen 25 YFVSGVCAGLLLTLCLLV 42 (153)
T ss_pred HHHHHHHHHHHHHHHHHH
Confidence 467788888877776654
No 368
>PHA03189 UL14 tegument protein; Provisional
Probab=30.57 E-value=3.6e+02 Score=27.48 Aligned_cols=25 Identities=20% Similarity=0.282 Sum_probs=17.7
Q ss_pred ccccccccccceeeeEee--cCCCCee
Q psy1672 262 RYVEAVSSENATVVCRVD--SIPPAAI 286 (600)
Q Consensus 262 ~~~~v~~G~~v~L~C~v~--g~P~p~i 286 (600)
.-+.+..|+.+++.|.+. ..|...|
T Consensus 60 AP~l~pyGdrvtVpC~fp~H~WPevsI 86 (348)
T PHA03189 60 APLLVPYGDRVTVPCTFPTHDWPEVSI 86 (348)
T ss_pred CccccCCCceeeeeeeecCCCCceeeE
Confidence 345677899999999886 3444444
No 369
>PF14914 LRRC37AB_C: LRRC37A/B like protein 1 C-terminal domain
Probab=30.44 E-value=94 Score=27.98 Aligned_cols=22 Identities=27% Similarity=0.531 Sum_probs=11.3
Q ss_pred cchhHHHHHHHHHHHHHHHHHH
Q psy1672 366 GHINGISLALFFLIILILIIII 387 (600)
Q Consensus 366 ~~i~gi~~g~~l~l~lillii~ 387 (600)
-.|.++.+.+++.++++++.++
T Consensus 120 klilaisvtvv~~iliii~CLi 141 (154)
T PF14914_consen 120 KLILAISVTVVVMILIIIFCLI 141 (154)
T ss_pred hhHHHHHHHHHHHHHHHHHHHH
Confidence 3566666666554444443333
No 370
>COG4736 CcoQ Cbb3-type cytochrome oxidase, subunit 3 [Posttranslational modification, protein turnover, chaperones]
Probab=30.13 E-value=59 Score=24.60 Aligned_cols=22 Identities=5% Similarity=0.129 Sum_probs=10.1
Q ss_pred HHHHHHHHHHHHHHHHhHhcCC
Q psy1672 375 LFFLIILILIIIIYLLIRMRTI 396 (600)
Q Consensus 375 ~~l~l~lillii~~~~~rkrr~ 396 (600)
.+.+.++.+.++++.|++++|.
T Consensus 15 t~~~~l~fiavi~~ayr~~~K~ 36 (60)
T COG4736 15 TIAFTLFFIAVIYFAYRPGKKG 36 (60)
T ss_pred HHHHHHHHHHHHHHHhcccchh
Confidence 3333344444455555555444
No 371
>PF15065 NCU-G1: Lysosomal transcription factor, NCU-G1
Probab=29.75 E-value=35 Score=35.69 Aligned_cols=31 Identities=19% Similarity=0.233 Sum_probs=16.6
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHhHhcCC
Q psy1672 366 GHINGISLALFFLIILILIIIIYLLIRMRTI 396 (600)
Q Consensus 366 ~~i~gi~~g~~l~l~lillii~~~~~rkrr~ 396 (600)
.+|+.+++|+.+-++++++..+|++.||+|.
T Consensus 318 lvi~i~~vgLG~P~l~li~Ggl~v~~~r~r~ 348 (350)
T PF15065_consen 318 LVIMIMAVGLGVPLLLLILGGLYVCLRRRRK 348 (350)
T ss_pred HHHHHHHHHhhHHHHHHHHhhheEEEecccc
Confidence 3444445555555555555555665555544
No 372
>TIGR03024 arch_pef_cterm PEF-C-terminal archaeal protein sorting domain. This domain, distantly related to the PEP-Cterm domain described in model TIGR02595, is found in Methanosarcina mazei in four different proteins, as well as in other archaea such as Methanococcoides burtonii. Several proteins with this domain have their genes only a short distance from a distant homology of EpsH, a proposed integral membrane transpeptidase.
Probab=29.61 E-value=73 Score=19.75 Aligned_cols=6 Identities=33% Similarity=0.562 Sum_probs=2.4
Q ss_pred HHhHhc
Q psy1672 389 LLIRMR 394 (600)
Q Consensus 389 ~~~rkr 394 (600)
++.|||
T Consensus 20 i~~rrK 25 (26)
T TIGR03024 20 ILRRRK 25 (26)
T ss_pred HHhhcc
Confidence 344443
No 373
>COG5526 Lysozyme family protein [General function prediction only]
Probab=29.40 E-value=57 Score=29.48 Aligned_cols=26 Identities=38% Similarity=0.493 Sum_probs=21.3
Q ss_pred cccCCCCCCCCcceeeeeccCCCCC--Cc
Q psy1672 549 NELLPNNIHPNAKTLRVWQRGVPVL--PP 575 (600)
Q Consensus 549 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 575 (600)
+-+|||-.|-+|||-||= ||-|-. ||
T Consensus 74 ~thLhNGdpL~aRT~rVP-kgRp~~~~Pp 101 (191)
T COG5526 74 GTHLHNGDPLGARTTRVP-KGRPPFTGPP 101 (191)
T ss_pred cccccCCCccccceeecc-CCCCCCCCCC
Confidence 358999999999999994 566665 88
No 374
>PF04906 Tweety: Tweety; InterPro: IPR006990 None of the members of the tweety (tty) family have been functionally characterised. However, they are considered to be transmembrane proteins with five potential membrane-spanning regions. A number of potential functions have been suggested on the basis of homology to the yeast FTR1 and FTH1 iron transporter proteins and the mammalian neurotensin receptors 1 and 2 in that they have a similar hydrophobicity profiles although there is no detectable sequence homology to the tweety-related proteins. It has been proposed that the tweety-related proteins could be involved in transport of iron or other divalent cations or alternatively that they may be membrane-bound receptors [].
Probab=29.17 E-value=76 Score=34.11 Aligned_cols=23 Identities=17% Similarity=0.267 Sum_probs=11.2
Q ss_pred chhHHHHHHHHHHHHHHHHHHHH
Q psy1672 367 HINGISLALFFLIILILIIIIYL 389 (600)
Q Consensus 367 ~i~gi~~g~~l~l~lillii~~~ 389 (600)
.+.|.++++.+++.+++++++.+
T Consensus 20 ~~la~v~~~~l~l~Ll~ll~yl~ 42 (406)
T PF04906_consen 20 LILASVAAACLALSLLFLLIYLI 42 (406)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHH
Confidence 34555555555555544444433
No 375
>PF05955 Herpes_gp2: Equine herpesvirus glycoprotein gp2; InterPro: IPR010278 This entry consists of a number of glycoprotein Gp2 sequences mainly found from equine herpesviruses [].; GO: 0016032 viral reproduction, 0016021 integral to membrane
Probab=28.67 E-value=4.9e+02 Score=24.33 Aligned_cols=66 Identities=20% Similarity=0.304 Sum_probs=37.7
Q ss_pred eeeeEee-cCCCCeeEEEEcCeeccCCcccCccceEEEeeCCc-eeeeeeEEEecCCCCCCeEEEEEEecC
Q psy1672 273 TVVCRVD-SIPPAAISWYWNGRLLLNNTAFSSYQRIFVIEQGE-YERKSSLVLTNAQESDSGRFYCVAENR 341 (600)
Q Consensus 273 ~L~C~v~-g~P~p~i~W~~~g~~l~~~~~~~~~~~~~~~~~g~-~~~~s~L~I~~v~~~d~G~Y~C~a~N~ 341 (600)
.-.|... -...|.|+|......+.+... .+..+-.+.|. ..-.+.+.+......++-.|.|.+.-.
T Consensus 111 rAvCitseL~s~PtitWsVgs~rl~n~gf---tqtwy~iqPGvCgilrS~v~~~R~~G~~~~~y~c~~~~~ 178 (226)
T PF05955_consen 111 RAVCITSELVSQPTITWSVGSDRLRNDGF---TQTWYGIQPGVCGILRSEVRIPRAEGRDNVDYLCEIRAL 178 (226)
T ss_pred EEEEeeccccCCCeEEEEeccceeecCCc---cceeecccCcceeeEeeeeecccCCCCCcccEEeccccc
Confidence 3457665 456789999985544443320 11111111221 112456778888888888999987754
No 376
>PF05393 Hum_adeno_E3A: Human adenovirus early E3A glycoprotein; InterPro: IPR008652 This family consists of several early glycoproteins (E3A), from human adenovirus type 2.; GO: 0016021 integral to membrane
Probab=27.82 E-value=1.8e+02 Score=23.78 Aligned_cols=19 Identities=21% Similarity=0.434 Sum_probs=11.2
Q ss_pred HHHHHHHHHHHHHhHhcCC
Q psy1672 378 LIILILIIIIYLLIRMRTI 396 (600)
Q Consensus 378 ~l~lillii~~~~~rkrr~ 396 (600)
+++++++.+.++..|||..
T Consensus 44 Fil~VilwfvCC~kRkrsR 62 (94)
T PF05393_consen 44 FILLVILWFVCCKKRKRSR 62 (94)
T ss_pred HHHHHHHHHHHHHHhhhcc
Confidence 3444445556677888744
No 377
>PF00558 Vpu: Vpu protein; InterPro: IPR008187 The Human immunodeficiency virus 1 (HIV-1) Vpu protein acts in the degradation of CD4 in the endoplasmic reticulum and in the enhancement of virion release from the plasma membrane of infected cells [].; GO: 0019076 release of virus from host; PDB: 2JPX_A 1PI8_A 2GOH_A 2GOF_A 1PI7_A 1PJE_A 1VPU_A 2K7Y_A.
Probab=27.58 E-value=76 Score=25.58 Aligned_cols=13 Identities=38% Similarity=0.358 Sum_probs=4.8
Q ss_pred hhHHHHHHHHHHH
Q psy1672 368 INGISLALFFLII 380 (600)
Q Consensus 368 i~gi~~g~~l~l~ 380 (600)
++++++.++++++
T Consensus 6 i~~iialiv~~ii 18 (81)
T PF00558_consen 6 ILAIIALIVALII 18 (81)
T ss_dssp --HHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 4455444444333
No 378
>PF15096 G6B: G6B family
Probab=26.95 E-value=1.5e+02 Score=27.80 Aligned_cols=26 Identities=27% Similarity=0.552 Sum_probs=17.6
Q ss_pred CCCCCeEEEEEEecCCCceeEEEEEEEEE
Q psy1672 327 QESDSGRFYCVAENRAGIADANFTLQVTY 355 (600)
Q Consensus 327 ~~~d~G~Y~C~a~N~~G~~~~~v~L~V~~ 355 (600)
...|+|+|.|..... .+....|+|..
T Consensus 82 s~GDSGTFfCkGr~e---~ESRT~LhVLG 107 (224)
T PF15096_consen 82 SAGDSGTFFCKGRQE---EESRTVLHVLG 107 (224)
T ss_pred hcCCccceEecCccc---ccceeeeeeec
Confidence 467999999984432 34456677754
No 379
>KOG4341|consensus
Probab=26.61 E-value=38 Score=36.02 Aligned_cols=134 Identities=20% Similarity=0.127 Sum_probs=82.1
Q ss_pred CCCCccEEEeecccC-cccCccc-cCCCCCccEEEccCCC-CCCCCccc-cCCCCCCCEEEccCCCCCccC--cccccCC
Q psy1672 73 GLLNLQKLFLARCHI-GQIDSGA-LDGLTNLIEIDLSDNL-LTSIPSLT-FQSVRFLRDLNLARNPISKIE--KGAFQFV 146 (600)
Q Consensus 73 ~l~~L~~L~L~~n~l-~~i~~~~-f~~l~~L~~L~Ls~N~-l~~l~~~~-f~~l~~L~~L~Ls~N~i~~l~--~~~~~~l 146 (600)
++..|+.|+.+++.- +...-.+ -.+..+|+.|-|+.++ ++..--.. -.+.+.|+.+++..+...... ...-.++
T Consensus 292 ~c~~lq~l~~s~~t~~~d~~l~aLg~~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~~~~d~tL~sls~~C 371 (483)
T KOG4341|consen 292 GCHALQVLCYSSCTDITDEVLWALGQHCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECGLITDGTLASLSRNC 371 (483)
T ss_pred hhhHhhhhcccCCCCCchHHHHHHhcCCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccceehhhhHhhhccCC
Confidence 688999999988743 2221111 2466899999998885 33221111 134577999999887543221 1122367
Q ss_pred CCcceeeCCCCcCc-ccC----hhhhcCCCCCCEEEcCCCcCCC-CCcccccccccccEEEccCCc
Q psy1672 147 PGLVKLDMSESRLE-HIS----PEAFTGAKSLESIKLNGNRLSH-FPVRSVEPLLKLMMIELHDNP 206 (600)
Q Consensus 147 ~~L~~L~Ls~n~l~-~i~----~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~~l~~L~~L~l~~N~ 206 (600)
+.|+.|.|+++.+. +.. ...-..+..|..|.|+++.+.. -....+..+++|+.+++-+..
T Consensus 372 ~~lr~lslshce~itD~gi~~l~~~~c~~~~l~~lEL~n~p~i~d~~Le~l~~c~~Leri~l~~~q 437 (483)
T KOG4341|consen 372 PRLRVLSLSHCELITDEGIRHLSSSSCSLEGLEVLELDNCPLITDATLEHLSICRNLERIELIDCQ 437 (483)
T ss_pred chhccCChhhhhhhhhhhhhhhhhccccccccceeeecCCCCchHHHHHHHhhCcccceeeeechh
Confidence 88999999977532 221 1122356788899999886653 223445566788888776543
No 380
>PF14851 FAM176: FAM176 family
Probab=25.82 E-value=1.7e+02 Score=26.68 Aligned_cols=20 Identities=10% Similarity=0.095 Sum_probs=10.2
Q ss_pred hHHHHHHHHHHHHHHHHHHH
Q psy1672 369 NGISLALFFLIILILIIIIY 388 (600)
Q Consensus 369 ~gi~~g~~l~l~lillii~~ 388 (600)
.-.+.|+++++++.+.+++.
T Consensus 24 LYFv~gVC~GLlLtLcllV~ 43 (153)
T PF14851_consen 24 LYFVSGVCAGLLLTLCLLVI 43 (153)
T ss_pred HHHHHHHHHHHHHHHHHHHh
Confidence 33455665555555444433
No 381
>PF05454 DAG1: Dystroglycan (Dystrophin-associated glycoprotein 1); InterPro: IPR008465 Dystroglycan is one of the dystrophin-associated glycoproteins, which is encoded by a 5.5 kb transcript in Homo sapiens. The protein product is cleaved into two non-covalently associated subunits, [alpha] (N-terminal) and [beta] (C-terminal). In skeletal muscle the dystroglycan complex works as a transmembrane linkage between the extracellular matrix and the cytoskeleton [alpha]-dystroglycan is extracellular and binds to merosin ([alpha]-2 laminin) in the basement membrane, while [beta]-dystroglycan is a transmembrane protein and binds to dystrophin, which is a large rod-like cytoskeletal protein, absent in Duchenne muscular dystrophy patients. Dystrophin binds to intracellular actin cables. In this way, the dystroglycan complex, which links the extracellular matrix to the intracellular actin cables, is thought to provide structural integrity in muscle tissues. The dystroglycan complex is also known to serve as an agrin receptor in muscle, where it may regulate agrin-induced acetylcholine receptor clustering at the neuromuscular junction. There is also evidence which suggests the function of dystroglycan as a part of the signal transduction pathway because it is shown that Grb2, a mediator of the Ras-related signal pathway, can interact with the cytoplasmic domain of dystroglycan. In general, aberrant expression of dystrophin-associated protein complex underlies the pathogenesis of Duchenne muscular dystrophy, Becker muscular dystrophy and severe childhood autosomal recessive muscular dystrophy. Interestingly, no genetic disease has been described for either [alpha]- or [beta]-dystroglycan. Dystroglycan is widely distributed in non-muscle tissues as well as in muscle tissues. During epithelial morphogenesis of kidney, the dystroglycan complex is shown to act as a receptor for the basement membrane. Dystroglycan expression in Mus musculus brain and neural retina has also been reported. However, the physiological role of dystroglycan in non-muscle tissues has remained unclear [].; PDB: 1EG4_P.
Probab=25.22 E-value=24 Score=35.86 Aligned_cols=34 Identities=24% Similarity=0.308 Sum_probs=0.0
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHhHhcCCCCCC
Q psy1672 367 HINGISLALFFLIILILIIIIYLLIRMRTITYPN 400 (600)
Q Consensus 367 ~i~gi~~g~~l~l~lillii~~~~~rkrr~~~~~ 400 (600)
+|.+++++++++++.+++.+.|..+|+-|....+
T Consensus 149 ~IpaVVI~~iLLIA~iIa~icyrrkR~GK~~~ee 182 (290)
T PF05454_consen 149 FIPAVVIAAILLIAGIIACICYRRKRKGKMSLEE 182 (290)
T ss_dssp ----------------------------------
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhhhhccccccch
Confidence 5667778888888888888899999999988743
No 382
>KOG4433|consensus
Probab=23.85 E-value=1.2e+02 Score=32.86 Aligned_cols=26 Identities=8% Similarity=0.034 Sum_probs=13.8
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHh
Q psy1672 366 GHINGISLALFFLIILILIIIIYLLI 391 (600)
Q Consensus 366 ~~i~gi~~g~~l~l~lillii~~~~~ 391 (600)
..++|.++|+++++.++.++++.+++
T Consensus 43 L~lla~l~aa~l~l~Ll~ll~yli~~ 68 (526)
T KOG4433|consen 43 LLLLAALAAACLGLSLLFLLFYLICR 68 (526)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 35566666665655555544443333
No 383
>PF11007 CotJA: Spore coat associated protein JA (CotJA); InterPro: IPR020256 cotJA is part of the cotJ operon, which encodes spore coat proteins. Interaction of CotJA with CotJC is required for the assembly of both CotJA and CotJC into the spore coat [].
Probab=23.78 E-value=40 Score=22.65 Aligned_cols=17 Identities=47% Similarity=0.724 Sum_probs=13.6
Q ss_pred eeccCCCCCCchhHHHH
Q psy1672 565 VWQRGVPVLPPVNALKR 581 (600)
Q Consensus 565 ~~~~~~~~~~~~~~~~~ 581 (600)
=||+=.++.+|-.||||
T Consensus 9 p~Q~~~~~y~~~eaL~~ 25 (36)
T PF11007_consen 9 PFQPWEPIYPPEEALKR 25 (36)
T ss_pred ccCCCCCCcCHHHHHhc
Confidence 48883389999999987
No 384
>PF07010 Endomucin: Endomucin; InterPro: IPR010740 This family consists of several mammalian endomucin proteins. Endomucin is an early endothelial-specific antigen that is also expressed on putative hematopoietic progenitor cells.
Probab=23.39 E-value=1.7e+02 Score=28.42 Aligned_cols=15 Identities=7% Similarity=0.122 Sum_probs=7.6
Q ss_pred HHHHHHHHHhHhcCC
Q psy1672 382 ILIIIIYLLIRMRTI 396 (600)
Q Consensus 382 illii~~~~~rkrr~ 396 (600)
++++.+|.++||+--
T Consensus 205 f~LvgLyr~C~k~dP 219 (259)
T PF07010_consen 205 FTLVGLYRMCWKTDP 219 (259)
T ss_pred HHHHHHHHHhhcCCC
Confidence 344445555566543
No 385
>PHA03376 BARF1; Provisional
Probab=23.21 E-value=2.6e+02 Score=26.63 Aligned_cols=70 Identities=20% Similarity=0.290 Sum_probs=38.3
Q ss_pred ccceeeeEeecCCCCeeEEEEcCe-eccCCcccCccceEEEeeCCceeeeeeEEEecCCCCCCeEEEEEEecCCCce
Q psy1672 270 ENATVVCRVDSIPPAAISWYWNGR-LLLNNTAFSSYQRIFVIEQGEYERKSSLVLTNAQESDSGRFYCVAENRAGIA 345 (600)
Q Consensus 270 ~~v~L~C~v~g~P~p~i~W~~~g~-~l~~~~~~~~~~~~~~~~~g~~~~~s~L~I~~v~~~d~G~Y~C~a~N~~G~~ 345 (600)
...++.|.+.|.|.|.++|.-+.. ....... .+...-..+|......-|.+...+.- ..+|+.+|..-..
T Consensus 140 ~~~~i~C~sggfP~P~~~Wle~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 210 (221)
T PHA03376 140 SVLTVTCTVNAFPHPHVQWLMPEGVEPAPTAA---NGGVMKEKDGSLSVAVDLSLPKPWHL---PVTCVGKNDKEEA 210 (221)
T ss_pred CeeEEEEecCCcCCchheeccccCCCCCCccc---cCceeecCCCcEEEEEEeecCCCccC---ceEEeccCchhhh
Confidence 455788998899999999987432 1111110 11222222332222233445555532 5899999875433
No 386
>PRK14750 kdpF potassium-transporting ATPase subunit F; Provisional
Probab=22.90 E-value=1.7e+02 Score=18.51 Aligned_cols=8 Identities=13% Similarity=0.218 Sum_probs=3.5
Q ss_pred HHHHHHHH
Q psy1672 370 GISLALFF 377 (600)
Q Consensus 370 gi~~g~~l 377 (600)
+++.|+++
T Consensus 4 ~vi~g~ll 11 (29)
T PRK14750 4 SIVCGALL 11 (29)
T ss_pred HHHHHHHH
Confidence 44444433
No 387
>PRK09801 transcriptional activator TtdR; Provisional
Probab=22.13 E-value=61 Score=33.12 Aligned_cols=32 Identities=28% Similarity=0.400 Sum_probs=24.7
Q ss_pred eeeeeccCCCCCCchhHHHHhh------cCCCCCCccc
Q psy1672 562 TLRVWQRGVPVLPPVNALKRVL------SRGSPDEGYQ 593 (600)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~ 593 (600)
.--||.+.-+.=|.+.++.+.+ .-+-||||||
T Consensus 271 ~~lv~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~~~ 308 (310)
T PRK09801 271 IWAVYREPLYRSMKLRVCVEFLAAWCQQRLGKPDEGYQ 308 (310)
T ss_pred EEEEEcCCCcCCHHHHHHHHHHHHHHHHhcCCCCcccc
Confidence 3448888888777787777766 4478999999
No 388
>PF03381 CDC50: LEM3 (ligand-effect modulator 3) family / CDC50 family; InterPro: IPR005045 Members of this family have no known function. They have predicted transmembrane helices.; GO: 0016020 membrane
Probab=21.40 E-value=4.2e+02 Score=26.81 Aligned_cols=13 Identities=15% Similarity=0.194 Sum_probs=8.2
Q ss_pred CCeEEEEEEecCC
Q psy1672 330 DSGRFYCVAENRA 342 (600)
Q Consensus 330 d~G~Y~C~a~N~~ 342 (600)
..|.|+-.+.|..
T Consensus 207 ~~G~y~i~I~nny 219 (278)
T PF03381_consen 207 PAGNYTIDITNNY 219 (278)
T ss_pred CCceEEEEEEEee
Confidence 3466777776655
Done!